10-K
YEAR ENDING 12.31.2016
Owens-Illinois, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-K
(Mark One)
(cid:2) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5)(cid:9)(cid:10)(cid:11)(cid:12)(cid:13)(cid:5)(cid:14)(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)(cid:25)
or
(cid:3)
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
(cid:26)(cid:3)(cid:18)(cid:18)(cid:27)(cid:10)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)(cid:28)(cid:27)(cid:13)(cid:8)(cid:5)(cid:15)(cid:29)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:21)(cid:30)(cid:31)!"(cid:25)
OWENS-ILLINOIS, INC.
(Exact name of registrant as specified in its charter)
(cid:17)(cid:8)(cid:13)(cid:12)#(cid:12)(cid:4)(cid:8)
(State or other jurisdiction of
incorporation or organization)
%(cid:15)(cid:8)(cid:5)&(cid:27)(cid:11)(cid:7)(cid:12)(cid:8)(cid:13)(cid:5)%#(cid:8)(cid:15)(cid:10)(cid:5)’(cid:12)(cid:14)(cid:22)(cid:5)*(cid:8)(cid:4)(cid:4)(cid:14)(cid:10)(cid:19)(cid:29)(cid:4)+(cid:22)(cid:5)%(cid:7)(cid:27)(cid:3)
(Address of principal executive offices)
(cid:23)(cid:23)(cid:30)(cid:23)"$(cid:21)(cid:31)(cid:20)(cid:20)
(IRS Employer
Identification No.)
43551
(Zip Code)
Registrant’s telephone number, including area code: /!(cid:25)"6(cid:5)(cid:20)(cid:20)(cid:25)(cid:30)!(cid:24)(cid:24)(cid:24)
Securities registered pursuant to Section 12(b) of the Act:
7(cid:27)(cid:6)(cid:13)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)(cid:8)(cid:12)(cid:11)(cid:7)(cid:5)(cid:11)(cid:13)(cid:12)(cid:10)(cid:10)
Common Stock, $.01 par value
8(cid:12)(cid:18)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)(cid:8)(cid:12)(cid:11)(cid:7)(cid:5)(cid:8):(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)(cid:3)(cid:15)(cid:5)#(cid:7)(cid:27)(cid:11)(cid:7)(cid:5)(cid:4)(cid:8)+(cid:27)(cid:10)(cid:6)(cid:8)(cid:4)(cid:8)(cid:16)
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the
Securities Act. Yes (cid:2) No (cid:3)
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or
Section 15(d) of the Act. Yes (cid:3) No (cid:2)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that
the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past
90 days. Yes (cid:2) No (cid:3)
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate
Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files). Yes (cid:2) No (cid:3)
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405
of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. (cid:3)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer or a smaller reporting company. See the definitions of “ large accelerated filer,”
“accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer (cid:2)
Accelerated filer (cid:3)
Non-accelerated filer (cid:3)
(Do not check if a
smaller reporting company)
Smaller reporting company (cid:3)
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Act). Yes (cid:3) No (cid:2)
The aggregate market value (based on the consolidated tape closing price on June 30, 2016) of the
voting and non-voting common equity held by non-affiliates of Owens-Illinois, Inc. was approximately
$3,717,494,000. For the sole purpose of making this calculation, the term “non-affiliate” has been interpreted
to exclude directors and executive officers of the Company. Such interpretation is not intended to be, and
should not be construed to be, an admission by Owens-Illinois, Inc. or such directors or executive officers of the
Company that such directors and executive officers of the Company are “affiliates” of Owens-Illinois, Inc., as
that term is defined under the Securities Act of 1934.
The number of shares of common stock, $.01 par value of Owens-Illinois, Inc. outstanding as of
January 31, 2017 was 162,354,026.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Owens-Illinois, Inc. Proxy Statement for The Annual Meeting of Share Owners To Be Held
Thursday, May 11, 2017 (“Proxy Statement”) are incorporated by reference into Part III hereof.
TABLE OF GUARANTORS
;:(cid:12)(cid:11)(cid:6)(cid:5)8(cid:12)(cid:18)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)<(cid:8)+(cid:27)(cid:10)(cid:6)(cid:4)(cid:12)(cid:15)(cid:6)(cid:5)=(cid:10)(cid:5)>?(cid:8)(cid:11)(cid:27)(cid:9)(cid:8)(cid:16)(cid:5)@(cid:15)(cid:5)@(cid:6)(cid:10)(cid:5)(cid:26)(cid:7)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)
Owens-Illinois Group, Inc.
Owens-Brockway Packaging, Inc.
>(cid:6)(cid:12)(cid:6)(cid:8)J(cid:26)(cid:3)(cid:29)(cid:15)(cid:6)(cid:4)(cid:14)(cid:5)(cid:3)(cid:28)
@(cid:15)(cid:11)(cid:3)(cid:4)?(cid:3)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
or Organization
Delaware
Delaware
*(cid:4)(cid:27)(cid:18)(cid:12)(cid:4)(cid:14)
Standard
@(cid:15)(cid:16)(cid:29)(cid:10)(cid:6)(cid:4)(cid:27)(cid:12)(cid:13)
(cid:26)(cid:13)(cid:12)(cid:10)(cid:10)(cid:27)(cid:9)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
(cid:26)(cid:3)(cid:16)(cid:8)(cid:5)8(cid:29)(cid:18)(cid:19)(cid:8)(cid:4)
6719
6719
@QQ(cid:5);(cid:18)?(cid:13)(cid:3)(cid:14)(cid:8)(cid:8)
@(cid:16)(cid:8)(cid:15)(cid:6)(cid:27)(cid:9)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
8(cid:29)(cid:18)(cid:19)(cid:8)(cid:4)
34-1559348
34-1559346
The address, including zip code, and telephone number, of each additional registrant’s principal executive
office is One Michael Owens Way, Perrysburg, Ohio 43551; (567) 336-5000. These companies are listed as
guarantors of the debt securities of the registrant. The consolidating condensed financial statements of the
Company depicting separately its guarantor and non-guarantor subsidiaries are presented in the notes to the
consolidated financial statements. All of the equity securities of each of the guarantors set forth in the table
above are owned, either directly or indirectly, by Owens-Illinois, Inc.
TABLE OF CONTENTS
PART I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ITEM 1.
ITEM 1A.
ITEM 1B.
ITEM 2.
ITEM 3.
ITEM 4.
BUSINESS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
RISK FACTORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
UNRESOLVED STAFF COMMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PROPERTIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
LEGAL PROCEEDINGS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
MINE SAFETY DISCLOSURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART II . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ITEM 5.
ITEM 6.
ITEM 7.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED
SHARE OWNER MATTERS AND ISSUER PURCHASES OF
EQUITY SECURITIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SELECTED FINANCIAL DATA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS . . . . . . . . . . . . . . . . . . . . . .
ITEM 7A.
QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT
ITEM 8.
ITEM 9.
ITEM 9A.
ITEM 9B.
MARKET RISK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA . . . . . . . . . . . . . . .
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE . . . . . . . . . . . . . . . . . . . .
CONTROLS AND PROCEDURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OTHER INFORMATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART III . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE . .
EXECUTIVE COMPENSATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
ITEM 10.
ITEM 11.
ITEM 12.
1
1
8
16
17
19
19
20
20
22
24
44
47
102
102
105
106
106
106
MANAGEMENT AND RELATED STOCKHOLDER MATTERS . . . . . . . . . .
106
ITEM 13.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND
ITEM 14.
DIRECTOR INDEPENDENCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PRINCIPAL ACCOUNTANT FEES AND SERVICES . . . . . . . . . . . . . . . . . . . . . . .
PART IV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES . . . . . . . . . . . . . . . . .
FORM 10-K SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ITEM 15.
ITEM 16.
107
107
108
109
113
SIGNATURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
192
EXHIBITS
PART I
ITEM 1. BUSINESS
Z(cid:8)(cid:15)(cid:8)(cid:4)(cid:12)(cid:13)(cid:5)(cid:17)(cid:8)[(cid:8)(cid:13)(cid:3)?(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)\(cid:29)(cid:10)(cid:27)(cid:15)(cid:8)(cid:10)(cid:10)
Owens-Illinois, Inc. (the “Company”), through its subsidiaries, is the successor to a business established
in 1903. The Company is the largest manufacturer of glass containers in the world with 79 glass manufacturing
plants in 23 countries. It competes in the glass container segment of the rigid packaging market and is the
leading glass container manufacturer in most of the countries where it has manufacturing facilities.
(cid:26)(cid:3)(cid:18)?(cid:12)(cid:15)(cid:14)(cid:5)>(cid:6)(cid:4)(cid:12)(cid:6)(cid:8)+(cid:14)
The Company’s strategy is to provide innovative and competitive packaging solutions for the world’s
leading food and beverage companies. The Company’s goal is to enhance shareholder value and enable the
future success of its customers and employees. The Company is employing a strategic plan to realize its goals
and vision including:
• 7(cid:3)(cid:5)(cid:19)(cid:8)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5)?(cid:4)(cid:8)(cid:28)(cid:8)(cid:4)(cid:4)(cid:8)(cid:16)(cid:5)(cid:10)(cid:29)??(cid:13)(cid:27)(cid:8)(cid:4)(cid:5)(cid:28)(cid:3)(cid:4)(cid:5)+(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)?(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:5)(cid:27)(cid:15)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5)+(cid:13)(cid:3)(cid:19)(cid:12)(cid:13)(cid:5)(cid:28)(cid:3)(cid:3)(cid:16)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:19)(cid:8)[(cid:8)(cid:4)(cid:12)+(cid:8)(cid:5)(cid:27)(cid:15)(cid:16)(cid:29)(cid:10)(cid:6)(cid:4)(cid:14) by
significantly improving the customer experience; aligning its activity with customers’ value; improving
quality and flexibility; and improving innovation and speed of commercialization; as well as increasing
sales, marketing, end-to-end supply chain capabilities and talent;
• 7(cid:3)(cid:5)(cid:19)(cid:8)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5)(cid:18)(cid:3)(cid:10)(cid:6)(cid:5)(cid:11)(cid:3)(cid:10)(cid:6)(cid:5)(cid:8)(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:27)[(cid:8)(cid:5)+(cid:13)(cid:3)(cid:19)(cid:12)(cid:13)(cid:5)+(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)?(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:5)?(cid:4)(cid:3)(cid:16)(cid:29)(cid:11)(cid:8)(cid:4)(cid:5)by ensuring asset stability and total
systems cost management; increasing efficiency, leveraging automation, and improving quality;
cultivating game changing concepts that create new competitive advantages; and focusing on
continuous improvement; and
• 7(cid:3)(cid:5)(cid:8):?(cid:12)(cid:15)(cid:16)(cid:5)(cid:27)(cid:6)(cid:10)(cid:5)(cid:19)(cid:29)(cid:10)(cid:27)(cid:15)(cid:8)(cid:10)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:12)(cid:6)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:8)(cid:22)(cid:5)+(cid:4)(cid:3)#(cid:27)(cid:15)+(cid:5)(cid:18)(cid:12)(cid:4)](cid:8)(cid:6)(cid:10)(cid:5)by growing with strategic customers;
expanding into attractive new markets; and evaluating expansion into the value chain.
The Company will achieve these ambitions by working together as One Team, One Enterprise, with One Plan.
<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:12)(cid:19)(cid:13)(cid:8)(cid:5)>(cid:8)+(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
The Company has four reportable segments based on its geographic locations: Europe, North America,
Latin America and Asia Pacific. In connection with the Company’s acquisition (the “Vitro Acquisition”) of
the food and beverage glass container business of Vitro S.A.B. de C.V. and its subsidiaries as conducted in the
United States, Mexico and Bolivia (the “Vitro Business”) on September 1, 2015, the Company has renamed the
former South America segment to the Latin America segment. Information as to sales, earnings from continuing
operations before interest expense (net), and provision for income taxes and excluding amounts related to
certain items that management considers not representative of ongoing operations (“segment operating profit”),
and total assets by reportable segment is included in Note 2 to the Consolidated Financial Statements.
*(cid:4)(cid:3)(cid:16)(cid:29)(cid:11)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)>(cid:8)(cid:4)[(cid:27)(cid:11)(cid:8)(cid:10)
The Company produces glass containers for alcoholic beverages, including beer, flavored malt beverages,
spirits and wine. The Company also produces glass packaging for a variety of food items, soft drinks, teas,
juices and pharmaceuticals. The Company manufactures glass containers in a wide range of sizes, shapes and
colors and is active in new product development and glass container innovation.
(cid:26)(cid:29)(cid:10)(cid:6)(cid:3)(cid:18)(cid:8)(cid:4)(cid:10)
In most of the countries where the Company competes, it has the leading position in the glass container
segment of the rigid packaging market based on sales revenue. The Company’s largest customers consist mainly
1
of the leading global food and beverage manufacturers, including (in alphabetical order) Anheuser-Busch InBev,
Carlsberg, Coca-Cola, Constellation, Diageo, Heineken, MillerCoors, Nestle, PepsiCo and Pernod Ricard. No
customer represents more than 10% of the Company’s consolidated net sales.
The Company sells most of its glass container products directly to customers under annual or multi-year
supply agreements. Multi-year contracts typically provide for price adjustments based on cost changes. The
Company also sells some of its products through distributors. Many customers provide the Company with
regular estimates of their product needs, which enables the Company to schedule glass container production to
maintain reasonable levels of inventory. Glass container manufacturing facilities are generally located in close
proximity to customers.
&(cid:12)(cid:4)](cid:8)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:8)(cid:6)(cid:27)(cid:6)(cid:27)[(cid:8)(cid:5)(cid:26)(cid:3)(cid:15)(cid:16)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
The Company’s principal markets for glass container products are in Europe, North America, Latin
America and Asia Pacific.
Europe. The Company has a leading share of the glass container segment of the rigid packaging market in
the European countries in which it operates, with 35 glass container manufacturing plants located in the Czech
Republic, Estonia, France, Germany, Hungary, Italy, the Netherlands, Poland, Spain and the United Kingdom.
These plants primarily produce glass containers for the beer, wine, champagne, spirits, non-alcoholic beverages
and food markets in these countries. The Company also has interests in two joint ventures that manufacture
glass containers in Italy. Throughout Europe, the Company competes directly with a variety of glass container
manufacturers including Verallia, Ardagh Group, Vetropack, Vidrala and BA Vidro.
North America. The Company has 19 glass container manufacturing plants in the U.S. and Canada, and
an interest in a joint venture that manufactures glass containers in the U.S. Also, the Company has a distribution
facility used to import glass containers from its business in Mexico. The Company has the leading share of the
glass container segment of the U.S. rigid packaging market, based on sales revenue by domestic producers. The
principal glass container competitors in the U.S. are the Ardagh Group and Anchor Glass Container. Imports
from China, Mexico, Taiwan and other countries also compete in U.S. glass container segments. Additionally,
there are several major consumer packaged goods companies that self-manufacture glass containers.
Latin America. The Company has 17 glass manufacturing plants in Latin America, located in Argentina,
Bolivia, Brazil, Colombia, Ecuador, Mexico, and Peru. In 2015, the Company’s acquisition of the Vitro
Business included six plants. In Latin America, the Company maintains a diversified portfolio serving
several markets, including beer, non-alcoholic beverages, spirits, flavored malt beverages, wine, food and
pharmaceuticals. The region also has a large infrastructure for returnable/refillable glass containers. The
Company competes directly with Verallia in Brazil and Argentina, and does not believe that it competes with
any other large, multinational glass container manufacturers in the rest of the region.
Asia Pacific. The Company has eight glass container manufacturing plants in the Asia Pacific region,
located in Australia, China, Indonesia and New Zealand. It also has interests in joint venture operations in
China, Malaysia and Vietnam. In Asia Pacific, the Company primarily produces glass containers for the
beer, wine, food and non-alcoholic beverage markets. The Company competes directly with Orora Limited
in Australia, and does not believe that it competes with any other large, multinational glass container
manufacturers in the rest of the region. In China, the glass container segments of the packaging market are
regional and highly fragmented with a large number of local competitors.
In addition to competing with other large and well-established manufacturers in the glass container
segment, the Company competes in all regions with manufacturers of other forms of rigid packaging,
principally aluminum cans and plastic containers. Competition is based on quality, price, service, innovation
and the marketing attributes of the container. The principal competitors producing metal containers include
Ball Corporation, Crown Holdings, Inc., and Silgan Holdings Inc. The principal competitors producing
plastic containers include Amcor, Consolidated Container Holdings, LLC, Reynolds Group Holdings Limited,
Plastipak Packaging, Inc. and Silgan Holdings Inc. The Company also competes with manufacturers of
non-rigid packaging alternatives, including flexible pouches, aseptic cartons and bag-in-box containers.
2
The Company seeks to provide products and services to customers ranging from large multinationals
to small local breweries and wineries in a way that creates a competitive advantage for the Company. The
Company believes that it is often the glass container partner of choice because of its innovation and branding
capabilities, its global footprint and its expertise in manufacturing know-how and process technology.
>(cid:8)(cid:12)(cid:10)(cid:3)(cid:15)(cid:12)(cid:13)(cid:27)(cid:6)(cid:14)
Sales of many glass container products such as beer, beverages and food are seasonal. Shipments in the
U.S. and Europe are typically greater in the second and third quarters of the year, while shipments in the Asia
Pacific region are typically greater in the first and fourth quarters of the year, and shipments in Latin America
are typically greater the last three quarters of the year.
&(cid:12)(cid:15)(cid:29)(cid:28)(cid:12)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
The Company has 79 glass manufacturing plants. It constantly seeks to improve the productivity of these
operations through the systematic upgrading of production capabilities, sharing of best practices among plants
and effective training of employees.
The Company also provides engineering support for its glass manufacturing operations through facilities
located in the U.S., Australia, France, Poland, Colombia and Peru.
>(cid:29)??(cid:13)(cid:27)(cid:8)(cid:4)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)<(cid:12)#(cid:5)&(cid:12)(cid:6)(cid:8)(cid:4)(cid:27)(cid:12)(cid:13)(cid:10)
The primary raw materials used in the Company’s glass container operations are sand, soda ash, limestone
and recycled glass. Each of these materials, as well as the other raw materials used to manufacture glass
containers, has historically been available in adequate supply from multiple sources. One of the sources is a
soda ash mining operation in Wyoming in which the Company has a 25% interest.
;(cid:15)(cid:8)(cid:4)+(cid:14)
The Company’s glass container operations require a continuous supply of significant amounts of energy,
principally natural gas, fuel oil and electrical power. Adequate supplies of energy are generally available at all
of the Company’s manufacturing locations. Energy costs typically account for 10-20% of the Company’s total
manufacturing costs, depending on the cost of energy, the type of energy available, the factory location and the
particular energy requirements. The percentage of total cost related to energy can vary significantly because of
volatility in market prices, particularly for natural gas and fuel oil in volatile markets such as North America
and Europe.
In North America, more than 90% of the sales volume is represented by customer contracts that contain
provisions that pass the commodity price of natural gas to the customer, effectively reducing the North America
segment’s exposure to changing natural gas market prices.
In Europe and Asia Pacific, the Company enters into fixed price contracts for a significant amount of its
energy requirements. These contracts have terms that can range from one to three years. In Latin America,
the Company primarily enters into fixed price contracts for its energy requirements in most of the countries in
which it operates and the remaining energy requirements are subject to changing natural gas market prices and
economic impacts. These fixed price contracts typically have terms of one to five years, and generally include
annual price adjustments for inflation and for certain contracts price adjustments for foreign currency variation.
Also, in order to limit the effects of fluctuations in market prices for natural gas, the Company uses
commodity forward contracts related to its forecasted requirements. The objective of these forward contracts
is to reduce potential volatility in cash flows and expense due to changing market prices. The Company
continually evaluates the energy markets with respect to its forecasted energy requirements to optimize its use
of commodity forward contracts.
3
<(cid:8)(cid:10)(cid:8)(cid:12)(cid:4)(cid:11)(cid:7)(cid:22)(cid:5)(cid:17)(cid:8)[(cid:8)(cid:13)(cid:3)?(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5);(cid:15)+(cid:27)(cid:15)(cid:8)(cid:8)(cid:4)(cid:27)(cid:15)+
Research, development and engineering constitute important parts of the Company’s technical
activities. Expenditures for these activities were $65 million, $64 million and $63 million for 2016, 2015
and 2014, respectively. The Company primarily focuses on advancements in the areas of product innovation,
manufacturing process control, melting technology, automatic inspection, light-weighting and further
automation of manufacturing activities. The Company’s research and development activities are conducted at
its corporate facilities in Perrysburg, Ohio. During 2013, the Company completed the construction of a new
research and development facility at this location. This facility has enabled the Company to expand its research
and development capabilities.
The Company holds a large number of patents related to a wide variety of products and processes and has a
substantial number of patent applications pending. While the aggregate of the Company’s patents are of material
importance to its businesses, the Company does not consider that any patent or group of patents relating to
a particular product or process is of material importance when judged from the standpoint of any individual
segment or its businesses as a whole.
The Company has agreements to license its proprietary glass container technology and to provide technical
assistance to a limited number of companies around the world. These agreements cover areas related to
manufacturing and engineering assistance. The worldwide licensee network provides a stream of revenue to
help support the Company’s development activities. In 2016, 2015 and 2014, the Company earned $13 million,
$12 million and $12 million, respectively, in royalties and net technical assistance revenue.
>(cid:29)(cid:10)(cid:6)(cid:12)(cid:27)(cid:15)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:14)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5);(cid:15)[(cid:27)(cid:4)(cid:3)(cid:15)(cid:18)(cid:8)(cid:15)(cid:6)
The Company is committed to reducing the impact its products and operations have on the environment.
As part of this commitment, the Company has set targets for increasing the use of recycled glass in its
manufacturing process, while reducing energy consumption and carbon dioxide equivalent (“CO2”) emissions.
Specific actions taken by the Company include working with governments and other organizations to establish
and financially support recycling initiatives, partnering with other entities throughout the supply chain to
improve the effectiveness of recycling efforts, reducing the weight of glass packaging and investing in research
and development to reduce energy consumption in its manufacturing process. The Company invests in
technology and training to improve safety, reduce energy use, decrease emissions and increase the amount of
cullet, or recycled glass, used in the production process.
The Company’s worldwide operations, in addition to other companies within the industry, are subject
to extensive laws, ordinances, regulations and other legal requirements relating to environmental protection,
including legal requirements governing investigation and clean-up of contaminated properties as well as water
discharges, air emissions, waste management and workplace health and safety. The Company strives to abide by
and uphold such laws and regulations.
Glass Recycling and Bottle Deposits
The Company is an important contributor to recycling efforts worldwide and is among the largest users
of recycled glass containers. If sufficient high-quality recycled glass were available on a consistent basis, the
Company has the technology to make glass containers containing a high proportion of recycled glass. Using
recycled glass in the manufacturing process reduces energy costs and impacts the operating life and efficiency
of the glass melting furnaces.
In the U.S., Canada, Europe and elsewhere, government authorities have adopted or are considering legal
requirements that would mandate certain recycling rates, the use of recycled materials, or limitations on or
preferences for certain types of packaging. The Company believes that governments worldwide will continue to
develop and enact legal requirements around guiding customer and end-consumer packaging choices.
4
Sales of beverage containers are affected by governmental regulation of packaging, including deposit
laws and extended producer responsibility regulations. As of December 31, 2016, there were a number of U.S.
states, Canadian provinces and territories, European countries and Australian states with some form of incentive
for consumer returns of glass bottles in their law. The structure and enforcement of such laws and regulations
can impact the sales of beverage containers in a given jurisdiction. Such laws and regulations also impact the
availability of post-consumer recycled glass for the Company to use in container production.
A number of states and provinces have recently considered or are now considering laws and regulations
to encourage curbside, deposit and on-premise glass recycling. Although there is no clear trend in the direction
of these state and provincial laws and proposals, the Company believes that states and provinces, as well as
municipalities within those jurisdictions, will continue to adopt recycling laws, which will impact supplies of
recycled glass. As a large user of recycled glass for making new glass containers, the Company has an interest
in laws and regulations impacting supplies of such material in its markets.
Air Emissions
In Europe, the European Union Emissions Trading Scheme (“EUETS”) is in effect to facilitate emissions
reduction. The Company’s manufacturing facilities which operate in EU countries must restrict the volume
of their CO2 emissions to the level of their individually allocated emissions allowances as set by country
regulators. If the actual level of emissions for any facility exceeds its allocated allowance, additional allowances
can be bought to cover deficits; conversely, if the actual level of emissions for any facility is less than its
allocation, the excess allowances can be sold. The EUETS has not had a material effect on the Company’s
results to date. However, should the regulators significantly restrict the number of emissions allowances
available, it could have a material effect in the future.
In North America, the U.S. and Canada are engaged in significant legislative and regulatory activity
relating to CO2 emissions, at the federal, state and provincial levels of government. The U.S. Environmental
Protection Agency (“EPA”) regulates emissions of hazardous air pollutants under the Clean Air Act, which
grants the EPA authority to establish limits for certain air pollutants and to require compliance, levy penalties
and bring civil judicial action against violators. The structure and scope of the EPA’s CO2 regulations are
currently the subject of litigation and are expected to be the subject of federal legislative activity. The EPA
regulations, if preserved as proposed, could have a significant long-term impact on the Company’s U.S.
operations. The EPA also implemented the Cross-State Air Pollution Rule, which set stringent emissions limits
in many states starting in 2012. The state of California in the U.S., and the provinces of Quebec and Ontario in
Canada, have adopted cap-and-trade legislation aimed at reducing greenhouse gas emissions.
In Asia Pacific, the National Greenhouse and Energy Reporting Act 2007 commenced on July 1, 2008 in
Australia and established a mandatory reporting system for corporate greenhouse gas emissions and energy
production and consumption. In July 2014, the Australian government introduced the Emissions Reduction
Fund (“ERF”) which comprises an element to credit emissions reductions, a fund to purchase emissions
reductions and a safeguard mechanism. The ERF purchases the lowest cost abatement (in the form of Australian
carbon credit units) from a wide range of sources, providing an incentive to businesses, households and
landowners to proactively reduce their emissions, while the safeguard mechanism (effective from July 1,
2016) ensures that emissions reductions paid for through the crediting and purchasing elements of the ERF are
not offset by significant increases in emissions above business-as-usual levels elsewhere in the economy. An
emissions trading scheme has been in effect in New Zealand since 2008.
In Latin America, the Brazilian government passed a law in 2009 requiring companies to reduce the
level of greenhouse gas emissions by the year 2025. In the other Latin American countries, national and local
governments are considering proposals that would also impose regulations to reduce CO2 emissions.
The Company is unable to predict what environmental legal requirements may be adopted in the future.
However, the Company continually monitors its operations in relation to environmental impacts and invests
in environmentally friendly and emissions-reducing projects. As such, the Company has made significant
5
expenditures for environmental improvements at certain of its facilities over the last several years; however,
these expenditures did not have a material adverse effect on the Company’s results of operations or cash flows.
The Company is unable to predict the impact of future environmental legal requirements on its results of
operations or cash flows.
;(cid:18)?(cid:13)(cid:3)(cid:14)(cid:8)(cid:8)(cid:10)
The Company’s worldwide operations employed approximately 27,000 persons as of December 31,
2016. Approximately 74% of North American employees are hourly workers covered by collective
bargaining agreements. The principal collective bargaining agreement, which at December 31, 2016, covered
approximately 76% of the Company’s union-affiliated employees in North America, will expire on March 31,
2019. Approximately 86% of employees in Latin America are covered by collective bargaining agreements.
The majority of the hourly workers in Australia and New Zealand are also covered by collective bargaining
agreements. The collective bargaining agreements in Latin America, Australia and New Zealand have varying
terms and expiration dates. In Europe, a large number of the Company’s employees are employed in countries in
which employment laws provide greater bargaining or other rights to employees than the laws of the U.S. Such
employment rights require the Company to work collaboratively with the legal representatives of the employees
to effect any changes to labor arrangements. The Company considers its employee relations to be good and does
not anticipate any material work stoppages in the near term.
=[(cid:12)(cid:27)(cid:13)(cid:12)(cid:19)(cid:13)(cid:8)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
The Company’s website is www.o-i.com. The Company’s annual report on Form 10-K, quarterly reports
on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant
to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 can be obtained from this site at no cost.
The Company’s SEC filings are also available for reading and copying at the SEC’s Public Reference Room
at 100 F Street, NE, Washington, D.C. 20549. Information on the operation of the Public Reference Room
may be obtained by calling the SEC at 1-800-SEC-0330. The SEC also maintains a website at www.sec.
gov that contains reports, proxy and information statements, and other information regarding issuers that file
electronically with the SEC.
The Company’s Corporate Governance Guidelines, Global Code of Business Conduct and Ethics and the
charters of the Audit, Compensation, Nominating/Corporate Governance and Risk Oversight Committees are
also available on the “Investors” section of the Company’s website. Copies of these documents are available in
print to share owners upon request, addressed to the Corporate Secretary at the address above.
6
;:(cid:8)(cid:11)(cid:29)(cid:6)(cid:27)[(cid:8)(cid:5)%(cid:28)(cid:28)(cid:27)(cid:11)(cid:8)(cid:4)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5)<(cid:8)+(cid:27)(cid:10)(cid:6)(cid:4)(cid:12)(cid:15)(cid:6)
In the following table the Company sets forth certain information regarding those persons currently serving
as executive officers of Owens-Illinois, Inc. as of February 10, 2017.
8(cid:12)(cid:18)(cid:8)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)=+(cid:8)
Andres A. Lopez (54) . . . . .
Miguel Alvarez (52) . . . . . .
James W. Baehren (66) . . . .
Jan A. Bertsch (60) . . . . . . .
Tim Connors (42) . . . . . . . .
Sergio B. O. Galindo (49) . .
John A. Haudrich (49) . . . .
Paul A. Jarrell (54) . . . . . . .
Vitaliano Torno (58) . . . . . .
MaryBeth Wilkinson (44) . .
Position
Chief Executive Officer since January 1, 2016; President, Glass Containers and
Chief Operating Officer 2015; Vice President and President of O-I Americas
2014-2015; Vice President and President of O-I South America 2009-2014; Vice
President of Global Manufacturing and Engineering 2006-2009.
President, O-I Latin America since 2014; President, O-I Brazil 2010 – 2014.
Previously held leadership positions in Chile, Argentina and Ecuador for
Belcorp, a leading global beauty products company 2005 – 2010.
Senior Vice President of Corporate Development and Special Advisor to
the Chief Executive Office since 2017; Senior Vice President and General
Counsel 2003-2016; Senior Vice President Strategic Planning 2006-2012;
Chief Administrative Officer 2004-2006; Corporate Secretary 1998-2010; Vice
President and Director of Finance 2001-2003.
Chief Financial Officer and Senior Vice President since November 23, 2015.
Previously Executive Vice President and Chief Financial Officer for Sigma-
Aldrich, a life science and technology company, 2012 - 2015. Vice President,
Controller and Principal Accounting Officer at BorgWarner 2011 – 2012; Vice
President and Treasurer, 2009 - 2011.
President, O-I Asia Pacific since June 1, 2015; General Manager of O-I
Australia 2013 – 2015; Vice President of Finance, Asia Pacific 2011 – 2013;
Vice President of Strategic Planning and Business Development, North America
2010 – 2011.
President, O-I North America since June 1, 2015; Vice President and President
of O-I Asia Pacific 2012 - 2015; General Manager of O-I Colombia 2009- 2012.
Senior Vice President and Chief Strategy and Integration Officer since
November 20, 2015; Vice President and Acting Chief Financial Officer 2015;
Vice President Finance and Corporate Controller 2011 – 2015; Vice President of
Investor Relations 2009 – 2011.
Senior Vice President since 2011; Chief Administrative Officer since 2013;
Chief Human Resources Officer 2011- 2012. Previously Executive Vice
President and Chief Human Resources Officer for DSM, a life sciences and
materials company based in The Netherlands, 2009-2011; Vice President and
Director of Human Resources for ITT, a fluid technologies and engineered
products company, 2006-2009.
President, O-I Europe since January 1, 2016; Managing Director, O-I Europe
2015; Vice President, European countries 2013 – 2015; Vice President,
Marketing and sales, Europe 2010 - 2013.
Senior Vice President and General Counsel since 2017; Corporate Secretary
since 2016; Associate General Counsel 2013 – 2016; Assistant General Counsel
2010 – 2012. Previously Partner with a global law firm 2007 – 2010.
(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:12)(cid:13)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)(cid:12)(cid:19)(cid:3)(cid:29)(cid:6)(cid:5)(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:17)(cid:3)(cid:18)(cid:8)(cid:10)(cid:6)(cid:27)(cid:11)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
Information as to net sales, segment operating profit, and assets of the Company’s reportable segments is
included in Note 2 to the Consolidated Financial Statements.
7
ITEM 1A. RISK FACTORS
Asbestos-Related Liability—The Company has made, and will continue to make, substantial payments
to resolve claims of persons alleging exposure to asbestos-containing products and may need to record
additional charges in the future for estimated asbestos-related costs. These substantial payments have
affected and may continue to affect the Company’s cost of borrowing, its ability to pursue global or domestic
acquisitions, its ability to reinvest in its operations, and its ability to pay dividends.
The Company is a defendant in numerous lawsuits alleging bodily injury and death as a result of exposure
to asbestos. From 1948 to 1958, one of the Company’s former business units commercially produced and sold
approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material
containing asbestos. The Company exited the insulation business in April 1958. The typical asbestos personal
injury lawsuit alleges various theories of liability, including negligence, gross negligence and strict liability
and seeks compensatory, and in some cases, punitive damages, in various amounts (herein referred to as
“asbestos claims”).
Beginning with the initial liability of $975 million established in 1993, the Company has accrued a total
of approximately $4.9 billion through 2016, before insurance recoveries, for its asbestos-related liability. The
Company’s ability to estimate its liability has been significantly affected by, among other factors, the volatility
of asbestos-related litigation in the United States, the significant number of co-defendants that have filed for
bankruptcy, the inherent uncertainty of future disease incidence and claiming patterns against the Company, the
significant expansion of the defendants that are now sued in this litigation, and the continuing changes in the
extent to which these defendants participate in the resolution of cases in which the Company is also a defendant.
For many years, the Company has conducted a comprehensive legal review of its asbestos-related liabilities
and costs annually in connection with finalizing its annual results of operations. In May 2016, the Company
revised its method for estimating its asbestos-related liabilities in connection with finalizing and reporting its
restated results of operations for the three years ended December 31, 2015. Its revised method uses estimated
future claims filings provided by a third party consultant and the Company’s legal judgment regarding estimated
future indemnity and legal costs to develop a reasonable estimate of its total asbestos-related liabilities. The
revised methodology has led the Company to conclude that an asbestos liability of $692 million was required as
of December 31, 2016.
The Company continues to believe that its ultimate asbestos-related liability cannot be estimated with
certainty. As part of its future annual comprehensive legal reviews, the Company will review its estimate of
its total asbestos-related liability, unless significant changes in trends or new developments warrant an earlier
review. Such reviews may result in significant adjustments to the liability accrued at the time of the review.
The significant assumptions underlying the material components of the Company’s accrual are:
a) settlements will continue to be limited almost exclusively to claimants who were exposed to the
Company’s asbestos-containing insulation prior to its exit from that business in 1958;
b) claims will continue to be resolved primarily under the Company’s administrative claims agreements
or on terms comparable to those set forth in those agreements;
c)
the incidence of serious asbestos-related disease cases and claiming patterns against the Company for
such cases do not change materially;
d)
the Company is substantially able to defend itself successfully at trial and on appeal;
e)
the number and timing of additional co-defendant bankruptcies do not change significantly the assets
available to participate in the resolution of cases in which the Company is a defendant; and
f) co-defendants with substantial resources and assets continue to participate significantly in the
resolution of future asbestos lawsuits and claims.
8
The ultimate amount of distributions that may be required to fund the Company’s asbestos-related
payments cannot be estimated with certainty. Asbestos-related payments continue to be substantial and the
continued use of significant amounts of cash for asbestos-related costs has affected and may continue to affect
the Company’s cost of borrowing, its ability to pursue global or domestic acquisitions, its ability to reinvest in
its operations, and its ability to pay dividends.
Substantial Leverage—The Company’s indebtedness could adversely affect the Company’s financial health.
The Company has a significant amount of debt. As of December 31, 2016, the Company had approximately
$5.3 billion of total debt outstanding, a decrease from $5.6 billion at December 31, 2015.
The Company’s indebtedness could result in the following consequences:
•
•
Increased vulnerability to general adverse economic and industry conditions;
Increased vulnerability to interest rate increases for the portion of the debt under the secured
credit agreement;
• Require the Company to dedicate a substantial portion of cash flow from operations to payments
on indebtedness, thereby reducing the availability of cash flow to fund working capital,
capital expenditures, acquisitions, share repurchases, development efforts and other general
corporate purposes;
• Limit flexibility in planning for, or reacting to, changes in the Company’s business and the rigid
packaging market;
•
Place the Company at a competitive disadvantage relative to its competitors that have less debt; and
• Limit, along with the financial and other restrictive covenants in the documents governing
indebtedness, among other things, the Company’s ability to borrow additional funds.
Ability to Service Debt—To service its indebtedness, the Company will require a significant amount of cash.
The Company’s ability to generate cash and refinance certain indebtedness depends on many factors beyond
its control.
The Company’s ability to make payments on and to refinance its indebtedness and to fund working capital,
capital expenditures, acquisitions, development efforts and other general corporate purposes depends on its
ability to generate cash in the future. The Company has no assurance that it will generate sufficient cash flow
from operations, or that future borrowings will be available under the secured credit agreement, in an amount
sufficient to enable the Company to pay its indebtedness, or to fund other liquidity needs. If short term interest
rates increase, the Company’s debt service cost will increase because some of its debt is subject to short term
variable interest rates. At December 31, 2016, the Company’s debt subject to variable interest rates represented
approximately 34% of total debt.
The Company may need to refinance all or a portion of its indebtedness on or before maturity. If the
Company is unable to generate sufficient cash flow and is unable to refinance or extend outstanding borrowings
on commercially reasonable terms or at all, it may have to take one or more of the following actions:
• Reduce or delay capital expenditures planned for replacements, improvements and expansions;
•
Sell assets;
• Restructure debt; and/or
• Obtain additional debt or equity financing.
The Company can provide no assurance that it could affect or implement any of these alternatives on
satisfactory terms, if at all.
9
Debt Restrictions—The Company may not be able to finance future needs or adapt its business plans
to changes because of restrictions placed on it by the secured credit agreement and the indentures and
instruments governing other indebtedness.
The secured credit agreement, the indentures governing the senior debentures and notes, and certain of the
agreements governing other indebtedness contain affirmative and negative covenants that limit the ability of the
Company to take certain actions. For example, these indentures restrict, among other things, the ability of the
Company and its restricted subsidiaries to borrow money, pay dividends on, or redeem or repurchase its stock,
make investments, create liens, enter into certain transactions with affiliates and sell certain assets or merge
with or into other companies. These restrictions could adversely affect the Company’s ability to operate its
businesses and may limit its ability to take advantage of potential business opportunities as they arise.
Failure to comply with these or other covenants and restrictions contained in the secured credit agreement,
the indentures or agreements governing other indebtedness could result in a default under those agreements,
and the debt under those agreements, together with accrued interest, could then be declared immediately due
and payable. If a default occurs under the secured credit agreement, the Company could no longer request
borrowings under the secured credit agreement, and the lenders could cause all of the outstanding debt
obligations under such secured credit agreement to become due and payable, which would result in a default
under a number of other outstanding debt securities and could lead to an acceleration of obligations related
to these debt securities. A default under the secured credit agreement, indentures or agreements governing
other indebtedness could also lead to an acceleration of debt under other debt instruments that contain cross
acceleration or cross-default provisions.
Foreign Currency Exchange Rates—The Company is subject to the effects of fluctuations in foreign
currency exchange rates, which could adversely impact the Company’s financial results.
The Company’s reporting currency is the U.S. dollar. A significant portion of the Company’s net sales,
costs, assets and liabilities are denominated in currencies other than the U.S. dollar, primarily the Euro,
Brazilian real, Colombian peso, Mexican peso and Australian dollar. In its consolidated financial statements, the
Company remeasures transactions denominated in a currency other than the functional currency of the reporting
entity (e.g. soda ash purchases) and translates local currency financial results into U.S. dollars based on the
exchange rates prevailing during the reporting period. During times of a strengthening U.S. dollar, the reported
revenues and earnings of the Company’s international operations will be reduced because the local currencies
will translate into fewer U.S. dollars. This could have a material adverse effect on the Company’s financial
condition, results of operations and cash flows.
International Operations—The Company is subject to risks associated with operating in foreign countries.
The Company operates manufacturing and other facilities throughout the world. Net sales from non-U.S.
operations totaled approximately $4.6 billion, representing approximately 69% of the Company’s net sales
for the year ended December 31, 2016. As a result of its non-U.S. operations, the Company is subject to risks
associated with operating in foreign countries, including:
•
Political, social and economic instability;
• War, civil disturbance or acts of terrorism;
• Taking of property by nationalization or expropriation without fair compensation;
• Changes in governmental policies and regulations;
• Devaluations and fluctuations in currency exchange rates;
•
Fluctuations in currency exchange rates and other impacts resulting from the United Kingdom’s
referendum on withdrawal from the European Union;
10
•
•
Imposition of limitations on conversions of foreign currencies into dollars or remittance of dividends
and other payments by foreign subsidiaries;
Imposition or increase of withholding and other taxes on remittances and other payments by
foreign subsidiaries;
• Hyperinflation in certain foreign countries;
•
Impositions or increase of investment and other restrictions or requirements by foreign governments;
• Loss or non-renewal of treaties or other agreements with foreign tax authorities;
• Changes in tax laws, or the interpretation thereof, affecting foreign tax credits or tax deductions
relating to our non-U.S. earnings or operations; and
• Complying with the U.S. Foreign Corrupt Practices Act, which prohibits companies and their
intermediaries from engaging in bribery or other prohibited payments to foreign officials for the
purposes of obtaining or retaining business or gaining an unfair business advantage and requires
companies to maintain accurate books and records and internal controls.
The risks associated with operating in foreign countries may have a material adverse effect on operations.
Competition—The Company faces intense competition from other glass container producers, as well as
from makers of alternative forms of packaging. Competitive pressures could adversely affect the Company’s
financial health.
The Company is subject to significant competition from other glass container producers, as well as from
makers of alternative forms of packaging, such as aluminum cans and plastic containers. The Company also
competes with manufacturers of non-rigid packaging alternatives, including flexible pouches and aseptic
cartons, in serving the packaging needs of certain end-use markets, including juice customers. The Company
competes with each rigid packaging competitor on the basis of price, quality, service and the marketing and
functional attributes of the container. Advantages or disadvantages in any of these competitive factors may be
sufficient to cause the customer to consider changing suppliers and/or using an alternative form of packaging.
The adverse effects of consumer purchasing decisions may be more significant in periods of economic
downturn and may lead to longer term reductions in consumer spending on glass packaged products.
Pressures from competitors and producers of alternative forms of packaging have resulted in excess
capacity in certain countries in the past and have led to capacity adjustments and significant pricing pressures in
the rigid packaging market.
Lower Demand Levels—Changes in consumer preferences may have a material adverse effect on the
Company’s financial results.
Changes in consumer preferences for the food and beverages they consume can reduce demand for the
Company’s products. Because many of the Company’s products are used to package consumer goods, the
Company’s sales and profitability could be negatively impacted by changes in consumer preferences for those
products. Examples of changes in consumer preferences include, but are not limited to, lower sales of major
domestic beer brands and shifts from beer to wine or spirits that results in the use of fewer glass containers. In
periods of lower demand, the Company’s sales and production levels may decrease causing a material adverse
effect on the Company’s profitability.
High Energy Costs—Higher energy costs worldwide and interrupted power supplies may have a material
adverse effect on operations.
Electrical power, natural gas, and fuel oil are vital to the Company’s operations as it relies on a continuous
energy supply to conduct its business. Depending on the location and mix of energy sources, energy accounts
11
for 10% to 20% of total production costs. Substantial increases and volatility in energy costs could cause the
Company to experience a significant increase in operating costs, which may have a material adverse effect
on operations.
Global Economic Environment—The global credit, financial and economic environment could have a
material adverse effect on operations and financial condition.
The global credit, financial and economic environment could have a material adverse effect on operations,
including the following:
• Downturns in the business or financial condition of any of the Company’s customers or suppliers could
result in a loss of revenues or a disruption in the supply of raw materials;
• Tightening of credit in financial markets could reduce the Company’s ability, as well as the ability of
the Company’s customers and suppliers, to obtain future financing;
• Volatile market performance could affect the fair value of the Company’s pension assets and liabilities,
potentially requiring the Company to make significant additional contributions to its pension plans to
maintain prescribed funding levels;
• The deterioration of any of the lending parties under the Company’s revolving credit facility or the
creditworthiness of the counterparties to the Company’s derivative transactions could result in such
parties’ failure to satisfy their obligations under their arrangements with the Company; and
• A significant weakening of the Company’s financial position or results of operations could result in
noncompliance with the covenants under the Company’s indebtedness.
Business Integration Risks—The Company may not be able to effectively integrate additional businesses it
has acquired or will acquire in the future.
The Company’s ability to realize the anticipated benefits of the Vitro Acquisition will depend, to a large
extent, on its ability to integrate the two businesses. The combination of two independent businesses is a
complex, costly and time-consuming process and there can be no assurance that the Company will be able to
successfully integrate the Vitro Business into its business, or if such integration is successfully accomplished,
that such integration will not be more costly or take longer than presently contemplated. Integration of the Vitro
Acquisition may include various risks and uncertainties, including the factors discussed in the paragraph below.
If the Company cannot successfully integrate and manage the Vitro Business within a reasonable time following
the Vitro Acquisition, the Company may not be able to realize the potential and anticipated benefits of the Vitro
Acquisition, which could have a material adverse effect on the Company’s share price, business, cash flows,
results of operations and financial position.
The Company may also consider other strategic transactions, including acquisitions that will complement,
strengthen and enhance growth in its worldwide glass operations. The Company evaluates opportunities on a
preliminary basis from time to time, but these transactions may not advance beyond the preliminary stages or be
completed. Such acquisitions are subject to various risks and uncertainties, including:
• The inability to integrate effectively the operations, products, technologies and personnel of
the acquired companies (some of which are located in diverse geographic regions) and achieve
expected synergies;
• The potential disruption of existing business and diversion of management’s attention from
day-to-day operations;
• The inability to maintain uniform standards, controls, procedures and policies;
• The need or obligation to divest portions of the acquired companies;
12
• The potential impairment of relationships with customers;
• The potential failure to identify material problems and liabilities during due diligence review of
acquisition targets;
• The potential failure to obtain sufficient indemnification rights to fully offset possible liabilities
associated with acquired businesses; and
• The challenges associated with operating in new geographic regions.
In addition, the Company cannot make assurances that the integration and consolidation of newly acquired
businesses will achieve any anticipated cost savings and operating synergies.
Customer Consolidation—The continuing consolidation of the Company’s customer base may intensify
pricing pressures and have a material adverse effect on operations.
Many of the Company’s largest customers have acquired companies with similar or complementary
product lines. This consolidation has increased the concentration of the Company’s business with its largest
customers. In many cases, such consolidation has been accompanied by pressure from customers for lower
prices, reflecting the increase in the total volume of products purchased or the elimination of a price differential
between the acquiring customer and the company acquired. Increased pricing pressures from the Company’s
customers may have a material adverse effect on operations.
Operational Disruptions—Profitability could be affected by unanticipated operational disruptions.
The Company’s glass container manufacturing process is asset intensive and includes the use of large
furnaces and machines. The Company periodically experiences unanticipated disruptions to its assets and these
events can have an adverse effect on its business operations and profitability. The impacts of these operational
disruptions include, but are not limited to, higher maintenance, production changeover and shipping costs,
higher capital spending, as well as lower absorption of fixed costs during periods of extended downtime. The
Company maintains insurance policies in amounts and with coverage and deductibles that are reasonable and
in line with industry standards; however, this insurance coverage may not be adequate to protect the Company
from all liabilities and expenses that may arise.
Seasonality—Profitability could be affected by varied seasonal demands.
Due principally to the seasonal nature of the consumption of beer and other beverages, for which demand
is stronger during the summer months, sales of the Company’s products have varied and are expected to vary
by quarter. Shipments in the U.S. and Europe are typically greater in the second and third quarters of the
year, while shipments in the Asia Pacific region are typically greater in the first and fourth quarters of the
year, and shipments in Latin America are typically greater in the last three quarters of the year. Unseasonably
cool weather during peak demand periods can reduce demand for certain beverages packaged in the
Company’s containers.
Raw Materials—Profitability could be affected by the availability and cost of raw materials.
The raw materials that the Company uses have historically been available in adequate supply from multiple
sources. For certain raw materials, however, there may be temporary shortages due to weather or other factors,
including disruptions in supply caused by raw material transportation or production delays. These shortages, as
well as material volatility in the cost of any of the principal raw materials that the Company uses, may have a
material adverse effect on operations.
In addition, the Company purchases its soda ash raw materials in U.S. dollars in the Latin America and
Asia Pacific regions. Given fluctuations in foreign currency exchange rates, this may cause these regions to
experience inflationary or deflationary impacts to their raw material costs.
13
Environmental Risks—The Company is subject to various environmental legal requirements and may be
subject to new legal requirements in the future. These requirements may have a material adverse effect
on operations.
The Company’s operations and properties are subject to extensive laws, ordinances, regulations and other
legal requirements relating to environmental protection, including legal requirements governing investigation
and clean-up of contaminated properties as well as water discharges, air emissions, waste management and
workplace health and safety. Such legal requirements frequently change and vary among jurisdictions. The
Company’s operations and properties must comply with these legal requirements. These requirements may have
a material adverse effect on operations.
The Company has incurred, and expects to incur, costs for its operations to comply with environmental
legal requirements, and these costs could increase in the future. Many environmental legal requirements provide
for substantial fines, orders (including orders to cease operations), and criminal sanctions for violations. These
legal requirements may apply to conditions at properties that the Company presently or formerly owned or
operated, as well as at other properties for which the Company may be responsible, including those at which
wastes attributable to the Company were disposed. A significant order or judgment against the Company, the
loss of a significant permit or license or the imposition of a significant fine may have a material adverse effect
on operations.
A number of governmental authorities have enacted, or are considering enacting, legal requirements that
would mandate certain rates of recycling, the use of recycled materials and/or limitations on certain kinds of
packaging materials. In addition, some companies with packaging needs have responded to such developments
and/or perceived environmental concerns of consumers by using containers made in whole or in part of recycled
materials. Such developments may reduce the demand for some of the Company’s products and/or increase the
Company’s costs, which may have a material adverse effect on operations.
Taxes—Potential tax law and U.S. trade policy changes could adversely affect net income and cash flow.
The Company is subject to income tax in the numerous jurisdictions in which it operates. Increases in
income tax rates or other tax law changes, as well as ongoing audits by domestic and international authorities,
could reduce the Company’s net income and cash flow from affected jurisdictions. In particular, potential
tax law changes in the U.S. regarding the treatment of the Company’s unrepatriated non-U.S. earnings, the
deductibility of interest expense or the cost of materials imported from other countries could have a material
adverse effect on net income and cash flow. In addition, the Company’s products are subject to import and
excise duties and/or sales or value-added taxes in many jurisdictions in which it operates. Increases in these
indirect taxes could affect the affordability of the Company’s products and, therefore, reduce demand.
In addition, existing free trade laws and regulations, such as the North American Free Trade Agreement,
provide certain beneficial duties and tariffs for qualifying imports and exports, subject to compliance with
the applicable classification and other requirements. Changes in laws or policies governing the terms of
foreign trade, and in particular increased trade restrictions, tariffs or taxes on imports from countries where
the Company manufactures products, such as Mexico, could have a material adverse effect on its business and
financial results. Also, a government’s adoption of “buy national” policies or retaliation by another government
against such policies may affect the prices of and demand for the Company’s products and could have a
negative impact on the Company’s results of operations.
Labor Relations—Some of the Company’s employees are unionized or represented by workers’ councils.
The Company is party to a number of collective bargaining agreements with labor unions which at
December 31, 2016, covered approximately 74% of the Company’s employees in North America. The
principal collective bargaining agreement, which at December 31, 2016 covered approximately 76% of the
Company’s union-affiliated employees in North America, will expire on March 31, 2019. Approximately 86%
of employees in Latin America are covered by collective bargaining agreements. The majority of the hourly
14
workers in Australia and New Zealand are also covered by collective bargaining agreements. The collective
bargaining agreements in Latin America, Australia and New Zealand have varying terms and expiration dates.
Upon the expiration of any collective bargaining agreement, if the Company is unable to negotiate acceptable
contracts with labor unions, it could result in strikes by the affected workers and increased operating costs
as a result of higher wages or benefits paid to union members. In Europe, a large number of the Company’s
employees are employed in countries in which employment laws provide greater bargaining or other rights
to employees than the laws of the U.S. Such employment rights require the Company to work collaboratively
with the legal representatives of the employees to effect any changes to labor arrangements. For example, most
of the Company’s employees in Europe are represented by workers’ councils that must approve any changes
in conditions of employment, including salaries and benefits and staff changes, and may impede efforts to
restructure the Company’s workforce. In addition, if the Company’s employees were to engage in a strike
or other work stoppage, the Company could experience a significant disruption of operations and/or higher
ongoing labor costs, which may have a material adverse effect on operations.
Key Management and Personnel Retention—Failure to retain key management and personnel could have a
material adverse effect on operations.
The Company believes that its future success depends, in part, on its experienced management team and
certain key personnel. The loss of certain key management and personnel could limit the Company’s ability to
implement its business plans and meet its objectives.
Joint Ventures—Failure by joint venture partners to observe their obligations could have a material adverse
effect on operations.
A portion of the Company’s operations is conducted through joint ventures, including joint ventures in the
Europe, North America, Asia Pacific segments and in retained corporate costs and other. If the Company’s joint
venture partners do not observe their obligations or are unable to commit additional capital to the joint ventures,
it is possible that the affected joint venture would not be able to operate in accordance with its business plans,
which could have a material adverse effect on the Company’s financial condition and results of operations.
Cybersecurity and Information Technology—Security threats and the failure or disruption of the integrity
of the Company’s information technology, or those of third parties with which it does business, could have a
material adverse effect on its business and the results of operations.
The Company relies on information technology to operate its plants, to communicate with its employees,
customers and suppliers, to store sensitive business information and intellectual property, and to report financial
and operating results. As with all large systems, the Company’s information technology systems could fail on
their own accord or may be vulnerable to a variety of interruptions due to events, including, but not limited
to, natural disasters, terrorist attacks, telecommunications failures, cybersecurity vulnerabilities, threats and
more sophisticated and targeted cyber-related attacks. The Company’s disaster recovery programs and other
preventative measures may be unable to prevent the failure or disruption of the Company’s information
technology systems, which could result in transaction errors, loss of customers, business disruptions, or loss of
or damage to intellectual property and could have a material adverse effect on operations.
As cyberattacks on various organizations have increased, the Company’s information technology systems
may be subject to increased security threats. The Company’s measures in place to prevent and detect global
security threats may be unable to prevent certain security breaches. This may result in the loss of customers and
business opportunities, regulatory fines, penalties or intervention, reputational damage, reimbursement or other
compensatory costs, and additional compliance costs. Failure or disruption of these systems, or the back-up
systems, for any reason could disrupt the Company’s operations and negatively impact the Company’s cash
flows or financial condition.
15
Accounting Estimates—The Company’s financial results are based upon estimates and assumptions that may
differ from actual results.
In preparing the Company’s consolidated financial statements in accordance with U.S. generally accepted
accounting principles, several estimates and assumptions are made that affect the accounting for and recognition
of assets, liabilities, revenues and expenses. These estimates and assumptions must be made due to certain
information used in the preparation of the Company’s financial statements which is dependent on future events,
cannot be calculated with a high degree of precision from data available or is not capable of being readily
calculated based on generally accepted methodologies. The Company believes that accounting for long-lived
assets, pension benefit plans, contingencies and litigation, and income taxes involves the more significant
judgments and estimates used in the preparation of its consolidated financial statements. Actual results for all
estimates could differ materially from the estimates and assumptions that the Company uses, which could have
a material adverse effect on the Company’s financial condition and results of operations.
Accounting Standards—The adoption of new accounting standards or interpretations could adversely impact
the Company’s financial results.
New accounting standards or pronouncements could adversely affect the Company’s operating results or
cause unanticipated fluctuations in its results in future periods. The accounting rules and regulations that the
Company must comply with are complex and continually changing. In addition, many companies’ accounting
policies are being subjected to heightened scrutiny by regulators and the public. The Company cannot predict
the impact of future changes to accounting principles or its accounting policies on its financial statements
going forward.
Goodwill—A significant write down of goodwill would have a material adverse effect on the Company’s
reported results of operations and net worth.
Goodwill at December 31, 2016 totaled $2.5 billion. The Company evaluates goodwill annually (or more
frequently if impairment indicators arise) for impairment using the required business valuation methods. These
methods include the use of a weighted average cost of capital to calculate the present value of the expected
future cash flows of the Company’s reporting units. Future changes in the cost of capital, expected cash flows,
or other factors may cause the Company’s goodwill to be impaired, resulting in a non-cash charge against
results of operations to write down goodwill for the amount of the impairment. If a significant write down is
required, the charge would have a material adverse effect on the Company’s reported results of operations and
net worth.
Pension Funding—An increase in the underfunded status of the Company’s pension plans could adversely
impact the Company’s operations, financial condition and liquidity.
The Company contributed $38 million, $17 million and $28 million to its defined benefit pension plans
in 2016, 2015 and 2014, respectively. The amount the Company is required to contribute to these plans is
determined by the laws and regulations governing each plan, and is generally related to the funded status of the
plans. A deterioration in the value of the plans’ investments or a decrease in the discount rate used to calculate
plan liabilities generally would increase the underfunded status of the plans. An increase in the underfunded
status of the plans could result in an increase in the Company’s obligation to make contributions to the plans,
thereby reducing the cash available for working capital and other corporate uses, and may have an adverse
impact on the Company’s operations, financial condition and liquidity.
ITEM 1B. UNRESOLVED STAFF COMMENTS
None.
16
ITEM 2. PROPERTIES
The principal manufacturing facilities and other material important physical properties of the Company
at December 31, 2016 are listed below. All properties are glass container plants and are owned in fee, except
where otherwise noted.
North American Operations
United States
Atlanta, GA
Auburn, NY
Brockway, PA
Crenshaw, PA
Danville, VA
Kalama, WA
Lapel, IN
Los Angeles, CA
Muskogee, OK
Portland, OR
Streator, IL
Toano, VA
Tracy, CA
Waco, TX
Windsor, CO
Winston-Salem, NC
Zanesville, OH
Canada
Brampton, Ontario
Montreal, Quebec
Asia Pacific Operations
Australia
Adelaide
Brisbane
China
Tianjin
Indonesia
Jakarta
New Zealand
Auckland
European Operations
Czech Republic
Dubi
Estonia
Jarvakandi
France
Beziers
Gironcourt
Labegude
Puy-Guillaume
Reims
Melbourne
Sydney
Zhaoqing
Nove Sedlo
Vayres
Veauche
Vergeze
Wingles
17
Germany
Bernsdorf
Holzminden
Hungary
Oroshaza
Italy
Asti
Aprilia
Bari
Marsala
Mezzocorona
The Netherlands
Leerdam
Maastricht
Poland
Jaroslaw
Spain
Barcelona
United Kingdom
Alloa
Latin American Operations
Argentina
Rosario
Bolivia
Cochabamba
Brazil
Recife
Rio de Janeiro (glass container
and tableware)
Colombia
Buga (tableware)
Envigado
Ecuador
Guayaquil
Rinteln
Origgio
Ottaviano
San Gemini
San Polo
Villotta
Schiedam
Poznan
Sevilla
Harlow
Sao Paulo
Soacha
Zipaquira
18
Mexico
Guadalajara
Los Reyes
Monterrey
Peru
Callao
Other Operations
Engineering Support Centers
Brockway, Pennsylvania
Cali, Colombia
Hawthorn, Australia(1)
Jaroslaw, Poland
Shared Service Centers
Medellin, Colombia
Monterrey, Mexico
Distribution Center
Laredo, TX(1)
(cid:26)(cid:3)(cid:4)?(cid:3)(cid:4)(cid:12)(cid:6)(cid:8)(cid:5)(cid:2)(cid:12)(cid:11)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)
Hawthorn, Australia(1)
Miami, Florida(1)
Queretaro
Toluca
Lurin(1)
Lurin, Peru
Perrysburg, Ohio
Villeurbanne, France
`
Perrysburg, Ohio
Poznan, Poland(1)
Perrysburg, Ohio(1)
Vufflens-la-Ville, Switzerland(1)
(1) This facility is leased in whole or in part.
The Company believes that its facilities are well maintained and currently adequate for its planned
production requirements over the next three to five years.
ITEM 3. LEGAL PROCEEDINGS
For further information on legal proceedings, see Note 12 to the Consolidated Financial Statements.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
19
PART II
ITEM 5.
MARKET FOR REGISTRANT’S COMMON STOCK AND RELATED SHARE OWNER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
The price range for the Company’s common stock on the New York Stock Exchange, as reported by the
Financial Industry Regulatory Authority, Inc., was as follows:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
High
_(cid:3)#
High
_(cid:3)#
First Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 17.06 $ 12.06 $ 26.99 $ 22.85
22.94
Second Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19.42
Third Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16.94
Fourth Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
15.46
16.81
17.00
25.98
22.93
23.83
20.18
19.12
19.46
The number of share owners of record on December 31, 2016 was 1,118. Approximately 100% of the
outstanding shares were registered in the name of Depository Trust Company, or CEDE, which held such shares
on behalf of a number of brokerage firms, banks, and other financial institutions. The shares attributed to these
financial institutions, in turn, represented the interests of more than 29,228 unidentified beneficial owners. No
dividends have been declared or paid since the Company’s initial public offering in December 1991 and the
Company does not anticipate paying any dividends in the near future. For restrictions on payment of dividends
on the Company’s common stock, see Management’s Discussion and Analysis of Financial Condition and
Results of Operations—Capital Resources and Liquidity—Current and Long-Term Debt and Note 11 to the
Consolidated Financial Statements.
Information with respect to securities authorized for issuance under equity compensation plans is included
herein under Item 12.
The Company did not purchase any shares of its common stock for the twelve months ended
December 31, 2016. The Company has $380 million remaining for repurchases as of December 31, 2016
pursuant to authorization by its Board of Directors in October 2014 to purchase up to $500 million of the
Company’s common stock until December 31, 2017.
20
2011
2012
2013
2014
2015
(cid:23)(cid:24)(cid:21)(cid:25)
(cid:5)‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5);(cid:15)(cid:16)(cid:27)(cid:15)+(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
Owens-Illinois, Inc. . . . . . . . . . . . . . . . $ 100.00 $ 109.75 $ 184.62 $ 139.27 $ 89.89 $ 89.93
198.18
S&P 500 . . . . . . . . . . . . . . . . . . . . . . . .
179.43
Packaging Group . . . . . . . . . . . . . . . . . .
116.00
109.20
153.57
151.22
174.60
169.03
100.00
100.00
177.01
169.26
The above graph compares the performance of the Company’s Common Stock with that of a broad market
index (the S&P 500 Composite Index) and a packaging group consisting of companies with lines of business or
product end uses comparable to those of the Company for which market quotations are available.
The packaging group consists of: AptarGroup, Inc., Ball Corp., Bemis Company, Inc., Crown
Holdings, Inc., Owens-Illinois, Inc., Sealed Air Corp., Silgan Holdings Inc., and Sonoco Products Co. The
comparison of total return on investment for each period is based on the investment of $100 on December 31,
2011 and the change in market value of the stock, including additional shares assumed purchased through
reinvestment of dividends, if any.
21
@7;&(cid:5)(cid:25)Q(cid:5) >;_;(cid:26)7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)(cid:17)=7=
The selected consolidated financial data presented below relates to each of the four years in the period
ended December 31, 2016, which was derived from the audited consolidated financial statements of the
Company. The selected consolidated financial data for the year ended December 31, 2012 has been omitted
from this table because it was not practicable for the Company to present this financial information without
undue effort. This was due to the Company’s May 2016 restatement of its consolidated financial statements
for the years ended December 31, 2015, 2014 and 2013 in order to correct an error related to the Company’s
method for estimating its future asbestos-related liabilities.
Consolidated operating results(a):
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling and administrative, research, development
and engineering . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings before interest expense and items below . . . . . . .
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations before
income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net (earnings) attributable to noncontrolling interests . . . .
Net earnings attributable to the Company . . . . . . . . . . . . .
Basic earnings per share of common stock:
Earnings from continuing operations . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average shares outstanding (in thousands) . . . . .
Diluted earnings per share of common stock:
(cid:23)(cid:24)(cid:21)(cid:25)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)
2015
2014
/(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)6
2013
$
$
6,702
(5,490)
1,212
6,156
(5,046)
1,110
$
6,784
(5,531)
1,253
$
6,967
(5,636)
1,331
(568)
(16)
628
(272)
356
(119)
237
(7)
230
(21)
209
$
(540)
(51)
519
(251)
268
(106)
162
(4)
158
(23)
135
$
(586)
(130)
537
(230)
307
(92)
215
(23)
192
(28)
164
$
(568)
(66)
697
(229)
468
(120)
348
(18)
330
(13)
317
$
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
2013
$
1.33
(0.04)
$
1.29
161,857
$
0.86
(0.03)
$
0.83
161,169
$
1.14
(0.14)
$
1.00
164,720
$
2.03
(0.11)
$
1.92
164,425
Earnings from continuing operations . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted average shares (in thousands) . . . . . . . . . . . . . . . .
$
1.32
(0.04)
$
1.28
162,825
$
0.85
(0.03)
$
0.82
162,135
$
1.13
(0.14)
$
0.99
166,047
$
2.02
(0.11)
$
1.91
165,828
22
Other data:
The following are included in earnings from
continuing operations:
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of intangibles . . . . . . . . . . . . . . . . . . . . .
Amortization of deferred finance fees (included in
interest expense) . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance sheet data (at end of period):
Working capital (current assets less current liabilities)
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total share owners’ equity . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)
2015
2014
/(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)6
2013
$
$
$
375
103
13
194
9,135
5,328
363
$
$
$
323
86
15
212
9,421
5,573
279
$
$
$
335
83
30
43
7,843
3,445
771
$
$
350
47
32
296
8,393
3,541
1,010
(a) Note that the items below relate to items management considers not representative of ongoing operations.
(cid:26)(cid:3)(cid:10)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:3)(cid:3)(cid:16)(cid:10)(cid:5)(cid:10)(cid:3)(cid:13)(cid:16)
Pension settlement charges . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value inventory adjustments
Restructuring, asset impairment and related charges
>(cid:8)(cid:13)(cid:13)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:12)(cid:16)(cid:18)(cid:27)(cid:15)(cid:27)(cid:10)(cid:6)(cid:4)(cid:12)(cid:6)(cid:27)[(cid:8)(cid:22)(cid:5)(cid:4)(cid:8)(cid:10)(cid:8)(cid:12)(cid:4)(cid:11)(cid:7)(cid:22)(cid:5)(cid:16)(cid:8)[(cid:8)(cid:13)(cid:3)?(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)
and engineering
Pension settlement charges . . . . . . . . . . . . . . . . . . . .
%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:8):?(cid:8)(cid:15)(cid:10)(cid:8)(cid:22)(cid:5)(cid:15)(cid:8)(cid:6)
Restructuring, asset impairment and other charges . .
Gain related to cash received from the Chinese
government as compensation for land in China
that the Company was required to return to
the government . . . . . . . . . . . . . . . . . . . . . . . . .
Charge for asbestos-related costs . . . . . . . . . . . . . . .
Strategic transaction costs . . . . . . . . . . . . . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value intangible adjustments
Equity earnings related charges . . . . . . . . . . . . . . . .
@(cid:15)(cid:6)(cid:8)(cid:4)(cid:8)(cid:10)(cid:6)(cid:5)(cid:8):?(cid:8)(cid:15)(cid:10)(cid:8)(cid:22)(cid:5)(cid:15)(cid:8)(cid:6)
Note repurchase premiums and additional interest
charges for the write-off of unamortized
deferred financing fees related to the early
extinguishment of debt . . . . . . . . . . . . . . . . . . .
*(cid:4)(cid:3)[(cid:27)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)(cid:28)(cid:3)(cid:4)(cid:5)(cid:27)(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)(cid:6)(cid:12):(cid:8)(cid:10)
Net tax (benefit) expense for income tax on
items above . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax expense (benefit) recorded for certain
(cid:23)(cid:24)(cid:21)(cid:25)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)
2014
2015
/(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)6
2013
$
98
$
— $
22
50
$
—
8
15
78
46
69
5
119
12
42
20
11
(15)
(34
(14)
129
75
16
23
10
5
(71)
9
1
tax adjustments . . . . . . . . . . . . . . . . . . . . . . . . .
(8)
8
(8)
8(cid:8)(cid:6)(cid:5)(cid:8)(cid:12)(cid:4)(cid:15)(cid:27)(cid:15)+(cid:10)(cid:5)(cid:12)(cid:6)(cid:6)(cid:4)(cid:27)(cid:19)(cid:29)(cid:6)(cid:12)(cid:19)(cid:13)(cid:8)(cid:5)(cid:6)(cid:3)(cid:5)(cid:15)(cid:3)(cid:15)(cid:11)(cid:3)(cid:15)(cid:6)(cid:4)(cid:3)(cid:13)(cid:13)(cid:27)(cid:15)+(cid:5)(cid:27)(cid:15)(cid:6)(cid:8)(cid:4)(cid:8)(cid:10)(cid:6)
Net impact of noncontrolling interests on items above
2
160
$
$
186
$
249
$
(13)
115
23
@7;&(cid:5)"Q(cid:5)
(cid:5)&=8=Z;&;87b>(cid:5)(cid:17)@>(cid:26)c>>@%8(cid:5)=8(cid:17)(cid:5)=8=_‘>@>(cid:5)%(cid:2)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)(cid:26)%8(cid:17)@7@%8(cid:5)=8(cid:17)(cid:5)
RESULTS OF OPERATIONS
The Company’s measure of profit for its reportable segments is segment operating profit, which consists
of consolidated earnings from continuing operations before interest income, interest expense, and provision for
income taxes and excludes amounts related to certain items that management considers not representative of
ongoing operations as well as certain retained corporate costs. The segment data presented below is prepared in
accordance with general accounting principles for segment reporting. The line titled “reportable segment totals”,
however, is a non-GAAP measure when presented outside of the financial statement footnotes. Management
has included reportable segment totals below to facilitate the discussion and analysis of financial condition and
results of operations. The Company’s management uses segment operating profit, in combination with selected
cash flow information, to evaluate performance and to allocate resources.
Financial information regarding the Company’s reportable segments is as follows (dollars in millions):
Net sales:
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
North America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Latin America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reportable segment totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Segment operating profit:
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
North America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Latin America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reportable segment totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Items excluded from segment operating profit:
Retained corporate costs and other . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring, asset impairment and other related charges . . . . . . .
Pension settlement charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Charge for asbestos-related costs . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on China land sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Strategic transaction costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value inventory adjustments . . . . . . . . . . .
Acquisition-related fair value intangible adjustments . . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations before income taxes . . . . . . . . . .
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings attributable to noncontrolling interests . . . . . . . . . . . . . . .
Net earnings attributable to the Company . . . . . . . . . . . . . . . . . . . . . . .
Net earnings from continuing operations attributable to the Company . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
$
$
$
2,300
2,220
1,432
684
6,636
66
6,702
(cid:23)(cid:24)(cid:21)(cid:25)
237
299
269
77
882
(98)
(129)
(98)
71
(272)
356
(119)
237
(7)
230
(21)
209
216
$
$
$
$
$
2,324
2,039
1,064
671
6,098
58
6,156
2015
209
265
183
83
740
(70)
(80)
(16)
(23)
(22)
(10)
(251)
268
(106)
162
(4)
158
(23)
135
139
$
$
$
$
$
2,794
2,003
1,159
793
6,749
35
6,784
2014
353
240
227
88
908
(100)
(91)
(65)
(46)
(69)
(230)
307
(92)
215
(23)
192
(28)
164
187
Note: all amounts excluded from reportable segment totals are discussed in the following applicable sections.
24
;:(cid:8)(cid:11)(cid:29)(cid:6)(cid:27)[(cid:8)(cid:5)%[(cid:8)(cid:4)[(cid:27)(cid:8)#f(cid:26)(cid:3)(cid:18)?(cid:12)(cid:4)(cid:27)(cid:10)(cid:3)(cid:15)(cid:5)(cid:3)(cid:28)(cid:5)(cid:23)(cid:24)(cid:21)(cid:25)(cid:5)#(cid:27)(cid:6)(cid:7)(cid:5)(cid:23)(cid:24)(cid:21)!
2016 Highlights
• The September 1, 2015 Vitro Acquisition increased net sales by $608 million and segment operating
profit by $122 million in 2016 compared to 2015
• Net sales in 2016 were $6.7 billion, up 9% from the prior year, primarily due to incremental net sales
from the Vitro Acquisition. Excluding the acquisition, shipments were comparable in both periods
• Driven by the Vitro Acquisition and progress on strategic initiatives, segment operating profit was
higher in all regions, except for Asia Pacific, in 2016 compared to the prior year
•
Issued €500 million of senior notes due 2024 and repaid higher-cost floating-rate debt
Net sales increased by $546 million compared to the prior year primarily due to approximately $608
million of incremental net sales from the Vitro Acquisition and slightly higher pricing, partially offset by the
unfavorable effect of changes in foreign currency exchange rates and an unfavorable sales mix.
Segment operating profit for reportable segments increased by $142 million compared to the prior year. The
increase was largely attributable to approximately $122 million of incremental segment operating profit from
the acquired Vitro Business. Higher selling prices also increased segment operating profit. Partially offsetting
this was the unfavorable effect of changes in foreign currency exchange rates and higher operating costs due to
cost inflation.
Net interest expense in 2016 increased $21 million compared to 2015. Net interest expense included
$9 million and $42 million in 2016 and 2015, respectively, for note repurchase premiums and the write-off
of finance fees related to debt that was repaid prior to its maturity. Exclusive of these items, net interest
expense increased $54 million in the current year primarily due to higher debt levels associated with the
Vitro Acquisition.
For 2016, the Company recorded earnings from continuing operations attributable to the Company of $216
million, or $1.32 per share (diluted), compared with earnings of $139 million, or $0.85 per share (diluted),
for 2015. Earnings in both periods included items that management considered not representative of ongoing
operations. These items decreased earnings from continuing operations attributable to the Company by
$160 million, or $0.99 per share, in 2016 and $186 million, or $1.15 per share, in 2015.
Results of Operations—Comparison of 2016 with 2015
Net Sales
The Company’s net sales in 2016 were $6,702 million compared with $6,156 million in 2015, an increase
of $546 million, or 9%. Driven by incremental shipments related to the Vitro Acquisition, total glass container
shipments, in tonnes, were up approximately 9% in 2016 compared to 2015. The Vitro Acquisition resulted in
approximately $608 million of additional sales. Excluding the impact of the Vitro Acquisition, shipments in
2016 were comparable to 2015. On a global basis, sales volumes of beer, wine, spirits, food and non-alcoholic
beverages all grew year-on-year. However, an unfavorable sales mix resulted in $41 million of lower net sales in
2016. Net sales also benefited from $79 million in higher selling prices in 2016. Unfavorable foreign currency
exchange rates, primarily due to a weaker Brazilian real, Mexican peso, Colombian peso, Canadian dollar and
British pound in relation to the U.S. dollar, impacted sales by $108 million in 2016 compared to 2015.
25
The change in net sales of reportable segments can be summarized as follows (dollars in millions):
Net sales— 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sales volume (excluding acquisitions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effects of changing foreign currency rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vitro Acquisition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total effect on net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net sales— 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
6,098
$
79
(41)
(108)
608
538
6,636
$
Europe: Net sales in Europe in 2016 were $2,300 million compared with $2,324 million in 2015, a
decrease of $24 million, or 1%. The primary reason for the decline in net sales in 2016 was a $28 million impact
due to foreign currency exchange rates, as the British pound weakened in relation to the U.S. dollar. Glass
container shipments in 2016, primarily to beer and wine customers, increased approximately 2% compared to
the prior year and this increased net sales by $30 million. Selling prices decreased in Europe due to competitive
pressures and resulted in a $26 million decrease in net sales in 2016. This trend in lower prices is expected to
continue into the first quarter of 2017.
North America: Net sales in North America in 2016 were $2,220 million compared with $2,039 million in
2015, an increase of $181 million, or 9%. Net sales from the acquired Vitro food and beverage business in the
United States increased the region’s net sales by $196 million in 2016. Total glass container shipments were
up nearly 7% in 2016 compared to 2015, primarily due to the acquired business and higher shipments in all
major end uses except beer, which was on par with prior year. Excluding the impact of the Vitro Acquisition in
the region, glass container shipments were up nearly 1% in 2016, however, an unfavorable sales mix resulted
in $36 million of lower sales. This impact to sales mix was due to several customers converting a portion of
their glass shipments from carton packaging to bulk shipments. Higher selling prices as a result of contractual
pass throughs increased net sales by $25 million in 2016. Unfavorable foreign currency exchange rate changes
decreased net sales by $4 million, as the Canadian dollar weakened in relation to the U.S. dollar.
Latin America: Net sales in Latin America in 2016 were $1,432 million compared with $1,064 million
in 2015, an increase of $368 million, or 35%. Net sales from the acquired Vitro food and beverage business
in Mexico and Bolivia increased the region’s net sales by approximately $412 million in 2016. Total glass
container shipments were up approximately 41% in 2016. Excluding the impact of the Vitro Acquisition in
the region, glass container shipments were down approximately 3% in 2016. This decline impacted net sales
by approximately $40 million and was primarily due to a general economic slowdown in Brazil and Ecuador,
which is expected to continue into 2017, partially offset by growth in Colombia and Peru. The unfavorable
effects of foreign currency exchange rate changes decreased net sales $75 million in 2016 compared to 2015,
principally due to a decline in the Brazilian real, Colombian peso, and the Mexican peso in relation to the U.S.
dollar. Improved pricing in the current year benefited net sales by $71 million.
Asia Pacific: Net sales in Asia Pacific in 2016 were $684 million compared with $671 million for 2015, an
increase of $13 million, or 2%. Glass container shipments were down approximately 3% compared to the prior
year, however, a slightly more favorable sales mix increased net sales by $5 million in 2016. Sales volumes in
mature markets in the region were higher than prior year, but production volumes in those countries were lower
due to planned engineering activity. These lower production volumes in the mature markets were supported by
importing from emerging markets in the region, which in turn, led to lower domestic sales in those markets.
Higher prices increased net sales by $9 million in the current year. The unfavorable effects of foreign currency
exchange rate changes decreased net sales $1 million in 2016 compared to 2015.
Earnings from Continuing Operations before Income Taxes and Segment Operating Profit
Earnings from continuing operations before income taxes were $356 million in 2016 compared to $268
million in 2015, an increase of $88 million, or 33%. This increase was primarily due to higher segment
operating profit, partially offset by higher retained corporate costs and higher net interest expense.
26
Operating profit of the reportable segments includes an allocation of some corporate expenses based on
both a percentage of sales and direct billings based on the costs of specific services provided. Unallocated
corporate expenses and certain other expenses not directly related to the reportable segments’ operations are
included in Retained corporate costs and other. For further information, see Segment Information included in
Note 2 to the Consolidated Financial Statements.
Segment operating profit of reportable segments in 2016 was $882 million compared to $740 million in
2015, an increase of $142 million, or 19%. The increase was largely attributable to approximately $122 million
of segment operating profit from the acquired Vitro Business. Higher selling prices also increased segment
operating profit by $79 million. Partially offsetting this was the unfavorable effect of changes in foreign
currency exchange rates ($26 million) and higher operating costs ($25 million), primarily due to inflation.
The change in segment operating profit of reportable segments can be summarized as follows (dollars
in millions):
Segment operating profit - 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sales volume (excluding acquisitions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effects of changing foreign currency rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vitro Acquisition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total net effect on segment operating profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Segment operating profit - 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
740
$
79
(8)
(25)
(26)
122
142
882
$
Europe: Segment operating profit in Europe in 2016 was $237 million compared with $209 million in
2015, an increase of $28 million, or 13%. The increase in sales volume discussed above improved segment
operating profit by $7 million. Segment operating profit also benefited from $51 million in lower operating
costs in 2016 than in the prior year due to energy deflation and improved operational performance. In 2015,
production volumes were lower due to asset optimization projects that have now been completed. In addition,
the region received an energy credit of approximately $10 million from a local government entity in 2016 that
had been delayed for legislative reasons in 2015. The unfavorable effects of foreign currency exchange rates,
especially the British pound, decreased segment operating profit by $14 million in 2016 compared to the prior
year. Lower selling prices also decreased segment operating profit by $26 million.
North America: Segment operating profit in North America in 2016 was $299 million compared with
$265 million in 2015, an increase of $34 million, or 13%. Segment operating profit from the acquired Vitro food
and beverage glass container distribution business in the region contributed $28 million of incremental profit in
2016. Higher selling prices as a result of contractual pass throughs increased segment operating profit by $25
million in 2016 compared to 2015. Higher production volumes and improved operating efficiencies were more
than offset by cost inflation. Together, this contributed to a $13 million reduction to segment operating profit
in 2016. The unfavorable sales mix discussed above reduced segment operating profit by $5 million. Also, the
unfavorable effects of the weakening of the Canadian dollar in relation to the U.S. dollar decreased segment
operating profit by $1 million.
Latin America: Segment operating profit in Latin America in 2016 was $269 million compared with
$183 million in 2015, an increase of $86 million, or 47%. Segment operating profit from the acquired Vitro
food and beverage business contributed approximately $94 million of incremental profit to the region in
2016. Excluding the impact of the Vitro Acquisition, the decline in sales volume discussed above reduced
segment operating profit by $13 million. The unfavorable effects of foreign currency rate changes, especially
the Brazilian real, Colombian peso and Mexican peso, decreased segment operating profit by $14 million in
the current year. Despite management interventions to contain costs and improve asset optimization, segment
operating profit was also unfavorably impacted by $57 million of higher operating costs, primarily due to
energy and soda ash inflation in the region. Partially offsetting these declines were higher selling prices that
increased segment operating profit by $71 million in 2016. In addition, approximately $5 million of gains
related to non-strategic asset sales benefited 2016.
27
Asia Pacific: Segment operating profit in Asia Pacific in 2016 was $77 million compared with $83 million
in 2015, a decrease of $6 million, or 7%. Cost inflation, higher production downtime due to furnace rebuild
activity and higher costs for intra-regional shipments drove operating costs $21 million higher in 2016
compared to the prior year. The favorable effects of foreign currency exchange rates increased segment
operating profit by $3 million in 2016. The more favorable sales mix discussed above improved segment
operating profit by $3 million. Higher selling prices also increased segment operating profit by $9 million in the
current year.
Interest Expense, net
Net interest expense in 2016 was $272 million compared with $251 million in 2015. Net interest expense
included $9 million and $42 million in 2016 and 2015, respectively, for note repurchase premiums and the
write-off of finance fees related to debt that was repaid prior to its maturity. Exclusive of these items, net
interest expense increased $54 million in the current year primarily due to higher debt levels associated with the
Vitro Acquisition.
Provision for Income Taxes
The Company’s effective tax rate from continuing operations for 2016 was 33.4%, compared with 39.6%
for 2015. The Company’s effective tax rate for 2016 was lower than 2015 due to the impact of significant costs
related to refinancing, restructuring and acquisition-related costs in 2015 within jurisdictions that generated
little or no tax benefit.
Excluding the amounts related to items that management considers not representative of ongoing
operations, the Company’s effective tax rate for 2016 was approximately 24%, compared with approximately
25% for 2015.
Net Earnings Attributable to Noncontrolling Interests
Net earnings attributable to noncontrolling interests for 2016 was $21 million compared to $23 million for
2015. The decrease in 2016 was largely attributable to the unfavorable effect of changes in foreign currency
exchange rates.
Earnings from Continuing Operations Attributable to the Company
For 2016, the Company recorded earnings from continuing operations attributable to the Company of $216
million, or $1.32 per share (diluted), compared with earnings of $139 million, or $0.85 per share (diluted), for
2015. The after tax effects of the items excluded from segment operating profit, the unusual tax items and the
additional interest charges increased or decreased earnings in 2016 and 2015 as set forth in the following table
(dollars in millions).
(cid:17)(cid:8)(cid:10)(cid:11)(cid:4)(cid:27)?(cid:6)(cid:27)(cid:3)(cid:15)
Restructuring, asset impairment and other charges . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Pension settlement charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Note repurchase premiums and write-off of finance fees . . . . . . . . . . . . . . . . . . . . . . .
Gain on China land sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax benefit (charge) for certain tax adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Strategic transaction costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Charge for asbestos-related costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value inventory adjustments . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value intangible adjustments . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
28
Net Earnings
@(cid:15)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)
/(cid:17)(cid:8)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)6
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(123) $
(98)
(9)
62
8
(160) $
(73)
(42)
(8)
(22)
(16)
(16)
(9)
(186)
Foreign Currency Exchange Rates
Given the global nature of its operations, the Company is subject to fluctuations in foreign currency
exchange rates. As described above, the Company’s reported revenues and segment operating profit in 2016
were reduced due to foreign currency effects compared to 2015.
This trend has continued into 2017 as a result of a strengthening U.S. dollar. During times of a
strengthening U.S. dollar, the reported revenues and segment operating profit of the Company’s international
operations will be reduced because the local currencies will translate into fewer U.S. dollars. The Company
uses certain derivative instruments to mitigate a portion of the risk associated with changing foreign currency
exchange rates.
;:(cid:8)(cid:11)(cid:29)(cid:6)(cid:27)[(cid:8)(cid:5)%[(cid:8)(cid:4)[(cid:27)(cid:8)#f(cid:26)(cid:3)(cid:18)?(cid:12)(cid:4)(cid:27)(cid:10)(cid:3)(cid:15)(cid:5)(cid:3)(cid:28)(cid:5)(cid:23)(cid:24)(cid:21)!(cid:5)#(cid:27)(cid:6)(cid:7)(cid:5)(cid:23)(cid:24)(cid:21)j
2015 Highlights
• The unfavorable effect of foreign currency exchange rates reduced net sales by 13% and segment
operating profit by 16% in 2015 compared to the prior year
• Acquired the food and beverage glass container business of Vitro, S.A.B. de C.V. for $2.297 billion
• Entered into a new senior secured credit facility that matures in April 2020. To finance the Vitro
Acquisition, this facility was then amended to borrow an incremental $1.25 billion. The Company also
issued $1 billion of senior notes due 2023 and 2025.
• Repaid the senior notes due 2016
• Repurchased $100 million of shares of common stock
Net sales decreased by $628 million compared to the prior year primarily due to the unfavorable effect of
changes in foreign currency exchange rates. Net sales for 2015 included approximately $258 million from the
acquired Vitro Business.
Segment operating profit for reportable segments decreased by $168 million compared to the prior year.
The decrease was largely attributable to the unfavorable effect of changes in foreign currency exchange
rates and higher operating costs due to cost inflation and lower operational performance in Europe. Segment
operating profit for 2015 included approximately $46 million from the acquired Vitro Business.
Net interest expense in 2015 increased $21 million compared to 2014. The increase was due to higher note
repurchase premiums and the write-off of finance fees related to debt that was repaid during 2015 prior to its
maturity. Exclusive of these items, net interest expense decreased $1 million in the current year primarily due to
debt management activities and the weaker Euro exchange rate in relation to the U.S. dollar, partially offset by
an increase in net interest expense as a result of higher debt due to the Vitro Acquisition.
For 2015, the Company recorded earnings from continuing operations attributable to the Company of $139
million, or $0.85 per share (diluted), compared with earnings of $187 million, or $1.13 per share (diluted),
for 2014. Earnings in both periods included items that management considered not representative of ongoing
operations. These items decreased earnings from continuing operations attributable to the Company by
$186 million, or $1.15 per share, in 2015 and $249 million, or $1.50 per share, in 2014.
Results of Operations—Comparison of 2015 with 2014
Net Sales
The Company’s net sales in 2015 were $6,156 million compared with $6,784 million in 2014, a decrease
of $628 million. Unfavorable foreign currency exchange rates, primarily due to a weaker Brazilian real,
Colombian peso, Euro, Canadian dollar and Australian dollar in relation to the U.S. dollar, impacted sales by
29
$881 million in 2015 compared to 2014. Driven by incremental shipments related to the Vitro Acquisition,
total glass container shipments, in tonnes, were up approximately 3% in 2015 compared to 2014. The Vitro
Acquisition resulted in approximately $258 million of additional sales. Excluding the impact of the Vitro
Acquisition, shipments in 2015 were comparable to 2014. On a global basis, sales volumes of wine, spirits,
food and non-alcoholic beverages all grew year-on-year. While sales volumes in the beer category declined by
approximately 1%, driven by a decline in mainstream beer, shipments into craft and premium beer customers
continued to expand. However, an unfavorable sales mix resulted in $47 million of lower net sales in 2015. Net
sales also benefited from slightly higher selling prices in 2015.
The change in net sales of reportable segments can be summarized as follows (dollars in millions):
Net sales— 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sales volume (excluding acquisitions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effects of changing foreign currency rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vitro Acquisition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total effect on net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net sales— 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6,749
$
$
19
(47)
(881)
258
(651)
6,098
$
Europe: Net sales in Europe in 2015 were $2,324 million compared with $2,794 million in 2014, a
decrease of $470 million, or 17%. The primary reason for the decline in net sales in the region in 2015 was a
$445 million impact due to foreign currency exchange rates, as the Euro weakened in relation to the U.S. dollar.
Glass container shipments in 2015 increased slightly compared to the prior year and this increased net sales
by $9 million. Selling prices decreased in Europe due to competitive pressures and resulted in a $34 million
decrease in net sales in 2015. This trend in lower prices is expected to continue into the first quarter of 2016.
North America: Net sales in North America in 2015 were $2,039 million compared with $2,003 million
in 2014, an increase of $36 million, or 2%. Net sales from the acquired Vitro food and beverage business in
the United States increased the region’s net sales by $80 million in 2015. Total glass container shipments in the
region were up 3% in 2015 compared to 2014. Excluding the impact of the Vitro Acquisition in the region, glass
container shipments were up slightly in 2015, however, an unfavorable sales mix resulted in $4 million of lower
sales. Lower selling prices decreased net sales by $14 million in 2015 due, in part, to the Company’s contractual
pass through provisions of lower natural gas costs. Unfavorable foreign currency exchange rate changes
decreased net sales by $26 million, as the Canadian dollar weakened in relation to the U.S. dollar.
Latin America: Net sales in Latin America in 2015 were $1,064 million compared with $1,159 million
in 2014, a decrease of $95 million, or 8%. The unfavorable effects of foreign currency exchange rate changes
decreased net sales $293 million in 2015 compared to 2014, principally due to a decline in the Brazilian real
and the Colombian peso in relation to the U.S. dollar. Net sales from the acquired Vitro food and beverage
business in Mexico and Bolivia increased the region’s net sales by approximately $178 million in 2015. Total
glass container shipments were up approximately 18% in 2015. Excluding the impact of the Vitro Acquisition
in the region, glass container shipments were down nearly 4% in 2015. This decline impacted net sales by
approximately $45 million and was primarily due to a general economic slowdown in Brazil, which is expected
to continue into 2016. Improved pricing in the current year benefited net sales by $65 million.
Asia Pacific: Net sales in Asia Pacific in 2015 were $671 million compared with $793 million for 2014, a
decrease of $122 million, or 15%. The unfavorable effects of foreign currency exchange rate changes decreased
net sales $117 million in 2015 compared to 2014, primarily due to the weakening of the Australian dollar in
relation to the U.S. dollar. Glass container shipments were down 3% compared to the prior year, largely due to
the planned plant closures in China in 2014. This resulted in $7 million of lower sales in 2015. Higher prices
increased net sales by $2 million in the current year.
30
Segment Operating Profit
Operating profit of the reportable segments includes an allocation of some corporate expenses based on
both a percentage of sales and direct billings based on the costs of specific services provided. Unallocated
corporate expenses and certain other expenses not directly related to the reportable segments’ operations are
included in Retained corporate costs and other. For further information, see Segment Information included in
Note 2 to the Consolidated Financial Statements.
Segment operating profit of reportable segments in 2015 was $740 million compared to $908 million
in 2014, a decrease of $168 million, or 19%. The decrease in segment operating profit was primarily due to
unfavorable foreign currency exchange rates. In addition, cost inflation and lower operational performance in
Europe increased operating costs in the current year. Segment operating profit for 2015 included approximately
$46 million from the acquired Vitro Businesses.
The change in segment operating profit of reportable segments can be summarized as follows (dollars
in millions):
Segment operating profit - 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sales volume (excluding acquisitions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vitro Acquisition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effects of changing foreign currency rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total net effect on segment operating profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Segment operating profit - 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
908
$
19
(8)
(84)
46
(141)
(168)
740
$
Europe: Segment operating profit in Europe in 2015 was $209 million compared with $353 million in
2014, a decrease of $144 million, or 41%. The unfavorable effects of foreign currency exchange rates in 2015
decreased segment operating profit by $63 million compared to the prior year. The region also had higher
operating costs and lower production volumes in 2015 due to a higher level of furnace rebuild activity and
lower productivity. In addition, the region did not receive an energy credit from a local government entity
in 2015 as it had in the prior year. Together, this activity contributed to a $49 million increase to operating
expenses in Europe in 2015 compared to 2014. Lower selling prices impacted segment operating profit by $34
million due to competitive activity, primarily in Southern Europe, while slightly higher sales volumes benefited
segment operating profit by $2 million in 2015.
North America: Segment operating profit in North America in 2015 was $265 million compared with
$240 million in 2014, an increase of $25 million, or 10%. Segment operating profit from the acquired Vitro
food and beverage glass container distribution business in the region contributed $4 million in 2015. Segment
operating profit also benefited from lower operating costs of $38 million in the current year, which were driven
by lower energy, supply chain and logistics costs. As a result of the lower energy costs and the Company’s
contractual pass through provisions, selling prices were $14 million lower in 2015 compared to 2014. Also, the
unfavorable effects of the weakening of the Canadian dollar in relation to the U.S. dollar decreased segment
operating profit by $3 million.
Latin America: Segment operating profit in Latin America in 2015 was $183 million compared with
$227 million in 2014, a decrease of $44 million, or 19%. The unfavorable effects of foreign currency rate
changes decreased segment operating profit by $58 million in the current year. Segment operating profit from
the acquired Vitro food and beverage business increased the region’s operating profit by $42 million in 2015.
Excluding the impact of the Vitro Acquisition, the decline in sales volume discussed above reduced segment
operating profit by $12 million. Segment operating profit was also impacted by $75 million of higher operating
costs, primarily due to energy and soda ash inflation in Brazil. In addition, approximately $6 million of non-
strategic asset sales, which benefited 2014, did not reoccur in 2015. Higher selling prices increased segment
operating profit by $65 million in 2015.
31
Asia Pacific: Segment operating profit in Asia Pacific in 2015 was $83 million compared with $88 million
in 2014, a decrease of $5 million, or 6%. The unfavorable effects of foreign currency exchange rates decreased
segment operating profit by $17 million. Despite the decline in sales volume discussed above, a favorable sales
mix resulted in a $2 million increase to segment operating profit. Segment operating profit also benefited as
operating costs decreased by $8 million in the current year driven by footprint savings from prior year capacity
reductions in the region and the favorable impact of an insurance recovery. Higher selling prices increased
segment operating profit by $2 million in the current year.
Interest Expense, net
Net interest expense in 2015 was $251 million compared with $230 million in 2014. The increase was due
to higher note repurchase premiums and the write-off of finance fees related to refinancing activities in 2015.
Exclusive of these items, net interest expense decreased $1 million in the current year primarily due to debt
management activities and the weaker Euro exchange rate in relation to the U.S. dollar, partially offset by an
increase in net interest expense as a result of higher debt due to the Vitro Acquisition.
Provision for Income Taxes
The Company’s effective tax rate from continuing operations for 2015 was 39.6%, compared with 30.0%
for 2014. The effective tax rate for 2015 was impacted by several charges that management considered not
representative of ongoing operations, including charges for note repurchase premiums, the write-off of finance
fees, restructuring charges and acquisition fees, for which no tax benefit was recorded due to the Company’s
valuation allowance recorded in the U.S. The effective tax rate for 2014 was impacted by a non-income tax
charge, which was not deductible for income tax purposes.
Excluding the amounts related to items that management considers not representative of ongoing
operations, the Company’s effective tax rate for 2015 was approximately 25%, compared with approximately
22% for 2014. The 2015 effective tax rate was higher due to the geographic mix of earnings and timing issues
associated with the establishment of the legal structure for the acquired operations in Mexico, the latter of which
was resolved by year end 2015.
Net Earnings Attributable to Noncontrolling Interests
Net earnings attributable to noncontrolling interests for 2015 was $23 million compared to $28 million for
2014. The decrease in 2015 was largely attributable to the unfavorable effect of changes in foreign currency
exchange rates.
32
Earnings (loss) from Continuing Operations Attributable to the Company
For 2015, the Company recorded earnings from continuing operations attributable to the Company of $139
million, or $0.85 per share (diluted), compared with earnings of $187 million, or $1.13 per share (diluted), for
2014. The after tax effects of the items excluded from segment operating profit, the unusual tax items and the
additional interest charges increased or decreased earnings in 2015 and 2014 as set forth in the following table
(dollars in millions).
(cid:17)(cid:8)(cid:10)(cid:11)(cid:4)(cid:27)?(cid:6)(cid:27)(cid:3)(cid:15)
Restructuring, asset impairment and other charges . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Note repurchase premiums and write-off of finance fees . . . . . . . . . . . . . . . . . . . . . . .
Strategic transaction costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Charge for asbestos-related costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value inventory adjustments . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value intangible adjustments . . . . . . . . . . . . . . . . . . . . . . . . .
Tax benefit (charge) for certain tax adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension settlement charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
Net Earnings
@(cid:15)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)
/(cid:17)(cid:8)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)6
2015
2014
(73) $
(42)
(22)
(16)
(16)
(9)
(8)
(186) $
(67)
(20)
(46)
8
(69)
(55)
(249)
Foreign Currency Exchange Rates
Given the global nature of its operations, the Company is subject to fluctuations in foreign currency
exchange rates. As described above, the Company’s reported revenues and segment operating profit in 2015
were reduced due to foreign currency effects compared to 2014.
This trend has continued into 2016 as a result of a strengthening U.S. dollar. During times of a
strengthening U.S. dollar, the reported revenues and segment operating profit of the Company’s international
operations will be reduced because the local currencies will translate into fewer U.S. dollars. The Company
uses certain derivative instruments to mitigate a portion of the risk associated with changing foreign currency
exchange rates.
Items Excluded from Reportable Segment Totals
Retained Corporate Costs and Other
Retained corporate costs and other for 2016 were $98 million compared with $70 million for 2015. These
costs were higher in 2016 primarily due to higher pension expense, management incentive compensation
expense and the impact from currency hedges.
Retained corporate costs and other for 2015 were $70 million compared with $100 million for 2014. These
costs were lower in 2015 primarily due to lower pension expense, management incentive compensation expense
and the favorable impact from currency hedges.
Restructuring, Asset Impairment and Other Charges
During 2016, the Company recorded charges totaling $129 million for restructuring, asset impairment and
other charges. These charges reflect $98 million of plant and furnace closures, primarily in the European and
Latin America regions. In addition, other charges of $31 million were recorded during 2016, primarily related to
an impairment charge recorded at one of the Company’s equity investments.
33
During 2015, the Company recorded charges totaling $80 million for restructuring, asset impairment and
other charges. These charges reflect $63 million of completed furnace closures, primarily in the North America
and Latin America regions and other charges of $17 million.
During 2014, the Company recorded charges totaling $91 million for restructuring, asset impairment and
other charges. These charges reflect $76 million of completed and planned furnace closures in Europe and Asia
Pacific and other charges of $15 million.
See Note 8 to the Consolidated Financial Statements for additional information.
Pension Settlement Charges
During 2016, the Company recorded charges totaling $98 million for pension settlements in the United States.
During 2014, the Company recorded charges totaling $65 million for pension settlements in the United
States and the Netherlands.
See Note 9 to the Consolidated Financial Statements for additional information.
Charge for Asbestos-Related Costs
For the year ended December 31, 2016, there was no adjustment required for asbestos-related costs,
compared to the charges of $16 million and $46 million for the years ended December 31, 2015 and 2014,
respectively. These charges resulted from the Company’s comprehensive annual legal review of asbestos-related
liabilities and costs. As part of its future comprehensive annual reviews, the Company will estimate its total
asbestos-related liability and such reviews may result in adjustments to the liability accrued at the time of the
review. The Company continues to believe that its ultimate asbestos-related liability cannot be estimated with
certainty.
See “Critical Accounting Estimates” and Note 12 to the Consolidated Financial Statements for
additional information.
Gain on China Land Compensation
During 2016, the Company recorded a gain of $71 million related to compensation received for land that
the Company was required to return to the Chinese government.
Acquisition-related Fair Value Adjustments and Strategic Transaction Costs
During 2015, the Company recorded charges of $23 million for strategic transaction costs related to the
Vitro Acquisition.
During 2015, the Company recorded charges of $22 million for acquisition-related fair value inventory
adjustments related to the Vitro Acquisition. These charges were due to the accounting rules requiring inventory
purchased in a business combination to be marked up to fair value and then recorded as an increase to cost
of goods sold as the inventory is sold. During 2015, the Company also recorded charges of $10 million for
acquisition-related fair value intangible asset adjustments related to trademark assets with short-term lives
acquired as part of the Vitro Acquisition.
Non-income tax charge
In 2014, the Company recorded a $69 million charge based on a ruling on a non-income tax assessment.
34
Discontinued Operations
On April 4, 2016, the annulment committee formed by the World Bank’s International Centre for
Settlement of Investment Disputes (“ICSID”) ruled that a subsidiary of the Company is free to pursue the
enforcement of a prior arbitration award against Venezuela. That award amounts to more than $485 million
after including interest from the date of the expropriation by Venezuela (October 26, 2010). Venezuela’s
application to annul the award is still pending, although the annulment proceedings were suspended in October
2016 because Venezuela has not paid its fees owed to ICSID. If the proceeding is stayed for non-payment
for a consecutive period in excess of six months, ICSID’s Secretary General could move that the committee
discontinue the annulment proceeding altogether. The Company intends to take appropriate steps to vigorously
enforce and collect the award, which is enforceable in approximately 150 member states that are party to the
ICSID Convention. However, even with the lifting of the stay of enforcement, the Company recognizes that the
collection of the award may present significant practical challenges. Because the award has yet to be satisfied
and the annulment proceeding is pending, the Company is unable at this stage to reasonably predict the efforts
that will be necessary to successfully enforce collection of the award, the amount of the award or the timing of
any such collection efforts. Therefore, the Company has not recognized this award in its financial statements.
A separate arbitration is pending with ICSID to obtain compensation primarily for third-party minority
shareholders’ lost interests in the two expropriated plants.
The loss from discontinued operations of $7 million and $4 million, for the years ended December 31, 2016
and 2015, respectively, relates to ongoing costs for the Venezuelan expropriation.
The loss from discontinued operations of $23 million for the year ended December 31, 2014 included a
settlement of a dispute with a purchaser of a previously disposed business, as well as ongoing costs related to
the Venezuelan expropriation.
l(cid:27)(cid:6)(cid:4)(cid:3)(cid:5)=(cid:11)m(cid:29)(cid:27)(cid:10)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)
On September 1, 2015, the Company completed the Vitro Acquisition in a cash transaction valued at
approximately $2.297 billion, subject to a working capital adjustment and certain other adjustments. The Vitro
Business in Mexico is the largest supplier of glass containers in that country, manufacturing glass containers
across multiple end uses, including food, soft drinks, beer, wine and spirits. The Vitro Acquisition included
five food and beverage glass container plants in Mexico, a plant in Bolivia and a North American distribution
business, and provided the Company with a competitive position in the glass packaging market in Mexico.
The results of the Vitro Business have been included in the Company’s consolidated financial statements since
September 1, 2015. Vitro’s food and beverage glass container operations in Mexico and Bolivia are included
in the Latin American operating segment while its distribution business is included in the North American
operating segment.
The Company financed the Vitro Acquisition with the proceeds from a senior notes offering, cash on hand
and the incremental term loan facilities (see Note 11 to the Consolidated Financial Statements).
(cid:26)(cid:12)?(cid:27)(cid:6)(cid:12)(cid:13)(cid:5)<(cid:8)(cid:10)(cid:3)(cid:29)(cid:4)(cid:11)(cid:8)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)_(cid:27)m(cid:29)(cid:27)(cid:16)(cid:27)(cid:6)(cid:14)
As of December 31, 2016, the Company had cash and total debt of $492 million and $5.3 billion,
respectively, compared to $399 million and $5.6 billion, respectively, as of December 31, 2015. A significant
portion of the cash was held in mature, liquid markets where the Company has operations, such as the U.S.,
Europe and Australia, and is readily available to fund global liquidity requirements. The amount of cash held in
non-U.S. locations as of December 31, 2016 was $459 million.
35
Current and Long-Term Debt
On April 22, 2015, the Company entered into a Senior Secured Credit Facility, which subsequently has
been amended several times with the most recent amendment being entered into on February 3, 2016 (the
“Amended Agreement”). In connection with the closing of the Vitro Acquisition on September 1, 2015 (see
Note 19 to the Consolidated Financial Statements), the Company incurred $1,250 million of senior secured
incremental term loan facilities, comprised of (i) a $675 million term loan A facility on substantially the same
terms and conditions (including as to maturity) as the term loan A facility in the Amended Agreement and (ii) a
$575 million term loan B facility, which was subsequently repaid in full in November 2016 as described below.
At December 31, 2016, the Amended Agreement includes a $300 million revolving credit facility, a $600
million multicurrency revolving credit facility, a $1,575 million term loan A facility ($1,395 million net of debt
issuance costs), and a €279 million term loan A facility ($282 million net of debt issuance costs), each of which
has a final maturity date of April 22, 2020. At December 31, 2016, the Company had unused credit of $884
million available under the Amended Agreement. The weighted average interest rate on borrowings outstanding
under the Amended Agreement at December 31, 2016 was 2.39%.
The Amended Agreement contains various covenants that restrict, among other things and subject to certain
exceptions, the ability of the Company to incur certain liens, make certain investments, become liable under
contingent obligations in certain defined instances only, make restricted payments, make certain asset sales
within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing
arrangements, alter its fundamental business, and amend certain subordinated debt obligations.
The Amended Agreement also contains one financial covenant, a Total Leverage Ratio that requires the
Company not to exceed a ratio calculated by dividing consolidated total debt, less cash and cash equivalents,
by consolidated EBITDA, as defined in the Amended Agreement. The Total Leverage Ratio could restrict the
ability of the Company to undertake additional financing or acquisitions to the extent that such financing or
acquisitions would cause the Total Leverage Ratio to exceed the specified maximum of (i) 4.5x for the four
fiscal quarters ending December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, and (ii)
4.0x for the fourth fiscal quarter ending December 31, 2017 and each fiscal quarter thereafter.
Failure to comply with these covenants and restrictions could result in an event of default under the
Amended Agreement. In such an event, the Company would be unable to request borrowings under the
revolving facility, and all amounts outstanding under the Amended Agreement, together with accrued interest,
could then be declared immediately due and payable. If an event of default occurs under the Amended
Agreement and the lenders cause all of the outstanding debt obligations under the Amended Agreement to
become due and payable, this would result in a default under a number of other outstanding debt securities
and could lead to an acceleration of obligations related to these debt securities. As of December 31, 2016, the
Company was in compliance with all covenants and restrictions in the Amended Agreement. In addition, the
Company believes that it will remain in compliance and that its ability to borrow funds under the Amended
Agreement will not be adversely affected by the covenants and restrictions.
The interest rates on borrowings under the Amended Agreement are, at the Company’s option, the Base
Rate or the Eurocurrency Rate, as defined in the Amended Agreement, plus an applicable margin. The
applicable margin for the term loan A facility and the revolving credit facility is linked to the Company’s Total
Leverage Ratio and ranges from 1.25% to 1.75% for Eurocurrency Rate loans and from 0.25% to 0.75% for
Base Rate loans. In addition, a facility fee is payable on the revolving credit facility commitments ranging from
0.20% to 0.30% per annum linked to the Total Leverage Ratio.
Borrowings under the Amended Agreement are secured by substantially all of the assets, excluding real
estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign
subsidiaries. Borrowings are also secured by a pledge of intercompany debt and equity investments in certain
of the Company’s domestic subsidiaries and, in the case of foreign borrowings, of stock of certain foreign
subsidiaries. All borrowings under the Amended Agreement are guaranteed by certain domestic subsidiaries of
the Company.
36
Also, in connection with the Vitro Acquisition, during August 2015, the Company issued senior notes
with a face value of $700 million that bear interest at 5.875% and are due August 15, 2023 (the “Senior Notes
due 2023”) and senior notes with a face value of $300 million that bear interest at 6.375% and are due August
15, 2025 (together with the Senior Notes due 2023, the “2015 Senior Notes”). The 2015 Senior Notes were
issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The
net proceeds from the 2015 Senior Notes, after deducting the debt discount and debt issuance costs, totaled
approximately $972 million and were used to finance, in part, the Vitro Acquisition.
During November 2016, the Company issued senior notes with a face value of €500 million that bear
interest at 3.125% and are due November 15, 2024. The notes were issued via a private placement and are
guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds, after deducting the debt
discount and debt issuance costs, totaled approximately $520 million and were used to repay the term loan B
facility under the Amended Agreement.
The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into
additional credit facilities and seek to issue equity and/or debt securities in the domestic and international
capital markets if market conditions are favorable. Also, depending on market conditions, the Company may
elect to repurchase portions of its debt securities in the open market.
The Company has a €185 million European accounts receivable securitization program, which extends
through March 2019, subject to periodic renewal of backup credit lines.
Information related to the Company’s accounts receivable securitization program as of December 31, 2016
and 2015 is as follows:
Balance (included in short-term loans) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
152
$
0.74%
158
1.21%
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Cash Flows
Operating activities: Cash provided by continuing operating activities was $758 million for 2016
compared to $612 million for 2015. Higher net earnings and the impact from higher depreciation and
amortization were the primary drivers for the improvement in cash provided by continuing operating activities
in 2016. In addition, lower asbestos-related payments and cash paid for restructuring activities in 2016 more
than offset the impact of higher pension contributions than in the prior year. Working capital was a source
of cash of $90 million and $88 million for 2016 and 2015, respectively, and included $128 million received
in 2016 as a refund on value added taxes previously paid by the Company in conjunction with the Vitro
Acquisition. This refund will not reoccur in 2017.
Investing activities: Cash utilized in investing activities was $417 million for 2016 compared to
$2,748 million for 2015. Capital spending for property, plant and equipment during 2016 was $454 million,
compared with $402 million in the prior year, and reflected a full year of capital spending related to the Vitro
Business in 2016 compared to only four months in 2015.
Investing activities in 2016 also included $56 million paid for acquisitions and primarily related to
additional contributions made to the Company’s investment in a joint venture in Nava, Mexico. In 2017, the
Company expects to contribute approximately $42 million for the joint venture’s expansion plans. Cash utilized
for acquisitions in 2015 was $2,351 and primarily related to the Vitro Acquisition. In 2016, the Company
received $85 million in net proceeds on the disposal of assets, which were primarily related to cash received
from the Chinese government for the Company’s sale of certain land use rights and related properties.
Financing activities: Cash utilized in financing activities was $228 million for 2016 compared to $2,057
million of cash provided by financing activities for 2015. Financing activities in 2016 included additions to
long-term debt of $1,235 million, which included the issuance of €500 million of senior notes. Financing
37
activities in 2016 also included the repayment of long-term debt of $1,453 million, which included the
repayment of floating-rate debt in the Company’s Senior Secured Credit Facility from the proceeds of the
previously mentioned senior note issuance. Financing activities in 2015 included additions to long-term debt
of $4,538 million, primarily related to the borrowings for the Vitro Acquisition and the refinancing of the
Company’s Senior Secured Credit Facility. Financing activities in 2015 included the repayment of long-term
debt of $2,321 million, which included the repayment of the previous credit agreement and the repayment of the
senior notes due in 2016. Borrowings under short-term loans increased by $10 million in 2016. The Company
paid approximately $9 million in note repurchase premiums and finance fees in 2016 compared to $90 million
in 2015.
The Company paid $16 million and $22 million in distributions to noncontrolling interests in 2016 and
2015, respectively. In 2016, the Company did not repurchase any shares of its common stock compared to $100
million repurchased in 2015.
The Company anticipates that cash flows from its operations and from utilization of credit available under
the Amended Agreement will be sufficient to fund its operating and seasonal working capital needs, debt
service and other obligations on a short-term (twelve months) and long-term basis. Based on the Company’s
expectations regarding future payments for lawsuits and claims and also based on the Company’s expected
operating cash flow, the Company believes that the payment of any deferred amounts of previously settled
or otherwise determined lawsuits and claims, and the resolution of presently pending and anticipated future
lawsuits and claims associated with asbestos, will not have a material adverse effect upon the Company’s
liquidity on a short-term or long-term basis.
Contractual Obligations and Off-Balance Sheet Arrangements
The following information summarizes the Company’s significant contractual cash obligations at
December 31, 2016 (dollars in millions).
Contractual cash obligations:
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . .
Capital lease obligations . . . . . . . . . . . . . . . . . .
Operating leases . . . . . . . . . . . . . . . . . . . . . . . .
Interest(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Purchase obligations(2) . . . . . . . . . . . . . . . . . . .
Pension benefit plan contributions(3) . . . . . . . .
Postretirement benefit plan benefit payments(1)
Equity affiliate investment obligation(4) . . . . . .
Total contractual cash obligations . . . . . . .
7(cid:3)(cid:6)(cid:12)(cid:13)
$ 5,109
57
205
1,267
1,742
32
102
42
$ 8,556
7(cid:3)(cid:6)(cid:12)(cid:13)
*(cid:12)(cid:14)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)(cid:5)(cid:16)(cid:29)(cid:8)(cid:5)(cid:19)(cid:14)(cid:5)?(cid:8)(cid:4)(cid:27)(cid:3)(cid:16)
1 - 3
(cid:14)(cid:8)(cid:12)(cid:4)(cid:10)
Less than
(cid:3)(cid:15)(cid:8)(cid:5)(cid:14)(cid:8)(cid:12)(cid:4)
3 - 5
(cid:14)(cid:8)(cid:12)(cid:4)(cid:10)
More than
!(cid:5)(cid:14)(cid:8)(cid:12)(cid:4)(cid:10)
$
27
6
65
233
637
32
11
42
$ 1,053
$
375
13
79
433
593
22
$ 2,414
14
37
320
168
$ 2,293
24
24
281
344
21
48
$ 1,515
$ 2,974
$ 3,014
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)(cid:11)(cid:3)(cid:18)(cid:18)(cid:27)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:8):?(cid:27)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)?(cid:8)(cid:4)(cid:5)?(cid:8)(cid:4)(cid:27)(cid:3)(cid:16)
1 - 3
(cid:14)(cid:8)(cid:12)(cid:4)(cid:10)
Less than
(cid:3)(cid:15)(cid:8)(cid:5)(cid:14)(cid:8)(cid:12)(cid:4)
3 - 5
(cid:14)(cid:8)(cid:12)(cid:4)(cid:10)
More than
!(cid:5)(cid:14)(cid:8)(cid:12)(cid:4)(cid:10)
Other commercial commitments:
Standby letters of credit . . . . . . . . . . . . . . . . . . .
Total commercial commitments . . . . . . . . .
$
$
56
56
$
$
56
56
$
$
— $
— $
— $
— $
—
—
(1) Amounts based on rates and assumptions at December 31, 2016.
38
(2) The Company’s purchase obligations consist principally of contracted amounts for energy and molds. In
cases where variable prices are involved, current market prices have been used. The amount above does not
include ordinary course of business purchase orders because the majority of such purchase orders may be
canceled. The Company does not believe such purchase orders will adversely affect its liquidity position.
(3) In order to maintain minimum funding requirements, the Company is required to make contributions to its
(cid:2)(cid:3)(cid:4)(cid:5)(cid:3)(cid:2)(cid:6)(cid:7)(cid:3)(cid:5)(cid:3)(cid:4)(cid:8)(cid:6)(cid:9)(cid:3)(cid:5)(cid:10)(cid:11)(cid:12)(cid:5)(cid:6)(cid:9)(cid:13)(cid:14)(cid:5)(cid:10)(cid:6)(cid:12)(cid:15)(cid:6)(cid:14)(cid:9)(cid:9)(cid:16)(cid:12)(cid:17)(cid:11)(cid:18)(cid:14)(cid:8)(cid:3)(cid:13)(cid:19)(cid:6)(cid:20)(cid:21)(cid:22)(cid:6)(cid:18)(cid:11)(cid:13)(cid:13)(cid:11)(cid:12)(cid:5)(cid:6)(cid:11)(cid:5)(cid:6)(cid:22)(cid:23)(cid:24)(cid:25)(cid:26)(cid:6)(cid:27)(cid:28)(cid:8)(cid:28)(cid:16)(cid:3)(cid:6)(cid:15)(cid:28)(cid:5)(cid:2)(cid:11)(cid:5)(cid:29)(cid:6)(cid:16)(cid:3)(cid:30)(cid:28)(cid:11)(cid:16)(cid:3)(cid:18)(cid:3)(cid:5)(cid:8)(cid:10)(cid:6)(cid:15)(cid:12)(cid:16)(cid:6)(cid:8)(cid:31)(cid:3)(cid:6)
Company’s pension plans will depend largely on actual asset returns and future actuarial assumptions, such
(cid:14)(cid:10)(cid:6)(cid:2)(cid:11)(cid:10)!(cid:12)(cid:28)(cid:5)(cid:8)(cid:6)(cid:16)(cid:14)(cid:8)(cid:3)(cid:10)"(cid:6)(cid:14)(cid:5)(cid:2)(cid:6)!(cid:14)(cid:5)(cid:6)#(cid:14)(cid:16)(cid:19)(cid:6)(cid:10)(cid:11)(cid:29)(cid:5)(cid:11)(cid:4)!(cid:14)(cid:5)(cid:8)(cid:13)(cid:19)(cid:26)
(4) In 2014, the Company entered into a joint venture agreement with Constellation Brands, Inc. to operate
a glass container plant in Nava, Mexico. To help meet current and rising demand from Constellation’s
adjacent brewery, the joint venture plans to expand the plant over the next two years. The Company expects
to contribute approximately $42 million for the joint venture’s expansion plans through 2017.
The Company is unable to make a reasonably reliable estimate as to when cash settlement with taxing
authorities may occur for its unrecognized tax benefits. Therefore, the liability for unrecognized tax benefits
is not included in the table above. See Note 10 to the Consolidated Financial Statements for additional
information.
Critical Accounting Estimates
The Company’s analysis and discussion of its financial condition and results of operations are based upon
its consolidated financial statements that have been prepared in accordance with accounting principles generally
accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with
U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets,
liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. The Company evaluates
these estimates and assumptions on an ongoing basis. Estimates and assumptions are based on historical and
other factors believed to be reasonable under the circumstances at the time the financial statements are issued.
The results of these estimates may form the basis of the carrying value of certain assets and liabilities and may
not be readily apparent from other sources. Actual results, under conditions and circumstances different from
those assumed, may differ from estimates.
The impact of, and any associated risks related to, estimates and assumptions are discussed within
Management’s Discussion and Analysis of Financial Condition and Results of Operations, as well as in the
Notes to the Consolidated Financial Statements, if applicable, where estimates and assumptions affect the
Company’s reported and expected financial results.
The Company believes that accounting for the impairment of long-lived assets, pension benefit plans,
contingencies and litigation related to its asbestos liability, and income taxes involves the more significant
judgments and estimates used in the preparation of its consolidated financial statements.
Impairment of Long-Lived Assets
Property, Plant and Equipment—The Company tests for impairment of PP&E whenever events or
changes in circumstances indicate that the carrying amount of the assets may not be recoverable. PP&E held
for use in the Company’s business is grouped for impairment testing at the lowest level for which cash flows
can reasonably be identified, typically a segment or a component of a segment. The Company evaluates the
recoverability of PP&E based on undiscounted projected cash flows, excluding interest and taxes. If an asset
group is considered impaired, the impairment loss to be recognized is measured as the amount by which the
asset group’s carrying amount exceeds its fair value. PP&E held for sale is reported at the lower of carrying
amount or fair value less cost to sell.
39
Impairment testing requires estimation of the fair value of PP&E based on the discounted value of projected
future cash flows generated by the asset group. The assumptions underlying cash flow projections represent
management’s best estimates at the time of the impairment review. Factors that management must estimate include,
among other things: industry and market conditions, sales volume and prices, production costs and inflation.
Changes in key assumptions or actual conditions which differ from estimates could result in an impairment charge.
The Company uses reasonable and supportable assumptions when performing impairment reviews and cannot
predict the occurrence of future events and circumstances that could result in impairment charges.
Goodwill –Goodwill is tested for impairment annually as of October 1 (or more frequently if impairment
indicators arise) using a two-step process. Step 1 compares the business enterprise value (“BEV”) of each
reporting unit with its carrying value. The BEV is computed based on estimated future cash flows, discounted
at the weighted average cost of capital of a hypothetical third-party buyer. If the BEV is less than the carrying
value for any reporting unit, then Step 2 must be performed. Step 2 compares the implied fair value of goodwill
with the carrying amount of goodwill. Any excess of the carrying value of the goodwill over the implied
fair value will be recorded as an impairment loss. The calculations of the BEV in Step 1 and the implied fair
value of goodwill in Step 2 are based on significant unobservable inputs, such as projected future cash flows
of the reporting units, discount rates, and terminal business value, and are classified as Level 3 in the fair
value hierarchy. The Company’s projected future cash flows incorporates management’s best estimates of
the expected future results including, but not limited to, price trends, customer demand, material costs, asset
replacement costs and any other known factors.
Goodwill is tested for impairment at the reporting unit level, which is the operating segment or one level
below the operating segment, also known as a component. Two or more components of an operating segment
shall be aggregated into a single reporting unit if the components have similar economic characteristics,
based on an assessment of various factors. The Company has determined that the Europe and North America
segments are reporting units. The Company aggregated the components of the Latin America and Asia Pacific
segments into single reporting units equal to the reportable segments. The aggregation of the components
of these segments was based on their economic similarity as determined by the Company using a number
of quantitative and qualitative factors, including gross margins, the manner in which the Company operates
the business, the consistent nature of products, services, production processes, customers and methods of
distribution, as well as the level of shared resources and assets between the components.
During the fourth quarter of 2016, the Company completed its annual impairment testing and determined
that no impairment of goodwill existed. Goodwill at December 31, 2016 totaled approximately $2.5 billion,
representing 27% of total assets. The Company has four reporting units of which three of the reporting units
have goodwill and include; approximately $800 million of recorded goodwill to the Company’s Europe segment,
approximately $600 million of recorded goodwill to the Company’s Latin America segment and approximately
$1 billion of recorded goodwill to the Company’s North America segment. The testing performed as of October
1, 2016, indicated a significant excess of BEV over book value for North America and Latin America. Europe
exceeded its carrying values by approximately 12%, and is determined to be the reporting unit having the
greatest risk of future impairment if actual results fall modestly short of expectations. If the Company’s projected
future cash flows were substantially lower, or if the assumed weighted average cost of capital was substantially
higher, the testing performed as of October 1, 2016, may have indicated an impairment of one or more of these
reporting units and, as a result, the related goodwill may also have been impaired. Any impairment charges
that the Company may take in the future could be material to its consolidated results of operations and financial
condition. However, less significant changes in projected future cash flows or the assumed weighted average
cost of capital would not have indicated an impairment. For example, if projected future cash flows had been
decreased by 5%, or if the weighted average cost of capital had been increased by 5%, or both, the resulting
lower BEV’s would still have exceeded the book value of each of these reporting units.
During the time subsequent to the annual evaluation, and at December 31, 2016, the Company considered
whether any events and/or changes in circumstances had resulted in the likelihood that the goodwill of any of its
reporting units may have been impaired and has determined that no such events have occurred. The Company
will monitor conditions throughout 2017 that might significantly affect the projections and variables used in
40
the impairment test to determine if a review prior to October 1 may be appropriate. If the results of impairment
testing confirm that a write down of goodwill is necessary, then the Company will record a charge in the fourth
quarter of 2017, or earlier if appropriate. In the event the Company would be required to record a significant
write down of goodwill, the charge would have a material adverse effect on reported results of operations and
net worth.
Other Long-Lived Assets - Intangibles – Other long-lived assets consist primarily of purchased customer
relationships intangibles and are amortized using the accelerated amortization method over their estimated
useful lives. The Company reviews these assets for impairment whenever events or changes in circumstances
indicate that the carrying amount of the asset may not be recoverable. In the event that a decline in fair value
of an asset occurs, and the decline in value is considered to be other than temporary, an impairment loss is
recognized. The test for impairment would require the Company to make estimates about fair value, which may
be determined based on discounted cash flows, third party appraisals or other methods that provide appropriate
estimates of value. The Company continually monitors the carrying value of their assets.
Pension Benefit Plans
Significant Estimates—The determination of pension obligations and the related pension expense or
credits to operations involves significant estimates. The most significant estimates are the discount rate used
to calculate the actuarial present value of benefit obligations and the expected long-term rate of return on plan
assets. The Company uses discount rates based on yields of high quality fixed rate debt securities at the end
of the year. At December 31, 2016, the weighted average discount rate was 4.17 % and 2.94 % for U.S. and
non-U.S. plans, respectively. The Company uses an expected long-term rate of return on assets that is based on
both past performance of the various plans’ assets and estimated future performance of the assets. Due to the
nature of the plans’ assets and the volatility of debt and equity markets, actual returns may vary significantly
from year to year. The Company refers to average historical returns over longer periods (up to 10 years) in
determining its expected rates of return because short-term fluctuations in market values do not reflect the
rates of return the Company expects to achieve based upon its long-term investing strategy. For purposes
of determining pension charges and credits in 2016, the Company’s estimated weighted average expected
long-term rate of return on plan assets is 7.50% for U.S. plans and 7.15% for non-U.S. plans compared to 8.00%
for U.S. plans and 7.21% for non-U.S. plans in 2015. The Company recorded pension expense from continuing
operations (exclusive of settlement charges) of $23 million, $24 million, and $19 million for the U.S. plans
in 2016, 2015 and 2014, respectively, and $8 million, $7 million, and $24 million for the non-U.S. plans in
2016, 2015, and 2014, respectively from its principal defined benefit pension plans. Depending on currency
translation rates, the Company expects to record approximately $29 million of total pension expense for the
full year of 2017. The 2017 pension expense will reflect a 7.50% expected long-term rate of return for the
U.S. assets.
Future effects on reported results of operations depend on economic conditions and investment
performance. For example, a one-half percentage point change in the actuarial assumption regarding discount
rates or in the expected rate of return used to calculate plan liabilities would result in a change of approximately
$7 million and $13 million, respectively, in the pretax pension expense for the full year 2017.
Recognition of Funded Status—The Company recognizes the funded status of each pension benefit plan on
the balance sheet. The funded status of each plan is measured as the difference between the fair value of plan
assets and actuarially calculated benefit obligations as of the balance sheet date. Actuarial gains and losses are
accumulated in Other Comprehensive Income and the portion of each plan that exceeds 10% of the greater of
that plan’s assets or projected benefit obligation is amortized to income on a straight-line basis over the average
remaining service period of employees still accruing benefits or the expected life of participants not accruing
benefits if all, or almost all, of the plan’s participants are no longer accruing benefits.
41
Contingencies and Litigation Related to Asbestos Liability
For many years, the Company has conducted a comprehensive legal review of its asbestos-related liabilities
and costs annually in connection with finalizing and reporting its annual results of operations, unless significant
changes in trends or new developments warrant an earlier review. As part of its current annual comprehensive
legal review, the Company provides historical claims filing data to a third party consultant with expertise in
predicting future claims filings based on actuarial inputs such as disease incidence and mortality. The Company
uses these estimates of total future claims, along with its legal judgment regarding an estimation of future
disposition costs and related legal costs, as inputs to develop a reasonable estimate of probable liability. If the
results of the annual comprehensive legal review indicate that the existing amount of the accrued liability is
lower (higher) than its reasonably estimable asbestos-related costs, then the Company will record an appropriate
charge (credit) to the Company’s results of operations to increase (decrease) the accrued liability.
The significant assumptions underlying the material components of the Company’s accrual are described in
the Risk Factors section and in Note 12 to the Consolidated Financial Statements. Changes in these significant
assumptions have the potential to impact the Company’s asbestos-related liability.
In addition, if trends relating to the Company’s actual claims filings materially differ, up or down, from
the amounts predicted, the total number of estimated claims indicated by future actuarial analyses could
change significantly. Significant changes in the total number of predicted claims could impact the total
predicted asbestos-related liability, which in turn could result in a material charge or credit to the Company’s
results of operations.
The Company uses historical data for both indemnity and related legal costs, as well as its legal judgment
and expectations about future inflationary and deflationary drivers, to predict the estimated disposition cost
per claim and the legal costs for the remainder of the litigation. If trends relating to the actual per claim cost
differ materially, up or down, from the previously estimated amount, the Company may in the future revise
its estimate of its asbestos-related liability. The same may also be true with respect to legal costs. Significant
changes in the estimated asbestos-related liability could result in a material charge or credit to the Company’s
results of operations.
The Company believes it is reasonably possible that it will incur a loss for its asbestos-related liabilities
in excess of the amount currently recognized, which is $692 million as of December 31, 2016. The Company
estimates that reasonably possible losses could be as high as $825 million. This estimate of additional
reasonably possible loss reflects a legal judgment about the number and cost of potential future claims. The
Company believes this estimate is consistent with the level of variability it has experienced when comparing
actual results to recent near-term projections. However, it is also possible that the ultimate asbestos-related
liability could be above this estimate.
Income Taxes
The Company accounts for income taxes as required by general accounting principles under which
management judgment is required in determining income tax expense and the related balance sheet amounts.
This judgment includes estimating and analyzing historical and projected future operating results, the reversal
of taxable temporary differences, tax planning strategies, and the ultimate outcome of uncertain income tax
positions. Actual income taxes paid may vary from estimates, depending upon changes in income tax laws,
actual results of operations, and the final audit of tax returns by taxing authorities. The Company has received
tax assessments in excess of established reserves. The Company believes that adequate provisions for all income
tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in
excess of established reserves, it could have a material impact to the Company’s results of operations, financial
position or cash flows. Changes in the estimates and assumptions used for calculating income tax expense and
potential differences in actual results from estimates could have a material impact on the Company’s results of
operations and financial condition.
42
Deferred tax assets and liabilities are recognized for the tax effects of temporary differences between the
financial reporting and tax bases of assets and liabilities measured using enacted tax rates and for operating
losses and tax credit carryforwards. Deferred tax assets and liabilities are determined separately for each tax
jurisdiction in which the Company conducts its operations or otherwise incurs taxable income or losses. A
valuation allowance is recorded when it is more likely than not that some portion or all of the deferred tax
assets will not be realized. The realization of deferred tax assets depends on the ability to generate sufficient
taxable income within the carryback or carryforward periods provided for in the tax law for each applicable
tax jurisdiction. The Company considers the following possible sources of taxable income when assessing the
realization of deferred tax assets:
•
•
•
•
future reversals of existing taxable temporary differences;
future taxable income exclusive of reversing temporary differences and carryforwards;
taxable income in prior carryback years; and
tax planning strategies
The assessment regarding whether a valuation allowance is required or should be adjusted also considers all
available positive and negative evidence, including but not limited to:
•
•
•
•
nature, frequency, and severity of recent losses;
duration of statutory carryforward periods;
historical experience with tax attributes expiring unused; and
near- and medium-term financial outlook.
The weight given to the positive and negative evidence is commensurate with the extent to which the
evidence may be objectively verified. Accordingly, it is difficult to conclude a valuation allowance is not
required when there is significant objective and verifiable negative evidence, such as cumulative losses in recent
years. The Company uses the actual results for the last three years and current year anticipated results as the
primary measure of cumulative losses in recent years.
The evaluation of deferred tax assets requires judgment in assessing the likely future tax consequences of
events recognized in the financial statements or tax returns and future profitability. The recognition of deferred
tax assets represents the Company’s best estimate of those future events. Changes in the current estimates, due
to unanticipated events or otherwise, could have a material effect on the Company’s results of operations and
financial condition.
In certain foreign jurisdictions, the Company’s analysis indicates that it has cumulative losses in recent
years. This is considered significant negative evidence which is objective and verifiable and, therefore, difficult
to overcome. However, the cumulative loss position is not solely determinative and, accordingly, the Company
considers all other available positive and negative evidence in its analysis. Based on its analysis, the Company
has recorded a valuation allowance for the portion of deferred tax assets where based on the weight of available
evidence it is unlikely to realize those deferred tax assets.
The utilization of tax attributes to offset taxable income reduces the overall level of deferred tax assets
subject to a valuation allowance. Additionally, the Company’s recorded effective tax rate is lower than the
applicable statutory tax rate, due primarily to income earned in jurisdictions for which a valuation allowance
is recorded. The effective tax rate will approach the statutory tax rate in periods after valuation allowances
are released. In the period in which valuation allowances are released, the Company will record a material tax
benefit, which could result in a negative effective tax rate.
43
@7;&(cid:5)"=Q(cid:5) pc=_@7=7@l;(cid:5)=8(cid:17)(cid:5)pc=87@7=7@l;(cid:5)(cid:17)@>(cid:26)_%>c<;>(cid:5)=\%c7(cid:5)&=q
Market risks relating to the Company’s operations result primarily from fluctuations in foreign currency
exchange rates, changes in interest rates, and changes in commodity prices, principally energy and soda ash.
The Company uses certain derivative instruments to mitigate a portion of the risk associated with changing
foreign currency exchange rates. The Company also uses certain derivative instruments to mitigate a portion of
the risk associated with fluctuating energy prices in its North American region. These instruments carry varying
degrees of counterparty credit risk. To mitigate this risk, the Company has defined a financial counterparty
policy that established criteria to select qualified counterparties based on credit ratings and CDC spreads.
The policy also limits the exposure with individual counterparties. The Company monitors these exposures
quarterly. The Company does not enter into derivative financial instruments for trading purposes.
Foreign Currency Exchange Rate Risk
Earnings of operations outside the United States
A substantial portion of the Company’s operations are conducted by subsidiaries outside the U.S. The
primary international markets served by the Company’s subsidiaries are in Canada, Australia, China, Latin
America (principally Brazil, Colombia, and Mexico), and Europe (principally France, Germany, Italy, the
Netherlands, Poland, Spain, and the United Kingdom). In general, revenues earned and costs incurred by the
Company’s major international operations are denominated in their respective local currencies. Consequently,
the Company’s reported financial results could be affected by factors such as changes in foreign currency
exchange rates or highly inflationary economic conditions in the international markets in which the Company’s
subsidiaries operate. When the U.S. dollar strengthens against foreign currencies, the reported U.S. dollar value
of local currency earnings generally decreases; when the U.S. dollar weakens against foreign currencies, the
reported U.S. dollar value of local currency earnings generally increases. For the years ended December 31,
2016, 2015 and 2014, the Company did not have any significant foreign subsidiaries whose functional currency
was the U.S. dollar.
Borrowings not denominated in the functional currency
Because the Company’s subsidiaries operate within their local economic environment, the Company
believes it is appropriate to finance those operations with borrowings denominated in the local currency to the
extent practicable where debt financing is desirable or necessary. This strategy mitigates the risk of reported
losses or gains in the event the foreign currency strengthens or weakens against the U.S. dollar. Considerations
which influence the amount of such borrowings include long- and short-term business plans, tax implications,
and the availability of borrowings with acceptable interest rates and terms.
Available excess funds of a subsidiary may be redeployed through intercompany loans to other subsidiaries
for debt repayment, capital investment, or other cash requirements. The intercompany loans give rise to foreign
currency exchange rate risk, which the Company mitigates through the use of forward exchange contracts that
effectively swap the intercompany loan and related interest to the appropriate local currency.
The Company believes the near term exposure to foreign currency exchange rate risk of its foreign currency
risk sensitive instruments was not material at December 31, 2016 and 2015.
Interest Rate Risk
The Company’s interest expense is most sensitive to changes in the general level of interest rates applicable
to the term loans under its Secured Credit Agreement (see Note 11 to the Consolidated Financial Statements for
further information). The Company’s interest rate risk management objective is to limit the impact of interest
rate changes on net income and cash flow, while minimizing interest payments and expense. To achieve this
objective, the Company regularly evaluates its mix of fixed and floating-rate debt, and, from time to time, may
enter into interest rate swap agreements.
44
The following table provides information about the Company’s interest rate sensitivity related to its
significant debt obligations at December 31, 2016. The table presents principal cash flows and related
weighted-average interest rates by expected maturity date.
/(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)6
Long-term debt at
variable rate:
Principal by expected
maturity . . . . . . . . . . . .
Avg. principal
outstanding . . . . . . . . .
Avg. interest rate . . . . . . .
Long-term debt at fixed rate:
Principal by expected
$
$
(cid:23)(cid:24)(cid:21)"
(cid:23)(cid:24)(cid:21)$
2019
2020
2021
There-
(cid:12)(cid:28)(cid:6)(cid:8)(cid:4)
7(cid:3)(cid:6)(cid:12)(cid:13)
Fair
l(cid:12)(cid:13)(cid:29)(cid:8)(cid:5)(cid:12)(cid:6)
(cid:21)(cid:23)J(cid:20)(cid:21)J(cid:23)(cid:24)(cid:21)(cid:25)
25
$
29
$
92
$
1,542
$
2
$
— $
1,690 $ 1,690
$
845
2.43%
$
1,678
2.43%
$
1,651
2.43%
1,590
2.43%
$ 773
$
2.43%
1
2.43%
maturity . . . . . . . . . . . .
$
8
$ 258
$
9
$ 532
$ 353
$
2,316 $
3,476 $ 3,771
Avg. principal
outstanding . . . . . . . . .
Avg. interest rate . . . . . . .
$ 3,474
$
5.50%
3,224
$
4.68%
3,224
$
4.18%
2,700
$
4.29%
2,346
$
4.09%
1,852
5.09%
The Company believes the near term exposure to interest rate risk of its debt obligations has not changed
materially since December 31, 2016.
In addition, the determination of pension obligations and the related pension expense or credits to
operations involves significant estimates. Future funding requirements for the Company’s pension plans will
depend largely on actual asset returns and future actuarial assumptions, such as discount rates, and can vary
significantly. The discount rate is a significant estimate that is used to calculate the actuarial present value of
benefit obligations and is based on yields of high quality fixed rate debt securities at the end of the year. For
example, a one-half percentage point change in the actuarial assumption regarding discount rates or in the
expected rate of return used to calculate plan liabilities would result in a change of approximately $7 million
and $13 million, respectively, in the pretax pension expense for the full year 2017.
Commodity Price Risk
The Company has exposure to commodity price risk, principally related to energy. In North America, the
Company enters into commodity forward contracts related to forecasted natural gas requirements, the objectives
of which are to limit the effects of fluctuations in the future market price paid for natural gas and the related
volatility in cash flows. The Company continually evaluates the natural gas market and related price risk and
periodically enters into commodity forward contracts in order to hedge a portion of its usage requirements.
The majority of the sales volume in North America is tied to customer contracts that contain provisions that
pass the price of natural gas to the customer. In certain of these contracts, the customer has the option of fixing
the natural gas price component for a specified period of time. At December 31, 2016, the Company had
entered into commodity forward contracts covering approximately 12,300,000 MM BTUs, primarily related to
customer requests to lock the price of natural gas. In Europe, the Company enters into fixed price contracts for a
significant amount of its energy requirements. These contracts typically have terms of 3 years or less.
The Company believes the near term exposure to commodity price risk of its commodity forward contracts
was not material at December 31, 2016.
45
Forward Looking Statements
This document contains “forward-looking” statements within the meaning of Section 21E of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) and Section 27A of the Securities Act of 1933.
Forward-looking statements reflect the Company’s current expectations and projections about future events at
the time, and thus involve uncertainty and risk. The words “believe,” “expect,” “anticipate,” “will,” “could,”
“would,” “should,” “may,” “plan,” “estimate,” “intend,” “predict,” “potential,” “continue,” and the negatives
of these words and other similar expressions generally identify forward-looking statements. It is possible the
Company’s future financial performance may differ from expectations due to a variety of factors including,
but not limited to the following: (1) the Company’s ability to integrate the Vitro Business in a timely and cost
effective manner, and to realize expected growth opportunities, cost savings and synergies from the Vitro
Acquisition, (2) foreign currency fluctuations relative to the U.S. dollar, (3) changes in capital availability or
cost, including interest rate fluctuations and the ability of the Company to refinance debt at favorable terms, (4)
the general political, economic and competitive conditions in markets and countries where the Company has
operations, including uncertainties related to economic and social conditions, disruptions in capital markets,
disruptions in the supply chain, competitive pricing pressures, inflation or deflation, and changes in tax rates
and laws, (5) the Company’s ability to generate sufficient future cash flows to ensure the Company’s goodwill
is not impaired, (6) consumer preferences for alternative forms of packaging, (7) cost and availability of raw
materials, labor, energy and transportation, (8) the Company’s ability to manage its cost structure, including its
success in implementing restructuring plans and achieving cost savings, (9) consolidation among competitors
and customers, (10) the Company’s ability to acquire businesses and expand plants, integrate operations
of acquired businesses and achieve expected synergies, (11) unanticipated expenditures with respect to
environmental, safety and health laws, (12) the Company’s ability to further develop its sales, marketing and
product development capabilities, (13) the Company’s ability to prevent and detect cybersecurity threats against
its information technology systems, (14) the Company’s ability to accurately estimate its total asbestos-related
liability or to control the timing and occurrence of events relates to asbestos-related claims, (15) changes in U.S.
trade policies, (16) the Company’s ability to achieve its strategic plan, and the other risk factors discussed in
this Annual Report on Form 10-K for the year ended December 31, 2016 and any subsequently filed Quarterly
Report on Form 10-Q. It is not possible to foresee or identify all such factors. Any forward-looking statements
in this document are based on certain assumptions and analyses made by the Company in light of its experience
and perception of historical trends, current conditions, expected future developments, and other factors it
believes are appropriate in the circumstances. Forward-looking statements are not a guarantee of future
performance and actual results or developments may differ materially from expectations. While the Company
continually reviews trends and uncertainties affecting the Company’s results of operations and financial
condition, the Company does not assume any obligation to update or supplement any particular forward-looking
statements contained in this document.
46
@7;&(cid:5)$Q(cid:5) (cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)=8(cid:17)(cid:5)>c**_;&;87=<‘(cid:5)(cid:17)=7=
Report of Independent Registered Public Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Balance Sheets at December 31, 2016 and 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
For the years ended December 31, 2016, 2015, and 2014:
Consolidated Results of Operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Comprehensive Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Share Owners’ Equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Cash Flows . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selected Quarterly Financial Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Page
48
51 - 52
49
50
53
54
55
100
47
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Share Owners of
Owens-Illinois, Inc.
We have audited the accompanying consolidated balance sheets of Owens-Illinois, Inc. as of December 31,
2016 and 2015, and the related consolidated statements of results of operations, comprehensive income, share
owners’ equity and cash flows for each of the three years in the period ended December 31, 2016. Our audits
also included the financial statement schedule listed in the Index at Item 15. These financial statements and
schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on
these financial statements and schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant estimates made by management, as well
as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis
for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the
consolidated financial position of Owens-Illinois, Inc. at December 31, 2016 and 2015, and the consolidated
results of its operations and its cash flows for each of the three years in the period ended December 31, 2016,
in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial
statement schedule, when considered in relation to the basic financial statements taken as a whole, presents
fairly in all material respects the information set forth therein.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight
Board (United States), Owens-Illinois, Inc.’s internal control over financial reporting as of December 31, 2016,
based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (2013 framework), and our report dated February 10, 2017
expressed an unqualified opinion thereon.
/s/ Ernst & Young LLP
Toledo, Ohio
February 10, 2017
48
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED RESULTS OF OPERATIONS
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling and administrative expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Research, development and engineering expense . . . . . . . . . . . . . . . . . . . . .
Interest expense, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations before income taxes . . . . . . . . . . . . . .
Provision for income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net (earnings) attributable to noncontrolling interests . . . . . . . . . . . . . . . . .
Net earnings attributable to the Company . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amounts attributable to the Company:
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Basic earnings per share:
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted earnings per share:
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
$ 6,702
(5,490)
1,212
(503)
(65)
(272)
60
(76)
356
(119)
237
(7)
230
(21)
209
$
$
$
$
$
$
$
216
(7)
209
1.33
(0.04)
1.29
1.32
(0.04)
1.28
2015
$ 6,156
(5,046)
1,110
(476)
(64)
(251)
60
(111)
268
(106)
162
(4)
158
(23)
135
$
$
$
$
$
$
$
139
(4)
135
0.86
(0.03)
0.83
0.85
(0.03)
0.82
2014
$ 6,784
(5,531)
1,253
(523)
(63)
(230)
64
(194)
307
(92)
215
(23)
192
(28)
164
$
$
$
$
$
$
$
187
(23)
164
1.14
(0.14)
1.00
1.13
(0.14)
0.99
See accompanying Notes to the Consolidated Financial Statements.
49
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED COMPREHENSIVE INCOME
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive loss:
Foreign currency translation adjustments. . . . . . . . . . . . . . . . . . . . . . . .
Pension and other postretirement benefit adjustments, net of tax . . . . .
Change in fair value of derivative instruments, net of tax . . . . . . . . . . .
Other comprehensive loss. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Comprehensive income attributable to noncontrolling interests . . . . . . . . . .
Comprehensive income (loss) attributable to the Company . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
230
$
158
$
192
(224)
52
13
(159)
71
(17)
54
$
(529)
(4)
(6)
(539)
(381)
(7)
(388) $
(305)
(90)
1
(394)
(202)
(7)
(209)
$
See accompanying Notes to the Consolidated Financial Statements.
50
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED BALANCE SHEETS
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
Assets
(cid:26)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:6)(cid:5)(cid:12)(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)u
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Trade receivables, net of allowances of $32 million and $29 million at
December 31, 2016 and 2015, respectively. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:12)(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)u
Equity investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangibles. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
*(cid:4)(cid:3)?(cid:8)(cid:4)(cid:6)(cid:14)(cid:22)(cid:5)?(cid:13)(cid:12)(cid:15)(cid:6)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:8)m(cid:29)(cid:27)?(cid:18)(cid:8)(cid:15)(cid:6)u
Land, at cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Buildings and equipment, at cost:
Buildings and building equipment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Factory machinery and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Transportation, office and miscellaneous equipment . . . . . . . . . . . . . . . . . . . . .
Construction in progress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less accumulated depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
492
$
399
580
983
199
2,254
433
40
602
464
2,462
4,001
562
1,007
366
2,334
409
32
599
597
2,489
4,126
241
252
1,090
4,496
85
238
6,150
3,270
2,880
$ 9,135
1,123
4,526
88
238
6,227
3,266
2,961
$ 9,421
See accompanying Notes to the Consolidated Financial Statements.
51
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)\=_=8(cid:26);(cid:5)>v;;7>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
_(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)>(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)%#(cid:15)(cid:8)(cid:4)(cid:10)b(cid:5);m(cid:29)(cid:27)(cid:6)(cid:14)
(cid:26)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:6)(cid:5)(cid:13)(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Salaries and wages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. and foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current portion of asbestos-related liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt due within one year. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
_(cid:3)(cid:15)+(cid:30)(cid:6)(cid:8)(cid:4)(cid:18)(cid:5)(cid:16)(cid:8)(cid:19)(cid:6). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:17)(cid:8)(cid:28)(cid:8)(cid:4)(cid:4)(cid:8)(cid:16)(cid:5)(cid:6)(cid:12):(cid:8)(cid:10). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
*(cid:8)(cid:15)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)(cid:19)(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8(cid:3)(cid:15)?(cid:8)(cid:15)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)?(cid:3)(cid:10)(cid:6)(cid:4)(cid:8)(cid:6)(cid:27)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:19)(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:10). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:13)(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
=(cid:10)(cid:19)(cid:8)(cid:10)(cid:6)(cid:3)(cid:10)(cid:30)(cid:4)(cid:8)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)(cid:13)(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
>(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:3)#(cid:15)(cid:8)(cid:4)(cid:10)b(cid:5)(cid:8)m(cid:29)(cid:27)(cid:6)(cid:14)u
>(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:3)#(cid:15)(cid:8)(cid:4)(cid:10)b(cid:5)(cid:8)m(cid:29)(cid:27)(cid:6)(cid:14)(cid:5)(cid:3)(cid:28)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:12)(cid:15)(cid:14)u
Common stock, par value $.01 per share, 250,000,000 shares authorized,
185,354,796 and 184,480,646 shares issued (including treasury shares),
respectively . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capital in excess of par value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Treasury stock, at cost, 23,017,367 and 23,519,049 shares, respectively . . . . . . . . .
Retained loss. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total share owners’ equity of the Company . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8(cid:3)(cid:15)(cid:11)(cid:3)(cid:15)(cid:6)(cid:4)(cid:3)(cid:13)(cid:13)(cid:27)(cid:15)+(cid:5)(cid:27)(cid:15)(cid:6)(cid:8)(cid:4)(cid:8)(cid:10)(cid:6)(cid:10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total share owners’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total liabilities and share owners’ equity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$ 1,135
174
58
115
383
162
33
2,060
5,133
100
552
162
188
577
$ 1,212
145
36
130
371
160
68
2,122
5,345
124
504
155
205
687
2
3,080
(560)
(96)
(2,172)
254
109
363
$ 9,135
2
3,064
(573)
(305)
(2,017)
171
108
279
$ 9,421
See accompanying Notes to the Consolidated Financial Statements.
52
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED SHARE OWNERS’ EQUITY
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
>(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)%#(cid:15)(cid:8)(cid:4)(cid:10)b(cid:5);m(cid:29)(cid:27)(cid:6)(cid:14)(cid:5)(cid:3)(cid:28)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:12)(cid:15)(cid:14)
(cid:26)(cid:3)(cid:18)(cid:18)(cid:3)(cid:15)(cid:5)
>(cid:6)(cid:3)(cid:11)]
(cid:26)(cid:12)?(cid:27)(cid:6)(cid:12)(cid:13)(cid:5)(cid:27)(cid:15)(cid:5)
;:(cid:11)(cid:8)(cid:10)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)
*(cid:12)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
7(cid:4)(cid:8)(cid:12)(cid:10)(cid:29)(cid:4)(cid:14)(cid:5)
>(cid:6)(cid:3)(cid:11)]
Retained
Earnings
(Loss)
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)
Other
(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)(cid:5)
Loss
Non-
(cid:11)(cid:3)(cid:15)(cid:6)(cid:4)(cid:3)(cid:13)(cid:13)(cid:27)(cid:15)+(cid:5)
Interests
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:5)
Share
%#(cid:15)(cid:8)(cid:4)(cid:10)b(cid:5)
;m(cid:29)(cid:27)(cid:6)(cid:14)
147 $
28
(21)
(37)
117
1,010
5
6
(32)
21
192
(394)
(37)
771
1
7
(100)
15
158
(539)
(22)
(12)
279
5
13
11
230
21
(159)
(4)
(16)
(16)
109 $ 363
23
(16)
(22)
6
108
Balance on January 1, 2014 . . . . . . . . . . . . . . . . . . . . . . . $
Issuance of common stock (0.3 million shares). . . . . . . .
Reissuance of common stock (0.2 million shares). . . . . .
Treasury shares purchased (1.1 million shares) . . . . . . . .
Stock compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss). . . . . . . . . . . . . . . . .
Distributions to noncontrolling interests . . . . . . . . . . . . .
Balance on December 31, 2014 . . . . . . . . . . . . . . . . . . . .
Issuance of common stock (0.2 million shares) . . . . . . .
Reissuance of common stock (0.3 million shares). . . . . .
Treasury shares purchased (4.1 million shares) . . . . . . . .
Stock compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss). . . . . . . . . . . . . . . . .
Distributions to noncontrolling interests . . . . . . . . . . . . .
Acquisitions of noncontrolling interests . . . . . . . . . . . . .
Balance on December 31, 2015 . . . . . . . . . . . . . . . . . . . .
Issuance of common stock (0.3 million shares) . . . . . . .
Reissuance of common stock (0.1 million shares). . . . . .
Stock compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss). . . . . . . . . . . . . . . . .
Distributions to noncontrolling interests . . . . . . . . . . . . .
Balance on December 31, 2016 . . . . . . . . . . . . . . . . . . . . $
2 $ 3,040 $ (454) $ (604) $
(1,121) $
5
21
6
(32)
164
(373)
2
3,066
1
(480)
(440)
(1,494)
7
(100)
15
135
(523)
2
(18)
3,064
5
(573)
(305)
(2,017)
13
11
209
(155)
2 $ 3,080 $ (560) $
(96) $
(2,172) $
See accompanying Notes to the Consolidated Financial Statements.
53
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED CASH FLOWS
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)
%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-cash charges (credits):
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of intangibles and other deferred items. . . . . . . . . . .
Amortization of finance fees and debt discount . . . . . . . . . . . . . . .
Deferred tax provision (benefit) . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension expense. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring, asset impairment and related charges . . . . . . . . . . .
Pension settlement charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment of equity investment. . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on China land sale. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asbestos-related costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value inventory adjustments . . . . . . . . . . .
Acquisition-related fair value intangible adjustments. . . . . . . . . . .
Pension contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asbestos-related payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash paid for restructuring activities . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in components of working capital . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash provided by continuing operating activities . . . . . . . . . . . . . .
Cash utilized in discontinued operating activities . . . . . . . . . . . . . .
Total cash provided by operating activities . . . . . . . . . . . . . . . . . . .
@(cid:15)[(cid:8)(cid:10)(cid:6)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Additions to property, plant and equipment . . . . . . . . . . . . . . . . . . . . . .
Acquisitions, net of cash acquired . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash proceeds related to sale of assets and other . . . . . . . . . . . . . . .
Net foreign exchange derivative activity . . . . . . . . . . . . . . . . . . . . . . . .
Net activity for non-controlling partner loans . . . . . . . . . . . . . . . . . . . .
Cash utilized in investing activities. . . . . . . . . . . . . . . . . . . . . . . . .
(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
230
7
375
103
13
(4)
31
98
98
25
(71)
(38)
(125)
(24)
90
(50)
758
(7)
751
(454)
(56)
85
8
158
4
323
86
15
12
31
63
16
22
10
(17)
(138)
(38)
88
(23)
612
(4)
608
(402)
(2,351)
1
4
(417)
(2,748)
$
192
23
335
83
30
(18)
43
76
65
69
46
(28)
(148)
(58)
117
(129)
698
(23)
675
(369)
(114)
19
9
(455)
Additions to long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Repayments of long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Increase (decrease) in short-term loans . . . . . . . . . . . . . . . . . . . . . . . . .
Payment of finance fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Distributions paid to noncontrolling interests. . . . . . . . . . . . . . . . . . . . .
Treasury shares purchased . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Issuance of common stock and other . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash provided by (utilized in) financing activities . . . . . . . . . . . . .
Effect of exchange rate fluctuations on cash . . . . . . . . . . . . . . . . . . . . . . . . .
Increase (decrease) in cash. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at beginning of period . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at end of period . . . . . . . . . . . . . . . . . . . . . . . . . .
1,235
(1,453)
10
(9)
(16)
5
(228)
(13)
93
399
492
$
$
4,538
(2,321)
51
(90)
(22)
(100)
1
2,057
(30)
(113)
512
399
1,247
(1,101)
(139)
(11)
(37)
(32)
3
(70)
(21)
129
383
512
$
See accompanying Notes to the Consolidated Financial Statements.
54
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:21)Q(cid:5)(cid:5)>(cid:27)+(cid:15)(cid:27)(cid:28)(cid:27)(cid:11)(cid:12)(cid:15)(cid:6)(cid:5)=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:27)(cid:15)+(cid:5)*(cid:3)(cid:13)(cid:27)(cid:11)(cid:27)(cid:8)(cid:10)
\(cid:12)(cid:10)(cid:27)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)(cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)>(cid:6)(cid:12)(cid:6)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)(cid:5) The consolidated financial statements of Owens-Illinois, Inc. (the
“Company”) include the accounts of its subsidiaries. Newly acquired subsidiaries have been included in the
consolidated financial statements from dates of acquisition.
The Company uses the equity method of accounting for investments in which it has a significant ownership
interest, generally 20% to 50%. Other investments are accounted for at cost. The Company monitors other than
temporary declines in fair value and records reductions in carrying values when appropriate.
8(cid:12)(cid:6)(cid:29)(cid:4)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)(cid:5) The Company is a leading manufacturer of glass container products. The
Company’s principal product lines are glass containers for the food and beverage industries. The Company has
glass container operations located in 23 countries. The principal markets and operations for the Company’s
products are in Europe, North America, Latin America and Asia Pacific.
c(cid:10)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5);(cid:10)(cid:6)(cid:27)(cid:18)(cid:12)(cid:6)(cid:8)(cid:10)(cid:5) The preparation of financial statements in conformity with accounting principles
generally accepted in the United States requires management of the Company to make estimates and
assumptions that affect certain amounts reported in the financial statements and accompanying notes. Actual
results may differ from those estimates, at which time the Company would revise its estimates accordingly.
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5)(cid:26)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:11)(cid:14)(cid:5)7(cid:4)(cid:12)(cid:15)(cid:10)(cid:13)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5) The assets and liabilities of non-U.S. subsidiaries are translated into
U.S. dollars at year-end exchange rates. Any related translation adjustments are recorded in accumulated other
comprehensive income in share owners’ equity.
<(cid:8)[(cid:8)(cid:15)(cid:29)(cid:8)(cid:5)<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5) The Company recognizes sales, net of estimated discounts and allowances, when
the title to the products and risk of loss are transferred to customers. Provisions for rebates to customers are
provided in the same period that the related sales are recorded.
>(cid:7)(cid:27)??(cid:27)(cid:15)+(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)v(cid:12)(cid:15)(cid:16)(cid:13)(cid:27)(cid:15)+(cid:5)(cid:26)(cid:3)(cid:10)(cid:6)(cid:10)(cid:5)(cid:5)(cid:5)Shipping and handling costs are included with cost of goods sold in the
Consolidated Results of Operations.
>(cid:6)(cid:3)(cid:11)](cid:30)\(cid:12)(cid:10)(cid:8)(cid:16)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:8)(cid:15)(cid:10)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15) The Company has various stock-based compensation plans consisting
of stock option grants and restricted share awards. Costs resulting from all share-based compensation plans
are required to be recognized in the financial statements. A public entity is required to measure the cost
of employee services received in exchange for an award of equity instruments based on the grant-date fair
value of the award. That cost is recognized over the required service period (usually the vesting period). No
compensation cost is recognized for equity instruments for which employees do not render the required service.
Cash The Company defines “cash” as cash and time deposits with maturities of three months or less when
purchased. Outstanding checks in excess of funds on deposit are included in accounts payable.
=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)(cid:5)<(cid:8)(cid:11)(cid:8)(cid:27)[(cid:12)(cid:19)(cid:13)(cid:8)(cid:5)(cid:5)(cid:5)Receivables are stated at amounts estimated by management to be the net realizable
value. The Company charges off accounts receivable when it becomes apparent based upon age or customer
circumstances that amounts will not be collected.
=(cid:13)(cid:13)(cid:3)#(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)(cid:28)(cid:3)(cid:4)(cid:5)(cid:17)(cid:3)(cid:29)(cid:19)(cid:6)(cid:28)(cid:29)(cid:13)(cid:5)=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)(cid:5)(cid:5)(cid:5)The allowance for doubtful accounts is established through charges to
the provision for bad debts. The Company evaluates the adequacy of the allowance for doubtful accounts on a
periodic basis. The evaluation includes historical trends in collections and write-offs, management’s judgment
of the probability of collecting accounts and management’s evaluation of business risk.
@(cid:15)[(cid:8)(cid:15)(cid:6)(cid:3)(cid:4)(cid:14)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5) Inventories are valued at the lower of average costs or market.
55
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Z(cid:3)(cid:3)(cid:16)#(cid:27)(cid:13)(cid:13)(cid:5) Goodwill represents the excess of cost over fair value of net assets of businesses acquired.
Goodwill is evaluated annually, as of October 1, for impairment or more frequently if an impairment
indicator exists.
@(cid:15)(cid:6)(cid:12)(cid:15)+(cid:27)(cid:19)(cid:13)(cid:8)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)_(cid:3)(cid:15)+(cid:30)_(cid:27)[(cid:8)(cid:16)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10) Intangible assets are amortized over the expected useful
life of the asset. Amortization expense directly attributed to the manufacturing of the Company’s products
is included in cost of goods sold. Amortization expense related to non-manufacturing activities is included
in selling and administrative and other. The Company evaluates the recoverability of intangible assets and
other long-lived assets based on undiscounted projected cash flows, excluding interest and taxes, when factors
indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
*(cid:4)(cid:3)?(cid:8)(cid:4)(cid:6)(cid:14)(cid:22)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:6)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5);m(cid:29)(cid:27)?(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:5)(cid:5)Property, plant and equipment (“PP&E”) is carried at cost and
includes expenditures for new facilities and equipment and those costs which substantially increase the useful
lives or capacity of existing PP&E. In general, depreciation is computed using the straight-line method and
recorded over the estimated useful life of the asset. Factory machinery and equipment is depreciated over
periods ranging from 5 to 25 years with the majority of such assets (principally glass-melting furnaces and
forming machines) depreciated over 7 to 15 years. Buildings and building equipment are depreciated over
periods ranging from 10 to 50 years. Depreciation expense directly attributed to the manufacturing of the
Company’s products is included in cost of goods sold. Depreciation expense related to non-manufacturing
activities is included in selling and administrative. Depreciation expense includes the amortization of assets
recorded under capital leases. Maintenance and repairs are expensed as incurred. Costs assigned to PP&E of
acquired businesses are based on estimated fair values at the date of acquisition. The Company evaluates the
recoverability of PP&E based on undiscounted projected cash flows, excluding interest and taxes, when factors
indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
(cid:17)(cid:8)(cid:4)(cid:27)[(cid:12)(cid:6)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:10)(cid:6)(cid:4)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10) The Company uses forward exchange contracts, options and commodity forward
contracts to manage risks generally associated with foreign exchange rate and commodity market volatility.
Derivative financial instruments are included on the balance sheet at fair value. When appropriate, derivative
instruments are designated as and are effective as hedges, in accordance with accounting principles generally
accepted in the United States. If the underlying hedged transaction ceases to exist, all changes in fair value of
the related derivatives that have not been settled are recognized in current earnings. The Company does not
enter into derivative financial instruments for trading purposes and is not a party to leveraged derivatives. Cash
flows from forward exchange contracts not designated as hedges are classified as an investing activity. Cash
flows of commodity forward contracts are classified as operating activities.
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)(cid:5)&(cid:8)(cid:12)(cid:10)(cid:29)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)(cid:5) Fair value is defined as the amount that would be received to sell an asset or
paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly
transaction between market participants. Generally accepted accounting principles defines a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring fair value as follows:
Level 1: Observable inputs such as quoted prices in active markets;
Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or
indirectly; and
Level 3: Unobservable inputs for which there is little or no market data, which requires the Company to
develop assumptions.
56
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
The carrying amounts reported for cash and short-term loans approximate fair value. In addition, carrying
amounts approximate fair value for certain long-term debt obligations subject to frequently redetermined
interest rates. Fair values for the Company’s significant fixed rate debt obligations are generally based on
published market quotations.
The Company’s derivative assets and liabilities consist of natural gas forwards and foreign exchange
option and forward contracts. The Company uses an income approach to valuing these contracts. Natural gas
forward rates and foreign exchange rates are the significant inputs into the valuation models. These inputs
are observable in active markets over the terms of the instruments the Company holds, and accordingly, the
Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also evaluates
counterparty risk in determining fair values.
<(cid:8)(cid:11)(cid:13)(cid:12)(cid:10)(cid:10)(cid:27)(cid:28)(cid:27)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) Certain reclassifications of prior years’ data have been made to conform to the current
year presentation.
8(cid:8)#(cid:5)=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:27)(cid:15)+(cid:5)>(cid:6)(cid:12)(cid:15)(cid:16)(cid:12)(cid:4)(cid:16)(cid:10)
Revenue from Contracts with Customers - In May 2014, the Financial Accounting Standards Board
(“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with
Customers,” which requires an entity to recognize the amount of revenue to which it expects to be entitled for
the transfer of promised goods or services to customers. In August 2015, the FASB issued ASU No. 2015-14,
“Revenue from Contracts with Customers”, which delayed by one year the effective date of the new revenue
recognition standard, which will be effective for the Company on January 1, 2018. The Company has started an
implementation process, including a review of customer contracts, to evaluate the effect this standard will have
on its consolidated financial statements and related disclosures. At this time, the Company does not expect that
the implementation of this standard in 2018 will have a significant impact on the timing in which it recognizes
revenue. While the Company continues to assess the potential impacts of the new standard, the Company does
not currently expect the adoption of the new standard to have a material impact on consolidated net income or
the consolidated balance sheet. The Company plans to select the modified retrospective transition method upon
adoption effective January 1, 2018.
Leases - In February 2016, the FASB issued ASU No. 2016-02, “Leases”. Under this guidance, lessees
will be required to recognize on the balance sheet a lease liability and a right-of-use asset for all leases, with
the exception of short-term leases. The lease liability represents the lessee’s obligation to make lease payments
arising from a lease, and will be measured as the present value of the lease payments. The right-of-use asset
represents the lessee’s right to use a specified asset for the lease term, and will be measured at the lease
liability amount, adjusted for lease prepayment, lease incentives received and the lessee’s initial direct costs.
The standard also requires a lessee to recognize a single lease cost allocated over the lease term, generally on
a straight-line basis. The new guidance is effective for the Company on January 1, 2019. ASU No. 2016-02 is
required to be applied using the modified retrospective approach for all leases existing as of the effective date
and provides for certain practical expedients. Early adoption is permitted. The Company is currently evaluating
the effects that the adoption of ASU No. 2016-02 will have on the Company’s consolidated financial statements,
and anticipates the new guidance will significantly impact its consolidated financial statements as the Company
has a significant number of leases. As further described in Note 16, Operating Leases, as of December 31, 2016,
the Company had minimum lease commitments under non-cancellable operating leases totaling $205 million.
57
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Credit Losses - In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance requires the measurement
of all expected credit losses for financial assets held at the reporting date based on historical experience,
current conditions and reasonable and supportable forecasts. This guidance also requires enhanced disclosures
regarding significant estimates and judgments used in estimating credit losses. The new guidance is effective
for the Company on January 1, 2020. Early adoption is permitted for fiscal years, and interim periods within
those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the
adoption of this guidance will have on its consolidated financial statements.
Stock Compensation - In March 2016, the FASB issued ASU No. 2016-09, “Improvements to Employee
Share-Based Payment Accounting,” which requires all excess tax benefits or deficiencies to be recognized as
income tax expense or benefit in the income statement. In addition, excess tax benefits should be classified
along with other income tax cash flows as an operating activity in the statement of cash flows. Application of
the standard is required for the Company on January 1, 2017. The Company does not expect a significant impact
in its Consolidated Financial Statements.
Pension Asset Value - In May 2015, the FASB issued ASU No. 2015-07, “Fair Value Measurement
(Topic 820): Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share (or
Its Equivalent).” Under the new guidance, investments measured at net asset value (“NAV”), as a practical
expedient for fair value, are excluded from the fair value hierarchy. Removing investments measured using the
practical expedient from the fair value hierarchy is intended to eliminate the diversity in practice that currently
exists with respect to the categorization of these investments. The new guidance is effective for the Company
on January 1, 2016. The guidance impacted the presentation of certain pension related assets that use NAV as a
practical expedient. See Note 9 for additional information.
(cid:23)Q(cid:5)(cid:5)>(cid:8)+(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)
The Company has four reportable segments based on its geographic locations: Europe, North America,
Latin America and Asia Pacific. In connection with the Company’s acquisition (the “Vitro Acquisition”) of
the food and beverage glass container business of Vitro S.A.B. de C.V. and its subsidiaries as conducted in the
United States, Mexico and Bolivia (the “Vitro Business”) on September 1, 2015 (see Note 19), the Company
has renamed the former South America segment to the Latin America segment. These four segments are aligned
with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass
operations. Certain assets and activities not directly related to one of the regions or to glass manufacturing
are reported with Retained corporate costs and other. These include licensing, equipment manufacturing,
global engineering, and certain equity investments. Retained corporate costs and other also includes certain
headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs
that are global in nature and are not allocable to the reportable segments.
The Company’s measure of profit for its reportable segments is segment operating profit, which consists
of consolidated earnings from continuing operations before interest income, interest expense, and provision
for income taxes and excludes amounts related to certain items that management considers not representative
of ongoing operations as well as certain retained corporate costs. The Company’s management uses segment
operating profit, in combination with selected cash flow information, to evaluate performance and to allocate
resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses
based on both a percentage of sales and direct billings based on the costs of specific services provided.
58
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Financial information regarding the Company’s reportable segments is as follows:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Net sales:
Europe. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
North America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Latin America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reportable segment totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 2,300
2,220
1,432
684
6,636
66
$ 6,702
$ 2,324
2,039
1,064
671
6,098
58
$ 6,156
$ 2,794
2,003
1,159
793
6,749
35
$ 6,784
Segment operating profit:
Europe. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
North America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Latin America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reportable segment totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Items excluded from segment operating profit:
Retained corporate costs and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Charge for asbestos-related costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring, asset impairment and other charges . . . . . . . . . . . . . . . .
Pension settlement charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on China land sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Strategic transaction costs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value inventory adjustments. . . . . . . . . . . . . . .
Acquisition-related fair value intangible adjustments . . . . . . . . . . . . . .
Non-income tax charge. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations before income taxes . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
237
299
269
77
882
(98)
(129)
(98)
71
$
209
265
183
83
740
(70)
(16)
(80)
(23)
(22)
(10)
(272)
356
$
(251)
268
$
$
353
240
227
88
908
(100)
(46)
(91)
(65)
(69)
(230)
307
59
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
;(cid:29)(cid:4)(cid:3)?(cid:8)
North
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
Latin
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
Asia
*(cid:12)(cid:11)(cid:27)(cid:9)(cid:11)
<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:12)(cid:19)(cid:13)(cid:8)(cid:5)
>(cid:8)+(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:10)
Retained
(cid:26)(cid:3)(cid:4)?(cid:5)(cid:26)(cid:3)(cid:10)(cid:6)(cid:10)(cid:5)
and Other
(cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:30)(cid:5)
dated
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:10)
Total assets:
2016 . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . .
Equity investments:
2016 . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . .
Equity earnings:
2016 . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . .
Capital expenditures:
2016 . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . .
Depreciation and amortization
expense:
2016 . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . .
$
$
$
$
$ 2,792 $ 2,522 $ 2,537 $
2,500
1,971
2,807
1,300
2,902
3,214
926 $ 8,777 $
917
1,018
9,126
7,503
358 $ 9,135
9,421
295
7,843
340
78 $
78
81
15 $
16
19
21 $
22
24
12 $
19
17
— $
— $
117 $
145
153
216 $
245
258
217 $
164
169
4 $
7
4
31 $
42
40
163 $
164
188
108 $
97
89
123 $
89
55
59 $
50
34
453 $
400
366
433
409
427
60
60
64
454
402
369
29 $
18
24
1 $
2
3
118 $
120
140
139 $
128
131
173 $
107
79
37 $
40
53
467 $
395
403
11 $
14
15
478
409
418
The Company’s net property, plant and equipment by geographic segment are as follows:
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
749 $ 2,131 $ 2,880
2,961
2,225
736
2,445
1,732
713
U.S.
Non-U.S.
7(cid:3)(cid:6)(cid:12)(cid:13)
The Company’s net sales by geographic segment are as follows:
U.S.
Non-U.S.
7(cid:3)(cid:6)(cid:12)(cid:13)
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2,124 $ 4,578 $ 6,702
6,156
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6,784
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1,939
1,852
4,217
4,932
Intercompany sales in Latin America totaled $195 million, $101 million and $0 for the years ended
December 31, 2016, 2015, and 2014, respectively.
Operations outside the U.S. that accounted for more than 10% of consolidated net sales from continuing
operations were in France (2015 — 10%, 2014 — 11%).
60
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:20)Q(cid:5)(cid:5)@(cid:15)[(cid:8)(cid:15)(cid:6)(cid:3)(cid:4)(cid:27)(cid:8)(cid:10)
Major classes of inventory are as follows:
Finished goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Raw materials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
$
827
118
38
983
$
858
113
36
$ 1,007
jQ(cid:5)(cid:5);m(cid:29)(cid:27)(cid:6)(cid:14)(cid:5)@(cid:15)[(cid:8)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
At December 31, 2016 the Company’s ownership percentage in affiliates include:
=(cid:28)(cid:9)(cid:13)(cid:27)(cid:12)(cid:6)(cid:8)(cid:10)
BJC O-I Glass Pte. Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CO Vidrieria SARL (“COV”) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rocky Mountain Bottle Company . . . . . . . . . . . . . . . . . . . . . . . . . .
Tata Chemical (Soda Ash) Partners . . . . . . . . . . . . . . . . . . . . . . . . .
Vetrerie Meridionali SpA (“VeMe”) . . . . . . . . . . . . . . . . . . . . . . . .
Vetri Speciali SpA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I
%#(cid:15)(cid:8)(cid:4)(cid:10)(cid:7)(cid:27)?(cid:5)
*(cid:8)(cid:4)(cid:11)(cid:8)(cid:15)(cid:6)(cid:12)+(cid:8)
\(cid:29)(cid:10)(cid:27)(cid:15)(cid:8)(cid:10)(cid:10)(cid:5)7(cid:14)?(cid:8)
50% Glass container manufacturer
50% Glass container manufacturer
50% Glass container manufacturer
25% Soda ash supplier
50% Glass container manufacturer
50% Specialty glass manufacturer
Summarized information pertaining to the Company’s equity affiliates follows:
Equity in earnings:
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dividends received. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
19
41
60
38
$
$
$
23
37
60
53
$
$
$
23
41
64
54
Summarized combined financial information for equity affiliates is as follows (unaudited):
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
At end of year:
Current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other liabilities and deferred items. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total liabilities and deferred items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
451
1,025
1,476
200
368
568
908
$
$
430
959
1,389
203
211
414
975
(cid:23)(cid:24)(cid:21)(cid:25)
2015
61
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5)(cid:14)(cid:8)(cid:12)(cid:4)u
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
$
755
182
134
$
$
$
719
193
139
$
$
$
752
198
150
Based on an evaluation of each of the Company’s equity investments for the three years ending December 31,
2016, no investments exceeded the significant subsidiary thresholds per Rule 3-09 of Regulation S-X. As such,
separate financial statements for the Company’s equity investments are not required to be filed.
The Company made purchases of approximately $176 million and $161 million from equity affiliates in
2016 and 2015, respectively, and owed approximately $76 million and $66 million to equity affiliates as of
December 31, 2016 and 2015, respectively.
There is a difference of approximately $12 million as of December 31, 2016, between the amount at which
certain investments are carried and the amount of underlying equity in net assets. The portion of the difference
related to inventory or amortizable assets is amortized as a reduction of the equity earnings. The remaining
difference is considered goodwill.
!Q(cid:5)(cid:5)Z(cid:3)(cid:3)(cid:16)#(cid:27)(cid:13)(cid:13)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)@(cid:15)(cid:6)(cid:12)(cid:15)+(cid:27)(cid:19)(cid:13)(cid:8)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
Goodwill
The changes in the carrying amount of goodwill for the years ended December 31, 2016, 2015 and 2014 are
as follows:
Balance as of January 1, 2014 . . . . . . . . . . . . . . . . .
Translation effects . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance as of December 31, 2014 . . . . . . . . . . . . . .
Acquisition related adjustments. . . . . . . . . . . . . . . .
Translation effects . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance as of December 31, 2015 . . . . . . . . . . . . . .
Acquisition related adjustments. . . . . . . . . . . . . . . .
Translation effects . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance as of December 31, 2016 . . . . . . . . . . . . . .
;(cid:29)(cid:4)(cid:3)?(cid:8)
$ 1,044
(118)
926
(86)
840
(32)
808
$
North
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
734
$
(11)
723
316
(19)
1,020
15
3
$ 1,038
Latin
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
276
$
(37)
239
480
(95)
624
26
(39)
611
$
Other
$
$
7(cid:3)(cid:6)(cid:12)(cid:13)
$ 2,059
(166)
1,893
796
(200)
2,489
41
(68)
$ 2,462
5
5
5
5
The acquisition related adjustments in 2016 and 2015 primarily relate to the Vitro Acquisition (see Note 19).
Goodwill for the Asia Pacific segment is $0 and net of accumulated impairment losses of $1,135 million as
of December 31, 2016, 2015 and 2014.
Goodwill is tested for impairment annually as of October 1 (or more frequently if impairment indicators
arise) using a two-step process. Step 1 compares the business enterprise value (“BEV”) of each reporting unit
with its carrying value. The BEV is computed based on estimated future cash flows, discounted at the weighted
average cost of capital of a hypothetical third-party buyer. If the BEV is less than the carrying value for any
reporting unit, then Step 2 must be performed. Step 2 compares the implied fair value of goodwill with the
carrying amount of goodwill. Any excess of the carrying value of the goodwill over the implied fair value will
be recorded as an impairment loss. The calculations of the BEV in Step 1 and the implied fair value of goodwill
62
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
in Step 2 are based on significant unobservable inputs, such as price trends, customer demand, material costs,
discount rates and asset replacement costs, and are classified as Level 3 in the fair value hierarchy.
During the fourth quarter of 2016, the Company completed its annual impairment testing and determined
that no impairment existed.
Intangible assets
On September 1, 2015, the Company acquired customer list intangibles as part of the Vitro Acquisition
(see Note 19).
Customer list intangible assets are amortized using the accelerated amortization method over their 20
year lives. Net intangible asset values were $464 million and $597 million for the years ended December 31,
2016 and 2015, respectively. Amortization expense for intangible assets was $39 million, $21 million and $1
million for the years ended December 31, 2016, 2015 and 2014, respectively. Estimated amortization related to
intangible assets through 2021 is as follows: 2017, $44 million; 2018, $44 million; 2019, $42 million; 2020, $41
million; and 2021, $39 million. No impairment existed on these assets at December 31, 2016.
The Company has determined that the fair value measurements related to the customer list intangibles are
based on significant unobservable inputs and are classified as Level 3 in the fair value hierarchy.
(cid:25)Q(cid:5)(cid:5)*(cid:4)(cid:8)?(cid:12)(cid:27)(cid:16)(cid:5);:?(cid:8)(cid:15)(cid:10)(cid:8)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
Prepaid expenses and other current assets at December 31, 2016 and 2015 are as follows:
Prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Value added taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets (noncurrent) consist of the following at December 31, 2016 and 2015:
Deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred returnable packaging costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Repair part inventories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capitalized software. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Value added taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred finance fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
$
$
$
50
46
103
199
(cid:23)(cid:24)(cid:21)(cid:25)
185
115
107
85
22
5
83
602
$
$
$
$
52
195
119
366
2015
177
110
118
86
17
6
85
599
Capitalized software includes costs related to the acquisition and development of internal-use software.
These costs are amortized over the estimated useful life of the software. Amortization expense for capitalized
software was $13 million, $19 million and $17 million for 2016, 2015 and 2014, respectively. Estimated
amortization related to capitalized software through 2021 is as follows: 2017, $14 million; 2018, $14 million;
2019, $13 million; 2020, $12 million; and 2021, $11 million.
63
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
"Q(cid:5)(cid:5)(cid:17)(cid:8)(cid:4)(cid:27)[(cid:12)(cid:6)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:10)(cid:6)(cid:4)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
The Company has certain derivative assets and liabilities which consist of natural gas forwards and foreign
exchange option and forward contracts. The Company uses an income approach to value these contracts.
Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models. These
inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly,
the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also
evaluates counterparty risk in determining fair values.
Commodity Forward Contracts Designated as Cash Flow Hedges
In North America, the Company enters into commodity forward contracts related to forecasted natural gas
requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for
natural gas and the related volatility in cash flows. The Company continually evaluates the natural gas market
and related price risk and periodically enters into commodity forward contracts in order to hedge a portion of its
usage requirements. The majority of the sales volume in North America is tied to customer contracts that contain
provisions that pass the price of natural gas to the customer. In certain of these contracts, the customer has the
option of fixing the natural gas price component for a specified period of time. At December 31, 2016 and 2015,
the Company had entered into commodity forward contracts covering approximately 12,300,000 MM BTUs
and 7,300,000 MM BTUs, respectively, primarily related to customer requests to lock the price of natural gas.
The Company accounts for the above forward contracts as cash flow hedges at December 31, 2016
and recognizes them on the balance sheet at fair value. The effective portion of changes in the fair value of
a derivative that is designated as, and meets the required criteria for, a cash flow hedge is recorded in the
Accumulated Other Comprehensive Income component of share owners’ equity (“OCI”) and reclassified
into earnings in the same period or periods during which the underlying hedged item affects earnings. An
unrecognized gain of $6 million at December 31, 2016 and an unrecognized loss of $4 million at December 31,
2015 related to the commodity forward contracts were included in Accumulated OCI, and will be reclassified
into earnings over the next twelve to twenty-four months. Any material portion of the change in the fair
value of a derivative designated as a cash flow hedge that is deemed to be ineffective is recognized in current
earnings. The ineffectiveness related to these natural gas hedges for the year ended December 31, 2016 and
2015 was not material.
The effect of the commodity forward contracts on the results of operations for the years ended December
31, 2016, 2015 and 2014 is as follows:
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:12)(cid:27)(cid:15)(cid:5)/(cid:13)(cid:3)(cid:10)(cid:10)6(cid:5)<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)w(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)%(cid:26)@(cid:5)(cid:3)(cid:15)
(cid:26)(cid:3)(cid:18)(cid:18)(cid:3)(cid:16)(cid:27)(cid:6)(cid:14)(cid:5)(cid:2)(cid:3)(cid:4)#(cid:12)(cid:4)(cid:16)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:10)
/;(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:27)[(cid:8)(cid:5)*(cid:3)(cid:4)(cid:6)(cid:27)(cid:3)(cid:15)6
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2014
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:12)(cid:27)(cid:15)(cid:5)/(cid:13)(cid:3)(cid:10)(cid:10)6(cid:5)<(cid:8)(cid:11)(cid:13)(cid:12)(cid:10)(cid:10)(cid:27)(cid:28)(cid:27)(cid:8)(cid:16)(cid:5)(cid:28)(cid:4)(cid:3)(cid:18)
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)%(cid:26)@(cid:5)(cid:27)(cid:15)(cid:6)(cid:3)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)
/(cid:4)(cid:8)?(cid:3)(cid:4)(cid:6)(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)(cid:11)(cid:3)(cid:10)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:3)(cid:3)(cid:16)(cid:10)(cid:5)(cid:10)(cid:3)(cid:13)(cid:16)6
/;(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:27)[(cid:8)(cid:5)*(cid:3)(cid:4)(cid:6)(cid:27)(cid:3)(cid:15)6
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2014
$
7 $
(4) $
3
$
— $
(1) $
2
Foreign Exchange Derivative Contracts and not Designated as Hedging Instruments
The Company may enter into short-term forward exchange or option agreements to purchase foreign
currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign
currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated
in currencies other than the subsidiaries’ functional currency. The Company may also use forward exchange
agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables,
64
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
payables and loans, not denominated in, or indexed to, their functional currencies. The Company records these
short-term forward exchange agreements on the balance sheet at fair value and changes in the fair value are
recognized in current earnings.
At December 31, 2016 and 2015, the Company had outstanding forward exchange and option agreements
denominated in various currencies covering the equivalent of approximately $490 million and $790 million,
respectively, related primarily to intercompany transactions and loans.
The effect of the foreign exchange derivative contracts on the results of operations for the years ended
December 31, 2016, 2015 and 2014 is as follows:
_(cid:3)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)(cid:3)(cid:28)(cid:5)Z(cid:12)(cid:27)(cid:15)(cid:5)/_(cid:3)(cid:10)(cid:10)6
<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)w(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)(cid:3)(cid:15)
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5);:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:10)
Other expense, net
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)Z(cid:12)(cid:27)(cid:15)(cid:5)/_(cid:3)(cid:10)(cid:10)6
<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)w(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)(cid:3)(cid:15)
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5);:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:10)
2015
6 $
10 $
2014
(8)
(cid:23)(cid:24)(cid:21)(cid:25)
$
Balance Sheet Classification
The Company records the fair values of derivative financial instruments on the balance sheet as follows:
(a) receivables if the instrument has a positive fair value and maturity within one year, (b) deposits, receivables,
and other assets if the instrument has a positive fair value and maturity after one year, and (c) other accrued
liabilities or other liabilities (current) if the instrument has a negative fair value and maturity within one year.
The following table shows the amount and classification (as noted above) of the Company’s derivatives as
of December 31, 2016 and 2015:
Asset Derivatives:
Derivatives designated as hedging instruments:
Commodity futures contracts . . . . . . . . . . . . . . . . . . . . . . .
Derivatives not designated as hedging instruments:
Foreign exchange derivative contracts . . . . . . . . . . . . . . . .
Total asset derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Liability Derivatives:
Derivatives designated as hedging instruments:
Commodity futures contracts . . . . . . . . . . . . . . . . . . . . . . .
Derivatives not designated as hedging instruments:
Foreign exchange derivative contracts . . . . . . . . . . . . . . . .
Total liability derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
\(cid:12)(cid:13)(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)>(cid:7)(cid:8)(cid:8)(cid:6)(cid:5)
_(cid:3)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
b
a
c
c
$
$
$
$
$
6
9
15
$
$
$
— $
5
5
$
—
14
14
3
2
5
$Q(cid:5)(cid:5)<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+(cid:5)=(cid:11)(cid:11)(cid:4)(cid:29)(cid:12)(cid:13)(cid:10)(cid:22)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:5)@(cid:18)?(cid:12)(cid:27)(cid:4)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:26)(cid:3)(cid:10)(cid:6)(cid:10)(cid:5)<(cid:8)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)(cid:6)(cid:3)(cid:5)(cid:26)(cid:13)(cid:3)(cid:10)(cid:8)(cid:16)(cid:5)(cid:2)(cid:12)(cid:11)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)
The Company continually reviews its manufacturing footprint and operating cost structure and may
decide to close operations or reduce headcount to gain efficiencies, integrate acquired operations, reduce future
expenses and other market factors. The Company incurs costs associated with these actions including employee
65
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
severance and benefits, other exit costs such as those related to contract terminations, and asset impairment
charges. The Company also may incur other costs related to closed facilities including environmental
remediation, clean up, dismantling and preparation for sale or other disposition.
The Company accounts for restructuring and other costs under applicable provisions of generally accepted
accounting principles. Charges for employee severance and related benefits are generally accrued based on
contractual arrangements with employees or their representatives. Other exit costs are accrued based on the
estimated cost to settle related contractual arrangements. Estimated environmental remediation costs are
accrued when specific claims have been received or are probable of being received.
The Company’s decisions to curtail selected production capacity have resulted in write downs of certain
long-lived assets to the extent their carrying amounts exceeded fair value or fair value less cost to sell. The
Company classified the significant assumptions used to determine the fair value of the impaired assets as Level
3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements.
When a decision is made to take these actions, the Company manages and accounts for them
programmatically apart from the on-going operations of the business. Information related to major programs
(as in the case of the European Asset Optimization and Asia Pacific Restructuring programs below) are
presented separately. Minor initiatives are presented on a combined basis as Other Restructuring Actions. These
restructuring initiatives taken by the Company are not related to the European Asset Optimization program or
the Asia Pacific restructuring plan. When charges related to major programs are completed, remaining accrual
balances are classified with Other Restructuring Actions.
European Asset Optimization
In 2011, the Company initiated the European Asset Optimization program to increase the efficiency and
capability of its European operations and to better align its European manufacturing footprint with market and
customer needs. This program involved making additional investments in certain facilities and addressing
assets with higher cost structures. As part of this program, the Company recorded charges of $0, $0, and $1
million for the years ended 2016, 2015 and 2014, respectively for employee costs, write-down of assets, and
environmental remediation related to decisions to close furnaces and manufacturing facilities in Europe. The
Company recorded total cumulative charges of $127 million and does not expect to execute any further actions
under this program.
Asia Pacific Restructuring
Since 2011, the Company has implemented a restructuring plan in its Asia Pacific segment, primarily
related to aligning its supply base with lower demand in the region. As part of this plan, the Company recorded
charges of $4 million, $5 million and $73 million for the years ended 2016, 2015 and 2014, respectively,
for employee costs, write-down of assets, and pension charges related to furnace closures and additional
restructuring activities. The Company recorded total cumulative charges of $224 million and does not expect to
execute any further actions under this program.
Other Restructuring Actions
In 2016, the Company recorded charges of $94 million for other restructuring actions. These charges
primarily represented employee costs, write-down of assets, and other exit costs of $64 million for plant
closures in Latin America, Europe, and North America and $30 million related to other restructuring actions.
The Company took certain other restructuring actions and recorded charges in 2015 of $58 million. These
66
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
charges primarily related to employee costs, write-down of assets and other exit costs totaling $14 million for
a plant closure and furnace closure in Latin America, $38 million for a plant closure in North America and
$6 million for other restructuring actions. In 2014, the Company took certain other restructuring actions and
recorded charges of $2 million for employee costs related to global headcount reduction initiatives.
The following table presents information related to restructuring, asset impairment and other costs related
to closed facilities from January 1, 2015 through December 31, 2015:
Balance at January1, 2015 . . . . . . . . . . . . . . . . . . .
Charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Write-down of assets to net realizable value. . . . . .
Net cash paid, principally severance and
related benefits . . . . . . . . . . . . . . . . . . . . . . . . .
Other, including foreign exchange translation . . . .
Balance at December 31, 2015 . . . . . . . . . . . . . . . .
;(cid:29)(cid:4)(cid:3)?(cid:8)(cid:12)(cid:15)(cid:5)
Asset
%?(cid:6)(cid:27)(cid:18)(cid:27)w(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
12
$
=(cid:10)(cid:27)(cid:12)(cid:5)*(cid:12)(cid:11)(cid:27)(cid:9)(cid:11)(cid:5)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
12
$
5
(4)
(5)
(4)
3
$
(5)
(1)
7
$
Other
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+(cid:5)
=(cid:11)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
$
$
36
58
(27)
(28)
(6)
33
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:5)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
60
$
63
(31)
(38)
(11)
43
$
The following table presents information related to restructuring, asset impairment and other costs related
to closed facilities from January 1, 2016 through December 31, 2016:
Balance at January1, 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Write-down of assets to net realizable value. . . . . . . . . . . . . . . . . .
Net cash paid, principally severance and related benefits . . . . . . .
Other, including foreign exchange translation . . . . . . . . . . . . . . . .
Balance at December 31, 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . .
=(cid:10)(cid:27)(cid:12)(cid:5)*(cid:12)(cid:11)(cid:27)(cid:9)(cid:11)(cid:5)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
7
$
4
(3)
(1)
7
$
Other
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+(cid:5)
=(cid:11)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
$
$
36
94
(28)
(21)
(3)
78
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:5)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
43
$
98
(28)
(24)
(4)
85
$
The restructuring accrual balance represents the Company’s estimates of the remaining future cash amounts
to be paid related to the actions noted above. As of December 31, 2016, the Company’s estimates include
approximately $67 million for employee benefits costs, $16 million for environmental remediation costs, and $2
million for other exit costs.
(cid:31)Q(cid:5)(cid:5)*(cid:8)(cid:15)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)*(cid:3)(cid:10)(cid:6)(cid:4)(cid:8)(cid:6)(cid:27)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:10)
Pension Benefit Plans
The Company has defined benefit pension plans covering a substantial number of employees located in
the United States and several other non-U.S. jurisdictions. Benefits generally are based on compensation for
salaried employees and on length of service for hourly employees. The Company’s policy is to fund pension
plans such that sufficient assets will be available to meet future benefit requirements. The Company’s defined
benefit pension plans use a December 31 measurement date. The following tables relate to the Company’s
principal defined benefit pension plans.
67
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
The changes in the pension benefit obligations for the year are as follows:
Obligations at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . .
Change in benefit obligations:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Actuarial (gain) loss, including the effect of change in
discount rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Curtailment, settlement, and plan amendment . . . . . . . . . .
Acquisitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Participant contributions . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . .
Net change in benefit obligations . . . . . . . . . . . . . . . . .
Obligations at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
$ 2,190
2015
$ 2,428
(cid:23)(cid:24)(cid:21)(cid:25)
$ 1,210
2015
$ 1,311
15
90
36
(200)
(175)
24
96
16
44
(107)
160
(252)
1
2
(71)
3
(129)
25
$ 1,235
15
44
(9)
37
1
(58)
(131)
(101)
$ 1,210
(234)
$ 1,956
(238)
$ 2,190
The changes in the fair value of the pension plans’ assets for the year are as follows:
Fair value at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in fair value:
Actual gain (loss) on plan assets . . . . . . . . . . . . . . . . . . . . .
Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Employer contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Participant contributions . . . . . . . . . . . . . . . . . . . . . . . . . . .
Settlements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net change in fair value of assets . . . . . . . . . . . . . . . . .
Fair value at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
$ 1,909
2015
$ 2,190
(cid:23)(cid:24)(cid:21)(cid:25)
$ 1,012
2015
$ 1,094
118
(175)
2
(200)
(32)
(252)
2
139
(71)
38
2
(255)
$ 1,654
1
(281)
$ 1,909
(111)
2
(1)
$ 1,011
42
(58)
15
1
22
(104)
(82)
$ 1,012
The Company recognizes the funded status of each pension benefit plan on the balance sheet. The
funded status of each plan is measured as the difference between the fair value of plan assets and actuarially
calculated benefit obligations as of the balance sheet date. Actuarial gains and losses are accumulated in Other
Comprehensive Income and the portion of each plan that exceeds 10% of the greater of that plan’s assets or
projected benefit obligation is amortized to income on a straight-line basis over the average remaining service
period of employees still accruing benefits or the expected life of participants not accruing benefits if all, or
almost all, of the plan’s participants are no longer accruing benefits.
68
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
The funded status of the pension plans at year end is as follows:
Plan assets at fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Projected benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Plan assets less than projected benefit obligations . . . . . . .
Items not yet recognized in pension expense:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service cost (credit) . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
$ 1,654
1,956
(302)
2015
$ 1,909
2,190
(281)
(cid:23)(cid:24)(cid:21)(cid:25)
$ 1,011
1,235
(224)
2015
$ 1,012
1,210
(198)
1,046
1
1,047
745
1,145
2
1,147
866
$
$
352
(1)
351
127
$
320
(1)
319
121
The net amount recognized is included in the Consolidated Balance Sheets at December 31, 2016 and 2015
as follows:
Pension assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current pension liability, included with other
accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
— $
— $
40
$
32
(7)
(295)
1,047
745
$
(1)
(280)
1,147
866
$
$
(7)
(257)
351
127
$
(6)
(224)
319
121
The following changes in plan assets and benefit obligations were recognized in accumulated other
comprehensive income at December 31, 2016 and 2015 as follows (amounts are pretax):
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Current year actuarial (gain) loss . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . .
Settlement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
66
(67)
(98)
(99)
Translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
95
(74)
$
87
(12)
21
75
(43)
32
$
$
(99) $
21
$
15
(15)
—
(31)
(31)
The accumulated benefit obligation for all defined benefit pension plans was $3,126 million and $3,306
million at December 31, 2016 and 2015, respectively.
69
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
The components of the net pension expense for the year are as follows:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected asset return . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service credit . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amortization . . . . . . . . . . . . . . . . . . . . . . . . .
Net expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S.
2015
$ 24
96
(170)
(cid:23)(cid:24)(cid:21)(cid:25)
$ 15
90
(149)
2014
$ 22
105
(176)
(cid:23)(cid:24)(cid:21)(cid:25)
$ 16
44
(65)
Non-U.S.
2015
$ 15
44
(67)
2014
$ 23
69
(86)
67
74
68
67
$ 23
74
$ 24
68
$ 19
$
13
13
8
15
15
7
$
18
18
$ 24
Effective January 1, 2016 the Company amended its salary pension plan in North America to freeze future
pension benefits. This action required an obligation remeasurement for the curtailment of benefits, which
resulted in a reduction of the Company’s pension expense.
In 2016, the Company settled a portion of the U.S. Hourly Pension Plan obligation, which resulted in
a settlement charge of $98 million. In 2014, the Company settled a portion of the U.S. Salary Pension Plan
pension obligation, which resulted in a settlement charge of $30 million. On October 1, 2014, the Company
settled the liability associated with its pension plan in the Netherlands, resulting in a settlement charge of
approximately $35 million. Non-U.S. pension expense excludes $3 million of pension settlement costs that were
recorded in restructuring expense in 2014. The table above excludes these charges.
Amounts that are expected to be amortized from accumulated other comprehensive income into net pension
expense during 2017:
Amortization:
U.S.
Non-U.S.
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
57
1
58
$
$
16
16
The following information is for plans with projected and accumulated benefit obligations in excess of the
fair value of plan assets at year end:
*(cid:4)(cid:3)x(cid:8)(cid:11)(cid:6)(cid:8)(cid:16)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:9)(cid:6)(cid:5)%(cid:19)(cid:13)(cid:27)+(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5);:(cid:11)(cid:8)(cid:8)(cid:16)(cid:10)(cid:5)
(cid:6)(cid:7)(cid:8)(cid:5)(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:9)(cid:6)(cid:5)%(cid:19)(cid:13)(cid:27)+(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)
;:(cid:11)(cid:8)(cid:8)(cid:16)(cid:10)(cid:5)(cid:6)(cid:7)(cid:8)(cid:5)(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
U.S.
Non-U.S.
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Projected benefit obligations . . . . . . . . .
Accumulated benefit obligation . . . . . .
Fair value of plan assets . . . . . . . . . . . .
$ 1,956 $ 2,190 $ 897 $ 876 $ 1,956 $ 2,190 $ 897 $ 876
850
1,956
645
1,654
1,956
1,654
2,160
1,909
2,160
1,909
867
632
867
632
850
645
70
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
The weighted average assumptions used to determine benefit obligations are as follows:
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rate of compensation increase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.17% 4.43% 2.94% 3.68%
2.97% 2.90% 2.84%
N/A
The weighted average assumptions used to determine net periodic pension costs are as follows:
(cid:23)(cid:24)(cid:21)(cid:25)
U.S.
2015
2014
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Non-U.S.
Discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rate of compensation increase . . . . . . . . . . . . . . .
Expected long-term rate of return on assets . . . . .
4.43% 4.05% 4.81% 3.68% 3.65% 4.14%
2.97% 2.96% 2.97% 2.84% 2.89% 3.31%
7.50% 8.00% 8.00% 7.15% 7.21% 7.23%
Future benefits are assumed to increase in a manner consistent with past experience of the plans, which, to
the extent benefits are based on compensation, includes assumed salary increases as presented above.
For 2016, the Company’s weighted average expected long-term rate of return on assets was 7.50% for
the U.S. plans and 7.15% for the non-U.S. plans. In developing this assumption the Company considered its
historical 10-year average return (through December 31, 2016) and evaluated input from its third party pension
plan asset consultants, including their review of asset class return expectations.
It is the Company’s policy to invest pension plan assets in a diversified portfolio consisting of an array of
asset classes within established target asset allocation ranges. The investment risk of the assets is limited by
appropriate diversification both within and between asset classes. The assets for the U.S. plans are maintained
in a group trust. The U.S. plans hold no individual assets other than the investment in the group trust. The
assets of the group trust and the Company’s non-U.S. plans are primarily invested in a broad mix of domestic
and international equities, domestic and international bonds, and real estate, subject to the target asset allocation
ranges. The assets are managed with a view to ensuring that sufficient liquidity will be available to meet
expected cash flow requirements.
The investment valuation policy of the Company is to value investments at fair value. All investments are
valued at their respective net asset values. Equity securities for which market quotations are readily available
are valued at the last reported sales price on their principal exchange on valuation date or official close for
certain markets. Fixed income investments are valued by an independent pricing service. Investments in
registered investment companies or collective pooled funds are valued at their respective net asset values.
Short-term investments are stated at amortized cost, which approximates fair value. The fair value of real estate
is determined by periodic appraisals.
In accordance with the Company’s adoption of ASU No. 2015-07 in 2016, certain investments measured
at net asset value (“NAV”), as a practical expedient for fair value, have been excluded from the fair value
hierarchy. The fair value measurements tables presented below have been amended to conform to the current
year presentation under ASU No. 2015-07. See Note 1 for more information.
The Company’s U.S. pension plan assets held in the group trust are measured at net asset value in the fair
value hierarchy. The total U.S. plan assets amounted to $1,654 million and $1,909 million as of December 31,
2016 and 2015, respectively. In 2016, the U.S. plan assets consisted of approximately 62% equity securities,
31% debt securities, and 7% real estate and other.
71
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
In 2016, the non-U.S. plan assets consisted of approximately 41% equity securities, 42% debt securities,
and 17% real estate and other. The following table sets forth by level, within the fair value hierarchy, the
Company’s non-U.S. pension plan assets at fair value as of December 31, 2016 and 2015:
Cash and cash equivalents . . . . . . . . .
Equity securities . . . . . . . . . . . . . . . . .
Debt securities . . . . . . . . . . . . . . . . . . .
Real estate . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . .
Investments measured at net
asset value . . . . . . . . . . . . . . . . . .
Total non-U.S. assets at fair value. . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:23)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:20)
7(cid:3)(cid:6)(cid:12)(cid:13)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:21)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:23)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:20)
7(cid:3)(cid:6)(cid:12)(cid:13)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:21)
$
24 $
— $
— $
37
2
4
6
10
37
39 $
$
61 $
24 $
—
39
4
43
$
30 $
— $
— $
16
24
24 $
46 $
5
6
11
30
—
16
5
30
$ 901
$
1,011
$ 931
$
1,012
The following is a reconciliation of the Company’s pension plan assets recorded at fair value using
significant unobservable inputs (Level 3):
Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net increase (decrease) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
11
(1)
10
$
$
5
6
11
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The net increase (decrease) in the fair value of the Company’s Level 3 pension plan assets is primarily due
to purchases and sales of unlisted real estate funds. The change in the fair value of Level 3 pension plan assets
due to actual return on those assets was immaterial in 2016.
In order to maintain minimum funding requirements, the Company is required to make contributions to its
defined benefit pension plans of $32 million in 2017.
The following estimated future benefit payments, which reflect expected future service, as appropriate, are
expected to be paid in the years indicated:
Year(s)
2017. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2021. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2022-2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
U.S.
157
146
145
143
140
656
Non-U.S.
53
$
51
54
57
60
343
72
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
The Company also sponsors several defined contribution plans for all salaried and hourly U.S. employees,
and employees in Canada, the U.K., The Netherlands and Australia. Participants’ contributions are based on
their compensation. The Company matches contributions of participants, up to various limits, in substantially
all plans. Company contributions to these plans amounted to $34 million in 2016, $29 million in 2015, and $19
million in 2014.
Postretirement Benefits Other Than Pensions
The Company provides retiree health care and life insurance benefits covering certain U.S. salaried and
hourly employees, and substantially all employees in Canada. Benefits provided by the Company for hourly
retirees are determined by collective bargaining. Employees are generally eligible for benefits upon retirement
and completion of a specified number of years of creditable service. The Company uses a December 31
measurement date to measure its postretirement benefit obligations.
The changes in the postretirement benefit obligations for the year are as follows:
Obligations at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . .
Change in benefit obligations:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Actuarial (gain) loss, including the effect of changing
discount rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net change in benefit obligations . . . . . . . . . . . . . . . . .
Obligations at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
97
$
111
$
68
$
81
4
(1)
(9)
1
(5)
92
$
4
(10)
(8)
1
3
9
(2)
2
(14)
97
$
$
13
81
$
1
3
(1)
(3)
(13)
(13)
68
The funded status of the postretirement benefit plans at year end is as follows:
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
(92) $
(97) $
(81) $
(68)
(21)
30
9
(83) $
(23)
38
15
(82) $
(6)
3
(6)
(87) $
3
(65)
Postretirement benefit obligations . . . . . . . . . . . . . . . . . . . . . . .
Items not yet recognized in net postretirement benefit cost:
Actuarial gain (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
73
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
The net amount recognized is included in the Consolidated Balance Sheets at December 31, 2016 and 2015
as follows:
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Current nonpension postretirement benefit, included with Other
accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Nonpension postretirement benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ (8) $ (8) $ (3) $ (2)
(66)
3
$ (83) $ (82) $ (87) $ (65)
(78)
(6)
(89)
15
(84)
9
The following changes in benefit obligations were recognized in accumulated other comprehensive income
at December 31, 2016 and 2015 as follows (amounts are pretax):
Current year actuarial (gain) loss. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of prior service credit. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S.
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$ (1) $ (10) $
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25) 2015
$ —
9
(1)
8
6
(2)
8
$ (4) $
$
9
$ —
The components of the net postretirement benefit cost for the year are as follows:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Curtailment gain
Amortization:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service credit . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amortization . . . . . . . . . . . . . . . . . . . . . . . . .
Net postretirement benefit (income) cost. . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
U.S.
2015
$ — $ — $ — $
4
2014
4
5
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25) 2015 2014
1
4
1
3
1
3
$
$
1
(7)
(6)
2
(8)
(6)
$ (2) $ (2) $ (1) $
2
(8)
(6)
—
$
4
—
$
4
—
5
Amounts that are expected to be amortized from accumulated other comprehensive income into net
postretirement benefit cost during 2017:
Amortization:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
(1) $
7
6
$
—
—
U.S.
Non-U.S.
74
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Amortization included in net postretirement benefit cost is based on the average remaining service of
employees. The weighted average discount rates used to determine the accumulated postretirement benefit
obligation and net postretirement benefit cost are as follows:
Accumulated postretirement benefit obligation. .
Net postretirement benefit cost . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)(cid:5)(cid:5)(cid:5)(cid:5)
4.11%
4.34%
U.S.
2015
4.35%
3.99%
2014
4.00%
4.63%
(cid:23)(cid:24)(cid:21)(cid:25)(cid:5)(cid:5)(cid:5)(cid:5)
3.55%
3.80%
Non-U.S.
2015
3.80%
3.75%
2014
3.75%
4.47%
The weighted average assumed health care cost trend rates at December 31 are as follows:
Health care cost trend rate assumed for next year . . . . . . . . . . . . . . . . .
Rate to which the cost trend rate is assumed to decline
U.S.
Non-U.S.
(cid:23)(cid:24)(cid:21)(cid:25)(cid:5)(cid:5)(cid:5)(cid:5)
6.40%
2015
6.60%
(cid:23)(cid:24)(cid:21)(cid:25)(cid:5)(cid:5)(cid:5)(cid:5)
5.00%
2015
5.00%
(ultimate trend rate) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Year that the rate reaches the ultimate trend rate . . . . . . . . . . . . . . . . . .
5.00%
2024
5.00%
2024
5.00%
N/A
5.00%
N/A
Assumed health care cost trend rates affect the amounts reported for the postretirement benefit plans.
A one-percentage-point change in assumed health care cost trend rates would have the following effects:
Effect on total of service and interest cost . . . . . . . . . . . . . . . . .
Effect on accumulated postretirement benefit obligations. . . . .
U.S.
(cid:21)(cid:30)*(cid:8)(cid:4)(cid:11)(cid:8)(cid:15)(cid:6)(cid:12)+(cid:8)(cid:30)*(cid:3)(cid:27)(cid:15)(cid:6)
@(cid:15)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8) (cid:17)(cid:8)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)
$
— $
4
— $
(3)
Non-U.S.
(cid:21)(cid:30)*(cid:8)(cid:4)(cid:11)(cid:8)(cid:15)(cid:6)(cid:12)+(cid:8)(cid:30)*(cid:3)(cid:27)(cid:15)(cid:6)
@(cid:15)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8) (cid:17)(cid:8)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)
(1)
(10)
1
13
$
Amortization included in net postretirement benefit cost is based on the average remaining service
of employees.
The following estimated future benefit payments, which reflect expected future service, as appropriate, are
expected to be paid in the years indicated:
Year(s)
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2022 - 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
U.S.
8
8
8
8
7
30
$
Non-U.S.
3
3
3
3
3
18
Other U.S. hourly retirees receive health and life insurance benefits from a multi-employer trust established
by collective bargaining. Payments to the trust as required by the bargaining agreements are based upon
specified amounts per hour worked and were $6 million in 2016, $6 million in 2015 and $6 million in 2014.
Postretirement health and life benefits for retirees of foreign subsidiaries are generally provided through the
national health care programs of the countries in which the subsidiaries are located.
75
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:21)(cid:24)Q(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)7(cid:12):(cid:8)(cid:10)
The provision for income taxes was calculated based on the following components of earnings (loss) before
income taxes:
(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:27)(cid:15)+(cid:5)(cid:3)?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:17)(cid:27)(cid:10)(cid:11)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)(cid:5)(cid:3)?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The provision (benefit) for income taxes consists of the following:
Current:
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred:
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total:
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total for continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total for discontinued operations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
(27) $
383
356
$
— $
268
268
$
36
271
307
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
— $
(7)
(7) $
— $
(4)
(4) $
(19)
(4)
(23)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
— $
123
123
3
(7)
(4)
$
9
85
94
10
2
12
3
116
119
—
$
119
19
87
106
—
$
106
7
103
110
—
(18)
(18)
7
85
92
—
92
$
$
$
$
$
$
76
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
A reconciliation of the provision for income taxes based on the statutory U.S. Federal tax rate of 35% to the
provision for income taxes is as follows:
Tax provision on pretax earnings from continuing operations at statutory
U.S. Federal tax rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
124
$
94
$
107
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Increase (decrease) in provision for income taxes due to:
Non-U.S. tax rates. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Changes in valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Withholding tax, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-deductible acquisition costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. tax on intercompany dividends and interest . . . . . . . . . . . . . . . . . .
Tax exempt income. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intraperiod tax allocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax law changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Changes in tax reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mexico inflationary adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Provision for income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(22)
3
22
3
(2)
(8)
(3)
(19)
8
6
7
119
$
(12)
1
18
6
16
(3)
(3)
(14)
5
3
(5)
106
$
(22)
(2)
18
1
(5)
(3)
(13)
11
92
$
Deferred income taxes reflect: (1) the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes;
and (2) carryovers and credits for income tax purposes.
Significant components of the Company’s deferred tax assets and liabilities at December 31, 2016 and 2015
are as follows:
Deferred tax assets:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Accrued postretirement benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asbestos-related liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign tax credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating and capital loss carryovers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other credit carryovers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
53
242
413
389
34
95
138
74
1,438
$
51
286
389
435
38
82
128
63
1,472
Deferred tax liabilities:
Property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangibles and deferred software. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
131
119
9
259
(1,094)
85
$
128
131
25
284
(1,135)
53
$
77
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Deferred taxes are included in the Consolidated Balance Sheets at December 31, 2016 and 2015 as follows:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
185
(100)
85
$
$
177
(124)
53
The Company reviews the likelihood that it will realize the benefit of its deferred tax assets and therefore
the need for valuation allowances on a quarterly basis, or whenever events indicate that a review is required. In
determining the requirement for a valuation allowance, the historical and projected financial results of the legal
entity or consolidated group recording the net deferred tax asset is considered, along with other positive and
negative evidence.
At December 31, 2016, before valuation allowance, the Company had unused foreign tax credits of $413
million expiring in 2017 through 2026, research tax credits of $14 million expiring from 2019 to 2036, and
alternative minimum tax credits of $18 million which do not expire and which will be available to offset future
U.S. Federal income tax. Approximately $151 million of the deferred tax assets related to operating and capital
loss carryforwards can be carried over indefinitely, with the remaining $238 million expiring between 2017
and 2036.
In certain jurisdictions, the Company’s analysis indicates that it has cumulative losses in recent years.
This is considered significant negative evidence which is objective and verifiable and, therefore, difficult to
overcome. However, the cumulative loss position is not solely determinative and, accordingly, the Company
considers all other available positive and negative evidence in its analysis. Based on its analysis, the Company
has recorded a valuation allowance for the portion of deferred tax assets where based on the weight of available
evidence it is unlikely to realize those deferred tax assets.
At December 31, 2016, the Company’s equity in the undistributed earnings of foreign subsidiaries for
which income taxes had not been provided approximated $2.2 billion. The Company intends to reinvest these
earnings indefinitely in the non-U.S. operations. It is not practicable to estimate the U.S. and foreign tax which
would be payable should these earnings be distributed. Deferred taxes are provided for earnings of non-U.S.
jurisdictions when the Company plans to remit those earnings.
The Company records a liability for unrecognized tax benefits related to uncertain tax positions. The
Company accrues interest and penalties associated with unrecognized tax benefits as a component of its income
tax expense.
78
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
The following is a reconciliation of the Company’s total gross unrecognized tax benefits for the years ended
December 31, 2016, 2015 and 2014:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Balance at January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Additions and reductions for tax positions of prior years. . . . . . . . . . . .
Additions based on tax positions related to the current year . . . . . . . . .
Reductions due to the lapse of the applicable statute of limitations. . . .
Reductions due to settlements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance at December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unrecognized tax benefits, which if recognized, would impact the
Company’s effective income tax rate . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued interest and penalties at December 31. . . . . . . . . . . . . . . . . . . . . . .
Interest and penalties included in tax expense for the years ended
December 31. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
$
$
74
$
15
(3)
(12)
74
66
23
$
$
$
77
1
10
(5)
(1)
(8)
74
67
25
$
$
$
$
100
(13)
10
(8)
(1)
(11)
77
70
29
(2) $
(1) $
(2)
Based upon the outcome of tax examinations, judicial proceedings, or expiration of statute of limitations,
it is reasonably possible that the ultimate resolution of these unrecognized tax benefits may result in a payment
that is materially different from the current estimate of the tax liabilities. The Company believes that it is
reasonably possible that the estimated liability could decrease up to $11 million within the next 12 months. This
is primarily the result of audit settlements or statute expirations in several taxing jurisdictions.
The Company is currently under examination in various tax jurisdictions in which it operates, including
Argentina, Bolivia, Brazil, China, Canada, Colombia, Ecuador, France, Germany, Indonesia, and Italy. The
years under examination range from 2006 through 2014. The Company has received tax assessments in excess
of established reserves. The Company believes that adequate provisions for all income tax uncertainties have
been made. However, if tax assessments are settled against the Company at amounts in excess of established
reserves, it could have a material impact to the Company’s results of operations, financial position or cash
flows. During 2016, the Company concluded income tax audits in several jurisdictions, including the Czech
Republic, Germany, Italy, and Hungary.
79
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:21)(cid:21)Q(cid:5)(cid:5)(cid:17)(cid:8)(cid:19)(cid:6)
The following table summarizes the long-term debt of the Company at December 31, 2016 and 2015:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Secured Credit Agreement:
Revolving Credit Facility:
Revolving Loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
— $
—
Term Loans:
Term Loan A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Term Loan A (€279 million at December 31, 2016) . . . . . . . . . . . . . . . . . . . . . .
Term Loan B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1,395
282
Senior Notes:
6.75%, due 2020 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.875%, due 2021 (€330 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.00%, due 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.875%, due 2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.125%, due 2024 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
523
345
495
682
520
297
294
1,546
301
563
542
357
494
680
296
293
Senior Debentures:
7.80%, due 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capital leases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total long-term debt. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less amounts due within one year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
250
57
26
5,166
33
$ 5,133
250
62
29
5,413
68
$ 5,345
On April 22, 2015, the Company entered into a Senior Secured Credit Facility, which subsequently has
been amended several times with the most recent amendment being entered into on February 3, 2016 (the
“Amended Agreement”). In connection with the closing of the Vitro Acquisition on September 1, 2015 (see
Note 19), the Company incurred $1,250 million of senior secured incremental term loan facilities, comprised of
(i) a $675 million term loan A facility on substantially the same terms and conditions (including as to maturity)
as the term loan A facility in the Amended Agreement and (ii) a $575 million term loan B facility, which was
subsequently repaid in full in November 2016 as described below.
At December 31, 2016, the Amended Agreement includes a $300 million revolving credit facility, a $600
million multicurrency revolving credit facility, a $1,575 million term loan A facility ($1,395 million net of debt
issuance costs), and a €279 million term loan A facility ($282 million net of debt issuance costs), each of which
has a final maturity date of April 22, 2020. At December 31, 2016, the Company had unused credit of $884
million available under the Amended Agreement. The weighted average interest rate on borrowings outstanding
under the Amended Agreement at December 31, 2016 was 2.39%.
80
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
The Amended Agreement contains various covenants that restrict, among other things and subject to certain
exceptions, the ability of the Company to incur certain liens, make certain investments, become liable under
contingent obligations in certain defined instances only, make restricted payments, make certain asset sales
within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing
arrangements, alter its fundamental business, and amend certain subordinated debt obligations.
The Amended Agreement also contains one financial covenant, a Total Leverage Ratio, that requires the
Company not to exceed a ratio calculated by dividing consolidated total debt, less cash and cash equivalents,
by consolidated EBITDA, as defined in the Amended Agreement. The Total Leverage Ratio could restrict the
ability of the Company to undertake additional financing or acquisitions to the extent that such financing or
acquisitions would cause the Total Leverage Ratio to exceed the specified maximum of (i) 4.5x for the four
fiscal quarters ending December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, and (ii)
4.0x for the fourth fiscal quarter ending December 31, 2017 and each fiscal quarter thereafter.
Failure to comply with these covenants and restrictions could result in an event of default under the
Amended Agreement. In such an event, the Company would be unable to request borrowings under the
revolving facility, and all amounts outstanding under the Amended Agreement, together with accrued interest,
could then be declared immediately due and payable. If an event of default occurs under the Amended
Agreement and the lenders cause all of the outstanding debt obligations under the Amended Agreement to
become due and payable, this would result in a default under a number of other outstanding debt securities
and could lead to an acceleration of obligations related to these debt securities. As of December 31, 2016, the
Company was in compliance with all covenants and restrictions in the Amended Agreement. In addition, the
Company believes that it will remain in compliance and that its ability to borrow funds under the Amended
Agreement will not be adversely affected by the covenants and restrictions.
The interest rates on borrowings under the Amended Agreement are, at the Company’s option, the Base
Rate or the Eurocurrency Rate, as defined in the Amended Agreement, plus an applicable margin. The
applicable margin for the term loan A facility and the revolving credit facility is linked to the Company’s Total
Leverage Ratio and ranges from 1.25% to 1.75% for Eurocurrency Rate loans and from 0.25% to 0.75% for
Base Rate loans. In addition, a facility fee is payable on the revolving credit facility commitments ranging from
0.20% to 0.30% per annum linked to the Total Leverage Ratio.
Borrowings under the Amended Agreement are secured by substantially all of the assets, excluding real
estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign
subsidiaries. Borrowings are also secured by a pledge of intercompany debt and equity investments in certain
of the Company’s domestic subsidiaries and, in the case of foreign borrowings, of stock of certain foreign
subsidiaries. All borrowings under the Amended Agreement are guaranteed by certain domestic subsidiaries of
the Company.
Also, in connection with the Vitro Acquisition, during August 2015, the Company issued senior notes
with a face value of $700 million that bear interest at 5.875% and are due August 15, 2023 (the “Senior Notes
due 2023”) and senior notes with a face value of $300 million that bear interest at 6.375% and are due August
15, 2025 (together with the Senior Notes due 2023, the “2015 Senior Notes”). The 2015 Senior Notes were
issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The
net proceeds from the 2015 Senior Notes, after deducting the debt discount and debt issuance costs, totaled
approximately $972 million and were used to finance, in part, the Vitro Acquisition.
81
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
During November 2016, the Company issued senior notes with a face value of €500 million that bear
interest at 3.125% and are due November 15, 2024. The notes were issued via a private placement and are
guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds, after deducting the debt
discount and debt issuance costs, totaled approximately $520 million and were used to repay the term loan B
facility under the Amended Agreement.
The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into
additional credit facilities and seek to issue equity and/or debt securities in the domestic and international
capital markets if market conditions are favorable. Also, depending on market conditions, the Company may
elect to repurchase portions of its debt securities in the open market.
The Company has a €185 million European accounts receivable securitization program, which extends
through March 2019, subject to periodic renewal of backup credit lines.
Information related to the Company’s accounts receivable securitization program as of December 31, 2016
and 2015 is as follows:
Balance (included in short-term loans)
Weighted average interest rate
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
152
0.74%
$
158
1.21%
The carrying amounts reported for the accounts receivable securitization program, and certain long-term
debt obligations subject to frequently redetermined interest rates, approximate fair value. Fair values for the
Company’s significant fixed rate debt obligations are based on published market quotations, and are classified
as Level 1 in the fair value hierarchy.
Annual maturities for all of the Company’s long-term debt through 2021 are as follows: 2017, $33 million;
2018, $287 million; 2019, $101 million; 2020, $2,074 million; and 2021, $354 million.
Fair values at December 31, 2016, of the Company’s significant fixed rate debt obligations are as follows:
*(cid:4)(cid:27)(cid:15)(cid:11)(cid:27)?(cid:12)(cid:13)(cid:5)
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)
@(cid:15)(cid:16)(cid:27)(cid:11)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)
Market
*(cid:4)(cid:27)(cid:11)(cid:8)
Fair
l(cid:12)(cid:13)(cid:29)(cid:8)
Senior Notes:
6.75%, due 2020 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.875%, due 2021 (€330 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.00%, due 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.875%, due 2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.125%, due 2024 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
526 $ 120.63
114.00
347
103.49
500
105.37
700
100.01
526
106.28
300
101.17
300
Senior Debentures:
7.80%, due 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
250
106.26
635
396
517
738
526
319
304
266
82
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:21)(cid:23)Q(cid:5)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)+(cid:8)(cid:15)(cid:11)(cid:27)(cid:8)(cid:10)
Asbestos
The Company is a defendant in numerous lawsuits alleging bodily injury and death as a result of exposure
to asbestos. From 1948 to 1958, one of the Company’s former business units commercially produced and sold
approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material
containing asbestos. The Company sold its insulation business unit at the end of April 1958. The typical
asbestos personal injury lawsuit alleges various theories of liability, including negligence, gross negligence and
strict liability and seeks compensatory and, in some cases, punitive damages in various amounts (herein referred
to as “asbestos claims”).
The following table shows the approximate number of plaintiffs and claimants who had asbestos claims
pending against the Company at the beginning of each listed year, the number of claims disposed of during that
year, the year’s filings and the claims pending at the end of each listed year (eliminating duplicate filings):
Pending at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Disposed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Filed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pending at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25) 2015 2014
2,080 2,260 2,620
1,750 1,460 1,830
1,070 1,280 1,470
1,400 2,080 2,260
Based on an analysis of the lawsuits pending as of December 31, 2016, approximately 88% of plaintiffs
either do not specify the monetary damages sought, or in the case of court filings, claim an amount sufficient to
invoke the jurisdictional minimum of the trial court. Approximately 9% of plaintiffs specifically plead damages
above the jurisdictional minimum up to, and including, $15 million or less, and 3% of plaintiffs specifically
plead damages greater than $15 million but less than or equal to $100 million.
As indicated by the foregoing summary, current pleading practice permits considerable variation in the
assertion of monetary damages. The Company’s experience resolving hundreds of thousands of asbestos claims
and lawsuits over an extended period demonstrates that the monetary relief alleged in a complaint bears little
relevance to a claim’s merits or disposition value. Rather, the amount potentially recoverable is determined
by such factors as the type and severity of the plaintiff’s asbestos disease, the plaintiff’s medical history and
exposure to other disease-causing agents, the product identification evidence against the Company and other
co-defendants, the defenses available to the Company and other co-defendants, the specific jurisdiction in which
the claim is made, and the plaintiff’s firm representing the claimant.
In addition to the pending claims set forth above, the Company has claims-handling agreements in place
with many plaintiffs’ counsel throughout the country. These agreements require evaluation and negotiation
regarding whether particular claimants qualify under the criteria established by such agreements. The criteria for
such claims include verification of a compensable illness and a reasonable probability of exposure to a product
manufactured by the Company’s former business unit during its manufacturing period ending in 1958.
The Company has also been a defendant in other asbestos-related lawsuits or claims involving maritime
workers, medical monitoring claimants, co-defendants and property damage claimants. Based upon its past
experience, the Company believes that these categories of lawsuits and claims will not involve any material
liability and they are not included in the above description of pending matters or in the following description of
disposed matters.
83
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Since receiving its first asbestos claim, the Company as of December 31, 2016, has disposed of the
asbestos claims of approximately 398,000 plaintiffs and claimants at an average indemnity payment per claim
of approximately $9,000. The Company’s asbestos indemnity payments have varied on a per claim basis, and
are expected to continue to vary considerably over time. Asbestos-related cash payments for 2016, 2015 and
2014 were $125 million, $138 million, and $148 million, respectively. The Company’s cash payments per
claim disposed (inclusive of legal costs) were approximately $71,000, $95,000 and $81,000 for the years ended
December 31, 2016, 2015 and 2014, respectively.
As discussed above, the Company’s objective is to achieve, where possible, resolution of asbestos claims
pursuant to claims-handling agreements. Failure of claimants to meet certain medical and product exposure
criteria in the Company’s administrative claims handling agreements has generally reduced the number of
claims that would otherwise have been received by the Company in the tort system. In addition, certain court
orders and legislative acts have reduced or eliminated the number of claims that the Company otherwise
would have received by the Company in the tort system. These developments generally have had the effect of
increasing the Company’s per-claim average indemnity payment over time.
Beginning with the initial liability of $975 million established in 1993, the Company has accrued a total
of approximately $4.9 billion through 2016, before insurance recoveries, for its asbestos-related liability. The
Company’s estimates of its liability have been significantly affected by, among other factors, the volatility
of asbestos-related litigation in the United States, the significant number of co-defendants that have filed for
bankruptcy, the inherent uncertainty of future disease incidence and claiming patterns against the Company, the
significant expansion of the defendants that are now sued in this litigation, and the continuing changes in the
extent to which these defendants participate in the resolution of cases in which the Company is also a defendant.
The Company continues to monitor trends that may affect its ultimate liability and analyze the
developments and variables likely to affect the resolution of pending and future asbestos claims against the
Company. The material components of the Company’s total accrued liability are determined by the Company
in connection with its annual comprehensive legal review and consist of the following estimates, to the extent it
is probable that such liabilities have been incurred and can be reasonably estimated: (i) the liability for asbestos
claims already asserted against the Company; (ii) the liability for asbestos claims not yet asserted against
the Company; and (iii) the legal defense costs estimated to be incurred in connection with the claims already
asserted and those claims the Company believes will be asserted.
As noted above, the Company conducts a comprehensive legal review of its asbestos-related liabilities and
costs annually in connection with finalizing and reporting its annual results of operations, unless significant
changes in trends or new developments warrant an earlier review. As part of its current annual comprehensive
legal review, the Company provides historical claims filing data to a third party with expertise in determining
the impact of disease incidence and mortality on future filing trends to develop information to assist the
Company in estimating the total number of future claims to be filed. The Company uses this estimate of total
future claims, along with an estimation of disposition costs and related legal costs, as inputs to develop its best
estimate of its total probable liability. If the results of the annual comprehensive legal review indicate that the
existing amount of the accrued liability is lower (higher) than its reasonably estimable asbestos-related costs,
then the Company will record an appropriate charge (credit) to the Company’s results of operations to increase
(decrease) the accrued liability.
The significant assumptions underlying the material components of the Company’s accrual are:
a)
settlements will continue to be limited almost exclusively to claimants who were exposed to the
Company’s asbestos-containing insulation prior to its exit from that business in 1958;
84
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
b)
c)
claims will continue to be resolved primarily under the Company’s administrative claims agreements
or on terms comparable to those set forth in those agreements;
the incidence of serious asbestos-related disease cases and claiming patterns against the Company for
such cases do not change materially;
d)
the Company is substantially able to defend itself successfully at trial and on appeal;
e)
f)
the number and timing of additional co-defendant bankruptcies do not change significantly the assets
available to participate in the resolution of cases in which the Company is a defendant; and
co-defendants with substantial resources and assets continue to participate significantly in the
resolution of future asbestos lawsuits and claims.
For the years ended December 31, 2016 and 2015, the Company concluded that accruals in the amounts of
$692 million and $817 million, respectively, were required. These amounts have not been discounted for the
time value of money. The Company’s comprehensive legal reviews resulted in charges of $0, $16 million and
$46 million for the years ended December 31, 2016, 2015 and 2014, respectively.
The Company believes it is reasonably possible that it will incur a loss for its asbestos-related liabilities
in excess of the amount currently recognized, which is $692 million as of December 31, 2016. The Company
estimates that reasonably possible losses could be as high as $825 million. This estimate of additional
reasonably possible loss reflects a legal judgment about the number and cost of potential future claims and legal
costs. The Company believes this estimate is consistent with the level of variability it has experienced when
comparing actual results to recent near-term projections. However, it is also possible that the ultimate asbestos-
related liability could be above this estimate.
The Company expects a significant majority of the total number of claims to be received in the next ten
years. This timeframe appropriately reflects the mortality of current and expected claimants in light of the
Company’s sale of its insulation business unit in 1958.
As noted above, the Company’s asbestos-related liability is based on a projection of new claims that will
eventually be filed against the Company and the estimated average disposition cost of these claims and related
legal costs. Changes in these projections, and estimates, as well as changes in the significant assumptions noted
above, have the potential to significantly impact the estimation of the Company’s asbestos-related liability.
Other Matters
The Company’s joint venture in China had been involved in litigation with its partner regarding whether
the joint venture should be dissolved. Following an ownership change in 2016 with respect to the joint venture
partner, this litigation has been withdrawn.
On July 5, 2016, the Company learned that the Enforcement Division of the SEC is conducting an
investigation into certain accounting and control matters pertaining to the Company’s determination of its
asbestos-related liabilities. On May 13, 2016, the Company restated its consolidated financial statements for the
years ended December 31, 2015, 2014 and 2013 in order to correct an error related to the Company’s method
for estimating its future asbestos-related liabilities. The Company is cooperating with the SEC’s investigation.
At this time, the Company is unable to predict the outcome of this matter or provide meaningful quantification
of how the final resolution of this matter may impact its future consolidated financial statements, results of
operations, or cash flows.
85
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Other litigation is pending against the Company, in many cases involving ordinary and routine claims
incidental to the business of the Company and in others presenting allegations that are non-routine and involve
compensatory, punitive or treble damage claims as well as other types of relief. The Company records a
liability for such matters when it is both probable that the liability has been incurred and the amount of the
liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the
factors upon which the estimates are based, including additional information, negotiations, settlements and other
events.
(cid:21)(cid:20)Q(cid:5)(cid:5)=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)/_(cid:3)(cid:10)(cid:10)6
The components of comprehensive income are: (a) net earnings; (b) change in fair value of certain
derivative instruments; (c) pension and other postretirement benefit adjustments; and (d) foreign currency
translation adjustments. The net effect of exchange rate fluctuations generally reflects changes in the relative
strength of the U.S. dollar against major foreign currencies between the beginning and end of the year.
The following table lists the beginning balance, annual activity and ending balance of each component of
accumulated other comprehensive income (loss):
Balance on January 1, 2015 . . . . . . . . . . . . . . . .
Change before reclassifications . . . . . . . . . . . . .
Amounts reclassified from accumulated other
comprehensive income . . . . . . . . . . . . . . . .
Translation effect . . . . . . . . . . . . . . . . . . . . . . . .
Tax effect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss)
attributable to the Company . . . . . . . . . . . .
Balance on December 31, 2015 . . . . . . . . . . . . .
Change before reclassifications . . . . . . . . . . . . .
Amounts reclassified from accumulated other
comprehensive income . . . . . . . . . . . . . . . .
Translation effect . . . . . . . . . . . . . . . . . . . . . . . .
Tax effect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intraperiod tax allocation . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss)
attributable to the Company . . . . . . . . . . . .
Balance on December 31, 2016 . . . . . . . . . . . . .
8(cid:8)(cid:6)(cid:5);(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:5)
(cid:3)(cid:28)(cid:5);:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)
Rate
(cid:2)(cid:13)(cid:29)(cid:11)(cid:6)(cid:29)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
$
Change
in Certain
(cid:17)(cid:8)(cid:4)(cid:27)[(cid:12)(cid:6)(cid:27)[(cid:8)(cid:5)
@(cid:15)(cid:10)(cid:6)(cid:4)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
(55) $
(513)
(11)
(4)
;(cid:18)?(cid:13)(cid:3)(cid:14)(cid:8)(cid:8)(cid:5)
\(cid:8)(cid:15)(cid:8)(cid:9)(cid:6)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:10)
$
(1,428) $
(58)
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:5)=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)
Other
(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)(cid:5)
@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)/_(cid:3)(cid:10)(cid:10)6
(513)
(568)
(220)
(1)(a)
(1)
(6)
(17)
7
6(a)
83(b)
(31)
2
(4)
(1,432)
(2)
72(b)
(25)
15
(8)
(1,494)
(575)
82
(31)
1
(523)
(2,017)
(215)
78
(25)
15
(8)
(220)
(788) $
$
13
(4)
$
52
(1,380) $
(155)
(2,172)
(a) Amount is included in Cost of goods sold on the Consolidated Results of Operations (see Note 7 for
additional information).
’(cid:7)*(cid:6) +(cid:18)(cid:12)(cid:28)(cid:5)(cid:8)(cid:6)(cid:11)(cid:10)(cid:6)(cid:11)(cid:5)!(cid:13)(cid:28)(cid:2)(cid:3)(cid:2)(cid:6)(cid:11)(cid:5)(cid:6)(cid:8)(cid:31)(cid:3)(cid:6)!(cid:12)(cid:18)(cid:9)(cid:28)(cid:8)(cid:14)(cid:8)(cid:11)(cid:12)(cid:5)(cid:6)(cid:12)(cid:15)(cid:6)(cid:5)(cid:3)(cid:8)(cid:6)(cid:9)(cid:3)(cid:16)(cid:11)(cid:12)(cid:2)(cid:11)!(cid:6)(cid:9)(cid:3)(cid:5)(cid:10)(cid:11)(cid:12)(cid:5)(cid:6)!(cid:12)(cid:10)(cid:8)(cid:6)(cid:14)(cid:5)(cid:2)(cid:6)(cid:5)(cid:3)(cid:8)(cid:6)(cid:9)(cid:12)(cid:10)(cid:8)(cid:16)(cid:3)(cid:8)(cid:11)(cid:16)(cid:3)(cid:18)(cid:3)(cid:5)(cid:8)(cid:6)(cid:7)(cid:3)(cid:5)(cid:3)(cid:4)(cid:8)(cid:6)!(cid:12)(cid:10)(cid:8)(cid:6)
(see Note 9 for additional information).
86
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:21)jQ(cid:5)(cid:5)>(cid:6)(cid:3)(cid:11)](cid:5)%?(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)>(cid:6)(cid:3)(cid:11)](cid:5)\(cid:12)(cid:10)(cid:8)(cid:16)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:8)(cid:15)(cid:10)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
The Company has various nonqualified plans approved by share owners under which it has granted stock
options, restricted shares and performance vested restricted share units. At December 31, 2016, there were
5,081,000 shares available for grants under these plans. Total compensation cost for all grants of shares and
units under these plans was $15 million, $15 million and $21 million for the years ended December 31, 2016,
2015 and 2014, respectively.
Stock Options
In general, subject to change in control, options become exercisable 25% per year beginning on the first
anniversary of grant. No options may be exercised in whole or in part during the first year after the date granted.
In general, options expire following termination of employment or the seventh anniversary of the option grant.
The fair value of options is amortized over the vesting periods which range from one to four years.
Stock option information at December 31, 2016 and for the year then ended is as follows:
Options outstanding at January 1, 2016 . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exercised. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited or expired . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options outstanding at December 31, 2016. . . . . . . . . . . . . .
Options vested or expected to vest at December 31, 2016 . .
Options exercisable at December 31, 2016 . . . . . . . . . . . . . .
Weighted
=[(cid:8)(cid:4)(cid:12)+(cid:8)
;:(cid:8)(cid:4)(cid:11)(cid:27)(cid:10)(cid:8)
*(cid:4)(cid:27)(cid:11)(cid:8)
/?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)6
$ 23.64
15.10
10.13
21.24
22.91
$ 22.91
$ 27.71
8(cid:29)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:3)(cid:28)
Shares
/(cid:6)(cid:7)(cid:3)(cid:29)(cid:10)(cid:12)(cid:15)(cid:16)(cid:10)6
2,621
1,098
(504)
(119)
3,096
3,096
1,342
Weighted
=[(cid:8)(cid:4)(cid:12)+(cid:8)
<(cid:8)(cid:18)(cid:12)(cid:27)(cid:15)(cid:27)(cid:15)+
(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:29)(cid:12)(cid:13)
7(cid:8)(cid:4)(cid:18)
/(cid:14)(cid:8)(cid:12)(cid:4)(cid:10)6
Aggregate
@(cid:15)(cid:6)(cid:4)(cid:27)(cid:15)(cid:10)(cid:27)(cid:11)
l(cid:12)(cid:13)(cid:29)(cid:8)
4.2
2.3
4.2
$
$
$
3
3
—
Certain additional information related to stock options is as follows for the periods indicated:
Weighted average grant-date fair value of options granted (per share) . . . . . .
Aggregate intrinsic value of options exercised . . . . . . . . . . . . . . . . . . . . . . . .
Aggregate cash received from options exercised. . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
4.98
2
5
$
$
$
$
$
$
2015
7.79
2014
$ 13.17
3
5
— $
$
1
The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing
model using the following weighted average assumptions:
Expected life of options (years) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected stock price volatility. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Risk-free interest rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected dividend yield. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)(cid:5)(cid:5)(cid:5)(cid:5)
2015
5.20
32.8%
1.5%
0.0%
5.00
34.5%
1.7%
0.0%
2014
5.00
43.0%
1.6%
0.0%
The expected life of options is determined from historical exercise and termination data. The expected
stock price volatility is determined by reference to historical prices over a period equal to the expected life.
87
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Restricted Shares and Restricted Share Units
Shares granted after March 21, 2005 and prior to 2011, vest 25% per year beginning on the first anniversary
and unvested shares are forfeited upon termination of employment. Restricted share units granted to employees
after 2010 vest 25% per year beginning on the first anniversary. Holders of vested restricted share units receive
one share of the Company’s common stock for each unit as units vest. Granted but unvested restricted share
units are forfeited upon termination, unless certain retirement criteria are met. Restricted share units granted to
directors vest after one year.
The fair value of the restricted shares and restricted share units is equal to the market price of the
Company’s common stock on the date of the grant. The fair value of restricted shares and restricted share units,
is amortized over the vesting periods which range from one to four years.
The activity of restricted shares and restricted share units is as follows:
Nonvested at January 1, 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Nonvested at December 31, 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Awards granted during 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Awards granted during 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8(cid:29)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:3)(cid:28)(cid:5)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:27)(cid:11)(cid:6)(cid:8)(cid:16)(cid:5)
Shares
/(cid:6)(cid:7)(cid:3)(cid:29)(cid:10)(cid:12)(cid:15)(cid:16)(cid:10)6
672
389
(215)
(10)
836
Weighted
=[(cid:8)(cid:4)(cid:12)+(cid:8)(cid:5)
Grant-
Date
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
/?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)6
$ 23.66
15.70
25.88
21.11
19.42
$ 22.69
$ 33.36
Total fair value of shares vested. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
6
$
4
$
5
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Performance Vested Restricted Share Units
Performance vested restricted share units vest on January 1 of the third year following the year in which
they are granted. Holders of vested units may receive up to 2 shares of the Company’s common stock for
each unit, depending upon the attainment of consolidated performance goals established by the Compensation
Committee of the Company’s Board of Directors. If minimum goals are not met, no shares will be issued.
Granted but unvested restricted share units are forfeited upon termination of employment, unless certain
retirement criteria are met.
The fair value of each performance vested restricted share unit is equal to the product of the fair value
of the Company’s common stock on the date of grant and the estimated number of shares into which the
performance vested restricted share unit will be converted. The fair value of performance vested restricted
share units is amortized ratably over the vesting period. Should the estimated number of shares into which the
performance vested restricted share unit will be converted change, an adjustment will be recorded to recognize
the accumulated difference in amortization between the revised and previous estimates.
88
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Performance vested restricted share unit activity is as follows:
Nonvested at January 1, 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited/Cancelled. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Nonvested at December 31, 2016 . . . . . . . . . . . . . . . . . . . . . . . . .
Awards granted during 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Awards granted during 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8(cid:29)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:3)(cid:28)(cid:5)*(cid:8)(cid:4)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:15)(cid:11)(cid:8)
l(cid:8)(cid:10)(cid:6)(cid:8)(cid:16)(cid:5)<(cid:8)(cid:10)(cid:6)(cid:4)(cid:27)(cid:11)(cid:6)(cid:8)(cid:16)(cid:5)>(cid:7)(cid:12)(cid:4)(cid:8)(cid:10)
c(cid:15)(cid:27)(cid:6)(cid:10)(cid:5)/(cid:6)(cid:7)(cid:3)(cid:29)(cid:10)(cid:12)(cid:15)(cid:16)(cid:10)6
’(cid:8)(cid:27)+(cid:7)(cid:6)(cid:8)(cid:16)(cid:5)=[(cid:8)(cid:4)(cid:12)+(cid:8)
Z(cid:4)(cid:12)(cid:15)(cid:6)(cid:30)(cid:17)(cid:12)(cid:6)(cid:8)(cid:5)(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
/?(cid:8)(cid:4)(cid:5)(cid:29)(cid:15)(cid:27)(cid:6)6
933
726
(158)
(146)
1,355
$
$
$
26.80
15.10
26.10
25.41
20.76
23.63
33.41
Approximately 158,000 shares were issued in 2016 with a fair value at issuance date of $4 million related
to performance vested restricted share units.
As of December 31, 2016, there was $17 million of total unrecognized compensation cost related to all
unvested stock options, restricted shares, restricted share units and performance vested restricted share units.
That cost is expected to be recognized over a weighted average period of approximately two years.
(cid:21)!Q(cid:5)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5);:?(cid:8)(cid:15)(cid:10)(cid:8)(cid:22)(cid:5)(cid:15)(cid:8)(cid:6)
Other expense, net for the years ended December 31, 2016, 2015 and 2014 included the following:
Restructuring, asset impairment and other charges . . . . . . . . . . . . . . . . . . . .
Intangible amortization expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment of equity investment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Charge for asbestos related costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on China land compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Royalty income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Strategic transaction costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value intangible adjustments . . . . . . . . . . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency exchange loss (gain) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other expense (income) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
$
104
39
25
(71)
(13)
6
(14)
76
$
75
21
16
(12)
23
10
(10)
(12)
111
$
$
68
1
46
(12)
69
(2)
24
194
In 2016, the Company evaluated the future estimated earnings and cash flow of an equity investment
and determined that it was other-than-temporarily impaired. As such, the Company recorded an impairment
charge of $25 million to reduce its carrying value down to its estimated fair value. The Company classified
the significant assumptions used to determine the fair value of the impaired assets as Level 3 in the fair value
hierarchy as set forth in the general accounting principles for fair value measurements.
In 2014, the Company recorded a charge of $69 million resulting from a non-income tax assessment from a
foreign tax authority.
89
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:21)(cid:25)Q(cid:5)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:15)+(cid:5)_(cid:8)(cid:12)(cid:10)(cid:8)(cid:10)
Rent expense attributable to all warehouse, office buildings and equipment operating leases was $80
million in 2016, $72 million in 2015, and $63 million in 2014. Minimum future rentals under operating leases
are as follows: 2017, $65 million; 2018, $47 million; 2019, $32 million; 2020, $23 million; 2021, $14 million;
and 2022 and thereafter, $24 million.
(cid:21)"Q(cid:5)(cid:5);(cid:12)(cid:4)(cid:15)(cid:27)(cid:15)+(cid:10)(cid:5)*(cid:8)(cid:4)(cid:5)>(cid:7)(cid:12)(cid:4)(cid:8)
The following table sets forth the computation of basic and diluted earnings per share:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Numerator:
Net earnings attributable to the Company . . . . . . . . . . . . . . . . . . . . .
$
209
$
135
$
164
Denominator (in thousands):
Denominator for basic earnings per share-weighted average
shares outstanding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
161,857
161,169
164,720
Effect of dilutive securities:
Stock options and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
968
966
1,327
Denominator for diluted earnings per share-adjusted weighted
average shares outstanding . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
162,825
162,135
166,047
Basic earnings per share:
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations. . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted earnings per share:
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations. . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
$
1.33
(0.04)
1.29
1.32
(0.04)
1.28
$
$
$
$
0.86
(0.03)
0.83
0.85
(0.03)
0.82
$
$
$
$
1.14
(0.14)
1.00
1.13
(0.14)
0.99
Options to purchase 2,770,458, 1,937,315 and 1,143,933 weighted average shares of common stock
which were outstanding during 2016, 2015 and 2014, respectively, were not included in the computation of
diluted earnings per share because the options’ exercise price was greater than the average market price of the
common shares.
90
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:21)$Q(cid:5)(cid:5)>(cid:29)??(cid:13)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:12)(cid:13)(cid:5)(cid:26)(cid:12)(cid:10)(cid:7)(cid:5)(cid:2)(cid:13)(cid:3)#(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
Changes in the components of working capital related to operations (net of the effects related to
acquisitions and divestitures) were as follows:
Decrease (increase) in current assets:
Receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Increase (decrease) in current liabilities:
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Salaries and wages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. and foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
(32) $
16
145
(14) $
(13)
(4)
(58)
(31)
32
18
90
$
100
21
12
(14)
88
$
59
(26)
(1)
103
12
(3)
(27)
117
The Company uses various factoring programs to sell certain receivables to financial institutions as part of
managing its cash flows. At December 31, 2016 and 2015, the amount of receivables sold by the Company was
$318 million and $317 million, respectively. Any continuing involvement with the sold receivables is immaterial.
Interest paid in cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes paid in cash (all non-U.S) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
261
99
227
101
$
199
101
Cash interest for the years ended December 31, 2016, 2015 and 2014 includes $9 million, $32 million and
$9 million of note repurchase premiums, respectively.
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
(cid:21)(cid:31)Q(cid:5)(cid:5)\(cid:29)(cid:10)(cid:27)(cid:15)(cid:8)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:18)(cid:19)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
On September 1, 2015, the Company completed the Vitro Acquisition in a cash transaction valued at
approximately $2.297 billion in cash, subject to a working capital adjustment and certain other adjustments.
The Vitro Business in Mexico is the largest supplier of glass containers in that country manufacturing glass
containers across multiple end uses, including food, soft drinks, beer, wine and spirits. The Vitro Acquisition
included five food and beverage glass container plants in Mexico, a plant in Bolivia and a North American
distribution business, and provided the Company with a competitive position in the glass packaging market
in Mexico. The results of the Vitro Business have been included in the Company’s consolidated financial
statements since September 1, 2015 and contributed approximately $608 million of incremental net sales and
$122 million of incremental segment operating profit in the year ended December 31, 2016. Vitro’s food
and beverage glass container operations in Mexico and Bolivia are included in the Latin American operating
segment while its distribution business is included in the North American operating segment.
The Company financed the Vitro Acquisition with the proceeds from a senior notes offering, cash on hand
and the incremental term loan facilities (see Note 11).
The total purchase price was allocated to the tangible and identifiable intangible assets and liabilities based
upon their respective fair values. The purchase agreement contained customary provisions for working capital
adjustments, which the Company resolved with the seller in the first quarter of 2016. The Company completed
the purchase price allocation process in the third quarter of 2016. The following table summarizes the fair value
91
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
of the assets and liabilities assumed on September 1, 2015 and subsequent adjustments identified through the
purchase price allocation process and recorded through the measurement period:
>(cid:8)?(cid:6)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:21)(cid:22)(cid:5)
2015
Cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Customer list intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net property, plant and equipment. . . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net assets acquired. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
17
344
1,073
406
597
2,437
93
11
36
2,297
&(cid:8)(cid:12)(cid:10)(cid:29)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)
Period
=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
$
— $
(10)
(236)
202
48
4
(7)
11
— $
$
>(cid:8)?(cid:6)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:24)(cid:22)(cid:5)
(cid:23)(cid:24)(cid:21)(cid:25)
17
334
837
608
645
2,441
86
11
47
2,297
The fair value of the tangible assets was estimated utilizing income and market approaches, considering
remaining useful life. The customer list intangible asset includes the Company’s established relationships with
its customers and the ability of these customers to generate future economic profits for the Company. The value
assigned to customer list intangibles is based on the present value of future earnings attributable to the asset
group after recognition of required returns to other contributory assets.
Recognized goodwill is attributable to the assembled workforce, expected synergies and other intangible
assets that do not qualify for separate recognition. The Vitro Acquisition goodwill is not deductible for tax
purposes.
The balance sheet adjustments identified above did not result in any significant adjustments to the periods’
income statements.
(cid:23)(cid:24)Q(cid:5)(cid:5)*(cid:4)(cid:3)(cid:5)(cid:2)(cid:3)(cid:4)(cid:18)(cid:12)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)y(cid:5)l(cid:27)(cid:6)(cid:4)(cid:3)(cid:5)=(cid:11)m(cid:29)(cid:27)(cid:10)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)
Had the Vitro Acquisition, described in Note 19 and the related financing described in Note 11, occurred at
the beginning of each respective period, unaudited pro forma consolidated net sales, earnings from continuing
operations and earnings from continuing operations per share of common stock (diluted) would have been
as follows:
(cid:5)‘(cid:8)(cid:12)(cid:4)(cid:5);(cid:15)(cid:16)(cid:27)(cid:15)+(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)!
Net sales
As
<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:8)(cid:16)
6,156
$
=(cid:11)m(cid:29)(cid:27)(cid:10)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)
=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
$
574
(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:15)+
=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
$
— $
*(cid:4)(cid:3)(cid:5)(cid:2)(cid:3)(cid:4)(cid:18)(cid:12)
=(cid:10)(cid:5)=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:8)(cid:16)
6,730
Earnings from continuing operations attributable to
the Company. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted earnings per share from continuing operations. .
$
$
139
$
79
$
(46)
0.85
$
$
172
1.06
92
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
(cid:23)(cid:21)Q(cid:5)(cid:5)(cid:17)(cid:27)(cid:10)(cid:11)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)(cid:5)
On April 4, 2016, the annulment committee formed by the World Bank’s International Centre for
Settlement of Investment Disputes (“ICSID”) ruled that a subsidiary of the Company is free to pursue the
enforcement of a prior arbitration award against Venezuela. That award amounts to more than $485 million
after including interest from the date of the expropriation by Venezuela (October 26, 2010). Venezuela’s
application to annul the award is still pending, although the annulment proceedings were suspended in October
2016 because Venezuela has not paid its fees owed to ICSID. If the proceeding is stayed for non-payment
for a consecutive period in excess of six months, ICSID’s Secretary General could move that the committee
discontinue the annulment proceeding altogether. The Company intends to take appropriate steps to vigorously
enforce and collect the award, which is enforceable in approximately 150 member states that are party to the
ICSID Convention. However, even with the lifting of the stay of enforcement, the Company recognizes that the
collection of the award may present significant practical challenges. Because the award has yet to be satisfied
and the annulment proceeding is pending, the Company is unable at this stage to reasonably predict the efforts
that will be necessary to successfully enforce collection of the award, the amount of the award or the timing of
any such collection efforts. Therefore, the Company has not recognized this award in its financial statements.
A separate arbitration is pending with ICSID to obtain compensation primarily for third-party minority
shareholders’ lost interests in the two expropriated plants.
The loss from discontinued operations of $7 million and $4 million, for the years ended December 31, 2016
and 2015, respectively, relates to ongoing costs for the Venezuelan expropriation.
The loss from discontinued operations of $23 million for the year ended December 31, 2014 included a
settlement of a dispute with a purchaser of a previously disposed business, as well as ongoing costs related to
the Venezuelan expropriation.
(cid:23)(cid:23)Q(cid:5)(cid:5)(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:12)(cid:13)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)(cid:28)(cid:3)(cid:4)(cid:5)>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:14)(cid:5)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)(cid:10)
The following presents condensed consolidating financial information for the Company, segregating:
(1) Owens-Illinois, Inc., the issuer of senior debentures (the “Parent”); (2) the two subsidiaries which have
guaranteed the senior debentures on a subordinated basis (the “Guarantor Subsidiaries”); and (3) all other
subsidiaries (the “Non-Guarantor Subsidiaries”). The Guarantor Subsidiaries are 100% owned direct and
indirect subsidiaries of the Company and their guarantees are full, unconditional and joint and several. They
have no operations and function only as intermediate holding companies.
93
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
Certain reclassifications have been made to conform all of the financial information to the financial
presentation on a consolidated basis. The principal eliminations relate to investments in subsidiaries and
intercompany balances and transactions.
\(cid:12)(cid:13)(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)>(cid:7)(cid:8)(cid:8)(cid:6)
Current assets:
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)(cid:5)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)(cid:25)
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)(cid:5)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
Cash and cash equivalents . . . . . . . . . . . . . $
Trade receivables, net . . . . . . . . . . . . . . . . .
Inventories
Prepaid expenses and other current assets. .
— $
— $
492 $
580
983
199
— $
492
580
983
199
Total current assets. . . . . . . . . . . . . . . . . . . . . . .
—
—
2,254
—
2,254
Investments in and advances to subsidiaries . . .
Property, plant and equipment, net . . . . . . . . . .
Intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1,198
946
(2,144)
2,880
464
2,462
1,075
—
2,880
464
2,462
1,075
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1,198 $
946 $
9,135 $
(2,144) $
9,135
Current liabilities :
Short-term loans and long-term debt due
within one year . . . . . . . . . . . . . . . . . . $
Current portion of asbestos liability . . . . . .
Accounts payable . . . . . . . . . . . . . . . . . . . .
Other liabilities . . . . . . . . . . . . . . . . . . . . . .
— $
115
2
— $
195 $
— $
1,135
615
(2)
(2)
Total current liabilities . . . . . . . . . . . . . . . . . . . .
117
—
1,945
Long-term debt. . . . . . . . . . . . . . . . . . . . . . . . . .
Asbestos-related liabilities . . . . . . . . . . . . . . . . .
Other long-term liabilities . . . . . . . . . . . . . . . . .
Share owners’ equity . . . . . . . . . . . . . . . . . . . . .
Noncontrolling interests. . . . . . . . . . . . . . . . . . .
250
577
254
5,133
(250)
1,002
946
109
(1,892)
946
Total liabilities and share owners’ equity. . . . . . $ 1,198 $
946 $
9,135 $
(2,144) $
9,135
94
195
115
1,135
615
2,060
5,133
577
1,002
254
109
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
\(cid:12)(cid:13)(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)>(cid:7)(cid:8)(cid:8)(cid:6)
Current assets:
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)(cid:5)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)!
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)(cid:5)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
Cash and cash equivalents . . . . . . . . . . . . . $
Trade receivables, net . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other current assets. .
— $
— $
399 $
562
1,007
366
— $
399
562
1,007
366
Total current assets. . . . . . . . . . . . . . . . . . . . . . .
—
—
2,334
—
2,334
Investments in and advances to subsidiaries . . .
Property, plant and equipment, net . . . . . . . . . .
Intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1,240
988
(2,228)
2,961
597
2,489
1,040
—
2,961
597
2,489
1,040
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1,240 $
988 $
9,421 $
(2,228) $
9,421
Current liabilities :
Short-term loans and long-term debt due
within one year . . . . . . . . . . . . . . . . . . $
Current portion of asbestos liability . . . . . .
Accounts payable . . . . . . . . . . . . . . . . . . . .
Other liabilities . . . . . . . . . . . . . . . . . . . . . .
— $
130
2
Total current liabilities . . . . . . . . . . . . . . . . . . . .
132
—
Long-term debt. . . . . . . . . . . . . . . . . . . . . . . . . .
Asbestos-related liabilities . . . . . . . . . . . . . . . . .
Other long-term liabilities . . . . . . . . . . . . . . . . .
Share owners’ equity . . . . . . . . . . . . . . . . . . . . .
Noncontrolling interests. . . . . . . . . . . . . . . . . . .
250
687
171
988
— $
228 $
— $
1,212
552
1,992
(2)
(2)
5,345
(250)
988
988
108
(1,976)
228
130
1,212
552
2,122
5,345
687
988
171
108
Total liabilities and share owners’ equity. . . . . . $ 1,240 $
988 $
9,421 $
(2,228) $
9,421
95
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)(cid:25)
<(cid:8)(cid:10)(cid:29)(cid:13)(cid:6)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . .
Parent
$
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
$
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
$
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
6,702
(5,490)
6,702 $
(5,490)
$
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . .
1,212
1,212
Selling and administrative expense . . . . . . . . .
Research, development and engineering
expense . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net intercompany interest . . . . . . . . . . . . . . . .
Interest expense, net. . . . . . . . . . . . . . . . . . . . .
Equity earnings from subsidiaries . . . . . . . . . .
Other equity earnings. . . . . . . . . . . . . . . . . . . .
Other expense, net . . . . . . . . . . . . . . . . . . . . . .
20
(20)
209
209
Earnings before income taxes . . . . . . . . . . . . .
Provision for income taxes. . . . . . . . . . . . . . . .
209
209
Earnings from continuing operations. . . . . . . .
Loss from discontinued operations . . . . . . . . .
209
209
(503)
(65)
(20)
(252)
—
60
(76)
356
(119)
237
(7)
(418)
(418)
(418)
(503)
(65)
—
(272)
—
60
(76)
356
(119)
237
(7)
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings attributable to noncontrolling
interests . . . . . . . . . . . . . . . . . . . . . . . . . . .
209
209
230
(418)
230
(21)
(21)
Net earnings attributable to the Company . . . . $ 209 $
209 $
209 $
(418) $
209
‘(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)(cid:25)
(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss). . . . . . . . .
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
$ 209 $
(176)
209 $
(176)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
230
(159)
230 $
(159)
(418) $
352
Total comprehensive income (loss) . . . . . . . . .
33
33
71
(66)
71
Comprehensive income attributable to
noncontrolling interests . . . . . . . . . . . . . .
Comprehensive income (loss) attributable to
(17)
(17)
the Company. . . . . . . . . . . . . . . . . . . . . . . $
33 $
33 $
54 $
(66) $
54
96
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)!
<(cid:8)(cid:10)(cid:29)(cid:13)(cid:6)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . .
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
$
— $
— $
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
6,156
(5,046)
6,156 $
(5,046)
— $
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . .
1,110
1,110
Selling and administrative expense . . . . . . . . .
Research, development and engineering
expense . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net intercompany interest . . . . . . . . . . . . . . . .
Interest expense, net. . . . . . . . . . . . . . . . . . . . .
Equity earnings from subsidiaries . . . . . . . . . .
Other equity earnings. . . . . . . . . . . . . . . . . . . .
Other expense, net . . . . . . . . . . . . . . . . . . . . . .
20
(20)
151
(16)
(476)
(64)
(20)
(231)
151
(302)
(476)
(64)
—
(251)
—
60
(111)
268
(106)
162
(4)
60
(95)
284
(106)
178
(4)
(302)
(302)
Earnings before income taxes . . . . . . . . . . . . .
Provision for income taxes. . . . . . . . . . . . . . . .
135
151
Earnings from continuing operations. . . . . . . .
Loss from discontinued operations . . . . . . . . .
135
151
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings attributable to noncontrolling
interests . . . . . . . . . . . . . . . . . . . . . . . . . . .
135
151
174
(302)
158
(23)
(23)
Net earnings attributable to the Company . . . . $ 135 $
151 $
151 $
(302) $
135
‘(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)!
(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss). . . . . . . . .
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
$ 135 $
(546)
151 $
(546)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
158
(539)
(302) $
1,092
174 $
(539)
Total comprehensive income (loss) . . . . . . . . .
(411)
(395)
(365)
790
(381)
Comprehensive income attributable to
noncontrolling interests . . . . . . . . . . . . . .
Comprehensive income (loss) attributable to
(7)
(7)
the Company. . . . . . . . . . . . . . . . . . . . . . . $ (411) $
(395) $
(372) $
790 $
(388)
97
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)j
<(cid:8)(cid:10)(cid:29)(cid:13)(cid:6)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . .
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
$
— $
— $
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
6,784
(5,531)
6,784 $
(5,531)
— $
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . .
1,253
1,253
Selling and administrative expense . . . . . . . . .
Research, development and engineering
expense . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net intercompany interest . . . . . . . . . . . . . . . .
Interest expense, net. . . . . . . . . . . . . . . . . . . . .
Equity earnings from subsidiaries . . . . . . . . . .
Other equity earnings. . . . . . . . . . . . . . . . . . . .
Other expense, net . . . . . . . . . . . . . . . . . . . . . .
20
(20)
210
(46)
(523)
(63)
(20)
(210)
210
(420)
(523)
(63)
—
(230)
—
64
(194)
307
(92)
215
(23)
64
(148)
353
(92)
261
(23)
(420)
(420)
Earnings before income taxes . . . . . . . . . . . . .
Provision for income taxes. . . . . . . . . . . . . . . .
164
210
Earnings from continuing operations. . . . . . . .
Loss from discontinued operations . . . . . . . . .
164
210
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings attributable to noncontrolling
interests . . . . . . . . . . . . . . . . . . . . . . . . . . .
164
210
238
(420)
192
(28)
(28)
Net earnings attributable to the Company . . . . $ 164 $
210 $
210 $
(420) $
164
‘(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)j
(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss). . . . . . . . .
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
$ 164 $
(401)
210 $
(401)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
192
(394)
(420) $
802
238 $
(394)
Total comprehensive income (loss) . . . . . . . . .
(237)
(191)
(156)
382
(202)
Comprehensive income attributable to
noncontrolling interests . . . . . . . . . . . . . .
Comprehensive income (loss) attributable to
(7)
(7)
the Company. . . . . . . . . . . . . . . . . . . . . . . $ (237) $
(191) $
(163) $
382 $
(209)
98
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)(cid:25)
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
(cid:26)(cid:12)(cid:10)(cid:7)(cid:5)(cid:2)(cid:13)(cid:3)#(cid:10)
Cash provided by (utilized in) operating
activities . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash utilized in investing activities . . . . . . . . .
Cash provided by (utilized in) financing
$ (125) $
— $
activities . . . . . . . . . . . . . . . . . . . . . . . . . .
125
Effect of exchange rate change on cash . . . . . .
Net change in cash . . . . . . . . . . . . . . . . . . . . . .
Cash at beginning of period . . . . . . . . . . . . . . .
—
—
876 $
(417)
(353)
(13)
93
399
— $
—
751
(417)
(228)
(13)
93
399
Cash at end of period . . . . . . . . . . . . . . . . . . . . $
— $
— $
492 $
— $
492
(cid:26)(cid:12)(cid:10)(cid:7)(cid:5)(cid:2)(cid:13)(cid:3)#(cid:10)
Cash provided by (utilized in) operating
activities . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash utilized in investing activities . . . . . . . . .
Cash provided by financing activities . . . . . . .
Effect of exchange rate change on cash . . . . . .
138
‘(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)!
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
$ (138) $
— $
746 $
— $
(2,748)
1,919
(30)
(113)
512
—
608
(2,748)
2,057
(30)
(113)
512
Net change in cash . . . . . . . . . . . . . . . . . . . . . .
Cash at beginning of period . . . . . . . . . . . . . . .
—
—
Cash at end of period . . . . . . . . . . . . . . . . . . . . $
— $
— $
399 $
— $
399
‘(cid:8)(cid:12)(cid:4)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)j
Parent
Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)
8(cid:3)(cid:15)(cid:30)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:3)(cid:4)
>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10) ;(cid:13)(cid:27)(cid:18)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) (cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
(cid:26)(cid:12)(cid:10)(cid:7)(cid:5)(cid:2)(cid:13)(cid:3)#(cid:10)
Cash provided by (utilized in) operating
activities . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash utilized in investing activities . . . . . . . . .
Cash provided by (utilized in) financing
$ (148) $
— $
activities . . . . . . . . . . . . . . . . . . . . . . . . . .
148
Effect of exchange rate change on cash . . . . . .
Net change in cash . . . . . . . . . . . . . . . . . . . . . .
Cash at beginning of period . . . . . . . . . . . . . . .
—
—
823 $
(455)
(218)
(21)
129
383
— $
—
675
(455)
(70)
(21)
129
383
Cash at end of period . . . . . . . . . . . . . . . . . . . . $
— $
— $
512 $
— $
512
99
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
>(cid:8)(cid:13)(cid:8)(cid:11)(cid:6)(cid:8)(cid:16)(cid:5)p(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:13)(cid:14)(cid:5)(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:12)(cid:13)(cid:5)(cid:17)(cid:12)(cid:6)(cid:12)(cid:5)/(cid:29)(cid:15)(cid:12)(cid:29)(cid:16)(cid:27)(cid:6)(cid:8)(cid:16)6 The following tables present selected financial data by
quarter for the years ended December 31, 2016 and 2015:
(cid:23)(cid:24)(cid:21)(cid:25)
Third
p(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:5)
p(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:5)
$ 1,588 $ 1,760 $ 1,712 $ 1,642 $ 6,702
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 319 $ 342 $ 336 $ 215 $ 1,212
Earnings (loss) from continuing operations attributable to
(cid:2)(cid:3)(cid:29)(cid:4)(cid:6)(cid:7)
p(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:5)
>(cid:8)(cid:11)(cid:3)(cid:15)(cid:16)
p(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:5)
7(cid:3)(cid:6)(cid:12)(cid:13)
Year
First
the Company (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
68 $ 107 $ 111 $ (70) $ 216
Loss from discontinued operations attributable to
the Company. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings (loss) attributable to the Company . . . . . . . . . . . .
$
(7)
(1)
67 $ 105 $ 108 $ (71) $ 209
(3)
(2)
(1)
Earnings per share of common stock (a) (b):
Basic:
Earnings (loss) from continuing operations . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . .
Net earnings (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted:
$ 0.42 $ 0.66 $ 0.68 $ (0.43) $ 1.33
(0.04)
$ 0.41 $ 0.65 $ 0.66 $ (0.44) $ 1.29
(0.01)
(0.02)
(0.01)
(0.01)
$ 0.42 $ 0.65 $ 0.68 $ (0.43) $ 1.32
Earnings (loss) from continuing operations . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . .
(0.04)
Net earnings (loss). . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.41 $ 0.64 $ 0.66 $ (0.44) $ 1.28
(0.02)
(0.01)
(0.01)
(0.01)
(a) Amounts management considers not representative of ongoing operations include:
(cid:6)
(cid:27)(cid:12)(cid:16)(cid:6)(cid:8)(cid:31)(cid:3)(cid:6)(cid:4)(cid:16)(cid:10)(cid:8)(cid:6)(cid:30)(cid:28)(cid:14)(cid:16)(cid:8)(cid:3)(cid:16)"(cid:6)(cid:11)(cid:5)!(cid:13)(cid:28)(cid:2)(cid:3)(cid:2)(cid:6)(cid:5)(cid:3)(cid:8)(cid:6)!(cid:31)(cid:14)(cid:16)(cid:29)(cid:3)(cid:10)(cid:6)(cid:8)(cid:12)(cid:8)(cid:14)(cid:13)(cid:11)(cid:5)(cid:29)(cid:6)(cid:20)(cid:24)(cid:23)(cid:6)(cid:18)(cid:11)(cid:13)(cid:13)(cid:11)(cid:12)(cid:5)(cid:6)(cid:14)(cid:15)(cid:8)(cid:3)(cid:16)<(cid:8)(cid:14)(cid:17)(cid:6)(cid:14)(cid:18)(cid:12)(cid:28)(cid:5)(cid:8)(cid:6)(cid:14)(cid:8)(cid:8)(cid:16)(cid:11)(cid:7)(cid:28)(cid:8)(cid:14)(cid:7)(cid:13)(cid:3)(cid:6)(cid:8)(cid:12)(cid:6)(cid:8)(cid:31)(cid:3)(cid:6)=(cid:12)(cid:18)(cid:9)(cid:14)(cid:5)(cid:19)(cid:26)(cid:6)
The effect of these charges was a reduction in earnings per share of $0.06.
For the fourth quarter, included net charges totaling $150 million after-tax amount attributable to the
Company. The effect of these charges was a reduction in earnings per share of $0.93.
(b) Earnings per share are computed independently for each period presented. As such, the sums of the
amounts calculated separately for each quarter do not equal the year-to-date amount.
100
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)?(cid:8)(cid:4)(cid:5)(cid:10)(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:12)(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)
2015
Third
p(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:5)
p(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:5)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 1,421 $ 1,543 $ 1,566 $ 1,626 $ 6,156
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 268 $ 274 $ 276 $ 292 $ 1,110
Earnings from continuing operations attributable to the
(cid:2)(cid:3)(cid:29)(cid:4)(cid:6)(cid:7)
p(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:5)
>(cid:8)(cid:11)(cid:3)(cid:15)(cid:16)
p(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:5)
7(cid:3)(cid:6)(cid:12)(cid:13)
Year
First
Company (c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
71 $
42 $
18 $
8 $ 139
Loss from discontinued operations attributable to the
Company. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings attributable to the Company . . . . . . . . . . . . . . . . . $
—
71 $
(2)
40 $
(1)
17 $
(1)
(4)
7 $ 135
Earnings per share of common stock (c) (d) . . . . . . . . . . . . . . .
Basic:
Earnings from continuing operations . . . . . . . . . . . . . $ 0.44 $ 0.26 $ 0.11 $ 0.05 $ 0.86
Loss from discontinued operations . . . . . . . . . . . . . . .
(0.03)
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.44 $ 0.25 $ 0.10 $ 0.04 $ 0.83
Diluted:
(0.01)
(0.01)
(0.01)
—
Earnings from continuing operations . . . . . . . . . . . . . $ 0.44 $ 0.26 $ 0.11 $ 0.04 $ 0.85
Loss from discontinued operations . . . . . . . . . . . . . . .
(0.03)
Net earnings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.44 $ 0.25 $ 0.10 $ 0.03 $ 0.82
(0.01)
(0.01)
(0.01)
—
(c) Amounts management considers not representative of ongoing operations include:
For the second quarter, included net charges totaling $55 million after-tax amount attributable to the
Company. The effect of these charges was a reduction in earnings per share of $0.34.
For the third quarter, included net charges totaling $75 million after-tax amount attributable to the
Company. The effect of these charges was a reduction in earnings per share of $0.46.
For the fourth quarter, included net charges totaling $56 million after-tax amount attributable to the
Company. The effect of these charges was a reduction in earnings per share of $0.35.
(d) Earnings per share are computed independently for each period presented. As such, the sums of the
amounts calculated separately for each quarter do not equal the year-to-date amount.
101
ITEM 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
None.
ITEM 9A. CONTROLS AND PROCEDURES
(cid:17)(cid:27)(cid:10)(cid:11)(cid:13)(cid:3)(cid:10)(cid:29)(cid:4)(cid:8)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:3)(cid:13)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)*(cid:4)(cid:3)(cid:11)(cid:8)(cid:16)(cid:29)(cid:4)(cid:8)(cid:10)
The Company maintains disclosure controls and procedures that are designed to ensure that information
required to be disclosed in the Company’s Exchange Act reports is recorded, processed, summarized and
reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and
that such information is accumulated and communicated to the Company’s management, including its Chief
Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required
disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that
any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance
of achieving the desired control objectives, and management is required to apply its judgment in evaluating the
cost-benefit relationship of possible controls and procedures. Also, the Company has investments in certain
unconsolidated entities. As the Company does not control or manage these entities, its disclosure controls and
procedures with respect to such entities are necessarily substantially more limited than those maintained with
respect to its consolidated subsidiaries.
As required by Rule 13a-15(b) of the Exchange Act, the Company carried out an evaluation, under the
supervision and with the participation of management, including its Chief Executive Officer and Chief Financial
Officer, of the effectiveness of the Company’s disclosure controls and procedures as of the end of the period
covered by this report. Based on the foregoing, the Company’s Chief Executive Officer and Chief Financial
Officer concluded that the Company’s disclosure controls and procedures were effective at the reasonable
assurance level as of December 31, 2016.
&(cid:12)(cid:15)(cid:12)+(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)b(cid:10)(cid:5)<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:5)(cid:3)(cid:15)(cid:5)@(cid:15)(cid:6)(cid:8)(cid:4)(cid:15)(cid:12)(cid:13)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:3)(cid:13)(cid:5)(cid:3)[(cid:8)(cid:4)(cid:5)(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:12)(cid:13)(cid:5)<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:27)(cid:15)+
The management of Owens-Illinois, Inc. is responsible for establishing and maintaining adequate internal
control over financial reporting. The Company’s internal control over financial reporting is designed to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles in the United
States. However, all internal control systems, no matter how well designed, have inherent limitations. Therefore,
even those systems determined to be effective can provide only reasonable assurance with respect to financial
statement preparation and reporting.
Management assessed the effectiveness of the Company’s internal control over financial reporting as of
December 31, 2016. In making this assessment management used the criteria for effective internal control
over financial reporting as described in “Internal Control—Integrated Framework” issued by the Committee of
Sponsoring Organizations of the Treadway Commission (the COSO framework) in 2013.
Based on this assessment, using the criteria above, management concluded that the Company’s system of
internal control over financial reporting was effective as of December 31, 2016.
The Company’s independent registered public accounting firm, Ernst & Young LLP, that audited the
Company’s consolidated financial statements, has issued an attestation report on the Company’s internal control
over financial reporting which is included below.
102
<(cid:8)(cid:18)(cid:8)(cid:16)(cid:27)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)(cid:3)(cid:28)(cid:5)*(cid:4)(cid:8)[(cid:27)(cid:3)(cid:29)(cid:10)(cid:13)(cid:14)(cid:5)(cid:17)(cid:27)(cid:10)(cid:11)(cid:13)(cid:3)(cid:10)(cid:8)(cid:16)(cid:5)&(cid:12)(cid:6)(cid:8)(cid:4)(cid:27)(cid:12)(cid:13)(cid:5)’(cid:8)(cid:12)](cid:15)(cid:8)(cid:10)(cid:10)
In 2016, the Company completed several changes to its internal control over financial reporting and
remediated the previously reported material weakness. A material weakness is a deficiency, or a combination
of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that
a material misstatement of the Company’s annual or interim financial statements will not be prevented or
detected on a timely basis. In its Amendment No. 1 to Annual Report on Form 10-K/A for the year ended
December 31, 2015, management reported a material weakness in the Company’s design of its control activities
for the estimation of liabilities related to probable losses for unasserted asbestos claims. Specifically, the
Company did not have sufficient controls in place to provide reasonable assurance that a material error would
be prevented or detected related to the application of ASC 450 to the estimation of probable losses from
unasserted asbestos claims.
The following changes were made to the Company’s internal control over financial reporting:
1.
2.
Established new policies, procedures and controls for the review, approval and application of generally
accepted accounting principles related to, and disclosure with respect to, unasserted asbestos claims.
As a result of the new controls discussed above, the Company made certain process changes regarding
the estimation of its probable asbestos-related liability. This included implementing a new model with
actuarial inputs to estimate the total number of future asbestos-related claims to be filed against the
Company.
3.
The Company uses the estimate of total future claims, along with an estimation of related disposition
costs and legal costs, as inputs to develop its best estimate of its probable asbestos-related liability.
The Company has completed the redesign of its controls related to estimating liabilities of probable losses
for unasserted asbestos claims. The Company has assessed both the design and operation of the redesigned
controls and found them to be both designed and operating effectively. The Company has determined that the
remediation activities implemented are sufficient to allow it to conclude that the previously disclosed material
weakness related to estimating liabilities of probable losses for unasserted asbestos claims has been remediated
as of December 31, 2016.
(cid:26)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)@(cid:15)(cid:6)(cid:8)(cid:4)(cid:15)(cid:12)(cid:13)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:3)(cid:13)(cid:5)(cid:3)[(cid:8)(cid:4)(cid:5)(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:12)(cid:13)(cid:5)<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:27)(cid:15)+
As required by Rule 13a-15(d) of the Exchange Act, the Company carried out an evaluation, under the
supervision and with the participation of management, including its Chief Executive Officer and Chief Financial
Officer, of any change in the Company’s internal control over financial reporting that has materially affected, or
is reasonably likely to materially affect, the Company’s internal control over financial reporting.
Other than as described above in “Remediation of Previously Disclosed Material Weakness,” there were no
changes in the Company’s internal control over financial reporting during the quarter ended December 31, 2016
that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over
financial reporting.
103
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Share Owners of
Owens-Illinois, Inc.
We have audited Owens-Illinois, Inc.’s internal control over financial reporting as of December 31, 2016,
based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (2013 framework) (the COSO criteria). Owens-Illinois, Inc.’s
management is responsible for maintaining effective internal control over financial reporting, and for its
assessment of the effectiveness of internal control over financial reporting included in the accompanying
Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion
on the company’s internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether effective internal control over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing
the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal
control based on the assessed risk, and performing such other procedures as we considered necessary in the
circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company’s internal control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles. A company’s internal control over
financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in
reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;
(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that receipts and expenditures
of the company are being made only in accordance with authorizations of management and directors of the
company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of the company’s assets that could have a material effect on the financial
statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.
In our opinion, Owens-Illinois, Inc. maintained, in all material respects, effective internal control over
financial reporting as of December 31, 2016, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight
Board (United States), the consolidated balance sheets of Owens-Illinois, Inc. as of December 31, 2016 and
2015, and the related consolidated statements of results of operations, comprehensive income, share owners’
equity and cash flows for each of the three years in the period ended December 31, 2016 and our report dated
February 10, 2017 expressed an unqualified opinion thereon.
/s/ Ernst & Young LLP
Toledo, Ohio
February 10, 2017
104
ITEM 9B. OTHER INFORMATION
None.
105
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Information with respect to non-officer directors and corporate governance is included in the 2017 Proxy
Statement in the sections entitled “Election of Directors” and “Section 16(a) Beneficial Ownership Reporting
Compliance” and such information is incorporated herein by reference.
Information with respect to executive officers is included herein in Item 1.
(cid:26)(cid:3)(cid:16)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)\(cid:29)(cid:10)(cid:27)(cid:15)(cid:8)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:16)(cid:29)(cid:11)(cid:6)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5);(cid:6)(cid:7)(cid:27)(cid:11)(cid:10)
The Company’s Global Code of Business Conduct and Ethics, which is applicable to all directors, officers
and employees of the Company, including the principal executive officer, the principal financial officer and the
principal accounting officer, is available on the Investor Relations section of the Company’s web site (www.o-i.
com). A copy of the Code is also available in print to share owners upon request, addressed to the Corporate
Secretary at Owens-Illinois, Inc., One Michael Owens Way, Perrysburg, Ohio 43551. The Company intends to
post amendments to or waivers from its Code of Business Conduct and Ethics (to the extent applicable to the
Company’s directors, executive officers or principal financial officers) at this location on its web site.
ITEM 11. EXECUTIVE COMPENSATION
The section entitled “Executive Compensation,” exclusive of the subsection entitled “Board Compensation
Committee Report,” which is included in the 2017 Proxy Statement, is incorporated herein by reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS
The section entitled “Security Ownership of Certain Beneficial Owners and Management” which is
included in the 2017 Proxy Statement is incorporated herein by reference.
The following table summarizes securities authorized for issuance under equity compensation plans as of
December 31, 2016.
;m(cid:29)(cid:27)(cid:6)(cid:14)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:8)(cid:15)(cid:10)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
(a)
/(cid:19)6
8(cid:29)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:3)(cid:28)(cid:5)(cid:10)(cid:8)(cid:11)(cid:29)(cid:4)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)
(cid:6)(cid:3)(cid:5)(cid:19)(cid:8)(cid:5)(cid:27)(cid:10)(cid:10)(cid:29)(cid:8)(cid:16)(cid:5)(cid:29)?(cid:3)(cid:15)
(cid:8):(cid:8)(cid:4)(cid:11)(cid:27)(cid:10)(cid:8)(cid:5)(cid:3)(cid:28)
(cid:3)(cid:29)(cid:6)(cid:10)(cid:6)(cid:12)(cid:15)(cid:16)(cid:27)(cid:15)+(cid:5)(cid:3)?(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)
#(cid:12)(cid:4)(cid:4)(cid:12)(cid:15)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:4)(cid:27)+(cid:7)(cid:6)(cid:10)/(cid:21)6
/(cid:6)(cid:7)(cid:3)(cid:29)(cid:10)(cid:12)(cid:15)(cid:16)(cid:10)6
’(cid:8)(cid:27)+(cid:7)(cid:6)(cid:8)(cid:16)(cid:30)(cid:12)[(cid:8)(cid:4)(cid:12)+(cid:8)
(cid:8):(cid:8)(cid:4)(cid:11)(cid:27)(cid:10)(cid:8)(cid:5)?(cid:4)(cid:27)(cid:11)(cid:8)(cid:5)(cid:3)(cid:28)
(cid:3)(cid:29)(cid:6)(cid:10)(cid:6)(cid:12)(cid:15)(cid:16)(cid:27)(cid:15)+(cid:5)(cid:3)?(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)(cid:22)
#(cid:12)(cid:4)(cid:4)(cid:12)(cid:15)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:4)(cid:27)+(cid:7)(cid:6)(cid:10)
/(cid:11)6
8(cid:29)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:3)(cid:28)(cid:5)(cid:10)(cid:8)(cid:11)(cid:29)(cid:4)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)
(cid:4)(cid:8)(cid:18)(cid:12)(cid:27)(cid:15)(cid:27)(cid:15)+(cid:5)(cid:12)[(cid:12)(cid:27)(cid:13)(cid:12)(cid:19)(cid:13)(cid:8)
(cid:28)(cid:3)(cid:4)(cid:5)(cid:28)(cid:29)(cid:6)(cid:29)(cid:4)(cid:8)(cid:5)(cid:27)(cid:10)(cid:10)(cid:29)(cid:12)(cid:15)(cid:11)(cid:8)
(cid:29)(cid:15)(cid:16)(cid:8)(cid:4)(cid:5)(cid:8)m(cid:29)(cid:27)(cid:6)(cid:14)
(cid:11)(cid:3)(cid:18)?(cid:8)(cid:15)(cid:10)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)?(cid:13)(cid:12)(cid:15)(cid:10)
/(cid:8):(cid:11)(cid:13)(cid:29)(cid:16)(cid:27)(cid:15)+(cid:5)(cid:10)(cid:8)(cid:11)(cid:29)(cid:4)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)
(cid:4)(cid:8)(cid:28)(cid:13)(cid:8)(cid:11)(cid:6)(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)(cid:11)(cid:3)(cid:13)(cid:29)(cid:18)(cid:15)(cid:5)/(cid:12)66
/(cid:6)(cid:7)(cid:3)(cid:29)(cid:10)(cid:12)(cid:15)(cid:16)(cid:10)6
3,096
$
—
3,096
$
22.91
—
22.91
5,081
—
5,081
*(cid:13)(cid:12)(cid:15)(cid:5)(cid:26)(cid:12)(cid:6)(cid:8)+(cid:3)(cid:4)(cid:14)
Equity compensation plans approved by
security holders. . . . . . . . . . . . . . . . . . . . .
Equity compensation plans not approved by
security holders. . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(1) Represents options to purchase shares of the Company’s common stock. There are no outstanding warrants
or rights.
106
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
The section entitled “Director and Executive Compensation and Other Information,” exclusive of the
subsection entitled “Board Compensation Committee Report on Executive Compensation,” which is included in
the 2017 Proxy Statement, is incorporated herein by reference.
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
Information with respect to principal accountant fees and services is included in the 2017 Proxy Statement
in the section entitled “Independent Registered Public Accounting Firm” and such information is incorporated
herein by reference.
107
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCHEDULES
Index of Financial Statements and Financial Statement Schedules Covered by Report of Independent Auditors.
(a) DOCUMENTS FILED AS PART OF THIS REPORT
1. See Index to Consolidated Financial Statements on page 47 hereof.
2. See Quarterly Results (Unaudited) beginning on page 100 hereof.
3. Financial Statement Schedule:
For the years ended December 31, 2016, 2015, and 2014:
II—Valuation and Qualifying Accounts (Consolidated). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
All other schedules have been omitted since the required information is not present or not
S-1
present in amounts sufficient to require submission of the schedule.
(ii) Separate Financial Statements of Affiliates Whose Securities Are Pledged As Collateral. . . .
114
10-K Page
4. See Exhibit Index beginning on page 109 hereof.
108
>(cid:30)q(cid:5)@(cid:6)(cid:8)(cid:18)(cid:5)(cid:25)(cid:24)(cid:21)(cid:5)8(cid:3)Q
2.1
__
EXHIBIT INDEX
(cid:17)(cid:3)(cid:11)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)
Stock Purchase Agreement, dated as of May 12, 2015, by and between Owens-
Brockway Glass Container Inc. and Vitro, S.A.B. de C.V., Distribuidora Alcali, S.A. de
C.V. and Vitro Packaging, LLC (filed as Exhibit 2.1 to the Owens-Illinois, Inc.’s Form
8-K/A filed on May 13, 2015, File No. 1-9576, and incorporated herein by reference).
3.1
3.2
4.1
4.2
4.3
— Third Restated Certificate of Incorporation of Owens-Illinois, Inc. (filed as Exhibit 3.1
to Owens-Illinois, Inc.’s Form 10-K for the year ended December 31, 2012, File No.
1-9576, and incorporated herein by reference).
— Third Amended and Restated Bylaws of Owens-Illinois, Inc., (filed as Exhibit 3.1 to
Owens-Illinois, Inc.’s Form 8-K dated April 23, 2009, File No. 1-9576, and incorporated
herein by reference).
— Indenture dated as of May 20, 1998, between Owens-Illinois, Inc. and The Bank of New
York, as Trustee (filed as Exhibit 4.1 to Owens-Illinois, Inc.’s Form 8-K dated May 20,
1998, File No. 1-9576, and incorporated herein by reference).
— Officers’ Certificate, dated May 20, 1998, establishing the terms of the 7.80% Senior
Notes due 2018; including the Form of 7.80% Senior Note due 2018 (filed as Exhibits
4.5 and 4.9, respectively, to Owens-Illinois, Inc.’s Form 8-K dated May 20, 1998, File
No. 1-9576, and incorporated herein by reference).
— Supplemental Indenture, dated as of June 26, 2001 among Owens-Illinois, Inc., Owens-
Illinois Group, Inc., Owens-Brockway Packaging, Inc. and The Bank of New York, as
Trustee (May 20, 1998 Indenture) (filed as Exhibit 4.1 to Owens-Illinois Inc.’s Form
10-Q for the quarter ended September 30, 2001, File No. 1-9576, and incorporated
herein by reference).
4.4
— Indenture, dated as of September 15, 2010, by and among OI European Group B.V.;
the guarantors party thereto; Deutsche Trustee Company Limited as trustee; Deutsche
Bank AG, London Branch as principal paying agent and transfer agent; and Deutsche
Bank Luxembourg S.A. as the registrar, Luxembourg paying agent and transfer agent,
including the form of the Senior Notes (filed as Exhibit 4.1 to Owens-Illinois Group,
Inc.’s Form 8-K dated September 10, 2010, File No. 33-13061, and incorporated herein
by reference).
4.5
— Indenture dated as of March 22, 2013, by and among OI European Group B.V.; the
guarantors party thereto; Deutsche Trustee Company Limited as trustee; Deutsche Bank
AG, London Branch as principal paying agent and transfer agent; and Deutsche Bank
Luxembourg S.A. as the registrar and Luxembourg transfer agent, including the form of
Notes (filed as Exhibit 4.1 to Owens-Illinois Group, Inc.’s Form 8-K dated March 22,
2013, File No. 33-13061, and incorporated herein by reference).
4.6
— Indenture dated as of December 3, 2014, by and among Owens-Brockway Glass
Container Inc., the guarantors party thereto and U.S. Bank National Association, as
trustee, including the form of 2022 Senior Notes and the form of 2025 Senior Notes
(filed as Exhibit 4.1 to Owens-Illinois Group, Inc.’s Form 8-K dated December 3, 2014,
File No. 33-13061, and incorporated herein by reference).
4.7
— Indenture dated as of August 24, 2015, by and among Owens-Brockway Glass Container
Inc., the guarantors party thereto and U.S. Bank National Association, as trustee,
including the form of 2023 Senior Notes and the form of 2025 Senior Notes (filed as
Exhibit 4.1 to Owens-Illinois Group, Inc.’s Form 8-K dated August 24, 2015, File No.
33-13061, and incorporated herein by reference).
109
>(cid:30)q(cid:5)@(cid:6)(cid:8)(cid:18)(cid:5)(cid:25)(cid:24)(cid:21)(cid:5)8(cid:3)Q
4.8
4.9
4.10
(cid:17)(cid:3)(cid:11)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)
— Indenture, dated as of November 3, 2016, by and among OI European Group B.V., the
guarantors party thereto, Deutsche Trustee Company Limited, as trustee, Deutsche Bank
AG, London Branch, as principal paying agent and transfer agent, and Deutsche Bank
Luxembourg S. A., as Luxembourg transfer agent and registrar, including the form of
Notes (filed as Exhibit 4.1 to Owens-Illinois, Inc.’s and Owens-Illinois Group, Inc.’s
combined Form 8-K dated November 3, 2016, File Nos. 1-9576 and 33-13061, and
incorporated herein by reference).
— Amended and Restated Credit Agreement and Syndicated Facility Agreement, dated as
of April 22, 2015, by and among the Borrowers named therein, Owens-Illinois General,
Inc., as Borrowers’ Agent, Deutsche Bank AG, New York Branch, as Administrative
Agent, and the other Agents, Arrangers and Lenders named therein (filed as Exhibit 4.1
to Owens-Illinois Group, Inc.’s Form 8-K dated April 22, 2015, File No. 33-13061, and
incorporated herein by reference).
— Amendment No. 1, dated July 24, 2015, to the Amended and Restated Credit Agreement
and Syndicated Facility Agreement, dated April 22, 2015, by and among the Borrowers
named therein, Owens-Illinois General Inc., as Borrowers’ Agent, Deutsche Bank
AG, New York Branch, as Administrative Agent, and the other Agents, Arrangers and
Lenders named therein (filed as Exhibit 4.2 to Owens-Illinois Inc.’s Form 10-Q for
the quarter ended September 30, 2015, File No. 1-9576, and incorporated herein by
reference).
4.11
— Amendment No. 2, dated September 1, 2015, to the Amended and Restated Credit
Agreement and Syndicated Facility Agreement, dated April 22, 2015, by and among the
Borrowers named therein, Owens-Illinois General Inc., as Borrowers’ Agent, Deutsche
Bank AG, New York Branch, as Administrative Agent, and the other Agents, Arrangers
and Lenders named therein (filed as Exhibit 10.1 to Owens-Illinois Inc.’s Form 8-K
dated September 1, 2015, File No. 1-9576, and incorporated herein by reference).
4.12
— Amendment No. 3, dated September 29, 2015, to the Amended and Restated Credit
Agreement and Syndicated Facility Agreement, dated April 22, 2015, by and among the
Borrowers named therein, Owens-Illinois General Inc., as Borrowers’ Agent, Deutsche
Bank AG, New York Branch, as Administrative Agent, and the other Agents, Arrangers
and Lenders named therein (filed as Exhibit 4.4 to Owens-Illinois Inc.’s Form 10-Q
for the quarter ended September 30, 2015, File No. 1-9576, and incorporated herein by
reference).
4.13
— Amendment No. 4, dated February 3, 2016, to the Amended and Restated Credit
Agreement and Syndicated Facility Agreement, dated as of April 22, 2015, by and
among the Borrowers named therein, Owens-Illinois General, Inc., as Borrowers’ Agent,
Deutsche Bank AG, New York Branch, as Administrative Agent, and the other Agents,
Arrangers and Lenders named therein (filed as Exhibit 4.1 to Owens-Illinois, Inc.’s Form
8-K dated February 3, 2016, File No. 1-9576, and incorporated herein by reference).
4.14
— First Incremental Amendment, dated September 1, 2015, to the Amended and Restated
Credit Agreement and Syndicated Facility Agreement, dated April 22, 2015, by and
among the Borrowers named therein, Owens-Illinois General Inc., as Borrowers’
Agent, Deutsche Bank AG, New York Branch, as Administrative Agent, and the other
Agents, Arrangers and Lenders named therein (filed as Exhibit 10.2 to Owens-Illinois
Inc.’s Form 8-K dated September 1, 2015, File No. 1-9576, and incorporated herein by
reference).
110
>(cid:30)q(cid:5)@(cid:6)(cid:8)(cid:18)(cid:5)(cid:25)(cid:24)(cid:21)(cid:5)8(cid:3)Q
4.15
(cid:17)(cid:3)(cid:11)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)
— Third Amended and Restated Intercreditor Agreement, dated as of May 19, 2011, by and
among Deutsche Bank AG, New York Branch, as Administrative Agent for the lenders
party to the Credit Agreement (as defined therein) and Deutsche Bank Trust Company
Americas, as Collateral Agent (as defined therein) and any other parties thereto (filed as
Exhibit 4.2 to Owens-Illinois Group, Inc.’s Form 8-K dated May 19, 2011, File No. 33-
13061, and incorporated herein by reference).
4.16
— Fourth Amended and Restated Pledge Agreement, dated as of April 22, 2015, between
Owens-Illinois Group, Inc., Owens-Brockway Packaging, Inc., and Deutsche Bank AG,
New York Branch, as Collateral Agent (as defined therein) and any other parties thereto
(filed as Exhibit 4.2 to Owens-Illinois Group, Inc.’s Form 8-K dated April 22, 2015, File
No. 33-13061, and incorporated herein by reference).
__ Amended and Restated Security Agreement, dated as of April 22, 2015, between Owens-
Illinois Group, Inc., each of the direct and indirect subsidiaries of Owens-Illinois Group,
Inc. signatory thereto, and Deutsche Bank AG, New York Branch, as Collateral Agent
(as defined therein) (filed as Exhibit 4.3 to Owens-Illinois Group, Inc.’s Form 8-K dated
April 22, 2015, File No. 33-13061, and incorporated herein by reference).
— Amended and Restated Owens-Illinois Supplemental Retirement Benefit Plan (filed as
Exhibit 10.1 to Owens-Illinois, Inc.’s Form 10-Q for the quarter ended June 30, 1998,
File No. 1-9576, and incorporated herein by reference).
4.17
10.1*
10.2*
— First Amendment to Amended and Restated Owens-Illinois Supplemental Retirement
10.3*
10.4*
10.5*
10.6*
10.7*
10.8*
10.9*
10.10*
10.11*
Benefit Plan (filed as Exhibit 10.3 to Owens-Illinois, Inc.’s Form 10-K for the year
ended December 31, 2000, File No. 1-9576, and incorporated herein by reference).
— Second Amendment to Amended and Restated Owens-Illinois Supplemental Retirement
Benefit Plan (filed as Exhibit 10.1 to Owens-Illinois, Inc.’s Form 10-Q for the quarter
ended March 31, 2002, File No. 1-9576, and incorporated herein by reference).
— Third Amendment to Amended and Restated Owens-Illinois Supplemental Retirement
Benefit Plan (filed as Exhibit 10.1 to Owens-Illinois, Inc.’s Form 10-Q for the quarter
ended March 31, 2003, File No. 1-9576, and incorporated herein by reference).
— Owens-Illinois, Inc. Directors Deferred Compensation Plan (filed as Exhibit 10.26
to Owens-Illinois, Inc.’s Form 10-K for the year ended December 31, 1995, File No.
1-9576, and incorporated herein by reference).
— First Amendment to Owens-Illinois, Inc. Directors Deferred Compensation Plan (filed
as Exhibit 10.27 to Owens-Illinois, Inc.’s Form 10-K for the year ended December 31,
1995, File No. 1-9576, and incorporated herein by reference).
— Second Amendment to Owens-Illinois, Inc. Directors Deferred Compensation Plan (filed
as Exhibit 10.2 to Owens-Illinois, Inc.’s Form 10-Q for the quarter ended March 31,
1997, File No. 1-9576, and incorporated herein by reference).
— Amended and Restated 1997 Equity Participation Plan of Owens-Illinois, Inc. (filed as
Exhibit 10.1 to Owens-Illinois, Inc.’s Form 10-Q for the quarter ended June 30, 1999,
File No. 1-9576, and incorporated herein by reference).
— First Amendment to Amended and Restated 1997 Equity Participation Plan of Owens-
Illinois, Inc. (filed as Exhibit 10.1 to Owens-Illinois, Inc.’s Form 10-Q for the quarter
ended June 30, 2002, File No. 1-9576, and incorporated herein by reference).
— Owens-Illinois, Inc. Executive Deferred Savings Plan (filed herewith).
— 2004 Equity Incentive Plan for Directors of Owens-Illinois, Inc. (filed as Exhibit 10.1 to
Owens-Illinois, Inc.’s Form 10-Q for the quarter ended June 30, 2004, File No. 1-9576,
and incorporated herein by reference).
10.12*
— Owens-Illinois 2004 Executive Life Insurance Plan (filed as Exhibit 10.32 to Owens-
Illinois, Inc.’s Form 10-K for the year ended December 31, 2004, File No. 1-9576, and
incorporated herein by reference).
111
>(cid:30)q(cid:5)@(cid:6)(cid:8)(cid:18)(cid:5)(cid:25)(cid:24)(cid:21)(cid:5)8(cid:3)Q
10.13*
10.14*
10.15*
(cid:17)(cid:3)(cid:11)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)
— Owens-Illinois 2004 Executive Life Insurance Plan for Non-U.S. Employees (filed as
Exhibit 10.33 to Owens-Illinois, Inc.’s Form 10-K for the year ended December 31,
2004, File No. 1-9576, and incorporated herein by reference).
— Amended and Restated Owens-Illinois, Inc. 2005 Incentive Award Plan dated as of April
24, 2009 (filed as Exhibit 10.1 to Owens-Illinois, Inc.’s Form 10-Q for the quarter ended
March 31, 2009, File No. 1-9576, and incorporated herein by reference).
— Form of Non-Qualified Stock Option Agreement for use under the Owens-Illinois, Inc.
2005 Incentive Award Plan (filed as Exhibit 10.25 to Owens-Illinois, Inc.’s Form 10-K
for the year ended December 31, 2011, File No. 1-9576, and incorporated herein by
reference).
10.16*
— Form of Restricted Stock Agreement for use under the Owens-Illinois, Inc. 2005
Incentive Award Plan (filed as Exhibit 10.30 to Owens-Illinois, Inc.’s Form 10-K for the
year ended December 31, 2005, File No. 1-9576, and incorporated herein by reference).
10.17*
— Form of Phantom Stock Agreement for use under the Owens-Illinois, Inc. 2005
Incentive Award Plan (filed as Exhibit 10.31 to Owens-Illinois, Inc.’s Form 10-K for the
year ended December 31, 2005, File No. 1-9576, and incorporated herein by reference).
10.18*
— Form of Restricted Stock Unit Agreement for use under the Owens-Illinois, Inc. 2005
10.19*
Incentive Award Plan (filed as Exhibit 10.28 to Owens-Illinois, Inc.’s Form 10-K for the
year ended December 31, 2011, File No. 1-9576, and incorporated herein by reference).
— Form of Performance Share Unit Agreement for use under the Owens-Illinois, Inc. 2005
Incentive Award Plan (filed as Exhibit 10.29 to Owens-Illinois, Inc.’s Form 10-K for the
year ended December 31, 2011, File No. 1-9576, and incorporated herein by reference).
10.20*
— Amended and restated letter agreement between Owens-Illinois, Inc. and Albert P.L.
10.21*
Stroucken (filed as Exhibit 10.1 to Owens-Illinois, Inc.’s Form 8-K dated October 26,
2011, File No. 1-9576, and incorporated herein by reference).
— Second Amended and Restated Owens-Illinois, Inc. 2005 Incentive Award Plan (filed as
Appendix B to Owens-Illinois, Inc.’s Definitive Proxy Statement on Schedule 14A filed
March 31, 2014, File No. 1-9576, and incorporated herein by reference).
10.22*
— Form of Non-Qualified Stock Option Agreement for use under Owens-Illinois, Inc.’s
Second Amended and Restated 2005 Incentive Award Plan (filed as Exhibit 10.1 to
Owens-Illinois, Inc.’s Form 8-K dated March 7, 2015, File No. 1-9576, and incorporated
herein by reference).
10.23*
— Form of Restricted Stock Unit Agreement for use under Owens-Illinois, Inc.’s Second
10.24*
10.25*
Amended and Restated 2005 Incentive Award Plan (filed as Exhibit 10.2 to Owens-
Illinois, Inc.’s Form 8-K dated March 7, 2015, File No. 1-9576, and incorporated herein
by reference).
— Form of Performance Stock Unit Agreement for use under Owens-Illinois, Inc.’s Second
Amended and Restated 2005 Incentive Award Plan (filed as Exhibit 10.3 to Owens-
Illinois, Inc.’s Form 8-K dated March 7, 2015, File No. 1-9576, and incorporated herein
by reference).
— Owens-Illinois, Inc. Executive Severance Policy (filed as Exhibit 10.4 to Owens-Illinois,
Inc.’s Form 8-K dated March 7, 2015, File No. 1-9576, and incorporated herein by
reference).
10.26*
— Letter Agreement dated March 7, 2015, between Owens-Illinois, Inc. and Stephen P.
Bramlage, Jr. (filed as Exhibit 10.5 to Owens-Illinois, Inc.’s Form 8-K dated March 7,
2015, File No. 1-9576, and incorporated herein by reference).
10.27*
— Letter Agreement signed November 20, 2015, between Owens-Illinois, Inc. and Jan
Bertsch (filed as Exhibit 10.1 to Owens-Illinois, Inc.’s Form 8-K dated November 23,
2015, File No. 1-9576, and incorporated herein by reference).
112
>(cid:30)q(cid:5)@(cid:6)(cid:8)(cid:18)(cid:5)(cid:25)(cid:24)(cid:21)(cid:5)8(cid:3)Q
10.28*
— Letter Agreement dated March 7, 2016, between Owens-Illinois, Inc. and James W.
Baehren (filed as Exhibit 10.1 to Owens-Illinois, Inc.’s Form 8-K dated March 7, 2016,
File No. 1-9576, and incorporated herein by reference).
(cid:17)(cid:3)(cid:11)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)
12
21
23
24
31.1
31.2
32.1**
32.2**
101
— Computation of Ratio of Earnings to Fixed Charges (filed herewith).
— Subsidiaries of Owens-Illinois, Inc. (filed herewith).
— Consent of Independent Registered Public Accounting Firm (filed herewith).
— Owens-Illinois, Inc. Power of Attorney (filed herewith).
— Certification of Principal Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002 (filed herewith).
— Certification of Principal Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002 (filed herewith).
— Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350
(furnished herewith).
— Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350
(furnished herewith).
— Financial statements from the Annual Report on Form 10-K of Owens-Illinois, Inc. for
the year ended December 31, 2016, formatted in XBRL: (i) the Consolidated Results of
Operations, (ii) the Consolidated Comprehensive Income, (iii) the Consolidated Balance
Sheets, (iv) the Consolidated Share Owners’ Equity, (v) the Consolidated Cash Flows
and (vi) the Notes to Consolidated Financial Statements.
?(cid:6)
@(cid:5)(cid:2)(cid:11)!(cid:14)(cid:8)(cid:3)(cid:10)(cid:6)(cid:14)(cid:6)(cid:18)(cid:14)(cid:5)(cid:14)(cid:29)(cid:3)(cid:18)(cid:3)(cid:5)(cid:8)(cid:6)!(cid:12)(cid:5)(cid:8)(cid:16)(cid:14)!(cid:8)(cid:6)(cid:12)(cid:16)(cid:6)!(cid:12)(cid:18)(cid:9)(cid:3)(cid:5)(cid:10)(cid:14)(cid:8)(cid:12)(cid:16)(cid:19)(cid:6)(cid:9)(cid:13)(cid:14)(cid:5)(cid:6)(cid:12)(cid:16)(cid:6)(cid:14)(cid:16)(cid:16)(cid:14)(cid:5)(cid:29)(cid:3)(cid:18)(cid:3)(cid:5)(cid:8)(cid:6)(cid:16)(cid:3)(cid:30)(cid:28)(cid:11)(cid:16)(cid:3)(cid:2)(cid:6)(cid:8)(cid:12)(cid:6)(cid:7)(cid:3)(cid:6)(cid:4)(cid:13)(cid:3)(cid:2)(cid:6)(cid:14)(cid:10)(cid:6)(cid:14)(cid:5)(cid:6)(cid:3)(cid:17)(cid:31)(cid:11)(cid:7)(cid:11)(cid:8)(cid:6)(cid:8)(cid:12)(cid:6)
this form pursuant to Item 15(c).
??(cid:6) [(cid:31)(cid:11)(cid:10)(cid:6)(cid:3)(cid:17)(cid:31)(cid:11)(cid:7)(cid:11)(cid:8)(cid:6)(cid:10)(cid:31)(cid:14)(cid:13)(cid:13)(cid:6)(cid:5)(cid:12)(cid:8)(cid:6)(cid:7)(cid:3)(cid:6)(cid:2)(cid:3)(cid:3)(cid:18)(cid:3)(cid:2)(cid:6)\(cid:4)(cid:13)(cid:3)(cid:2)](cid:6)(cid:15)(cid:12)(cid:16)(cid:6)(cid:9)(cid:28)(cid:16)(cid:9)(cid:12)(cid:10)(cid:3)(cid:10)(cid:6)(cid:12)(cid:15)(cid:6)^(cid:3)!(cid:8)(cid:11)(cid:12)(cid:5)(cid:6)(cid:24){(cid:6)(cid:12)(cid:15)(cid:6)(cid:8)(cid:31)(cid:3)(cid:6)^(cid:3)!(cid:28)(cid:16)(cid:11)(cid:8)(cid:11)(cid:3)(cid:10)(cid:6)|(cid:17)!(cid:31)(cid:14)(cid:5)(cid:29)(cid:3)(cid:6)+!(cid:8)(cid:6)(cid:12)(cid:15)(cid:6)(cid:24)}(cid:21)~"(cid:6)
(cid:14)(cid:10)(cid:6)(cid:14)(cid:18)(cid:3)(cid:5)(cid:2)(cid:3)(cid:2)"(cid:6)(cid:14)(cid:5)(cid:2)(cid:6)(cid:11)(cid:10)(cid:6)(cid:5)(cid:12)(cid:8)(cid:6)(cid:11)(cid:5)!(cid:12)(cid:16)(cid:9)(cid:12)(cid:16)(cid:14)(cid:8)(cid:3)(cid:2)(cid:6)(cid:7)(cid:19)(cid:6)(cid:16)(cid:3)(cid:15)(cid:3)(cid:16)(cid:3)(cid:5)!(cid:3)(cid:6)(cid:11)(cid:5)(cid:8)(cid:12)(cid:6)(cid:14)(cid:5)(cid:19)(cid:6)(cid:4)(cid:13)(cid:11)(cid:5)(cid:29)(cid:6)(cid:12)(cid:15)(cid:6)(cid:8)(cid:31)(cid:3)(cid:6)=(cid:12)(cid:18)(cid:9)(cid:14)(cid:5)(cid:19)"(cid:6)(cid:127)(cid:31)(cid:3)(cid:8)(cid:31)(cid:3)(cid:16)(cid:6)(cid:18)(cid:14)(cid:2)(cid:3)(cid:6)(cid:7)(cid:3)(cid:15)(cid:12)(cid:16)(cid:3)(cid:6)(cid:12)(cid:16)(cid:6)
(cid:14)(cid:15)(cid:8)(cid:3)(cid:16)(cid:6)(cid:8)(cid:31)(cid:3)(cid:6)(cid:2)(cid:14)(cid:8)(cid:3)(cid:6)(cid:31)(cid:3)(cid:16)(cid:3)(cid:12)(cid:15)"(cid:6)(cid:16)(cid:3)(cid:29)(cid:14)(cid:16)(cid:2)(cid:13)(cid:3)(cid:10)(cid:10)(cid:6)(cid:12)(cid:15)(cid:6)(cid:14)(cid:5)(cid:19)(cid:6)(cid:29)(cid:3)(cid:5)(cid:3)(cid:16)(cid:14)(cid:13)(cid:6)(cid:11)(cid:5)!(cid:12)(cid:16)(cid:9)(cid:12)(cid:16)(cid:14)(cid:8)(cid:11)(cid:12)(cid:5)(cid:6)(cid:13)(cid:14)(cid:5)(cid:29)(cid:28)(cid:14)(cid:29)(cid:3)(cid:6)(cid:11)(cid:5)(cid:6)(cid:10)(cid:28)!(cid:31)(cid:6)(cid:4)(cid:13)(cid:11)(cid:5)(cid:29)(cid:26)
@7;&(cid:5)(cid:21)(cid:25)Q(cid:5)(cid:5) (cid:2)%<&(cid:5)(cid:21)(cid:24)(cid:30)q(cid:5)>c&&=<‘
None.
113
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Share Owner of
Owens-Brockway Packaging, Inc.
We have audited the accompanying consolidated balance sheets of Owens-Brockway Packaging, Inc. (the
Company) as of December 31, 2016 and 2015, and the related consolidated statements of results of operations,
comprehensive income, share owner’s equity and cash flows for each of the three years in the period ended
December 31, 2016. These financial statements are the responsibility of the Company’s management. Our
responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material misstatement. We were not engaged to
perform an audit of the Company’s internal control over financial reporting. Our audits included consideration
of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal
control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining,
on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by management, and evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the
consolidated financial position of Owens-Brockway Packaging, Inc. at December 31, 2016 and 2015, and the
consolidated results of its operations and its cash flows for each of the three years in the period ended December
31, 2016, in conformity with U.S. generally accepted accounting principles
/s/ Ernst & Young LLP
Toledo, Ohio
February 10, 2017
114
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED RESULTS OF OPERATIONS
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling and administrative expense . . . . . . . . . . . . . . . . . . . . . . . . . . .
Research, development and engineering expense . . . . . . . . . . . . . . . .
Equity earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations before income taxes . . . . . . . . .
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings attributable to noncontrolling interests . . . . . . . . . . . . . .
Net earnings attributable to the Company . . . . . . . . . . . . . . . . . . . . . .
Amounts attributable to the Company:
$
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
6,702 $
(5,387)
1,315
(411)
(65)
60
(253)
(78)
568
(123)
445
(7)
438
(21)
417
$
6,156 $
(5,060)
1,096
(389)
(64
60
(232)
(77)
394
(101)
293
(4)
289
(23)
266
$
6,784
(5,523)
1,261
(412
(63)
64
(210)
(138)
502
(93)
409
(4)
405
(28)
377
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
424
(7)
417
$
$
270
(4 )
266
$
$
381
(4)
377
See accompanying Notes to the Consolidated Financial Statements.
115
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED COMPREHENSIVE INCOME
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss):
Foreign currency translation adjustments . . . . . . . . . . . . . . . . . . . .
Pension and other postretirement benefit adjustments, net of tax . .
Change in fair value of derivative instruments, net of tax . . . . . . .
Other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Comprehensive income attributable to noncontrolling interests . . . . . .
Comprehensive income (loss) attributable to the Company . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
438 $
289 $
405
(224)
(38)
13
(249)
189
(17)
172
$
(529)
13
(6)
(522 )
(233)
(7)
(240 ) $
(305)
112
1
(192)
213
(7)
206
$
See accompanying Notes to the Consolidated Financial Statements.
116
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED BALANCE SHEETS
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
Assets
(cid:26)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:6)(cid:5)(cid:12)(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)u
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Trade receivables, net of allowances of $32 million and $29 million at
December 31, 2016 and 2015, respectively . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:12)(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)u
Equity investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
*(cid:4)(cid:3)?(cid:8)(cid:4)(cid:6)(cid:14)(cid:22)(cid:5)?(cid:13)(cid:12)(cid:15)(cid:6)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:8)m(cid:29)(cid:27)?(cid:18)(cid:8)(cid:15)(cid:6)u
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
465
$
394
580
983
183
2,211
433
40
538
464
2,462
3,937
562
1,007
352
2,315
409
32
527
597
2,489
4,054
Land, at cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Buildings and equipment, at cost:
Buildings and building equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Factory machinery and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Transportation, office and miscellaneous equipment . . . . . . . . . . . . . . . . . . .
Construction in progress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less accumulated depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
237
248
1,048
4,491
66
237
6,079
3,224
2,855
9,003
$
1,080
4,520
68
236
6,152
3,221
2,931
9,300
$
See accompanying Notes to the Consolidated Financial Statements.
117
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED BALANCE SHEETS ((cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16))
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
_(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)>(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)%#(cid:15)(cid:8)(cid:4)b(cid:10)(cid:5);m(cid:29)(cid:27)(cid:6)(cid:14)
(cid:26)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:6)(cid:5)(cid:13)(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Accounts payable including amount to related parties of $7 million and
$3 million at December 31, 2016 and 2015, respectively . . . . . . . . . . . . . . .
Salaries and wages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. and foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt due within one year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
;:(cid:6)(cid:8)(cid:4)(cid:15)(cid:12)(cid:13)(cid:5)(cid:13)(cid:3)(cid:15)+(cid:30)(cid:6)(cid:8)(cid:4)(cid:18)(cid:5)(cid:16)(cid:8)(cid:19)(cid:6)(cid:5) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:17)(cid:8)(cid:28)(cid:8)(cid:4)(cid:4)(cid:8)(cid:16)(cid:5)(cid:6)(cid:12):(cid:8)(cid:10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
*(cid:8)(cid:15)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)(cid:19)(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:10)(cid:5) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8(cid:3)(cid:15)?(cid:8)(cid:15)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)?(cid:3)(cid:10)(cid:6)(cid:4)(cid:8)(cid:6)(cid:27)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:19)(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:13)(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
>(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:3)#(cid:15)(cid:8)(cid:4)b(cid:10)(cid:5)(cid:8)m(cid:29)(cid:27)(cid:6)(cid:14)u
Investment by and advances from Parent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total share owner’s equity of the Company . . . . . . . . . . . . . . . . . . . . . . . . . .
Noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total share owner’s equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total liabilities and share owner’s equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
$
$
1,124
156
58
330
162
32
1,862
4,876
144
257
78
174
2,562
(1,059)
1,503
109
1,612
9,003
$
1,200
139
34
332
160
67
1,932
5,087
200
224
66
186
2,311
(814)
1,497
108
1,605
9,300
See accompanying Notes to the Consolidated Financial Statements.
118
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED SHARE OWNER’S EQUITY
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
@(cid:15)[(cid:8)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:19)(cid:14)(cid:5)(cid:12)(cid:15)(cid:16)
=(cid:16)[(cid:12)(cid:15)(cid:11)(cid:8)(cid:10)(cid:5)(cid:28)(cid:4)(cid:3)(cid:18)
Parent
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)
Other
(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)
@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)/_(cid:3)(cid:10)(cid:10)6
Non-
(cid:11)(cid:3)(cid:15)(cid:6)(cid:4)(cid:3)(cid:13)(cid:13)(cid:27)(cid:15)+
Interests
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:5)>(cid:7)(cid:12)(cid:4)(cid:8)
%#(cid:15)(cid:8)(cid:4)b(cid:10)
;m(cid:29)(cid:27)(cid:6)(cid:14)
(137) $
147 $
Balance on January 1, 2014 . . . . . . . . . . . . . .
Net intercompany transactions . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive loss . . . . . . . . . . . . . . .
Distributions to noncontrolling interests . . . .
Balance on December 31, 2014 . . . . . . . . . . .
Net intercompany transactions . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive loss . . . . . . . . . . . . . . .
Distributions to noncontrolling interests . . . .
Acquisitions of noncontrolling interests . . . .
Balance on December 31, 2015 . . . . . . . . . . .
Net intercompany transactions . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive loss . . . . . . . . . . . . . . . .
Distributions to noncontrolling interests . . . .
Balance on December 31, 2016 . . . . . . . . . . .
$
2,305 $
(274)
377
2,408
(345)
266
(18)
2,311
(166)
417
(171)
(308)
(506)
(814)
(245)
2,315
(274)
405
(192)
(37)
2,217
(345)
289
(522)
(22)
(12)
1,605
(166)
438
(249)
(16)
1,612
28
(21)
(37)
117
23
(16)
(22)
6
108
21
(4)
(16)
109
$
$
2,562
$
(1,059) $
See accompanying Notes to the Consolidated Financial Statements.
119
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
438
7
$
289
4
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED CASH FLOWS
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-cash charges (credits):
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of intangibles and other deferred items . . . . . . . .
Amortization of finance fees and debt discount . . . . . . . . . . . .
Deferred tax provision (benefit) . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring, asset impairment and related charges . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on China land sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment of equity investment . . . . . . . . . . . . . . . . . . . . . . . .
Cash paid for restructuring activities . . . . . . . . . . . . . . . . . . . . . . . .
Change in components of working capital . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash provided by continuing operating activities . . . . . . . . . . .
Cash utilized in discontinued operating activities . . . . . . . . . . .
Total cash provided by operating activities . . . . . . . . . . . . . . . .
@(cid:15)[(cid:8)(cid:10)(cid:6)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Additions to property, plant and equipment . . . . . . . . . . . . . . . . . . .
Acquisitions, net of cash acquired . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash proceeds related to sale of assets and other . . . . . . . . . . . .
Net activity for non-controlling partner loans . . . . . . . . . . . . . . . . . .
Net foreign exchange derivative activity . . . . . . . . . . . . . . . . . . . . . .
Cash utilized in investing activities . . . . . . . . . . . . . . . . . . . . . .
371
96
13
(8)
96
(71)
25
(24)
88
(126)
905
(7)
898
(452)
(56)
84
8
(416)
(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Additions to long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Repayments of long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Increase (decrease) in short-term loans . . . . . . . . . . . . . . . . . . . . . . .
Net receipts from (distribution to) parent . . . . . . . . . . . . . . . . . . . . .
Payment of finance fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Distributions to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . .
Cash provided by (utilized in) financing activities . . . . . . . . . . . . . .
Effect of exchange rate fluctuations on cash . . . . . . . . . . . . . . . . . . .
Increase (decrease) in cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at beginning of period . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at end of period . . . . . . . . . . . . . . . . . . . . . . .
1,235
(1,452)
10
(166)
(9)
(16)
(398)
(13)
71
394
465
$
$
See accompanying Notes to the Consolidated Financial Statements.
120
405
4
331
75
20
(18)
76
69
(58)
158
(116)
946
(4)
942
(369)
(113)
16
9
(457)
1,226
(1,100)
(139
(276)
(11)
(37)
(337)
(21)
127
356
483
$
319
77
14
7
63
(38)
101
41
877
(4 )
873
(400)
(2,351)
1
4
(2,746)
4,538
(2,317)
51
(346 )
(90)
(22)
1,814
(30)
(89
483
394
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:21)Q(cid:5)>(cid:27)+(cid:15)(cid:27)(cid:28)(cid:27)(cid:11)(cid:12)(cid:15)(cid:6)(cid:5)=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:27)(cid:15)+(cid:5)*(cid:3)(cid:13)(cid:27)(cid:11)(cid:27)(cid:8)(cid:10)
\(cid:12)(cid:10)(cid:27)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)(cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)>(cid:6)(cid:12)(cid:6)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10) The consolidated financial statements of Owens-Brockway
Packaging, Inc. (the “Company”) include the accounts of its subsidiaries. Newly acquired subsidiaries have
been included in the consolidated financial statements from dates of acquisition.
The Company uses the equity method of accounting for investments in which it has a significant ownership
interest, generally 20% to 50%. Other investments are accounted for at cost. The Company monitors other than
temporary declines in fair value and records reductions in carrying values when appropriate.
<(cid:8)(cid:13)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)(cid:7)(cid:27)?(cid:5)#(cid:27)(cid:6)(cid:7)(cid:5)%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:5)Z(cid:4)(cid:3)(cid:29)?(cid:22)(cid:5)@(cid:15)(cid:11)Q(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q The Company is a 100%-owned
subsidiary of Owens-Illinois Group, Inc. (“OI Group”) and an indirect subsidiary of Owens-Illinois, Inc.
(“OI Inc.”). Although OI Inc. does not conduct any operations, it has substantial obligations related to
outstanding indebtedness and asbestos-related payments. OI Inc. relies primarily on distributions from its direct
and indirect subsidiaries to meet these obligations.
For federal and certain state income tax purposes, the taxable income of the Company is included in the
consolidated tax returns of OI Inc. and income taxes are allocated to the Company on a basis consistent with
separate returns.
8(cid:12)(cid:6)(cid:29)(cid:4)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) The Company is a leading manufacturer of glass container products. The Company’s
principal product lines are glass containers for the food and beverage industries. The Company has glass
container operations located in 23 countries. The principal markets and operations for the Company’s products
are in Europe, North America, Latin America and Asia Pacific.
c(cid:10)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5);(cid:10)(cid:6)(cid:27)(cid:18)(cid:12)(cid:6)(cid:8)(cid:10)(cid:5) The preparation of financial statements in conformity with accounting principles
generally accepted in the United States requires management of the Company to make estimates and
assumptions that affect certain amounts reported in the financial statements and accompanying notes. Actual
results may differ from those estimates, at which time the Company would revise its estimates accordingly.
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5)(cid:26)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:11)(cid:14)(cid:5)7(cid:4)(cid:12)(cid:15)(cid:10)(cid:13)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5) The assets and liabilities of non-U.S. subsidiaries are translated into
U.S. dollars at year-end exchange rates. Any related translation adjustments are recorded in accumulated other
comprehensive income in share owner’s equity.
<(cid:8)[(cid:8)(cid:15)(cid:29)(cid:8)(cid:5)<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5) The Company recognizes sales, net of estimated discounts and allowances, when
the title to the products and risk of loss are transferred to customers. Provisions for rebates to customers are
provided in the same period that the related sales are recorded.
>(cid:7)(cid:27)??(cid:27)(cid:15)+(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)v(cid:12)(cid:15)(cid:16)(cid:13)(cid:27)(cid:15)+(cid:5)(cid:26)(cid:3)(cid:10)(cid:6)(cid:10)(cid:5)(cid:5)(cid:5)Shipping and handling costs are included with cost of goods sold in the
Consolidated Results of Operations.
Cash The Company defines “cash” as cash and time deposits with maturities of three months or less when
purchased. Outstanding checks in excess of funds on deposit are included in accounts payable.
=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)(cid:5)<(cid:8)(cid:11)(cid:8)(cid:27)[(cid:12)(cid:19)(cid:13)(cid:8)(cid:5)(cid:5)(cid:5)Receivables are stated at amounts estimated by management to be the net realizable
value. The Company charges off accounts receivable when it becomes apparent based upon age or customer
circumstances that amounts will not be collected.
=(cid:13)(cid:13)(cid:3)#(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)(cid:28)(cid:3)(cid:4)(cid:5)(cid:17)(cid:3)(cid:29)(cid:19)(cid:6)(cid:28)(cid:29)(cid:13)(cid:5)=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)(cid:5)(cid:5)(cid:5)The allowance for doubtful accounts is established through charges to
the provision for bad debts. The Company evaluates the adequacy of the allowance for doubtful accounts on a
periodic basis. The evaluation includes historical trends in collections and write-offs, management’s judgment
of the probability of collecting accounts and management’s evaluation of business risk.
121
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
@(cid:15)[(cid:8)(cid:15)(cid:6)(cid:3)(cid:4)(cid:14)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5) Inventories are valued at the lower of average costs or market.
Z(cid:3)(cid:3)(cid:16)#(cid:27)(cid:13)(cid:13)(cid:5) Goodwill represents the excess of cost over fair value of net assets of businesses acquired.
Goodwill is evaluated annually, as of October 1, for impairment or more frequently if an impairment
indicator exists.
@(cid:15)(cid:6)(cid:12)(cid:15)+(cid:27)(cid:19)(cid:13)(cid:8)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)_(cid:3)(cid:15)+(cid:30)_(cid:27)[(cid:8)(cid:16)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10) Intangible assets are amortized over the expected useful
life of the asset. Amortization expense directly attributed to the manufacturing of the Company’s products
is included in cost of goods sold. Amortization expense related to non-manufacturing activities is included
in selling and administrative and other. The Company evaluates the recoverability of intangible assets and
other long-lived assets based on undiscounted projected cash flows, excluding interest and taxes, when factors
indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
*(cid:4)(cid:3)?(cid:8)(cid:4)(cid:6)(cid:14)(cid:22)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:6)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5);m(cid:29)(cid:27)?(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:5)(cid:5)Property, plant and equipment (“PP&E”) is carried at cost and
includes expenditures for new facilities and equipment and those costs which substantially increase the useful
lives or capacity of existing PP&E. In general, depreciation is computed using the straight-line method and
recorded over the estimated useful life of the asset. Factory machinery and equipment is depreciated over
periods ranging from 5 to 25 years with the majority of such assets (principally glass-melting furnaces and
forming machines) depreciated over 7 to 15 years. Buildings and building equipment are depreciated over
periods ranging from 10 to 50 years. Depreciation expense directly attributed to the manufacturing of the
Company’s products is included in cost of goods sold. Depreciation expense related to non-manufacturing
activities is included in selling and administrative. Depreciation expense includes the amortization of assets
recorded under capital leases. Maintenance and repairs are expensed as incurred. Costs assigned to PP&E of
acquired businesses are based on estimated fair values at the date of acquisition. The Company evaluates the
recoverability of PP&E based on undiscounted projected cash flows, excluding interest and taxes, when factors
indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
(cid:17)(cid:8)(cid:4)(cid:27)[(cid:12)(cid:6)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:10)(cid:6)(cid:4)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10) The Company uses forward exchange contracts, options and commodity forward
contracts to manage risks generally associated with foreign exchange rate and commodity market volatility.
Derivative financial instruments are included on the balance sheet at fair value. When appropriate, derivative
instruments are designated as and are effective as hedges, in accordance with accounting principles generally
accepted in the United States. If the underlying hedged transaction ceases to exist, all changes in fair value of
the related derivatives that have not been settled are recognized in current earnings. The Company does not
enter into derivative financial instruments for trading purposes and is not a party to leveraged derivatives. Cash
flows from forward exchange contracts not designated as hedges are classified as an investing activity. Cash
flows of commodity forward contracts are classified as operating activities.
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)(cid:5)&(cid:8)(cid:12)(cid:10)(cid:29)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)(cid:5) Fair value is defined as the amount that would be received to sell an asset or
paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly
transaction between market participants. Generally accepted accounting principles defines a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring fair value as follows:
Level 1: Observable inputs such as quoted prices in active markets;
Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or
indirectly; and
Level 3: Unobservable inputs for which there is little or no market data, which requires the Company to
develop assumptions.
122
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The carrying amounts reported for cash and short-term loans approximate fair value. In addition, carrying
amounts approximate fair value for certain long-term debt obligations subject to frequently redetermined
interest rates. Fair values for the Company’s significant fixed rate debt obligations are generally based on
published market quotations.
The Company’s derivative assets and liabilities consist of natural gas forwards and foreign exchange
option and forward contracts. The Company uses an income approach to valuing these contracts. Natural gas
forward rates and foreign exchange rates are the significant inputs into the valuation models. These inputs
are observable in active markets over the terms of the instruments the Company holds, and accordingly, the
Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also evaluates
counterparty risk in determining fair values.
<(cid:8)(cid:11)(cid:13)(cid:12)(cid:10)(cid:10)(cid:27)(cid:28)(cid:27)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) Certain reclassifications of prior years’ data have been made to conform to the current
year presentation.
8(cid:8)#(cid:5)=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:27)(cid:15)+(cid:5)>(cid:6)(cid:12)(cid:15)(cid:16)(cid:12)(cid:4)(cid:16)(cid:10)(cid:5)
Revenue from Contracts with Customers - In May 2014, the Financial Accounting Standards Board
(“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with
Customers,” which requires an entity to recognize the amount of revenue to which it expects to be entitled for
the transfer of promised goods or services to customers. In August 2015, the FASB issued ASU No. 2015-14,
“Revenue from Contracts with Customers”, which delayed by one year the effective date of the new revenue
recognition standard, which will be effective for the Company on January 1, 2018. The Company has started an
implementation process, including a review of customer contracts, to evaluate the effect this standard will have
on its consolidated financial statements and related disclosures. At this time, the Company does not expect that
the implementation of this standard in 2018 will have a significant impact on the timing in which it recognizes
revenue. While the Company continues to assess the potential impacts of the new standard, the Company does
not currently expect the adoption of the new standard to have a material impact on consolidated net income or
the consolidated balance sheet. The Company plans to select the modified retrospective transition method upon
adoption effective January 1, 2018.
Leases - In February 2016, the FASB issued ASU No. 2016-02, “Leases”. Under this guidance, lessees
will be required to recognize on the balance sheet a lease liability and a right-of-use asset for all leases, with
the exception of short-term leases. The lease liability represents the lessee’s obligation to make lease payments
arising from a lease, and will be measured as the present value of the lease payments. The right-of-use asset
represents the lessee’s right to use a specified asset for the lease term, and will be measured at the lease
liability amount, adjusted for lease prepayment, lease incentives received and the lessee’s initial direct costs.
The standard also requires a lessee to recognize a single lease cost allocated over the lease term, generally on
a straight-line basis. The new guidance is effective for the Company on January 1, 2019. ASU No. 2016-02 is
required to be applied using the modified retrospective approach for all leases existing as of the effective date
and provides for certain practical expedients. Early adoption is permitted. The Company is currently evaluating
the effects that the adoption of ASU No. 2016-02 will have on the Company’s consolidated financial statements,
and anticipates the new guidance will significantly impact its consolidated financial statements as the Company
has a significant number of leases. As further described in Note 15, Operating Leases, as of December 31, 2016,
the Company had minimum lease commitments under non-cancellable operating leases totaling $205 million.
Credit Losses - In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance requires the measurement
of all expected credit losses for financial assets held at the reporting date based on historical experience,
123
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
current conditions and reasonable and supportable forecasts. This guidance also requires enhanced disclosures
regarding significant estimates and judgments used in estimating credit losses. The new guidance is effective
for the Company on January 1, 2020. Early adoption is permitted for fiscal years, and interim periods within
those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the
adoption of this guidance will have on its consolidated financial statements.
Stock Compensation - In March 2016, the FASB issued ASU No. 2016-09, “Improvements to Employee
Share-Based Payment Accounting,” which requires all excess tax benefits or deficiencies to be recognized as
income tax expense or benefit in the income statement. In addition, excess tax benefits should be classified
along with other income tax cash flows as an operating activity in the statement of cash flows. Application of
the standard is required for the Company on January 1, 2017. The Company does not expect a significant impact
in its Consolidated Financial Statements.
Pension Asset Value - In May 2015, the FASB issued ASU No. 2015-07, “Fair Value Measurement
(Topic 820): Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share (or
Its Equivalent).” Under the new guidance, investments measured at net asset value (“NAV”), as a practical
expedient for fair value, are excluded from the fair value hierarchy. Removing investments measured using the
practical expedient from the fair value hierarchy is intended to eliminate the diversity in practice that currently
exists with respect to the categorization of these investments. The new guidance is effective for the Company
on January 1, 2016. The guidance impacted the presentation of certain pension related assets that use NAV as a
practical expedient. See Note 9 for additional information.
*(cid:12)(cid:4)(cid:6)(cid:27)(cid:11)(cid:27)?(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)(cid:27)(cid:15)(cid:5)%@(cid:5)@(cid:15)(cid:11)Q(cid:5)>(cid:6)(cid:3)(cid:11)](cid:5)%?(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)>(cid:6)(cid:3)(cid:11)](cid:5)\(cid:12)(cid:10)(cid:8)(cid:16)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:8)(cid:15)(cid:10)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15) The Company
participates in the equity compensation plans of OI Inc. under which employees of the Company may be
granted options to purchase common shares of OI Inc., restricted common shares of OI Inc., or restricted share
units of OI Inc.
Stock Options
In general, subject to change in control, options become exercisable 25% per year beginning on the first
anniversary of grant. No options may be exercised in whole or in part during the first year after the date granted.
In general, options expire following termination of employment or the seventh anniversary of the option
grant. The fair value of options is amortized over the vesting periods which range from one to four years.
Restricted Shares and Restricted Share Units
Shares granted after March 21, 2005 and prior to 2011, vest 25% per year beginning on the first anniversary
and unvested shares are forfeited upon termination of employment. Restricted share units granted to employees
after 2010 vest 25% per year beginning on the first anniversary. Holders of vested restricted share units receive
one share of the Company’s common stock for each unit as units vest. Granted but unvested restricted share
units are forfeited upon termination, unless certain retirement criteria are met. Restricted share units granted to
directors vest after one year.
The fair value of the restricted shares and restricted share units is equal to the market price of the
Company’s common stock on the date of the grant. The fair value of restricted shares and restricted share units
is amortized over the vesting periods which range from one to four years.
124
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Performance Vested Restricted Share Units
Performance vested restricted share units vest on January 1 of the third year following the year in which
they are granted. Holders of vested units may receive up to two shares of OI Inc.’s common stock for each unit,
depending upon the attainment of consolidated performance goals established by the Compensation Committee
of OI Inc.’s Board of Directors. If minimum goals are not met, no shares will be issued. Granted but unvested
restricted share units are forfeited upon termination of employment, unless certain retirement criteria are met.
The fair value of each performance vested restricted share unit is equal to the product of the fair value of
OI Inc.’s common stock on the date of grant and the estimated number of shares into which the performance
vested restricted share unit will be converted. The fair value of performance vested restricted share units is
amortized ratably over the vesting period. Should the estimated number of shares into which the performance
vested restricted share unit will be converted change, an adjustment will be recorded to recognize the
accumulated difference in amortization between the revised and previous estimates.
As discussed in Note 21, costs incurred under these plans by OI Inc. related to stock-based compensation
awards granted directly to the Company’s employees are included in the allocable costs charged to the Company
and other operating subsidiaries of OI Inc. on an intercompany basis.
(cid:23)Q(cid:5)>(cid:8)+(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
The Company has four reportable segments based on its geographic locations: Europe, North America,
Latin America and Asia Pacific. In connection with the Company’s acquisition (the “Vitro Acquisition”) of
the food and beverage glass container business of Vitro S.A.B. de C.V. and its subsidiaries as conducted in the
United States, Mexico and Bolivia (the “Vitro Business”) on September 1, 2015 (see Note 17), the Company
has renamed the former South America segment to the Latin America segment. These four segments are aligned
with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass
operations. Certain assets and activities not directly related to one of the regions or to glass manufacturing
are reported with Retained corporate costs and other. These include licensing, equipment manufacturing,
global engineering, and certain equity investments. Retained corporate costs and other also includes certain
headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs
that are global in nature and are not allocable to the reportable segments.
The Company’s measure of profit for its reportable segments is segment operating profit, which consists
of consolidated earnings from continuing operations before interest income, interest expense, and provision
for income taxes and excludes amounts related to certain items that management considers not representative
of ongoing operations as well as certain retained corporate costs. The Company’s management uses segment
operating profit, in combination with selected cash flow information, to evaluate performance and to allocate
resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses
based on both a percentage of sales and direct billings based on the costs of specific services provided.
125
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Financial information regarding the Company’s reportable segments is as follows:
Net sales:
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
North America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Latin America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reportable segment totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Segment operating profit:
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
North America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Latin America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reportable segment totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Items excluded from segment operating profit:
Other income(expense) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring, asset impairment and other charges . . . . . . . . . . .
Gain on China land sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Strategic transaction costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value inventory adjustments . . . . . . . . .
Acquisition-related fair value intangible adjustments . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension Settlement charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations before income taxes . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
$
$
$
$
2,300
2,220
1,432
684
6,636
66
6,702
$
$
2,324
2,039
1,064
671
6,098
58
6,156
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
237
299
269
77
882
(5)
(127)
71
209
265
183
83
740
2
(80)
(4)
(22)
(10)
(253)
568
$
(232)
394
$
$
2,794
2,003
1,159
793
6,749
35
6,784
2014
353
240
227
88
908
(1)
(91)
(69)
(35)
(210)
502
126
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
;(cid:29)(cid:4)(cid:3)?(cid:8)
North
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
Latin
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
Asia
*(cid:12)(cid:11)(cid:27)(cid:9)(cid:11)
<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:12)(cid:19)(cid:13)(cid:8)
>(cid:8)+(cid:18)(cid:8)(cid:15)(cid:6)
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:10)
Other
(cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:10)
Total assets:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
$ 2,793 $ 2,515
2,492
1,963
2,902
3,215
$ 2,536
2,807
1,300
$
926
917
1,018
Equity investments:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
Equity earnings:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
Capital expenditures:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
Depreciation and
amortization expense:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
$
$
$
$
$
$
$
78
78
81
15
16
19
163
164
188
21
22
24
12
19
17
107
97
89
118 $
120
140
139
128
131
$
— $
$
— $
$
$
$
$
123
89
55
173
107
79
117
145
153
4
7
4
59
50
34
37
40
53
$
$
$
$
$
$
$
$
$
$
8,770
9,118
7,496
216
245
258
31
42
40
452
400
366
467
395
403
$
$
$
233
182
181
217
164
169
29
18
24
— $
3
— $
1
3
9,003
9,300
7,677
433
409
427
60
60
64
452
400
369
467
396
406
The Company’s net property, plant and equipment by geographic segment are as follows:
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The Company’s net sales by geographic segment are as follows:
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
U.S.
722
704
678
Non-U.S.
2,133
$
2,227
$
1,734
U.S.
2,124
1,939
1,852
Non-U.S.
4,578
$
4,217
4,932
$
$
$
7(cid:3)(cid:6)(cid:12)(cid:13)
2,855
2,931
2,412
7(cid:3)(cid:6)(cid:12)(cid:13)
6,702
6,156
6,784
Intercompany sales in Latin America totaled $195 million, $101 million and $0 for the years ended
December 31, 2016, 2015, and 2014, respectively.
Operations outside the U.S. that accounted for more than 10% of consolidated net sales from continuing
operations were in France (2015 — 10%, 2014 — 11%).
127
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:20)Q(cid:5)@(cid:15)[(cid:8)(cid:15)(cid:6)(cid:3)(cid:4)(cid:27)(cid:8)(cid:10)
Major classes of inventory are as follows:
Finished goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Raw materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
827 $
118
38
983 $
858
113
36
1,007
$
$
jQ(cid:5);m(cid:29)(cid:27)(cid:6)(cid:14)(cid:5)@(cid:15)[(cid:8)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
At December 31, 2016 the Company’s ownership percentage in affiliates include:
=(cid:28)(cid:9)(cid:13)(cid:27)(cid:12)(cid:6)(cid:8)(cid:10)
BJC O-I Glass Pte. Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . .
CO Vidrieria SARL (“COV”) . . . . . . . . . . . . . . . . . . . . . . .
Rocky Mountain Bottle Company . . . . . . . . . . . . . . . . . . .
Tata Chemical (Soda Ash) Partners . . . . . . . . . . . . . . . . . .
Vetrerie Meridionali SpA (“VeMe”) . . . . . . . . . . . . . . . . . .
Vetri Speciali SpA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
%(cid:30)@(cid:5)%#(cid:15)(cid:8)(cid:4)(cid:10)(cid:7)(cid:27)?(cid:5)
*(cid:8)(cid:4)(cid:11)(cid:8)(cid:15)(cid:6)(cid:12)+(cid:8)
\(cid:29)(cid:10)(cid:27)(cid:15)(cid:8)(cid:10)(cid:10)(cid:5)7(cid:14)?(cid:8)
50% Glass container manufacturer
50% Glass container manufacturer
50% Glass container manufacturer
25% Soda ash supplier
50% Glass container manufacturer
50% Specialty glass manufacturer
Summarized information pertaining to the Company’s equity affiliates follows:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Equity in earnings:
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dividends received . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
28
32
60
38
$
$
$
23
37
60
53
Summarized combined financial information for equity affiliates is as follows (unaudited):
At end of year:
Current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other liabilities and deferred items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total liabilities and deferred items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
451
1,025
1,476
200
368
568
908
$
$
$
$
$
$
$
23
41
64
54
2015
430
959
1,389
203
211
414
975
128
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
For the year:
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
755
182
134
$
$
$
719
193
139
$
$
$
752
198
150
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Based on an evaluation of each of the Company’s equity investments for the three years ending
December 31, 2016, no investments exceeded the significant subsidiary thresholds per Rule 3-09 of Regulation
S-X. As such, separate financial statements for the Company’s equity investments are not required to be filed.
The Company made purchases of approximately $176 million and $161 million from equity affiliates in
2016 and 2015, respectively, and owed approximately $76 million and $66 million to equity affiliates as of
December 31, 2016 and 2015, respectively.
There is a difference of approximately $12 million as of December 31, 2016, between the amount at which
certain investments are carried and the amount of underlying equity in net assets. The portion of the difference
related to inventory or amortizable assets is amortized as a reduction of the equity earnings. The remaining
difference is considered goodwill.
!Q(cid:5)Z(cid:3)(cid:3)(cid:16)#(cid:27)(cid:13)(cid:13)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)@(cid:15)(cid:6)(cid:12)(cid:15)+(cid:27)(cid:19)(cid:13)(cid:8)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
Goodwill
The changes in the carrying amount of goodwill for the years ended December 31, 2016, 2015 and 2014 are
as follows:
Balance as of January 1, 2014 . . . . . . . . . . .
Translation effects . . . . . . . . . . . . . . . . . . . .
Balance as of December 31, 2014 . . . . . . . .
Acquisition related adjustments . . . . . . . . . .
Translation effects . . . . . . . . . . . . . . . . . . . .
Balance as of December 31, 2015 . . . . . . . .
Acquisition related adjustments . . . . . . . . . .
Translation effects . . . . . . . . . . . . . . . . . . . .
Balance as of December 31, 2016 . . . . . . . .
$
$
;(cid:29)(cid:4)(cid:3)?(cid:8)
$
1,044
(118)
926
(86)
840
(32)
808
$
North
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
Latin
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
734
(11)
723
316
(19)
1,020
15
3
1,038
$
$
276
(37)
239
480
(95)
624
26
(39)
611
Other
$
$
5
5
5
$
5
$
7(cid:3)(cid:6)(cid:12)(cid:13)
2,059
(166)
1,893
796
(200)
2,489
41
(68)
2,462
The acquisition related adjustments in 2016 and 2015 primarily relate to the Vitro Acquisition (see Note 17).
Goodwill for the Asia Pacific segment is $0 and net of accumulated impairment losses of $1,135 million as
of December 31, 2016, 2015 and 2014.
Goodwill is tested for impairment annually as of October 1 (or more frequently if impairment indicators
arise) using a two-step process. Step 1 compares the business enterprise value (“BEV”) of each reporting unit
with its carrying value. The BEV is computed based on estimated future cash flows, discounted at the weighted
average cost of capital of a hypothetical third-party buyer. If the BEV is less than the carrying value for any
reporting unit, then Step 2 must be performed. Step 2 compares the implied fair value of goodwill with the
129
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
carrying amount of goodwill. Any excess of the carrying value of the goodwill over the implied fair value will
be recorded as an impairment loss. The calculations of the BEV in Step 1 and the implied fair value of goodwill
in Step 2 are based on significant unobservable inputs, such as price trends, customer demand, material costs,
discount rates and asset replacement costs, and are classified as Level 3 in the fair value hierarchy.
During the fourth quarter of 2016, the Company completed its annual impairment testing and determined
that no impairment existed.
Intangible assets
On September 1, 2015, the Company acquired customer list intangibles as part of the Vitro Acquisition (see
Note 17).
Customer list intangible assets are amortized using the accelerated amortization method over their 20
year lives. Net intangible asset values were $464 million and $597 million for the years ended December 31,
2016 and 2015, respectively. Amortization expense for intangible assets was $39 million, $21 million and $1
million for the years ended December 31, 2016, 2015 and 2014, respectively. Estimated amortization related to
intangible assets through 2021 is as follows: 2017, $44 million; 2018, $44 million; 2019, $42 million; 2020, $41
million; and 2021, $39 million. No impairment existed on these assets at December 31, 2016.
The Company has determined that the fair value measurements related to the customer list intangibles are
based on significant unobservable inputs and are classified as Level 3 in the fair value hierarchy.
(cid:25)Q(cid:5)*(cid:4)(cid:8)?(cid:12)(cid:27)(cid:16)(cid:5);:?(cid:8)(cid:15)(cid:10)(cid:8)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
Prepaid expenses and other current assets at December 31, 2016 and 2015 are as follows:
Prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Value added taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets (noncurrent) consist of the following at December 31, 2016 and 2015:
Deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred returnable packaging costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Repair part inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Value added taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capitalized software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred finance fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
$
$
$
38
46
99
183
(cid:23)(cid:24)(cid:21)(cid:25)
189
115
107
22
31
5
69
538
$
$
$
$
42
195
115
352
2015
177
110
118
17
28
6
71
527
Capitalized software includes costs related to the acquisition and development of internal-use software.
These costs are amortized over the estimated useful life of the software. Amortization expense for capitalized
software was $6 million, $9 million and $8 million for 2016, 2015 and 2014, respectively. Estimated
amortization related to capitalized software through 2021 is as follows: 2017, $6 million; 2018, $6 million;
2019, $5 million; 2020, $5 million; and 2021, $4 million.
130
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
"Q(cid:5)(cid:17)(cid:8)(cid:4)(cid:27)[(cid:12)(cid:6)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:10)(cid:6)(cid:4)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
The Company has certain derivative assets and liabilities which consist of natural gas forwards and foreign
exchange option and forward contracts. The Company uses an income approach to value these contracts.
Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models. These
inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly,
the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also
evaluates counterparty risk in determining fair values.
Commodity Forward Contracts Designated as Cash Flow Hedges
In North America, the Company enters into commodity forward contracts related to forecasted natural gas
requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for
natural gas and the related volatility in cash flows. The Company continually evaluates the natural gas market
and related price risk and periodically enters into commodity forward contracts in order to hedge a portion of its
usage requirements. The majority of the sales volume in North America is tied to customer contracts that contain
provisions that pass the price of natural gas to the customer. In certain of these contracts, the customer has the
option of fixing the natural gas price component for a specified period of time. At December 31, 2016 and 2015,
the Company had entered into commodity forward contracts covering approximately 12,300,000 MM BTUs and
7,300,000 MM BTUs, respectively, primarily related to customer requests to lock the price of natural gas.
The Company accounts for the above forward contracts as cash flow hedges at December 31, 2016
and recognizes them on the balance sheet at fair value. The effective portion of changes in the fair value of
a derivative that is designated as, and meets the required criteria for, a cash flow hedge is recorded in the
Accumulated Other Comprehensive Income component of share owners’ equity (“OCI”) and reclassified
into earnings in the same period or periods during which the underlying hedged item affects earnings. An
unrecognized gain of $6 million at December 31, 2016 and an unrecognized loss of $4 million at December 31,
2015 related to the commodity forward contracts were included in Accumulated OCI, and will be reclassified
into earnings over the next twelve to twenty-four months. Any material portion of the change in the fair
value of a derivative designated as a cash flow hedge that is deemed to be ineffective is recognized in current
earnings. The ineffectiveness related to these natural gas hedges for the year ended December 31, 2016 and
2015 was not material.
The effect of the commodity forward contracts on the results of operations for the years ended December
31, 2016, 2015 and 2014 is as follows:
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:12)(cid:27)(cid:15)(cid:5)/(cid:13)(cid:3)(cid:10)(cid:10)6(cid:5)<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)w(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)%(cid:26)@(cid:5)(cid:3)(cid:15)
(cid:26)(cid:3)(cid:18)(cid:18)(cid:3)(cid:16)(cid:27)(cid:6)(cid:14)(cid:5)(cid:2)(cid:3)(cid:4)#(cid:12)(cid:4)(cid:16)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:10)
/;(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:27)[(cid:8)(cid:5)*(cid:3)(cid:4)(cid:6)(cid:27)(cid:3)(cid:15)6
2015
2014
(cid:23)(cid:24)(cid:21)(cid:25)
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:12)(cid:27)(cid:15)(cid:5)/(cid:13)(cid:3)(cid:10)(cid:10)6(cid:5)<(cid:8)(cid:11)(cid:13)(cid:12)(cid:10)(cid:10)(cid:27)(cid:9)(cid:8)(cid:16)(cid:5)(cid:28)(cid:4)(cid:3)(cid:18)
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)%(cid:26)@(cid:5)(cid:27)(cid:15)(cid:6)(cid:3)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)
/(cid:4)(cid:8)?(cid:3)(cid:4)(cid:6)(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)(cid:11)(cid:3)(cid:10)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:3)(cid:3)(cid:16)(cid:10)(cid:5)(cid:10)(cid:3)(cid:13)(cid:16)6
/;(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:27)[(cid:8)(cid:5)*(cid:3)(cid:4)(cid:6)(cid:27)(cid:3)(cid:15)6
2015
2014
(cid:23)(cid:24)(cid:21)(cid:25)
$
7 $
(4) $
3 $
— $
(1) $
2
Foreign Exchange Derivative Contracts and not Designated as Hedging Instruments
The Company may enter into short-term forward exchange or option agreements to purchase foreign
currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign
currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated
in currencies other than the subsidiaries’ functional currency. The Company may also use forward exchange
131
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables,
payables and loans, not denominated in, or indexed to, their functional currencies. The Company records these
short-term forward exchange agreements on the balance sheet at fair value and changes in the fair value are
recognized in current earnings.
At December 31, 2016 and 2015, the Company had outstanding forward exchange and option agreements
denominated in various currencies covering the equivalent of approximately $490 million and $790 million,
respectively, related primarily to intercompany transactions and loans.
The effect of the foreign exchange derivative contracts on the results of operations for the years ended
December 31, 2016, 2015 and 2014 is as follows:
_(cid:3)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)(cid:3)(cid:28)(cid:5)Z(cid:12)(cid:27)(cid:15)(cid:5)/_(cid:3)(cid:10)(cid:10)6
<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)w(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)(cid:3)(cid:15)
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5);:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:10)
Other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance Sheet Classification
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)Z(cid:12)(cid:27)(cid:15)(cid:5)/_(cid:3)(cid:10)(cid:10)6
<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)w(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)(cid:3)(cid:15)
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5);:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:10)
2015
2014
(cid:23)(cid:24)(cid:21)(cid:25)
$
6 $
10 $
(8)
The Company records the fair values of derivative financial instruments on the balance sheet as follows:
(a) receivables if the instrument has a positive fair value and maturity within one year, (b) deposits, receivables,
and other assets if the instrument has a positive fair value and maturity after one year, and (c) other accrued
liabilities or other liabilities (current) if the instrument has a negative fair value and maturity within one year.
The following table shows the amount and classification (as noted above) of the Company’s derivatives as
of December 31, 2016 and 2015:
Asset Derivatives:
Derivatives designated as hedging instruments:
Commodity futures contracts . . . . . . . . . . . . . . . . . . . . . . . . .
Derivatives not designated as hedging instruments:
Foreign exchange derivative contracts . . . . . . . . . . . . . . . . .
Total asset derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Liability Derivatives:
Derivatives designated as hedging instruments:
Commodity futures contracts . . . . . . . . . . . . . . . . . . . . . . . . .
Derivatives not designated as hedging instruments:
Foreign exchange derivative contracts . . . . . . . . . . . . . . . . . .
Total liability derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
\(cid:12)(cid:13)(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)>(cid:7)(cid:8)(cid:8)(cid:6)
_(cid:3)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
b
a
c
c
$
$
$
$
$
6
9
15
$
$
$
— $
5
5
$
—
14
14
3
2
5
132
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
$Q(cid:5)(cid:5)<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+(cid:5)=(cid:11)(cid:11)(cid:4)(cid:29)(cid:12)(cid:13)(cid:10)(cid:22)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:5)@(cid:18)?(cid:12)(cid:27)(cid:4)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:26)(cid:3)(cid:10)(cid:6)(cid:10)(cid:5)<(cid:8)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)(cid:6)(cid:3)(cid:5)(cid:26)(cid:13)(cid:3)(cid:10)(cid:8)(cid:16)(cid:5)(cid:2)(cid:12)(cid:11)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)
The Company continually reviews its manufacturing footprint and operating cost structure and may
decide to close operations or reduce headcount to gain efficiencies, integrate acquired operations, reduce future
expenses and other market factors. The Company incurs costs associated with these actions including employee
severance and benefits, other exit costs such as those related to contract terminations, and asset impairment
charges. The Company also may incur other costs related to closed facilities including environmental
remediation, clean up, dismantling and preparation for sale or other disposition.
The Company accounts for restructuring and other costs under applicable provisions of generally accepted
accounting principles. Charges for employee severance and related benefits are generally accrued based on
contractual arrangements with employees or their representatives. Other exit costs are accrued based on the
estimated cost to settle related contractual arrangements. Estimated environmental remediation costs are
accrued when specific claims have been received or are probable of being received.
The Company’s decisions to curtail selected production capacity have resulted in write downs of certain
long-lived assets to the extent their carrying amounts exceeded fair value or fair value less cost to sell. The
Company classified the significant assumptions used to determine the fair value of the impaired assets as
Level 3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements.
When a decision is made to take these actions, the Company manages and accounts for them
programmatically apart from the on-going operations of the business. Information related to major programs
(as in the case of the European Asset Optimization and Asia Pacific Restructuring programs below) are
presented separately. Minor initiatives are presented on a combined basis as Other Restructuring Actions. These
restructuring initiatives taken by the Company are not related to the European Asset Optimization program or
the Asia Pacific restructuring plan. When charges related to major programs are completed, remaining accrual
balances are classified with Other Restructuring Actions.
European Asset Optimization
In 2011, the Company initiated the European Asset Optimization program to increase the efficiency and
capability of its European operations and to better align its European manufacturing footprint with market and
customer needs. This program involved making additional investments in certain facilities and addressing
assets with higher cost structures. As part of this program, the Company recorded charges of $0, $0, and $1
million for the years ended 2016, 2015 and 2014, respectively for employee costs, write-down of assets, and
environmental remediation related to decisions to close furnaces and manufacturing facilities in Europe. The
Company recorded total cumulative charges of $127 million and does not expect to execute any further actions
under this program.
Asia Pacific Restructuring
Since 2011, the Company has implemented a restructuring plan in its Asia Pacific segment, primarily
related to aligning its supply base with lower demand in the region. As part of this plan, the Company recorded
charges of $4 million, $5 million and $73 million for the years ended 2016, 2015 and 2014, respectively,
for employee costs, write-down of assets, and pension charges related to furnace closures and additional
restructuring activities. The Company recorded total cumulative charges of $224 million and does not expect to
execute any further actions under this program.
133
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Other Restructuring Actions
In 2016, the Company recorded charges of $92 million for other restructuring actions. These charges
primarily represented employee costs, write-down of assets, and other exit costs of $64 million for a plant
closures in Latin America, Europe and North America and $28 million related to other restructuring actions. The
Company took certain other restructuring actions and recorded charges in 2015 of $58 million. These charges
primarily related to employee costs, write-down of assets and other exit costs totaling $14 million for a plant
closure and furnace closure in Latin America, $38 million for a plant closure in North America and $6 million
for other restructuring actions. In 2014, the Company took certain other restructuring actions and recorded
charges of $2 million for employee costs related to global headcount reduction initiatives.
The following table presents information related to restructuring, asset impairment and other costs related
to closed facilities from January 1, 2015 through December 31, 2015:
Balance at January 1, 2015 . . . . . . . . . . . . . . . . . . . .
Charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Write-down of assets to net realizable value . . . . . .
Net cash paid, principally severance and
related benefits . . . . . . . . . . . . . . . . . . . . . . . . .
Other, including foreign exchange translation . . . . .
Balance at December 31, 2015 . . . . . . . . . . . . . . . . .
;(cid:29)(cid:4)(cid:3)?(cid:8)(cid:12)(cid:15)
Asset
%?(cid:6)(cid:27)(cid:18)(cid:27)w(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
12
$
=(cid:10)(cid:27)(cid:12)(cid:5)*(cid:12)(cid:11)(cid:27)(cid:9)(cid:11)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
12
$
5
(4)
(5)
(4)
3
$
(5)
(1)
7
$
Other
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
=(cid:11)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
$
$
36
58
(27)
(28)
(6)
33
7(cid:3)(cid:6)(cid:12)(cid:13)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
$
60
63
(31)
(38)
(11)
43
$
The following table presents information related to restructuring, asset impairment and other costs related
to closed facilities from January 1, 2016 through December 31, 2016:
Balance at January 1, 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Write-down of assets to net realizable value . . . . . . . . . . . . . . . . . .
Net cash paid, principally severance and related benefits . . . . . . . .
Other, including foreign exchange translation . . . . . . . . . . . . . . . . .
Balance at December 31, 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
=(cid:10)(cid:27)(cid:12)(cid:5)*(cid:12)(cid:11)(cid:27)(cid:9)(cid:11)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
7
$
4
(3)
(1)
7
$
Other
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
=(cid:11)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
$
$
36
92
(28)
(21)
(3)
76
7(cid:3)(cid:6)(cid:12)(cid:13)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
43
$
96
(28)
(24)
(4)
83
$
The restructuring accrual balance represents the Company’s estimates of the remaining future cash amounts
to be paid related to the actions noted above. As of December 31, 2016, the Company’s estimates include
approximately $65 million for employee benefits costs, $16 million for environmental remediation costs, and $2
million for other exit costs.
134
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:31)Q(cid:5)*(cid:8)(cid:15)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)*(cid:3)(cid:10)(cid:6)(cid:4)(cid:8)(cid:6)(cid:27)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:10)
Pension Benefit Plans
The Company participates in OI Inc.’s defined benefit pension plans for a substantial number of employees
located in the United States. Benefits generally are based on compensation for salaried employees and on length
of service for hourly employees. OI Inc.’s policy is to fund pension plans such that sufficient assets will be
available to meet future benefit requirements. Independent actuaries determine pension costs for each subsidiary
of OI Inc. included in the plans; however, accumulated benefit obligation information and plan assets pertaining
to each subsidiary have not been separately determined. As such, the accumulated benefit obligation and the
plan assets related to the pension plans for domestic employees have been retained by another subsidiary of
OI Inc. Net expense to results of operations for the Company’s allocated portion of the domestic pension costs
amounted to $23 million in 2016, $24 million in 2015 and $19 million in 2014.
OI Inc. also sponsors several defined contribution plans for all salaried and hourly U.S. employees of
the Company. Participation is voluntary and participants’ contributions are based on their compensation.
OI Inc. matches contributions of participants, up to various limits, in substantially all plans. OI Inc. charges
the Company for its share of the match. The Company’s share of the contributions to these plans amounted to
$32 million in 2016, $27 million in 2015 and $17 million in 2014.
The Company also has defined benefit pension plans covering a substantial number of employees in several
non-U.S. jurisdictions. Benefits generally are based on compensation for salaried employees and on length of
service for hourly employees. The Company’s policy is to fund pension plans such that sufficient assets will be
available to meet future benefit requirements. The Company’s defined benefit pension plans use a December 31
measurement date.
The changes in the non-U.S. pension benefit obligations for the year are as follows:
Obligations at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in benefit obligations:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Actuarial (gain) loss, including the effect of change in discount rates . . . . . . . . .
Acquisitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Participant contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net change in benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Obligations at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
1,210
$
2015
1,311
$
16
44
160
2
(71)
3
(129)
25
1,235
$
15
44
(9)
37
1
(58)
(131)
(101)
1,210
$
135
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The changes in the fair value of the non-U.S. pension plans’ assets for the year are as follows:
Fair value at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in fair value:
Actual gain (loss) on plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Employer contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Participant contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net change in fair value of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fair value at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The funded status of the non-U.S. pension plans at year end are as follows:
Plan assets at fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Projected benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Plan assets less than projected benefit obligations . . . . . . . . . . . . . . . . . . . . . . . .
Items not yet recognized in pension expense:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service cost (credit) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
1,012
$
2015
1,094
$
139
(71)
38
2
(111)
2
(1)
1,011
(cid:23)(cid:24)(cid:21)(cid:25)
1,011
1,235
(224)
352
(1)
351
127
42
(58)
15
1
22
(104)
(82)
1,012
2015
1,012
1,210
(198)
320
(1 )
319
121
$
$
$
$
$
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
The following changes in plan assets and benefit obligations were recognized in accumulated other
comprehensive income at December 31, 2016 and 2015 as follows (amounts are pretax):
Pension assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current pension liability, included with other accrued liabilities . . . . . . . . . . . . . . . . .
Pension benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
40
(7)
(257)
351
127
$
$
32
(6)
(224)
319
121
$
$
The following changes in plan assets and benefit obligations were recognized in accumulated other
comprehensive income at December 31, 2016 and 2015 as follows (amounts are pretax):
Current year actuarial (gain) loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Settlement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
87
(12)
75
(43)
32
$
15
(15)
—
(31)
(31)
$
$
136
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The components of the non-U.S. pension plans’ net pension expense for the year are as follows:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected asset return . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
16
44
(65)
13
13
8
$
$
15
44
(67)
15
15
7
$
$
23
69
(86)
18
—
18
24
On October 1, 2014, the Company settled the liability associated with its pension plan in the Netherlands,
resulting in a settlement charge of approximately $35 million. Non-U.S. pension expense excludes $3 million
of pension settlement costs that were recorded in restructuring expense in 2014. The table above excludes
these charges.
Amounts that are expected to be amortized from accumulated other comprehensive income into net pension
expense during 2017:
Amortization:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
16
16
The following information is for plans with projected and accumulated benefit obligations in excess of the
fair value of plan assets at year end:
*(cid:4)(cid:3)x(cid:8)(cid:11)(cid:6)(cid:8)(cid:16)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:9)(cid:6)
%(cid:19)(cid:13)(cid:27)+(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5);:(cid:11)(cid:8)(cid:8)(cid:16)(cid:10)
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
(cid:3)(cid:28)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:9)(cid:6)
%(cid:19)(cid:13)(cid:27)+(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5);:(cid:11)(cid:8)(cid:8)(cid:16)(cid:10)
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)(cid:5)(cid:3)(cid:28)
*(cid:13)(cid:12)(cid:15)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Projected benefit obligations . . . . . . . . . . . . . . . . . . . . . . .
Accumulated benefit obligation . . . . . . . . . . . . . . . . . . . . .
Fair value of plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
897
867
632
$
876
850
645
$
897
867
632
876
850
645
The weighted average assumptions used to determine benefit obligations are as follows:
Discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rate of compensation increase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2.94%
2.90%
3.68%
2.84%
The weighted average assumptions used to determine net periodic pension costs are as follows:
Discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rate of compensation increase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected long-term rate of return on assets . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
3.68%
2.84%
7.15%
3.65%
2.89%
7.21%
4.14%
3.31%
7.23%
137
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Future benefits are assumed to increase in a manner consistent with past experience of the plans, which, to
the extent benefits are based on compensation, includes assumed salary increases as presented above.
For 2016, the Company’s weighted average expected long-term rate of return on assets was 7.15% for the
non-U.S. plans. In developing this assumption, the Company considered its historical 10-year average return
(through December 31, 2016) and evaluated input from its third party pension plan asset consultants, including
their review of asset class return expectations
It is the Company’s policy to invest pension plan assets in a diversified portfolio consisting of an array
of asset classes within established target asset allocation ranges. The investment risk of the assets is limited
by appropriate diversification both within and between asset classes. The assets of the group trust and the
Company’s non-U.S. plans are primarily invested in a broad mix of domestic and international equities,
domestic and international bonds, and real estate, subject to the target asset allocation ranges. The assets
are managed with a view to ensuring that sufficient liquidity will be available to meet expected cash flow
requirements.
The investment valuation policy of the Company is to value investments at fair value. All investments are
valued at their respective net asset values. Equity securities for which market quotations are readily available
are valued at the last reported sales price on their principal exchange on valuation date or official close for
certain markets. Fixed income investments are valued by an independent pricing service. Investments in
registered investment companies or collective pooled funds are valued at their respective net asset values.
Short-term investments are stated at amortized cost, which approximates fair value. The fair value of real estate
is determined by periodic appraisals.
In accordance with the Company’s adoption of ASU No. 2015-07 in 2016, certain investments measured
at net asset value (“NAV”), as a practical expedient for fair value, have been excluded from the fair value
hierarchy. The fair value measurements tables presented below have been amended to conform to the current
year presentation under ASU No. 2015-07. See Note 1 for more information.
In 2016, the non-U.S. plan assets consisted of approximately 41% equity securities, 42% debt securities,
and 17% real estate and other. The following table sets forth by level, within the fair value hierarchy, the
Company’s non-U.S. pension plan assets at fair value as of December 31, 2016 and 2015:
Cash and cash equivalents . .
Equity securities . . . . . . . . .
Debt securities . . . . . . . . . .
Real estate . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . .
Investments measured at
net asset value . . . . . . .
Total non-U.S. assets at
fair value . . . . . . . . . . .
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:21)
24
$
37
$
61
$
(cid:23)(cid:24)(cid:21)(cid:25)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:20)
7(cid:3)(cid:6)(cid:12)(cid:13)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:23)
$
— $
— $
2015
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:20)
7(cid:3)(cid:6)(cid:12)(cid:13)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:23)
$
— $
— $
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:21)
30
$
16
24
—
39
4
43
24
24
$
5
6
11
$
46
$
30
—
16
5
30
$ 901
$
1,011
$ 931
$
1,012
2
37
39
4
6
10
$
138
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The following is a reconciliation of the Company’s pension plan assets recorded at fair value using
significant unobservable inputs (Level 3):
Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net increase (decrease) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
11
(1)
10
$
$
5
6
11
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The net increase (decrease) in the fair value of the Company’s Level 3 pension plan assets is primarily due
to purchases and sales of unlisted real estate funds. The change in the fair value of Level 3 pension plan assets
due to actual return on those assets was immaterial in 2016.
In order to maintain minimum funding requirements, the Company is required to make contributions to its
non-U.S. defined benefit pension plans of approximately $24 million in 2017.
The following estimated future benefit payments, which reflect expected future service, as appropriate, are
expected to be paid in the years indicated:
Year(s)
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2022 - 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
53
51
54
57
60
343
Postretirement Benefits Other Than Pensions
OI Inc. provides retiree health care and life insurance benefits covering certain U.S. salaried and hourly
employees. Benefits provided by the Company for hourly retirees are determined by collective bargaining.
Employees are generally eligible for benefits upon retirement and completion of a specified number of years of
creditable service. OI Inc. uses a December 31 measurement date to measure its postretirement benefit obligations.
The Company’s net periodic postretirement benefit income, as allocated by OI Inc., for domestic employees
was $2 million, $2 million, and $1 million at December 31, 2016, 2015 and 2014, respectively.
The Company also has postretirement benefit plans covering substantially all employees in Canada. The
following tables relate to the Company’s postretirement benefit plans in Canada.
The changes in the postretirement benefit obligations for the year are as follows:
Obligations at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in benefit obligations:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Actuarial (gain) loss, including the effect of changing discount rates . . . . . . . . .
Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net change in benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Obligations at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
68
$
81
1
3
9
(2)
2
13
81
$
1
3
(1)
(3)
(13)
(13)
68
$
139
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The funded status of the postretirement benefit plans at year end is as follows:
Postretirement benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
(81) $
(68)
Items not yet recognized in net postretirement benefit cost:
Actuarial gain (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
(6)
(87) $
3
(65)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The net amount recognized is included in the Consolidated Balance Sheets at December 31, 2016 and 2015
as follows:
Current nonpension postretirement benefit, included with Other accrued liabilities . .
Nonpension postretirement benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
(3) $
(78)
(6)
(87) $
(2)
(66)
3
(65)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The following changes in benefit obligations were recognized in accumulated other comprehensive income
at December 31, 2016 and 2015 as follows (amounts are pretax):
Current year actuarial (gain) loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
9
$
—
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The components of the net postretirement benefit cost for the year are as follows:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net postretirement benefit cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
1
3
4
$
$
1
3
4
$
$
1
4
5
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
The weighted average discount rates used to determine the accumulated postretirement benefit obligation
and net postretirement benefit cost are as follows:
Accumulated postretirement benefit obligation . . . . . . . . . . . . . . . . . . . .
Net postretirement benefit cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.55%
3.80%
3.80%
3.75%
3.75%
4.47%
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
The weighted average assumed health care cost trend rates at December 31 are as follows:
Health care cost trend rate assumed for next year . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rate to which the cost trend rate is assumed to decline (ultimate trend rate) . . . . . . .
Year that the rate reaches the ultimate trend rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
5.00%
5.00%
N/A
5.00%
5.00%
N/A
140
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Assumed health care cost trend rates affect the amounts reported for the postretirement benefit plans. A
one-percentage-point change in assumed health care cost trend rates would have the following effects:
(cid:21)(cid:30)*(cid:8)(cid:4)(cid:11)(cid:8)(cid:15)(cid:6)(cid:12)+(cid:8)(cid:5)*(cid:3)(cid:27)(cid:15)(cid:6)
@(cid:15)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)
(cid:17)(cid:8)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)
Effect on total of service and interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Effect on accumulated postretirement benefit obligations . . . . . . . . . . . . . . . . . . . . . .
$
1
13
(1)
(10)
Amortization included in net postretirement benefit cost is based on the average remaining service
of employees.
The following estimated future benefit payments, which reflect expected future service, as appropriate, are
expected to be paid in the years indicated:
Year(s)
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2022 - 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
3
3
3
3
3
18
(cid:21)(cid:24)Q(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)7(cid:12):(cid:8)(cid:10)
The provision for income taxes was calculated based on the following components of earnings (loss) before
income taxes:
(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:27)(cid:15)+(cid:5)(cid:3)?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:17)(cid:27)(cid:10)(cid:11)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)(cid:5)(cid:3)?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
185
383
568
$
$
125
269
394
$
$
231
271
502
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
— $
(7)
(7) $
— $
(4)
(4) $
—
(4)
(4)
$
$
$
$
141
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The provision (benefit) for income taxes consists of the following:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Current:
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
Deferred:
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
8
123
131
(1)
(7)
(8)
$
9
85
94
5
2
7
Total:
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
7
116
123
$
14
87
101
$
8
103
111
—
(18)
(18)
8
85
93
A reconciliation of the provision for income taxes based on the statutory U.S. Federal tax rate of 35% to the
provision for income taxes is as follows:
Tax provision on pretax earnings (loss) from continuing operations at
statutory U.S. Federal tax rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
199
$
138
$
177
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Increase (decrease) in provision for income taxes due to:
Non-U.S. tax rates under U.S. rates . . . . . . . . . . . . . . . . . . . . . . . . .
Changes in valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Withholding tax, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-deductible acquisition costs . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. tax on intercompany dividends and interest . . . . . . . . . . . . . . .
U.S. tax consolidation benefit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax exempt income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax law changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in tax reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mexico inflationary adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
(22)
8
20
3
(74)
(2)
(3)
(17)
8
6
(3)
123
$
(12)
21
18
16
(70)
(3)
(3)
(14)
5
3
2
101
(22)
(24)
18
1
(47)
(5)
(3)
(13)
11
93
Deferred income taxes reflect: (1) the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes;
and (2) carryovers and credits for income tax purposes.
142
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Significant components of the Company’s deferred tax assets and liabilities at December 31, 2016 and 2015
are as follows:
Deferred tax assets:
Accrued postretirement benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign tax credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating and capital loss carryovers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other credit carryovers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred tax liabilities:
Property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangibles and deferred software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
$
21
414
280
14
75
30
51
885
112
119
9
240
(600)
45
$
$
18
389
296
13
68
27
38
849
112
131
26
269
(603)
(23)
Deferred taxes are included in the Consolidated Balance Sheets at December 31, 2016 and 2015 as follows:
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
$
189
(144)
45
$
$
177
(200)
(23)
The Company reviews the likelihood that it will realize the benefit of its deferred tax assets and therefore
the need for valuation allowances on a quarterly basis, or whenever events indicate that a review is required. In
determining the requirement for a valuation allowance, the historical and projected financial results of the legal
entity or consolidated group recording the net deferred tax asset is considered, along with other positive and
negative evidence.
In certain foreign jurisdictions, the Company’s analysis indicates that it has cumulative losses in recent
years. This is considered significant negative evidence which is objective and verifiable and, therefore, difficult
to overcome. However, the cumulative loss position is not solely determinative and, accordingly, the Company
considers all other available positive and negative evidence in its analysis. Based on its analysis, the Company
has recorded a valuation allowance for the portion of deferred tax assets where based on the weight of available
evidence it is unlikely to realize those deferred tax assets.
At December 31, 2016, before valuation allowance, the Company had unused foreign tax credits of
$414 million expiring in 2017 through 2026, and research tax credit of $14 million expiring from 2019 to
2036, which will be available to offset future income tax. Approximately $151 million of the deferred tax
assets related to operating and capital loss carryforwards can be carried over indefinitely, with the remaining
$129 million expiring between 2017 and 2036.
143
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
At December 31, 2016, the Company’s equity in the undistributed earnings of foreign subsidiaries for
which income taxes had not been provided approximated $2.2 billion. The Company intends to reinvest these
earnings indefinitely in the non-U.S. operations. It is not practicable to estimate the U.S. and foreign tax which
would be payable should these earnings be distributed. Deferred taxes are provided for earnings of non-U.S.
jurisdictions when the Company plans to remit those earnings.
The Company is included in OI Inc.’s consolidated tax returns for U.S. federal and certain state income
tax purposes. The consolidated group has net operating losses, capital losses, alternative minimum tax credits,
foreign tax credits and research and development credits available to offset future U.S. Federal income tax.
Income taxes are allocated to the Company on a basis consistent with separate returns.
The Company records a liability for unrecognized tax benefits related to uncertain tax positions. The
Company accrues interest and penalties associated with unrecognized tax benefits as a component of its income
tax expense. The following is a reconciliation of the Company’s total gross unrecognized tax benefits for the
years ended December 31, 2016, 2015 and 2014:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Balance at January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Additions and reductions for tax positions of prior years . . . . . . . . .
Additions based on tax positions related to the current year . . . . . . .
Reductions due to the lapse of the applicable statute of limitations . .
Reductions due to settlements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance at December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unrecognized tax benefits, which if recognized, would impact the
Company’s effective income tax rate . . . . . . . . . . . . . . . . . . . . . . . .
Accrued interest and penalties at December 31 . . . . . . . . . . . . . . . . . . . .
Interest and penalties included in tax expense for the years ended
December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
$
$
74
$
15
(3)
(12)
74
66
23
$
$
$
77
1
10
(5)
(1)
(8)
74
67
25
$
$
$
$
100
(13)
10
(8)
(1)
(11)
77
70
29
(2) $
(1) $
(2)
Based upon the outcome of tax examinations, judicial proceedings, or expiration of statute of limitations,
it is reasonably possible that the ultimate resolution of these unrecognized tax benefits may result in a payment
that is materially different from the current estimate of the tax liabilities. The Company believes that it is
reasonably possible that the estimated liability could decrease up to $11 million within the next 12 months. This
is primarily the result of audit settlements or statute expirations in several taxing jurisdictions.
The Company is currently under examination in various tax jurisdictions in which it operates, including
Argentina, Bolivia, Brazil, China, Canada, Colombia, Ecuador, France, Germany, Indonesia, and Italy. The
years under examination range from 2006 through 2014. The Company has received tax assessments in excess
of established reserves. The Company believes that adequate provisions for all income tax uncertainties have
been made. However, if tax assessments are settled against the Company at amounts in excess of established
reserves, it could have a material impact to the Company’s results of operations, financial position or cash
flows. During 2016, the Company concluded income tax audits in several jurisdictions, including the Czech
Republic, Germany, Italy, and Hungary.
144
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:21)(cid:21)Q(cid:5);:(cid:6)(cid:8)(cid:4)(cid:15)(cid:12)(cid:13)(cid:5)(cid:17)(cid:8)(cid:19)(cid:6)
The following table summarizes the external long-term debt of the Company at December 31, 2016
and 2015:
Secured Credit Agreement:
Revolving Credit Facility:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Revolving Loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
— $
—
Term Loans:
Term Loan A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Term Loan A (€279 million at December 31, 2016) . . . . . . . . . . . . . . . . . . .
Term Loan B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Senior Notes:
6.75%, due 2020 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.875%, due 2021 (€330 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.00%, due 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.875%, due 2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.125%, due 2024 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capital leases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less amounts due within one year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
1,395
282
523
345
495
682
520
297
294
55
20
4,908
32
4,876
1,546
301
563
542
357
494
680
296
293
52
30
5,154
67
5,087
$
On April 22, 2015, the Company entered into a Senior Secured Credit Facility, which subsequently has
been amended several times with the most recent amendment being entered into on February 3, 2016 (the
“Amended Agreement”). In connection with the closing of the Vitro Acquisition on September 1, 2015 (see
Note 17), the Company incurred $1,250 million of senior secured incremental term loan facilities, comprised of
(i) a $675 million term loan A facility on substantially the same terms and conditions (including as to maturity)
as the term loan A facility in the Amended Agreement and (ii) a $575 million term loan B facility, which was
subsequently repaid in full in November 2016 as described below.
At December 31, 2016, the Amended Agreement includes a $300 million revolving credit facility, a $600
million multicurrency revolving credit facility, a $1,575 million term loan A facility ($1,395 million net of debt
issuance costs), and a €279 million term loan A facility ($282 million net of debt issuance costs), each of which
has a final maturity date of April 22, 2020. At December 31, 2016, the Company had unused credit of $884
million available under the Amended Agreement. The weighted average interest rate on borrowings outstanding
under the Amended Agreement at December 31, 2016 was 2.39%.
The Amended Agreement contains various covenants that restrict, among other things and subject to certain
exceptions, the ability of the Company to incur certain liens, make certain investments, become liable under
contingent obligations in certain defined instances only, make restricted payments, make certain asset sales
within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing
arrangements, alter its fundamental business, and amend certain subordinated debt obligations.
145
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The Amended Agreement also contains one financial covenant, a Total Leverage Ratio, that requires the
Company not to exceed a ratio calculated by dividing consolidated total debt, less cash and cash equivalents,
by consolidated EBITDA, as defined in the Amended Agreement. The Total Leverage Ratio could restrict the
ability of the Company to undertake additional financing or acquisitions to the extent that such financing or
acquisitions would cause the Total Leverage Ratio to exceed the specified maximum of (i) 4.5x for the four
fiscal quarters ending December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, and (ii)
4.0x for the fourth fiscal quarter ending December 31, 2017 and each fiscal quarter thereafter.
Failure to comply with these covenants and restrictions could result in an event of default under the
Amended Agreement. In such an event, the Company would be unable to request borrowings under the
revolving facility, and all amounts outstanding under the Amended Agreement, together with accrued interest,
could then be declared immediately due and payable. If an event of default occurs under the Amended
Agreement and the lenders cause all of the outstanding debt obligations under the Amended Agreement to
become due and payable, this would result in a default under a number of other outstanding debt securities
and could lead to an acceleration of obligations related to these debt securities. As of December 31, 2016, the
Company was in compliance with all covenants and restrictions in the Amended Agreement. In addition, the
Company believes that it will remain in compliance and that its ability to borrow funds under the Amended
Agreement will not be adversely affected by the covenants and restrictions.
The interest rates on borrowings under the Amended Agreement are, at the Company’s option, the Base
Rate or the Eurocurrency Rate, as defined in the Amended Agreement, plus an applicable margin. The
applicable margin for the term loan A facility and the revolving credit facility is linked to the Company’s Total
Leverage Ratio and ranges from 1.25% to 1.75% for Eurocurrency Rate loans and from 0.25% to 0.75% for
Base Rate loans. In addition, a facility fee is payable on the revolving credit facility commitments ranging from
0.20% to 0.30% per annum linked to the Total Leverage Ratio.
Borrowings under the Amended Agreement are secured by substantially all of the assets, excluding real
estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign
subsidiaries. Borrowings are also secured by a pledge of intercompany debt and equity investments in certain
of the Company’s domestic subsidiaries and, in the case of foreign borrowings, of stock of certain foreign
subsidiaries. All borrowings under the Amended Agreement are guaranteed by certain domestic subsidiaries of
the Company.
Also, in connection with the Vitro Acquisition, during August 2015, the Company issued senior notes
with a face value of $700 million that bear interest at 5.875% and are due August 15, 2023 (the “Senior Notes
due 2023”) and senior notes with a face value of $300 million that bear interest at 6.375% and are due August
15, 2025 (together with the Senior Notes due 2023, the “2015 Senior Notes”). The 2015 Senior Notes were
issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The
net proceeds from the 2015 Senior Notes, after deducting the debt discount and debt issuance costs, totaled
approximately $972 million and were used to finance, in part, the Vitro Acquisition.
During November 2016, the Company issued senior notes with a face value of €500 million that bear
interest at 3.125% and are due November 15, 2024. The notes were issued via a private placement and are
guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds, after deducting the debt
discount and debt issuance costs, totaled approximately $520 million and were used to repay the term loan B
facility under the Amended Agreement.
146
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into
additional credit facilities and seek to issue equity and/or debt securities in the domestic and international
capital markets if market conditions are favorable. Also, depending on market conditions, the Company may
elect to repurchase portions of its debt securities in the open market.
The Company has a €185 million European accounts receivable securitization program, which extends
through March 2019, subject to periodic renewal of backup credit lines.
Information related to the Company’s accounts receivable securitization program as of December 31, 2016
and 2015 is as follows:
Balance (included in short-term loans) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
152
$
0.74%
158
1.21%
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The carrying amounts reported for the accounts receivable securitization program, and certain long-term
debt obligations subject to frequently redetermined interest rates, approximate fair value. Fair values for the
Company’s significant fixed rate debt obligations are based on published market quotations, and are classified
as Level 1 in the fair value hierarchy.
Annual maturities for all of the Company’s long-term debt through 2021 are as follows: 2017, $33 million;
2018, $287 million; 2019, $101 million; 2020, $2,074 million; and 2021, $354 million.
Fair values at December 31, 2016, of the Company’s significant fixed rate debt obligations are as follows:
*(cid:4)(cid:27)(cid:15)(cid:11)(cid:27)?(cid:12)(cid:13)
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)
@(cid:15)(cid:16)(cid:27)(cid:11)(cid:12)(cid:6)(cid:8)(cid:16)
&(cid:12)(cid:4)](cid:8)(cid:6)(cid:5)*(cid:4)(cid:27)(cid:11)(cid:8)
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
Senior Notes:
6.75%, due 2020 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . .
4.875%, due 2021 (€330 million) . . . . . . . . . . . . . . . . . . . . . . .
5.00%, due 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.875%, due 2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.125%, due 2024 (€500 million) . . . . . . . . . . . . . . . . . . . . . . .
5.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
526
347
500
700
526
300
300
$
120.63
114.00
103.49
105.37
100.01
101.17
106.28
635
396
517
738
526
304
319
(cid:21)(cid:23)Q(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)+(cid:8)(cid:15)(cid:11)(cid:27)(cid:8)(cid:10)
Certain litigation is pending against the Company, in many cases involving ordinary and routine claims
incidental to the business of the Company and in others presenting allegations that are nonroutine and involve
compensatory, punitive or treble damage claims as well as other types of relief. The Company records a
liability for such matters when it is both probable that the liability has been incurred and the amount of the
liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the
factors upon which the estimates are based including additional information, negotiations, settlements, and
other events. The ultimate legal and financial liability of the Company in respect to this pending litigation
cannot reasonably be estimated. However, the Company believes, based on its examination and review of such
matters and experience to date, that such ultimate liability will not have a material adverse effect on its results
of operations or financial condition.
147
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The Company’s joint venture in China had been involved in litigation with its partner regarding whether
the joint venture should be dissolved. Following an ownership change in 2016 with respect to the joint venture
partner, this litigation has been withdrawn.
Other litigation is pending against the Company, in many cases involving ordinary and routine claims
incidental to the business of the Company and in others presenting allegations that are non-routine and involve
compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability
for such matters when it is both probable that the liability has been incurred and the amount of the liability can be
reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which
the estimates are based, including additional information, negotiations, settlements and other events.
(cid:21)(cid:20)Q(cid:5)=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)/_(cid:3)(cid:10)(cid:10)6
The components of comprehensive income are: (a) net earnings; (b) change in fair value of certain
derivative instruments; (c) pension and other postretirement benefit adjustments; and (d) foreign currency
translation adjustments. The net effect of exchange rate fluctuations generally reflects changes in the relative
strength of the U.S. dollar against major foreign currencies between the beginning and end of the year.
The following table lists the beginning balance, annual activity and ending balance of each component of
accumulated other comprehensive income (loss):
8(cid:8)(cid:6)(cid:5);(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:5)(cid:3)(cid:28)
;:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)<(cid:12)(cid:6)(cid:8)
(cid:2)(cid:13)(cid:29)(cid:11)(cid:6)(cid:29)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
$
(55) $
(513)
Change in
Certain
(cid:17)(cid:8)(cid:4)(cid:27)[(cid:12)(cid:6)(cid:27)[(cid:8)
@(cid:15)(cid:10)(cid:6)(cid:4)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
2
(4)
;(cid:18)?(cid:13)(cid:3)(cid:14)(cid:8)(cid:8)
\(cid:8)(cid:15)(cid:8)(cid:9)(cid:6)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:10)
$
(255)
27
7(cid:3)(cid:6)(cid:12)(cid:13)
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)
Other
(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)
Loss
$
Balance on January 1, 2015 . . . . . . . . . . . .
Change before reclassifications . . . . . . . . .
Amounts reclassified from accumulated
other comprehensive income . . . . . . . .
Translation effect . . . . . . . . . . . . . . . . . . . .
Tax effect . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss)
attributable to the Company . . . . . . . .
Balance on December 31, 2015 . . . . . . . . .
Change before reclassifications . . . . . . . . .
Amounts reclassified from accumulated
other comprehensive income . . . . . . . .
Translation effect . . . . . . . . . . . . . . . . . . . .
Tax effect . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss)
attributable to the Company . . . . . . . .
Balance on December 31, 2016 . . . . . . . . .
(1)(a)
(1)
(6)
(4)
7
6 (a)
$
(513)
(568) $
(220)
(220)
(788)
$
13
9
15 (b)
(31)
2
13
(242)
(96)
$
18 (b)
25
15
(38)
(280)
(308)
(490)
14
(31)
1
(506)
(814)
(309)
24
25
15
(245)
(1,059)
(a) Amount is included in Cost of goods sold on the Consolidated Results of Operations (see Note 7 for
additional information).
’(cid:7)*(cid:6) +(cid:18)(cid:12)(cid:28)(cid:5)(cid:8)(cid:6)(cid:11)(cid:10)(cid:6)(cid:11)(cid:5)!(cid:13)(cid:28)(cid:2)(cid:3)(cid:2)(cid:6)(cid:11)(cid:5)(cid:6)(cid:8)(cid:31)(cid:3)(cid:6)!(cid:12)(cid:18)(cid:9)(cid:28)(cid:8)(cid:14)(cid:8)(cid:11)(cid:12)(cid:5)(cid:6)(cid:12)(cid:15)(cid:6)(cid:5)(cid:3)(cid:8)(cid:6)(cid:9)(cid:3)(cid:16)(cid:11)(cid:12)(cid:2)(cid:11)!(cid:6)(cid:9)(cid:3)(cid:5)(cid:10)(cid:11)(cid:12)(cid:5)(cid:6)!(cid:12)(cid:10)(cid:8)(cid:6)(cid:14)(cid:5)(cid:2)(cid:6)(cid:5)(cid:3)(cid:8)(cid:6)(cid:9)(cid:12)(cid:10)(cid:8)(cid:16)(cid:3)(cid:8)(cid:11)(cid:16)(cid:3)(cid:18)(cid:3)(cid:5)(cid:8)(cid:6)(cid:7)(cid:3)(cid:5)(cid:3)(cid:4)(cid:8)(cid:6)!(cid:12)(cid:10)(cid:8)(cid:6)’(cid:10)(cid:3)(cid:3)(cid:6)
Note 9 for additional information).
148
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:21)jQ(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5);:?(cid:8)(cid:15)(cid:10)(cid:8)(cid:22)(cid:5)(cid:15)(cid:8)(cid:6)
Other expense, net for the years ended December 31, 2016, 2015 and 2014 included the following:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Restructuring, asset impairment and other charges . . . . . . . . . . . . . . . .
Intangible amortization expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment of equity investment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on China land compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Royalty income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Strategic transaction costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value intangible adjustments . . . . . . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency exchange loss (gain) . . . . . . . . . . . . . . . . . . . . . . . . . .
Other expense (income) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
102
39
25
(71)
(13)
6
(10)
78
$
$
$
75
21
68
1
(12)
4
10
(10)
(11)
77
$
(12)
69
(2)
15
138
In 2016, the Company evaluated the future estimated earnings and cash flow of an equity investment
and determined that it was other-than-temporarily impaired. As such, the Company recorded an impairment
charge of $25 million to reduce its carrying value down to its estimated fair value. The Company classified
the significant assumptions used to determine the fair value of the impaired assets as Level 3 in the fair value
hierarchy as set forth in the general accounting principles for fair value measurements.
In 2014, the Company recorded a charge of $69 million resulting from a non-income tax assessment from a
foreign tax authority.
(cid:21)!Q(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:15)+(cid:5)_(cid:8)(cid:12)(cid:10)(cid:8)(cid:10)
Rent expense attributable to all warehouse, office buildings, and equipment operating leases was
$76 million in 2016, $68 million in 2015 and $53 million in 2014. Minimum future rentals under operating
leases are as follows: 2017, $61 million; 2018, $42 million; 2019, $28 million; 2020, $18 million; 2021,
$12 million; and 2022 and thereafter, $18 million.
(cid:21)(cid:25)Q(cid:5)>(cid:29)??(cid:13)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:12)(cid:13)(cid:5)(cid:26)(cid:12)(cid:10)(cid:7)(cid:5)(cid:2)(cid:13)(cid:3)#(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
Changes in the components of working capital related to operations (net of the effects related to
acquisitions and divestitures) were as follows:
Decrease (increase) in current assets:
Receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Increase (decrease) in current liabilities:
Accounts payable and accrued liabilities . . . . . . . . . . . . . . . . . . . .
Salaries and wages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. and foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
(25) $
13
148
(91)
20
23
88
$
(20) $
(13)
(8)
139
16
(13)
101
$
83
(27)
29
48
12
13
158
149
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The Company uses various factoring programs to sell certain receivables to financial institutions as part
of managing its cash flows. At December 31, 2016 and 2015, the amount of receivables sold by the Company
was $318 million and $317 million, respectively. Any continuing involvement with the sold receivables
is immaterial.
Interest paid in cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes paid in cash (all non-U.S) . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
241
99
$
207
101
179
101
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Cash interest for the years ended December 31, 2016, 2015 and 2014 includes $9 million, $32 million and
$9 million of note repurchase premiums, respectively.
(cid:21)"Q(cid:5)(cid:5)\(cid:29)(cid:10)(cid:27)(cid:15)(cid:8)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:18)(cid:19)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
On September 1, 2015, the Company completed the Vitro Acquisition in a cash transaction valued at
approximately $2.297 billion in cash, subject to a working capital adjustment and certain other adjustments.
The Vitro Business in Mexico is the largest supplier of glass containers in that country manufacturing glass
containers across multiple end uses, including food, soft drinks, beer, wine and spirits. The Vitro Acquisition
included five food and beverage glass container plants in Mexico, a plant in Bolivia and a North American
distribution business, and provided the Company with a competitive position in the glass packaging market
in Mexico. The results of the Vitro Business have been included in the Company’s consolidated financial
statements since September 1, 2015 and contributed approximately $608 million of incremental net sales and
$122 million of incremental segment operating profit in the year ended December 31, 2016. Vitro’s food
and beverage glass container operations in Mexico and Bolivia are included in the Latin American operating
segment while its distribution business is included in the North American operating segment.
The Company financed the Vitro Acquisition with the proceeds from a senior notes offering, cash on hand
and the incremental term loan facilities (see Note 11).
The total purchase price was allocated to the tangible and identifiable intangible assets and liabilities based
upon their respective fair values. The purchase agreement contained customary provisions for working capital
adjustments, which the Company resolved with the seller in the first quarter of 2016. The Company completed
the purchase price allocation process in the third quarter of 2016. The following table summarizes the fair value
of the assets and liabilities assumed on September 1, 2015 and subsequent adjustments identified through the
purchase price allocation process and recorded through the measurement period:
>(cid:8)?(cid:6)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:21)(cid:22)
2015
Cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Customer list intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net assets acquired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
17
344
1,073
406
597
2,437
93
11
36
2,297
150
&(cid:8)(cid:12)(cid:10)(cid:29)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)
Period
=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
$
>(cid:8)?(cid:6)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:24)(cid:22)
(cid:23)(cid:24)(cid:21)(cid:25)
— $
(10)
(236)
202
48
4
(7)
11
— $
$
17
334
837
608
645
2,441
86
11
47
2,297
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The fair value of the tangible assets was estimated utilizing income and market approaches, considering
remaining useful life. The customer list intangible asset includes the Company’s established relationships with
its customers and the ability of these customers to generate future economic profits for the Company. The value
assigned to customer list intangibles is based on the present value of future earnings attributable to the asset
group after recognition of required returns to other contributory assets.
Recognized goodwill is attributable to the assembled workforce, expected synergies and other intangible
assets that do not qualify for separate recognition. The Vitro Acquisition goodwill is not deductible for
tax purposes.
The balance sheet adjustments identified above did not result in any significant adjustments to the periods’
income statements.
(cid:21)$Q(cid:5)(cid:5)*(cid:4)(cid:3)(cid:5)(cid:2)(cid:3)(cid:4)(cid:18)(cid:12)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)y(cid:5)l(cid:27)(cid:6)(cid:4)(cid:3)(cid:5)=(cid:11)m(cid:29)(cid:27)(cid:10)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)
Had the Vitro Acquisition, described in Note 17 and the related financing described in Note 11, occurred
at the beginning of each respective period, unaudited pro forma consolidated net sales and earnings from
continuing operations would have been as follows:
(cid:5)‘(cid:8)(cid:12)(cid:4)(cid:5);(cid:15)(cid:16)(cid:27)(cid:15)+(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)!
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations attributable to
the Company . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
(cid:21)(cid:31)Q(cid:5)(cid:17)(cid:27)(cid:10)(cid:11)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
As
<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:8)(cid:16)
6,156
=(cid:11)m(cid:29)(cid:27)(cid:10)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)
=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
574
$
(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:15)+
=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
$
— $
*(cid:4)(cid:3)(cid:5)(cid:2)(cid:3)(cid:4)(cid:18)(cid:12)
=(cid:10)(cid:5)=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:8)(cid:16)
6,730
270
$
79
$
(46) $
303
On April 4, 2016, the annulment committee formed by the World Bank’s International Centre for
Settlement of Investment Disputes (“ICSID”) ruled that a subsidiary of the Company is free to pursue the
enforcement of a prior arbitration award against Venezuela. That award amounts to more than $485 million
after including interest from the date of the expropriation by Venezuela (October 26, 2010). Venezuela’s
application to annul the award is still pending, although the annulment proceedings were suspended in October
2016 because Venezuela has not paid its fees owed to ICSID. If the proceeding is stayed for non-payment
for a consecutive period in excess of six months, ICSID’s Secretary General could move that the committee
discontinue the annulment proceeding altogether. The Company intends to take appropriate steps to vigorously
enforce and collect the award, which is enforceable in approximately 150 member states that are party to the
ICSID Convention. However, even with the lifting of the stay of enforcement, the Company recognizes that the
collection of the award may present significant practical challenges. Because the award has yet to be satisfied
and the annulment proceeding is pending, the Company is unable at this stage to reasonably predict the efforts
that will be necessary to successfully enforce collection of the award, the amount of the award or the timing of
any such collection efforts. Therefore, the Company has not recognized this award in its financial statements.
The loss from discontinued operations of $7 million, $4 million and $4 million, for the years ended
December 31, 2016, 2015 and 2014, respectively, relates to ongoing costs for the Venezuelan expropriation.
151
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:23)(cid:24)Q(cid:5)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:8)(cid:8)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)(cid:17)(cid:8)(cid:19)(cid:6)
OI Group and the Company guarantee OI Inc.’s senior debentures on a subordinated basis. The fair value of
the OI Inc. debt being guaranteed was $266 at December 31, 2016.
(cid:23)(cid:21)Q(cid:5)<(cid:8)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)*(cid:12)(cid:4)(cid:6)(cid:14)(cid:5)7(cid:4)(cid:12)(cid:15)(cid:10)(cid:12)(cid:11)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
Charges for administrative services are allocated to the Company by OI Inc. based on an annual utilization
level. Such services include compensation and benefits administration, payroll processing, use of certain general
accounting systems, auditing, income tax planning and compliance, and treasury services.
Allocated costs also include charges associated with OI Inc.’s equity compensation plans. A substantial
number of the options, restricted share units and performance vested restricted share units granted under these
plans have been granted to key employees of another subsidiary of OI Inc., some of whose compensation costs,
including stock-based compensation, are included in an allocation of costs to all operating subsidiaries of
OI Inc., including the Company.
Management believes that such transactions are on terms no less favorable to the Company than those that
could be obtained from unaffiliated third parties.
The following information summarizes the Company’s significant related party transactions:
Revenues:
Sales to affiliated companies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expenses:
Administrative services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate management fee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Year ended
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
2015
2014
(cid:23)(cid:24)(cid:21)(cid:25)
$
$
$
— $
— $
2
75
77
$
$
2
74
76
$
$
—
2
75
77
The above expenses are recorded in the results of operations as follows:
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative expenses . . . . . . . . . . . . . . . . .
Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
— $
77
77
$
— $
76
76
$
Year ended
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2014
—
77
77
152
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Share Owner of
Owens-Brockway Glass Container, Inc.
We have audited the accompanying consolidated balance sheets of Owens-Brockway Glass Container,
Inc. (the Company) as of December 31, 2016 and 2015, and the related consolidated statements of results of
operations, comprehensive income, share owner’s equity and cash flows for each of the three years in the period
ended December 31, 2016. These financial statements are the responsibility of the Company’s management. Our
responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material misstatement. We were not engaged to
perform an audit of the Company’s internal control over financial reporting. Our audits included consideration
of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal
control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining,
on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by management, and evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the
consolidated financial position of Owens-Brockway Glass Container, Inc. at December 31, 2016 and 2015,
and the consolidated results of its operations and its cash flows for each of the three years in the period ended
December 31, 2016, in conformity with U.S. generally accepted accounting principles.
/s/ Ernst & Young LLP
Toledo, Ohio
February 10, 2017
153
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED RESULTS OF OPERATIONS
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling and administrative expense . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Research, development and engineering expense . . . . . . . . . . . . . . . . .
Equity earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations before income taxes . . . . . . . . . .
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings attributable to noncontrolling interests . . . . . . . . . . . . . . .
Net earnings attributable to the Company . . . . . . . . . . . . . . . . . . . . . . .
Amounts attributable to the Company:
$
(cid:23)(cid:24)(cid:21)(cid:25)
6,702 $
(5,387)
1,315
(411)
(65)
60
(253)
(78)
568
(123)
445
(7)
438
(21)
417
$
2015
6,156 $
(5,060)
1,096
(389)
(64)
60
(232)
(77)
394
(101)
293
(4)
289
(23)
266
$
2014
6,784
(5,523)
1,261
(412)
(63)
64
(210)
(138)
502
(93)
409
(4)
405
(28)
377
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
424
(7)
417
$
$
270
(4 )
266
$
$
381
(4)
377
See accompanying Notes to the Consolidated Financial Statements.
154
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED COMPREHENSIVE INCOME
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Other comprehensive income (loss):
Foreign currency translation adjustments . . . . . . . . . . . . . . . . . . . . .
Pension and other postretirement benefit adjustments, net of tax . . .
Change in fair value of derivative instruments, net of tax . . . . . . . .
Other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Comprehensive income attributable to noncontrolling interests . . . . . . .
Comprehensive income (loss) attributable to the Company . . . . . . . . . . .
$
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
438 $
289 $
405
(224)
(38)
13
(249)
189
(17)
172
$
(529)
13
(6)
(522 )
(233)
(7)
(240 ) $
(305)
112
1
(192)
213
(7)
206
See accompanying Notes to the Consolidated Financial Statements.
155
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED BALANCE SHEETS
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
Assets
(cid:26)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:6)(cid:5)(cid:12)(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)u
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Trade receivables, net of allowances of $32 million and $29 million at
December 31, 2016 and 2015, respectively . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:12)(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)u
Equity investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
*(cid:4)(cid:3)?(cid:8)(cid:4)(cid:6)(cid:14)(cid:22)(cid:5)?(cid:13)(cid:12)(cid:15)(cid:6)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:8)m(cid:29)(cid:27)?(cid:18)(cid:8)(cid:15)(cid:6)u
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
465
$
394
580
983
183
2,211
433
40
538
464
2,462
3,937
562
1,007
352
2,315
409
32
527
597
2,489
4,054
Land, at cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Buildings and equipment, at cost:
Buildings and building equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Factory machinery and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Transportation, office and miscellaneous equipment . . . . . . . . . . . . . . . . . . .
Construction in progress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less accumulated depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
237
248
1,048
4,491
66
237
6,079
3,224
2,855
9,003
$
1,080
4,520
68
236
6,152
3,221
2,931
9,300
$
See accompanying Notes to the Consolidated Financial Statements.
156
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED BALANCE SHEETS ((cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16))
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
_(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)>(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)%#(cid:15)(cid:8)(cid:4)b(cid:10)(cid:5);m(cid:29)(cid:27)(cid:6)(cid:14)
(cid:26)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:6)(cid:5)(cid:13)(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Accounts payable including amount to related parties of $7 million and
$3 million at December 31, 2016 and 2015, respectively . . . . . . . . . . . . . . .
Salaries and wages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. and foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt due within one year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
;:(cid:6)(cid:8)(cid:4)(cid:15)(cid:12)(cid:13)(cid:5)(cid:13)(cid:3)(cid:15)+(cid:30)(cid:6)(cid:8)(cid:4)(cid:18)(cid:5)(cid:16)(cid:8)(cid:19)(cid:6) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:17)(cid:8)(cid:28)(cid:8)(cid:4)(cid:4)(cid:8)(cid:16)(cid:5)(cid:6)(cid:12):(cid:8)(cid:10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
*(cid:8)(cid:15)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)(cid:19)(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8(cid:3)(cid:15)?(cid:8)(cid:15)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)?(cid:3)(cid:10)(cid:6)(cid:4)(cid:8)(cid:6)(cid:27)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:19)(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:13)(cid:27)(cid:12)(cid:19)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
>(cid:7)(cid:12)(cid:4)(cid:8)(cid:5)(cid:3)#(cid:15)(cid:8)(cid:4)b(cid:10)(cid:5)(cid:8)m(cid:29)(cid:27)(cid:6)(cid:14)u
Investment by and advances from Parent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total share owner’s equity of the Company . . . . . . . . . . . . . . . . . . . . . . . . . .
Noncontrolling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total share owner’s equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total liabilities and share owner’s equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
$
$
1,124
156
58
330
162
32
1,862
4,876
144
257
78
174
2,562
(1,059)
1,503
109
1,612
9,003
$
1,200
139
34
332
160
67
1,932
5,087
200
224
66
186
2,311
(814)
1,497
108
1,605
9,300
See accompanying Notes to the Consolidated Financial Statements.
157
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED SHARE OWNER’S EQUITY
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
@(cid:15)[(cid:8)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:19)(cid:14)(cid:5)(cid:12)(cid:15)(cid:16)
=(cid:16)[(cid:12)(cid:15)(cid:11)(cid:8)(cid:10)(cid:5)(cid:28)(cid:4)(cid:3)(cid:18)
Parent
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)
Other
(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)
@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)/_(cid:3)(cid:10)(cid:10)6
Non-
(cid:11)(cid:3)(cid:15)(cid:6)(cid:4)(cid:3)(cid:13)(cid:13)(cid:27)(cid:15)+
Interests
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:5)>(cid:7)(cid:12)(cid:4)(cid:8)
%#(cid:15)(cid:8)(cid:4)b(cid:10)
;m(cid:29)(cid:27)(cid:6)(cid:14)
Balance on January 1, 2014 . . . .
Net intercompany transactions . .
Net earnings . . . . . . . . . . . . . . . .
Other comprehensive loss . . . . .
Distributions to noncontrolling
interests . . . . . . . . . . . . . . . .
Balance on December 31, 2014 . .
Net intercompany transactions . .
Net earnings . . . . . . . . . . . . . . . .
Other comprehensive loss . . . . . .
Distributions to noncontrolling
interests . . . . . . . . . . . . . . . .
Acquisitions of noncontrolling
interests . . . . . . . . . . . . . . . .
Balance on December 31, 2015 . .
Net intercompany transactions . .
Net earnings . . . . . . . . . . . . . . . .
Other comprehensive loss . . . . . .
Distributions to noncontrolling
interests . . . . . . . . . . . . . . . .
Balance on December 31, 2016 . .
$
2,305
(274)
377
2,408
(345)
266
(18)
2,311
(166)
417
$
(137) $
147
$
(171)
(308)
(506)
(814)
(245)
28
(21)
(37)
117
23
(16)
(22)
6
108
21
(4)
$
2,562
$
(1,059) $
(16)
109
$
2,315
(274)
405
(192)
(37)
2,217
(345)
289
(522)
(22)
(12)
1,605
(166)
438
(249)
(16)
1,612
See accompanying Notes to the Consolidated Financial Statements.
158
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
438
7
$
289
4
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
CONSOLIDATED CASH FLOWS
(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-cash charges (credits):
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of intangibles and other deferred items . . . . . . . .
Amortization of finance fees and debt discount . . . . . . . . . . . .
Deferred tax provision (benefit) . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring, asset impairment and related charges . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on China land sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment of equity investment . . . . . . . . . . . . . . . . . . . . . . . .
Cash paid for restructuring activities . . . . . . . . . . . . . . . . . . . . . . . .
Change in components of working capital . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash provided by continuing operating activities . . . . . . . . . . .
Cash utilized in discontinued operating activities . . . . . . . . . . .
Total cash provided by operating activities . . . . . . . . . . . . . . . .
@(cid:15)[(cid:8)(cid:10)(cid:6)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Additions to property, plant and equipment . . . . . . . . . . . . . . . . . . .
Acquisitions, net of cash acquired . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash proceeds related to sale of assets and other . . . . . . . . . . . .
Net activity for non-controlling partner loans . . . . . . . . . . . . . . . . . .
Net foreign exchange derivative activity . . . . . . . . . . . . . . . . . . . . . .
Cash utilized in investing activities . . . . . . . . . . . . . . . . . . . . . .
371
96
13
(8)
96
(71)
25
(24)
88
(126)
905
(7)
898
(452)
(56)
84
8
(416)
(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:15)+(cid:5)(cid:12)(cid:11)(cid:6)(cid:27)[(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)u
Additions to long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Repayments of long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Increase (decrease) in short-term loans . . . . . . . . . . . . . . . . . . . . . . .
Net receipts from (distribution to) parent . . . . . . . . . . . . . . . . . . . . .
Payment of finance fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Distributions to noncontrolling interests . . . . . . . . . . . . . . . . . . . . . .
Cash provided by (utilized in) financing activities . . . . . . . . . . . . . .
Effect of exchange rate fluctuations on cash . . . . . . . . . . . . . . . . . . .
Increase (decrease) in cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at beginning of period . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at end of period . . . . . . . . . . . . . . . . . . . . . . .
1,235
(1,452)
10
(166)
(9)
(16)
(398)
(13)
71
394
465
$
$
See accompanying Notes to the Consolidated Financial Statements.
159
405
4
331
75
20
(18)
76
69
(58)
158
(116)
946
(4)
942
(369)
(113)
16
9
(457)
1,226
(1,100)
(139)
(276)
(11)
(37)
(337)
(21)
127
356
483
$
319
77
14
7
63
(38)
101
41
877
(4 )
873
(400)
(2,351)
1
4
(2,746)
4,538
(2,317)
51
(346 )
(90)
(22)
1,814
(30)
(89)
483
394
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:21)Q(cid:5)>(cid:27)+(cid:15)(cid:27)(cid:28)(cid:27)(cid:11)(cid:12)(cid:15)(cid:6)(cid:5)=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:27)(cid:15)+(cid:5)*(cid:3)(cid:13)(cid:27)(cid:11)(cid:27)(cid:8)(cid:10)
\(cid:12)(cid:10)(cid:27)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)(cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)>(cid:6)(cid:12)(cid:6)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10) The consolidated financial statements of Owens-Brockway Glass
Container, Inc. (the “Company”) include the accounts of its subsidiaries. Newly acquired subsidiaries have been
included in the consolidated financial statements from dates of acquisition.
The Company uses the equity method of accounting for investments in which it has a significant ownership
interest, generally 20% to 50%. Other investments are accounted for at cost. The Company monitors other than
temporary declines in fair value and records reductions in carrying values when appropriate.
<(cid:8)(cid:13)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)(cid:7)(cid:27)?(cid:5)#(cid:27)(cid:6)(cid:7)(cid:5)%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)*(cid:12)(cid:11)](cid:12)+(cid:27)(cid:15)+(cid:22)(cid:5)@(cid:15)(cid:11)Q(cid:22)(cid:5)%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:5)Z(cid:4)(cid:3)(cid:29)?(cid:22)(cid:5)@(cid:15)(cid:11)Q(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)
%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q The Company is a 100%-owned subsidiary of Owens-Brockway Packaging, Inc. (“OB
Packaging”), and an indirect subsidiary of Owens-Illinois Group, Inc. (“OI Group”) and Owens-Illinois, Inc.
(“OI Inc.”). Although OI Inc. does not conduct any operations, it has substantial obligations related to
outstanding indebtedness and asbestos-related payments. OI Inc. relies primarily on distributions from its direct
and indirect subsidiaries to meet these obligations.
For federal and certain state income tax purposes, the taxable income of the Company is included in the
consolidated tax returns of OI Inc. and income taxes are allocated to the Company on a basis consistent with
separate returns.
8(cid:12)(cid:6)(cid:29)(cid:4)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) The Company is a leading manufacturer of glass container products. The Company’s
principal product lines are glass containers for the food and beverage industries. The Company has glass
container operations located in 23 countries. The principal markets and operations for the Company’s products
are in Europe, North America, Latin America and Asia Pacific.
c(cid:10)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5);(cid:10)(cid:6)(cid:27)(cid:18)(cid:12)(cid:6)(cid:8)(cid:10)(cid:5) The preparation of financial statements in conformity with accounting principles
generally accepted in the United States requires management of the Company to make estimates and
assumptions that affect certain amounts reported in the financial statements and accompanying notes. Actual
results may differ from those estimates, at which time the Company would revise its estimates accordingly.
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5)(cid:26)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:11)(cid:14)(cid:5)7(cid:4)(cid:12)(cid:15)(cid:10)(cid:13)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5) The assets and liabilities of non-U.S. subsidiaries are translated into
U.S. dollars at year-end exchange rates. Any related translation adjustments are recorded in accumulated other
comprehensive income in share owner’s equity.
<(cid:8)[(cid:8)(cid:15)(cid:29)(cid:8)(cid:5)<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5) The Company recognizes sales, net of estimated discounts and allowances, when
the title to the products and risk of loss are transferred to customers. Provisions for rebates to customers are
provided in the same period that the related sales are recorded.
>(cid:7)(cid:27)??(cid:27)(cid:15)+(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)v(cid:12)(cid:15)(cid:16)(cid:13)(cid:27)(cid:15)+(cid:5)(cid:26)(cid:3)(cid:10)(cid:6)(cid:10)(cid:5)(cid:5)(cid:5)Shipping and handling costs are included with cost of goods sold in the
Consolidated Results of Operations.
Cash The Company defines “cash” as cash and time deposits with maturities of three months or less when
purchased. Outstanding checks in excess of funds on deposit are included in accounts payable.
=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)(cid:5)<(cid:8)(cid:11)(cid:8)(cid:27)[(cid:12)(cid:19)(cid:13)(cid:8)(cid:5)(cid:5)(cid:5)Receivables are stated at amounts estimated by management to be the net realizable
value. The Company charges off accounts receivable when it becomes apparent based upon age or customer
circumstances that amounts will not be collected.
=(cid:13)(cid:13)(cid:3)#(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)(cid:28)(cid:3)(cid:4)(cid:5)(cid:17)(cid:3)(cid:29)(cid:19)(cid:6)(cid:28)(cid:29)(cid:13)(cid:5)=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:10)(cid:5)(cid:5)(cid:5)The allowance for doubtful accounts is established through charges to
the provision for bad debts. The Company evaluates the adequacy of the allowance for doubtful accounts on a
periodic basis. The evaluation includes historical trends in collections and write-offs, management’s judgment
of the probability of collecting accounts and management’s evaluation of business risk.
160
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
@(cid:15)[(cid:8)(cid:15)(cid:6)(cid:3)(cid:4)(cid:14)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5) Inventories are valued at the lower of average costs or market.
Z(cid:3)(cid:3)(cid:16)#(cid:27)(cid:13)(cid:13)(cid:5) Goodwill represents the excess of cost over fair value of net assets of businesses acquired.
Goodwill is evaluated annually, as of October 1, for impairment or more frequently if an impairment
indicator exists.
@(cid:15)(cid:6)(cid:12)(cid:15)+(cid:27)(cid:19)(cid:13)(cid:8)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)_(cid:3)(cid:15)+(cid:30)_(cid:27)[(cid:8)(cid:16)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10) Intangible assets are amortized over the expected useful
life of the asset. Amortization expense directly attributed to the manufacturing of the Company’s products
is included in cost of goods sold. Amortization expense related to non-manufacturing activities is included
in selling and administrative and other. The Company evaluates the recoverability of intangible assets and
other long-lived assets based on undiscounted projected cash flows, excluding interest and taxes, when factors
indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
*(cid:4)(cid:3)?(cid:8)(cid:4)(cid:6)(cid:14)(cid:22)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:6)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5);m(cid:29)(cid:27)?(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)(cid:5)(cid:5)Property, plant and equipment (“PP&E”) is carried at cost and
includes expenditures for new facilities and equipment and those costs which substantially increase the useful
lives or capacity of existing PP&E. In general, depreciation is computed using the straight-line method and
recorded over the estimated useful life of the asset. Factory machinery and equipment is depreciated over
periods ranging from 5 to 25 years with the majority of such assets (principally glass-melting furnaces and
forming machines) depreciated over 7 to 15 years. Buildings and building equipment are depreciated over
periods ranging from 10 to 50 years. Depreciation expense directly attributed to the manufacturing of the
Company’s products is included in cost of goods sold. Depreciation expense related to non-manufacturing
activities is included in selling and administrative. Depreciation expense includes the amortization of assets
recorded under capital leases. Maintenance and repairs are expensed as incurred. Costs assigned to PP&E of
acquired businesses are based on estimated fair values at the date of acquisition. The Company evaluates the
recoverability of PP&E based on undiscounted projected cash flows, excluding interest and taxes, when factors
indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
(cid:17)(cid:8)(cid:4)(cid:27)[(cid:12)(cid:6)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:10)(cid:6)(cid:4)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10) The Company uses forward exchange contracts, options and commodity forward
contracts to manage risks generally associated with foreign exchange rate and commodity market volatility.
Derivative financial instruments are included on the balance sheet at fair value. When appropriate, derivative
instruments are designated as and are effective as hedges, in accordance with accounting principles generally
accepted in the United States. If the underlying hedged transaction ceases to exist, all changes in fair value of
the related derivatives that have not been settled are recognized in current earnings. The Company does not
enter into derivative financial instruments for trading purposes and is not a party to leveraged derivatives. Cash
flows from forward exchange contracts not designated as hedges are classified as an investing activity. Cash
flows of commodity forward contracts are classified as operating activities.
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)(cid:5)&(cid:8)(cid:12)(cid:10)(cid:29)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)(cid:5) Fair value is defined as the amount that would be received to sell an asset or
paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly
transaction between market participants. Generally accepted accounting principles defines a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring fair value as follows:
Level 1: Observable inputs such as quoted prices in active markets;
Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or
indirectly; and
Level 3: Unobservable inputs for which there is little or no market data, which requires the Company to
develop assumptions.
161
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The carrying amounts reported for cash and short-term loans approximate fair value. In addition, carrying
amounts approximate fair value for certain long-term debt obligations subject to frequently redetermined
interest rates. Fair values for the Company’s significant fixed rate debt obligations are generally based on
published market quotations.
The Company’s derivative assets and liabilities consist of natural gas forwards and foreign exchange
option and forward contracts. The Company uses an income approach to valuing these contracts. Natural gas
forward rates and foreign exchange rates are the significant inputs into the valuation models. These inputs
are observable in active markets over the terms of the instruments the Company holds, and accordingly, the
Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also evaluates
counterparty risk in determining fair values.
<(cid:8)(cid:11)(cid:13)(cid:12)(cid:10)(cid:10)(cid:27)(cid:28)(cid:27)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10) Certain reclassifications of prior years’ data have been made to conform to the current
year presentation.
8(cid:8)#(cid:5)=(cid:11)(cid:11)(cid:3)(cid:29)(cid:15)(cid:6)(cid:27)(cid:15)+(cid:5)>(cid:6)(cid:12)(cid:15)(cid:16)(cid:12)(cid:4)(cid:16)(cid:10)(cid:5)
Revenue from Contracts with Customers - In May 2014, the Financial Accounting Standards Board
(“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with
Customers,” which requires an entity to recognize the amount of revenue to which it expects to be entitled for
the transfer of promised goods or services to customers. In August 2015, the FASB issued ASU No. 2015-14,
“Revenue from Contracts with Customers”, which delayed by one year the effective date of the new revenue
recognition standard, which will be effective for the Company on January 1, 2018. The Company has started an
implementation process, including a review of customer contracts, to evaluate the effect this standard will have
on its consolidated financial statements and related disclosures. At this time, the Company does not expect that
the implementation of this standard in 2018 will have a significant impact on the timing in which it recognizes
revenue. While the Company continues to assess the potential impacts of the new standard, the Company does
not currently expect the adoption of the new standard to have a material impact on consolidated net income or
the consolidated balance sheet. The Company plans to select the modified retrospective transition method upon
adoption effective January 1, 2018.
Leases - In February 2016, the FASB issued ASU No. 2016-02, “Leases”. Under this guidance, lessees
will be required to recognize on the balance sheet a lease liability and a right-of-use asset for all leases, with
the exception of short-term leases. The lease liability represents the lessee’s obligation to make lease payments
arising from a lease, and will be measured as the present value of the lease payments. The right-of-use asset
represents the lessee’s right to use a specified asset for the lease term, and will be measured at the lease
liability amount, adjusted for lease prepayment, lease incentives received and the lessee’s initial direct costs.
The standard also requires a lessee to recognize a single lease cost allocated over the lease term, generally on
a straight-line basis. The new guidance is effective for the Company on January 1, 2019. ASU No. 2016-02 is
required to be applied using the modified retrospective approach for all leases existing as of the effective date
and provides for certain practical expedients. Early adoption is permitted. The Company is currently evaluating
the effects that the adoption of ASU No. 2016-02 will have on the Company’s consolidated financial statements,
and anticipates the new guidance will significantly impact its consolidated financial statements as the Company
has a significant number of leases. As further described in Note 15, Operating Leases, as of December 31, 2016,
the Company had minimum lease commitments under non-cancellable operating leases totaling $205 million.
Credit Losses - In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance requires the measurement
of all expected credit losses for financial assets held at the reporting date based on historical experience,
162
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
current conditions and reasonable and supportable forecasts. This guidance also requires enhanced disclosures
regarding significant estimates and judgments used in estimating credit losses. The new guidance is effective
for the Company on January 1, 2020. Early adoption is permitted for fiscal years, and interim periods within
those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the
adoption of this guidance will have on its consolidated financial statements.
Stock Compensation - In March 2016, the FASB issued ASU No. 2016-09, “Improvements to Employee
Share-Based Payment Accounting,” which requires all excess tax benefits or deficiencies to be recognized as
income tax expense or benefit in the income statement. In addition, excess tax benefits should be classified
along with other income tax cash flows as an operating activity in the statement of cash flows. Application of
the standard is required for the Company on January 1, 2017. The Company does not expect a significant impact
in its Consolidated Financial Statements.
Pension Asset Value - In May 2015, the FASB issued ASU No. 2015-07, “Fair Value Measurement
(Topic 820): Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share (or
Its Equivalent).” Under the new guidance, investments measured at net asset value (“NAV”), as a practical
expedient for fair value, are excluded from the fair value hierarchy. Removing investments measured using the
practical expedient from the fair value hierarchy is intended to eliminate the diversity in practice that currently
exists with respect to the categorization of these investments. The new guidance is effective for the Company
on January 1, 2016. The guidance impacted the presentation of certain pension related assets that use NAV as a
practical expedient. See Note 9 for additional information.
*(cid:12)(cid:4)(cid:6)(cid:27)(cid:11)(cid:27)?(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)(cid:27)(cid:15)(cid:5)%@(cid:5)@(cid:15)(cid:11)Q(cid:5)>(cid:6)(cid:3)(cid:11)](cid:5)%?(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)>(cid:6)(cid:3)(cid:11)](cid:5)\(cid:12)(cid:10)(cid:8)(cid:16)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:8)(cid:15)(cid:10)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15) The Company
participates in the equity compensation plans of OI Inc. under which employees of the Company may be
granted options to purchase common shares of OI Inc., restricted common shares of OI Inc., or restricted share
units of OI Inc.
Stock Options
In general, subject to change in control, options become exercisable 25% per year beginning on the first
anniversary of grant. No options may be exercised in whole or in part during the first year after the date granted.
In general, options expire following termination of employment or the seventh anniversary of the option
grant. The fair value of options is amortized over the vesting periods which range from one to four years.
Restricted Shares and Restricted Share Units
Shares granted after March 21, 2005 and prior to 2011, vest 25% per year beginning on the first anniversary
and unvested shares are forfeited upon termination of employment. Restricted share units granted to employees
after 2010 vest 25% per year beginning on the first anniversary. Holders of vested restricted share units receive
one share of the Company’s common stock for each unit as units vest. Granted but unvested restricted share
units are forfeited upon termination, unless certain retirement criteria are met. Restricted share units granted to
directors vest after one year.
The fair value of the restricted shares and restricted share units is equal to the market price of the
Company’s common stock on the date of the grant. The fair value of restricted shares and restricted share units
is amortized over the vesting periods which range from one to four years.
163
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Performance Vested Restricted Share Units
Performance vested restricted share units vest on January 1 of the third year following the year in which
they are granted. Holders of vested units may receive up to two shares of OI Inc.’s common stock for each unit,
depending upon the attainment of consolidated performance goals established by the Compensation Committee
of OI Inc.’s Board of Directors. If minimum goals are not met, no shares will be issued. Granted but unvested
restricted share units are forfeited upon termination of employment, unless certain retirement criteria are met.
The fair value of each performance vested restricted share unit is equal to the product of the fair value of
OI Inc.’s common stock on the date of grant and the estimated number of shares into which the performance
vested restricted share unit will be converted. The fair value of performance vested restricted share units is
amortized ratably over the vesting period. Should the estimated number of shares into which the performance
vested restricted share unit will be converted change, an adjustment will be recorded to recognize the
accumulated difference in amortization between the revised and previous estimates.
As discussed in Note 21, costs incurred under these plans by OI Inc. related to stock-based compensation
awards granted directly to the Company’s employees are included in the allocable costs charged to the Company
and other operating subsidiaries of OI Inc. on an intercompany basis.
(cid:23)Q(cid:5)>(cid:8)+(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
The Company has four reportable segments based on its geographic locations: Europe, North America,
Latin America and Asia Pacific. In connection with the Company’s acquisition (the “Vitro Acquisition”) of
the food and beverage glass container business of Vitro S.A.B. de C.V. and its subsidiaries as conducted in the
United States, Mexico and Bolivia (the “Vitro Business”) on September 1, 2015 (see Note 17), the Company
has renamed the former South America segment to the Latin America segment. These four segments are aligned
with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass
operations. Certain assets and activities not directly related to one of the regions or to glass manufacturing
are reported with Retained corporate costs and other. These include licensing, equipment manufacturing,
global engineering, and certain equity investments. Retained corporate costs and other also includes certain
headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs
that are global in nature and are not allocable to the reportable segments.
The Company’s measure of profit for its reportable segments is segment operating profit, which consists
of consolidated earnings from continuing operations before interest income, interest expense, and provision
for income taxes and excludes amounts related to certain items that management considers not representative
of ongoing operations as well as certain retained corporate costs. The Company’s management uses segment
operating profit, in combination with selected cash flow information, to evaluate performance and to allocate
resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses
based on both a percentage of sales and direct billings based on the costs of specific services provided.
164
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Financial information regarding the Company’s reportable segments is as follows:
Net sales:
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
North America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Latin America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reportable segment totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Segment operating profit:
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
North America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Latin America . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reportable segment totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Items excluded from segment operating profit:
Other income(expense) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring, asset impairment and other charges . . . . . . . . . . . . .
Gain on China land sale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Strategic transaction costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value inventory adjustments . . . . . . . . . . .
Acquisition-related fair value intangible adjustments . . . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension Settlement charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations before income taxes . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
$
$
$
$
2,300
2,220
1,432
684
6,636
66
6,702
(cid:23)(cid:24)(cid:21)(cid:25)
237
299
269
77
882
(5)
(127)
71
$
$
$
2,324
2,039
1,064
671
6,098
58
6,156
2015
209
265
183
83
740
2
(80)
(4)
(22)
(10)
(253)
568
$
(232)
394
$
$
2,794
2,003
1,159
793
6,749
35
6,784
2014
353
240
227
88
908
(1)
(91)
(69)
(35)
(210)
502
165
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
;(cid:29)(cid:4)(cid:3)?(cid:8)
North
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
Latin
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
Asia
*(cid:12)(cid:11)(cid:27)(cid:9)(cid:11)
<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:12)(cid:19)(cid:13)(cid:8)
>(cid:8)+(cid:18)(cid:8)(cid:15)(cid:6)
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:10)
Other
(cid:26)(cid:3)(cid:15)(cid:10)(cid:3)(cid:13)(cid:27)(cid:16)(cid:12)(cid:6)(cid:8)(cid:16)
7(cid:3)(cid:6)(cid:12)(cid:13)(cid:10)
Total assets:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
$ 2,793 $ 2,515
2,492
1,963
2,902
3,215
$ 2,536
2,807
1,300
$
926
917
1,018
Equity investments:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
Equity earnings:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
Capital expenditures:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
Depreciation and
amortization expense:
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
$
$
$
$
$
$
$
78
78
81
15
16
19
163
164
188
21
22
24
12
19
17
107
97
89
118 $
120
140
139
128
131
$
— $
$
— $
$
$
$
$
123
89
55
173
107
79
117
145
153
4
7
4
59
50
34
37
40
53
$
$
$
$
$
$
$
$
$
$
8,770
9,118
7,496
216
245
258
31
42
40
452
400
366
467
395
403
$
$
$
233
182
181
217
164
169
29
18
24
— $
3
— $
1
3
9,003
9,300
7,677
433
409
427
60
60
64
452
400
369
467
396
406
The Company’s net property, plant and equipment by geographic segment are as follows:
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The Company’s net sales by geographic segment are as follows:
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S.
Non-U.S.
7(cid:3)(cid:6)(cid:12)(cid:13)
$
$
$
$
$
722
704
678
U.S.
2,124
1,939
1,852
2,133
2,227
1,734
Non-U.S.
4,578
4,217
4,932
$
$
$
2,855
2,931
2,412
7(cid:3)(cid:6)(cid:12)(cid:13)
6,702
6,156
6,784
Intercompany sales in Latin America totaled $195 million, $101 million and $0 for the years ended
December 31, 2016, 2015, and 2014, respectively.
Operations outside the U.S. that accounted for more than 10% of consolidated net sales from continuing
operations were in France (2015 — 10%, 2014 — 11%).
166
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:20)Q(cid:5)@(cid:15)[(cid:8)(cid:15)(cid:6)(cid:3)(cid:4)(cid:27)(cid:8)(cid:10)
Major classes of inventory are as follows:
Finished goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Raw materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
827 $
118
38
983 $
858
113
36
1,007
$
$
jQ(cid:5);m(cid:29)(cid:27)(cid:6)(cid:14)(cid:5)@(cid:15)[(cid:8)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
At December 31, 2016 the Company’s ownership percentage in affiliates include:
=(cid:28)(cid:9)(cid:13)(cid:27)(cid:12)(cid:6)(cid:8)(cid:10)
BJC O-I Glass Pte. Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CO Vidrieria SARL (“COV”) . . . . . . . . . . . . . . . . . . . . . . . .
Rocky Mountain Bottle Company . . . . . . . . . . . . . . . . . . . .
Tata Chemical (Soda Ash) Partners . . . . . . . . . . . . . . . . . . .
Vetrerie Meridionali SpA (“VeMe”) . . . . . . . . . . . . . . . . . . .
Vetri Speciali SpA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
%(cid:30)@(cid:5)%#(cid:15)(cid:8)(cid:4)(cid:10)(cid:7)(cid:27)?
*(cid:8)(cid:4)(cid:11)(cid:8)(cid:15)(cid:6)(cid:12)+(cid:8)
\(cid:29)(cid:10)(cid:27)(cid:15)(cid:8)(cid:10)(cid:10)(cid:5)7(cid:14)?(cid:8)
50% Glass container manufacturer
50% Glass container manufacturer
50% Glass container manufacturer
25% Soda ash supplier
50% Glass container manufacturer
50% Specialty glass manufacturer
Summarized information pertaining to the Company’s equity affiliates follows:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Equity in earnings:
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dividends received . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
28
32
60
38
$
$
$
23
37
60
53
Summarized combined financial information for equity affiliates is as follows (unaudited):
At end of year:
Current assets
Non-current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other liabilities and deferred items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total liabilities and deferred items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
451
1,025
1,476
200
368
568
908
$
$
$
$
$
$
$
23
41
64
54
2015
430
959
1,389
203
211
414
975
167
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
For the year:
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
755
182
134
$
$
$
719
193
139
$
$
$
752
198
150
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Based on an evaluation of each of the Company’s equity investments for the three years ending December
31, 2016, no investments exceeded the significant subsidiary thresholds per Rule 3-09 of Regulation S-X. As
such, separate financial statements for the Company’s equity investments are not required to be filed.
The Company made purchases of approximately $176 million and $161 million from equity affiliates in
2016 and 2015, respectively, and owed approximately $76 million and $66 million to equity affiliates as of
December 31, 2016 and 2015, respectively.
There is a difference of approximately $12 million as of December 31, 2016, between the amount at which
certain investments are carried and the amount of underlying equity in net assets. The portion of the difference
related to inventory or amortizable assets is amortized as a reduction of the equity earnings. The remaining
difference is considered goodwill.
!Q(cid:5)Z(cid:3)(cid:3)(cid:16)#(cid:27)(cid:13)(cid:13)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)@(cid:15)(cid:6)(cid:12)(cid:15)+(cid:27)(cid:19)(cid:13)(cid:8)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
Goodwill
The changes in the carrying amount of goodwill for the years ended December 31, 2016, 2015 and 2014 are
as follows:
Balance as of January 1, 2014 . . . . . . . . . . .
Translation effects . . . . . . . . . . . . . . . . . . . .
Balance as of December 31, 2014 . . . . . . . .
Acquisition related adjustments . . . . . . . . . .
Translation effects . . . . . . . . . . . . . . . . . . . .
Balance as of December 31, 2015 . . . . . . . .
Acquisition related adjustments . . . . . . . . . .
Translation effects . . . . . . . . . . . . . . . . . . . .
Balance as of December 31, 2016 . . . . . . . .
$
$
;(cid:29)(cid:4)(cid:3)?(cid:8)
$
1,044
(118)
926
(86)
840
(32)
808
$
North
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
Latin
=(cid:18)(cid:8)(cid:4)(cid:27)(cid:11)(cid:12)
734
(11)
723
316
(19)
1,020
15
3
1,038
$
$
276
(37)
239
480
(95)
624
26
(39)
611
Other
$
$
5
5
5
$
5
$
7(cid:3)(cid:6)(cid:12)(cid:13)
2,059
(166)
1,893
796
(200)
2,489
41
(68)
2,462
The acquisition related adjustments in 2016 and 2015 primarily relate to the Vitro Acquisition (see Note 17).
Goodwill for the Asia Pacific segment is $0 and net of accumulated impairment losses of $1,135 million as
of December 31, 2016, 2015 and 2014.
Goodwill is tested for impairment annually as of October 1 (or more frequently if impairment indicators
arise) using a two-step process. Step 1 compares the business enterprise value (“BEV”) of each reporting unit
with its carrying value. The BEV is computed based on estimated future cash flows, discounted at the weighted
average cost of capital of a hypothetical third-party buyer. If the BEV is less than the carrying value for any
reporting unit, then Step 2 must be performed. Step 2 compares the implied fair value of goodwill with the
168
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
carrying amount of goodwill. Any excess of the carrying value of the goodwill over the implied fair value will
be recorded as an impairment loss. The calculations of the BEV in Step 1 and the implied fair value of goodwill
in Step 2 are based on significant unobservable inputs, such as price trends, customer demand, material costs,
discount rates and asset replacement costs, and are classified as Level 3 in the fair value hierarchy.
During the fourth quarter of 2016, the Company completed its annual impairment testing and determined
that no impairment existed.
Intangible assets
On September 1, 2015, the Company acquired customer list intangibles as part of the Vitro Acquisition (see
Note 17).
Customer list intangible assets are amortized using the accelerated amortization method over their 20
year lives. Net intangible asset values were $464 million and $597 million for the years ended December 31,
2016 and 2015, respectively. Amortization expense for intangible assets was $39 million, $21 million and $1
million for the years ended December 31, 2016, 2015 and 2014, respectively. Estimated amortization related to
intangible assets through 2021 is as follows: 2017, $44 million; 2018, $44 million; 2019, $42 million; 2020, $41
million; and 2021, $39 million. No impairment existed on these assets at December 31, 2016.
The Company has determined that the fair value measurements related to the customer list intangibles are
based on significant unobservable inputs and are classified as Level 3 in the fair value hierarchy.
(cid:25)Q(cid:5)*(cid:4)(cid:8)?(cid:12)(cid:27)(cid:16)(cid:5);:?(cid:8)(cid:15)(cid:10)(cid:8)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
Prepaid expenses and other current assets at December 31, 2016 and 2015 are as follows:
Prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Value added taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets (noncurrent) consist of the following at December 31, 2016 and 2015:
Deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred returnable packaging costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Repair part inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Value added taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capitalized software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred finance fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
$
$
$
38
46
99
183
(cid:23)(cid:24)(cid:21)(cid:25)
189
115
107
22
31
5
69
538
$
$
$
$
42
195
115
352
2015
177
110
118
17
28
6
71
527
Capitalized software includes costs related to the acquisition and development of internal-use software.
These costs are amortized over the estimated useful life of the software. Amortization expense for capitalized
software was $6 million, $9 million and $8 million for 2016, 2015 and 2014, respectively. Estimated
amortization related to capitalized software through 2021 is as follows: 2017, $6 million; 2018, $6 million;
2019, $5 million; 2020, $5 million; and 2021, $4 million.
169
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
"Q(cid:5)(cid:17)(cid:8)(cid:4)(cid:27)[(cid:12)(cid:6)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:10)(cid:6)(cid:4)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
The Company has certain derivative assets and liabilities which consist of natural gas forwards and foreign
exchange option and forward contracts. The Company uses an income approach to value these contracts.
Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models. These
inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly,
the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also
evaluates counterparty risk in determining fair values.
Commodity Forward Contracts Designated as Cash Flow Hedges
In North America, the Company enters into commodity forward contracts related to forecasted natural gas
requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for
natural gas and the related volatility in cash flows. The Company continually evaluates the natural gas market
and related price risk and periodically enters into commodity forward contracts in order to hedge a portion of its
usage requirements. The majority of the sales volume in North America is tied to customer contracts that contain
provisions that pass the price of natural gas to the customer. In certain of these contracts, the customer has the
option of fixing the natural gas price component for a specified period of time. At December 31, 2016 and 2015,
the Company had entered into commodity forward contracts covering approximately 12,300,000 MM BTUs and
7,300,000 MM BTUs, respectively, primarily related to customer requests to lock the price of natural gas.
The Company accounts for the above forward contracts as cash flow hedges at December 31, 2016
and recognizes them on the balance sheet at fair value. The effective portion of changes in the fair value of
a derivative that is designated as, and meets the required criteria for, a cash flow hedge is recorded in the
Accumulated Other Comprehensive Income component of share owners’ equity (“OCI”) and reclassified
into earnings in the same period or periods during which the underlying hedged item affects earnings. An
unrecognized gain of $6 million at December 31, 2016 and an unrecognized loss of $4 million at December 31,
2015 related to the commodity forward contracts were included in Accumulated OCI, and will be reclassified
into earnings over the next twelve to twenty-four months. Any material portion of the change in the fair
value of a derivative designated as a cash flow hedge that is deemed to be ineffective is recognized in current
earnings. The ineffectiveness related to these natural gas hedges for the year ended December 31, 2016 and
2015 was not material.
The effect of the commodity forward contracts on the results of operations for the years ended
December 31, 2016, 2015 and 2014 is as follows:
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:12)(cid:27)(cid:15)(cid:5)/(cid:13)(cid:3)(cid:10)(cid:10)6(cid:5)<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)w(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)%(cid:26)@(cid:5)(cid:3)(cid:15)
(cid:26)(cid:3)(cid:18)(cid:18)(cid:3)(cid:16)(cid:27)(cid:6)(cid:14)(cid:5)(cid:2)(cid:3)(cid:4)#(cid:12)(cid:4)(cid:16)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:10)
/;(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:27)[(cid:8)(cid:5)*(cid:3)(cid:4)(cid:6)(cid:27)(cid:3)(cid:15)6
2015
2014
(cid:23)(cid:24)(cid:21)(cid:25)
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:12)(cid:27)(cid:15)(cid:5)/(cid:13)(cid:3)(cid:10)(cid:10)6(cid:5)<(cid:8)(cid:11)(cid:13)(cid:12)(cid:10)(cid:10)(cid:27)(cid:9)(cid:8)(cid:16)(cid:5)(cid:28)(cid:4)(cid:3)(cid:18)
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)%(cid:26)@(cid:5)(cid:27)(cid:15)(cid:6)(cid:3)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)
/(cid:4)(cid:8)?(cid:3)(cid:4)(cid:6)(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)(cid:11)(cid:3)(cid:10)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)+(cid:3)(cid:3)(cid:16)(cid:10)(cid:5)(cid:10)(cid:3)(cid:13)(cid:16)6
/;(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:27)[(cid:8)(cid:5)*(cid:3)(cid:4)(cid:6)(cid:27)(cid:3)(cid:15)6
2015
2014
(cid:23)(cid:24)(cid:21)(cid:25)
$
7 $
(4) $
3 $
— $
(1) $
2
Foreign Exchange Derivative Contracts and not Designated as Hedging Instruments
The Company may enter into short-term forward exchange or option agreements to purchase foreign
currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign
currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated
in currencies other than the subsidiaries’ functional currency. The Company may also use forward exchange
170
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables,
payables and loans, not denominated in, or indexed to, their functional currencies. The Company records these
short-term forward exchange agreements on the balance sheet at fair value and changes in the fair value are
recognized in current earnings.
At December 31, 2016 and 2015, the Company had outstanding forward exchange and option agreements
denominated in various currencies covering the equivalent of approximately $490 million and $790 million,
respectively, related primarily to intercompany transactions and loans.
The effect of the foreign exchange derivative contracts on the results of operations for the years ended
December 31, 2016, 2015 and 2014 is as follows:
_(cid:3)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)(cid:3)(cid:28)(cid:5)Z(cid:12)(cid:27)(cid:15)(cid:5)/_(cid:3)(cid:10)(cid:10)6
<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)w(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)(cid:3)(cid:15)
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5);:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:10)
Other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Balance Sheet Classification
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)(cid:5)(cid:3)(cid:28)(cid:5)Z(cid:12)(cid:27)(cid:15)(cid:5)/_(cid:3)(cid:10)(cid:10)6
<(cid:8)(cid:11)(cid:3)+(cid:15)(cid:27)w(cid:8)(cid:16)(cid:5)(cid:27)(cid:15)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)(cid:3)(cid:15)
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5);:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:4)(cid:12)(cid:11)(cid:6)(cid:10)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2014
6 $
10 $
(8)
The Company records the fair values of derivative financial instruments on the balance sheet as follows:
(a) receivables if the instrument has a positive fair value and maturity within one year, (b) deposits, receivables,
and other assets if the instrument has a positive fair value and maturity after one year, and (c) other accrued
liabilities or other liabilities (current) if the instrument has a negative fair value and maturity within one year.
The following table shows the amount and classification (as noted above) of the Company’s derivatives as
of December 31, 2016 and 2015:
Asset Derivatives:
Derivatives designated as hedging instruments:
Commodity futures contracts . . . . . . . . . . . . . . . . . . . . . . .
Derivatives not designated as hedging instruments:
Foreign exchange derivative contracts . . . . . . . . . . . . . . .
Total asset derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Liability Derivatives:
Derivatives designated as hedging instruments:
Commodity futures contracts . . . . . . . . . . . . . . . . . . . . . . .
Derivatives not designated as hedging instruments:
Foreign exchange derivative contracts . . . . . . . . . . . . . . .
Total liability derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
\(cid:12)(cid:13)(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)>(cid:7)(cid:8)(cid:8)(cid:6)
_(cid:3)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
b
a
c
c
$
$
$
$
$
6
9
15
$
$
$
— $
5
5
$
—
14
14
3
2
5
171
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
$Q(cid:5)(cid:5)<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+(cid:5)=(cid:11)(cid:11)(cid:4)(cid:29)(cid:12)(cid:13)(cid:10)(cid:22)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:5)@(cid:18)?(cid:12)(cid:27)(cid:4)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:26)(cid:3)(cid:10)(cid:6)(cid:10)(cid:5)<(cid:8)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)(cid:6)(cid:3)(cid:5)(cid:26)(cid:13)(cid:3)(cid:10)(cid:8)(cid:16)(cid:5)(cid:2)(cid:12)(cid:11)(cid:27)(cid:13)(cid:27)(cid:6)(cid:27)(cid:8)(cid:10)
The Company continually reviews its manufacturing footprint and operating cost structure and may
decide to close operations or reduce headcount to gain efficiencies, integrate acquired operations, reduce future
expenses and other market factors. The Company incurs costs associated with these actions including employee
severance and benefits, other exit costs such as those related to contract terminations, and asset impairment
charges. The Company also may incur other costs related to closed facilities including environmental
remediation, clean up, dismantling and preparation for sale or other disposition.
The Company accounts for restructuring and other costs under applicable provisions of generally accepted
accounting principles. Charges for employee severance and related benefits are generally accrued based on
contractual arrangements with employees or their representatives. Other exit costs are accrued based on the
estimated cost to settle related contractual arrangements. Estimated environmental remediation costs are
accrued when specific claims have been received or are probable of being received.
The Company’s decisions to curtail selected production capacity have resulted in write downs of certain
long-lived assets to the extent their carrying amounts exceeded fair value or fair value less cost to sell. The
Company classified the significant assumptions used to determine the fair value of the impaired assets as Level
3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements.
When a decision is made to take these actions, the Company manages and accounts for them
programmatically apart from the on-going operations of the business. Information related to major programs
(as in the case of the European Asset Optimization and Asia Pacific Restructuring programs below) are
presented separately. Minor initiatives are presented on a combined basis as Other Restructuring Actions. These
restructuring initiatives taken by the Company are not related to the European Asset Optimization program or
the Asia Pacific restructuring plan. When charges related to major programs are completed, remaining accrual
balances are classified with Other Restructuring Actions.
European Asset Optimization
In 2011, the Company initiated the European Asset Optimization program to increase the efficiency and
capability of its European operations and to better align its European manufacturing footprint with market and
customer needs. This program involved making additional investments in certain facilities and addressing
assets with higher cost structures. As part of this program, the Company recorded charges of $0, $0, and $1
million for the years ended 2016, 2015 and 2014, respectively for employee costs, write-down of assets, and
environmental remediation related to decisions to close furnaces and manufacturing facilities in Europe. The
Company recorded total cumulative charges of $127 million and does not expect to execute any further actions
under this program.
Asia Pacific Restructuring
Since 2011, the Company has implemented a restructuring plan in its Asia Pacific segment, primarily
related to aligning its supply base with lower demand in the region. As part of this plan, the Company recorded
charges of $4 million, $5 million and $73 million for the years ended 2016, 2015 and 2014, respectively,
for employee costs, write-down of assets, and pension charges related to furnace closures and additional
restructuring activities. The Company recorded total cumulative charges of $224 million and does not expect to
execute any further actions under this program.
172
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Other Restructuring Actions
In 2016, the Company recorded charges of $92 million for other restructuring actions. These charges
primarily represented employee costs, write-down of assets, and other exit costs of $64 million for a plant
closures in Latin America, Europe and North America and $28 million related to other restructuring actions. The
Company took certain other restructuring actions and recorded charges in 2015 of $58 million. These charges
primarily related to employee costs, write-down of assets and other exit costs totaling $14 million for a plant
closure and furnace closure in Latin America, $38 million for a plant closure in North America and $6 million
for other restructuring actions. In 2014, the Company took certain other restructuring actions and recorded
charges of $2 million for employee costs related to global headcount reduction initiatives.
The following table presents information related to restructuring, asset impairment and other costs related
to closed facilities from January 1, 2015 through December 31, 2015:
Balance at January 1, 2015 . . . . . . . . . . . . . . . . . . . .
Charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Write-down of assets to net realizable value . . . . . .
Net cash paid, principally severance and
related benefits . . . . . . . . . . . . . . . . . . . . . . . . .
Other, including foreign exchange translation . . . . .
Balance at December 31, 2015 . . . . . . . . . . . . . . . . .
;(cid:29)(cid:4)(cid:3)?(cid:8)(cid:12)(cid:15)
Asset
%?(cid:6)(cid:27)(cid:18)(cid:27)w(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
12
$
=(cid:10)(cid:27)(cid:12)(cid:5)*(cid:12)(cid:11)(cid:27)(cid:9)(cid:11)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
12
$
5
(4)
(5)
(4)
3
$
(5)
(1)
7
$
Other
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
=(cid:11)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
$
$
36
58
(27)
(28)
(6)
33
7(cid:3)(cid:6)(cid:12)(cid:13)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
$
60
63
(31)
(38)
(11)
43
$
The following table presents information related to restructuring, asset impairment and other costs related
to closed facilities from January 1, 2016 through December 31, 2016:
Balance at January 1, 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Write-down of assets to net realizable value . . . . . . . . . . . . . . . . . .
Net cash paid, principally severance and related benefits . . . . . . . .
Other, including foreign exchange translation . . . . . . . . . . . . . . . .
Balance at December 31, 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
=(cid:10)(cid:27)(cid:12)(cid:5)*(cid:12)(cid:11)(cid:27)(cid:9)(cid:11)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
7
$
4
(3)
(1)
7
$
Other
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
=(cid:11)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
$
$
36
92
(28)
(21)
(3)
76
7(cid:3)(cid:6)(cid:12)(cid:13)
<(cid:8)(cid:10)(cid:6)(cid:4)(cid:29)(cid:11)(cid:6)(cid:29)(cid:4)(cid:27)(cid:15)+
43
$
96
(28)
(24)
(4)
83
$
The restructuring accrual balance represents the Company’s estimates of the remaining future cash amounts
to be paid related to the actions noted above. As of December 31, 2016, the Company’s estimates include
approximately $65 million for employee benefits costs, $16 million for environmental remediation costs, and $2
million for other exit costs.
173
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:31)Q(cid:5)*(cid:8)(cid:15)(cid:10)(cid:27)(cid:3)(cid:15)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)*(cid:3)(cid:10)(cid:6)(cid:4)(cid:8)(cid:6)(cid:27)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:28)(cid:27)(cid:6)(cid:10)
Pension Benefit Plans
The Company participates in OI Inc.’s defined benefit pension plans for a substantial number of employees
located in the United States. Benefits generally are based on compensation for salaried employees and on length
of service for hourly employees. OI Inc.’s policy is to fund pension plans such that sufficient assets will be
available to meet future benefit requirements. Independent actuaries determine pension costs for each subsidiary
of OI Inc. included in the plans; however, accumulated benefit obligation information and plan assets pertaining
to each subsidiary have not been separately determined. As such, the accumulated benefit obligation and the
plan assets related to the pension plans for domestic employees have been retained by another subsidiary of
OI Inc. Net expense to results of operations for the Company’s allocated portion of the domestic pension costs
amounted to $23 million in 2016, $24 million in 2015 and $19 million in 2014.
OI Inc. also sponsors several defined contribution plans for all salaried and hourly U.S. employees of
the Company. Participation is voluntary and participants’ contributions are based on their compensation.
OI Inc. matches contributions of participants, up to various limits, in substantially all plans. OI Inc. charges
the Company for its share of the match. The Company’s share of the contributions to these plans amounted to
$32 million in 2016, $27 million in 2015 and $17 million in 2014.
The Company also has defined benefit pension plans covering a substantial number of employees in several
non-U.S. jurisdictions. Benefits generally are based on compensation for salaried employees and on length of
service for hourly employees. The Company’s policy is to fund pension plans such that sufficient assets will be
available to meet future benefit requirements. The Company’s defined benefit pension plans use a December 31
measurement date.
The changes in the non-U.S. pension benefit obligations for the year are as follows:
Obligations at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in benefit obligations:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Actuarial (gain) loss, including the effect of change in discount rates . . . . . . . . .
Acquisitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Participant contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net change in benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Obligations at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
1,210
$
2015
1,311
$
16
44
160
2
(71)
3
(129)
25
1,235
$
15
44
(9)
37
1
(58)
(131)
(101)
1,210
$
174
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The changes in the fair value of the non-U.S. pension plans’ assets for the year are as follows:
Fair value at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in fair value:
Actual gain (loss) on plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Employer contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Participant contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net change in fair value of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fair value at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The funded status of the non-U.S. pension plans at year end are as follows:
Plan assets at fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Projected benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Plan assets less than projected benefit obligations . . . . . . . . . . . . . . . . . . . . . . . .
Items not yet recognized in pension expense:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service cost (credit) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
1,012
$
2015
1,094
$
139
(71)
38
2
(111)
2
(1)
1,011
(cid:23)(cid:24)(cid:21)(cid:25)
1,011
1,235
(224)
352
(1)
351
127
42
(58)
15
1
22
(104)
(82)
1,012
2015
1,012
1,210
(198)
320
(1 )
319
121
$
$
$
$
$
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
The following changes in plan assets and benefit obligations were recognized in accumulated other
comprehensive income at December 31, 2016 and 2015 as follows (amounts are pretax):
Pension assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current pension liability, included with other accrued liabilities . . . . . . . . . . . . . . . . .
Pension benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
40
(7)
(257)
351
127
$
$
32
(6)
(224)
319
121
$
$
The following changes in plan assets and benefit obligations were recognized in accumulated other
comprehensive income at December 31, 2016 and 2015 as follows (amounts are pretax):
Current year actuarial (gain) loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Settlement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
87
(12)
75
(43)
32
$
15
(15)
—
(31)
(31)
$
$
175
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The components of the non-U.S. pension plans’ net pension expense for the year are as follows:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected asset return . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
16
44
(65)
13
13
8
$
$
15
44
(67)
15
15
7
$
$
23
69
(86)
18
—
18
24
On October 1, 2014, the Company settled the liability associated with its pension plan in the Netherlands,
resulting in a settlement charge of approximately $35 million. Non-U.S. pension expense excludes $3 million
of pension settlement costs that were recorded in restructuring expense in 2014. The table above excludes
these charges.
Amounts that are expected to be amortized from accumulated other comprehensive income into net pension
expense during 2017:
Amortization:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prior service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
16
16
The following information is for plans with projected and accumulated benefit obligations in excess of the
fair value of plan assets at year end:
*(cid:4)(cid:3)x(cid:8)(cid:11)(cid:6)(cid:8)(cid:16)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:9)(cid:6)
%(cid:19)(cid:13)(cid:27)+(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5);:(cid:11)(cid:8)(cid:8)(cid:16)(cid:10)
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
(cid:3)(cid:28)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)\(cid:8)(cid:15)(cid:8)(cid:9)(cid:6)
%(cid:19)(cid:13)(cid:27)+(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5);:(cid:11)(cid:8)(cid:8)(cid:16)(cid:10)
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)(cid:5)(cid:3)(cid:28)
*(cid:13)(cid:12)(cid:15)(cid:5)=(cid:10)(cid:10)(cid:8)(cid:6)(cid:10)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Projected benefit obligations . . . . . . . . . . . . . . . . . . . . . . .
Accumulated benefit obligation . . . . . . . . . . . . . . . . . . . . .
Fair value of plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
897
867
632
$
876
850
645
$
897
867
632
876
850
645
The weighted average assumptions used to determine benefit obligations are as follows:
Discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rate of compensation increase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2.94%
2.90%
3.68%
2.84%
The weighted average assumptions used to determine net periodic pension costs are as follows:
Discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rate of compensation increase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected long-term rate of return on assets . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
3.68%
2.84%
7.15%
3.65%
2.89%
7.21%
4.14%
3.31%
7.23%
176
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Future benefits are assumed to increase in a manner consistent with past experience of the plans, which,
to the extent benefits are based on compensation, includes assumed salary increases as presented above. For
2016, the Company’s weighted average expected long-term rate of return on assets was 7.15% for the non-U.S.
plans. In developing this assumption, the Company considered its historical 10-year average return (through
December 31, 2016) and evaluated input from its third party pension plan asset consultants, including their
review of asset class return expectations
It is the Company’s policy to invest pension plan assets in a diversified portfolio consisting of an array
of asset classes within established target asset allocation ranges. The investment risk of the assets is limited
by appropriate diversification both within and between asset classes. The assets of the group trust and the
Company’s non-U.S. plans are primarily invested in a broad mix of domestic and international equities, domestic
and international bonds, and real estate, subject to the target asset allocation ranges. The assets are managed with
a view to ensuring that sufficient liquidity will be available to meet expected cash flow requirements.
The investment valuation policy of the Company is to value investments at fair value. All investments are
valued at their respective net asset values. Equity securities for which market quotations are readily available
are valued at the last reported sales price on their principal exchange on valuation date or official close for
certain markets. Fixed income investments are valued by an independent pricing service. Investments in
registered investment companies or collective pooled funds are valued at their respective net asset values.
Short-term investments are stated at amortized cost, which approximates fair value. The fair value of real estate
is determined by periodic appraisals.
In accordance with the Company’s adoption of ASU No. 2015-07 in 2016, certain investments measured
at net asset value (“NAV”), as a practical expedient for fair value, have been excluded from the fair value
hierarchy. The fair value measurements tables presented below have been amended to conform to the current
year presentation under ASU No. 2015-07. See Note 1 for more information.
In 2016, the non-U.S. plan assets consisted of approximately 41% equity securities, 42% debt securities,
and 17% real estate and other. The following table sets forth by level, within the fair value hierarchy, the
Company’s non-U.S. pension plan assets at fair value as of December 31, 2016 and 2015:
Cash and cash equivalents . .
Equity securities . . . . . . . . .
Debt securities . . . . . . . . . .
Real estate . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . .
Investments measured at
net asset value . . . . . . .
Total non-U.S. assets at
fair value . . . . . . . . . . .
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:21)
24
$
37
$
61
$
(cid:23)(cid:24)(cid:21)(cid:25)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:20)
7(cid:3)(cid:6)(cid:12)(cid:13)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:23)
$
— $
— $
2015
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:20)
7(cid:3)(cid:6)(cid:12)(cid:13)
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:23)
$
— $
— $
_(cid:8)[(cid:8)(cid:13)(cid:5)(cid:21)
30
$
16
24
—
39
4
43
24
24
$
5
6
11
$
46
$
30
—
16
5
30
$ 901
$
1,011
$ 931
$
1,012
2
37
39
4
6
10
$
177
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The following is a reconciliation of the Company’s pension plan assets recorded at fair value using
significant unobservable inputs (Level 3):
Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net increase (decrease) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
11
(1)
10
$
$
5
6
11
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The net increase (decrease) in the fair value of the Company’s Level 3 pension plan assets is primarily due
to purchases and sales of unlisted real estate funds. The change in the fair value of Level 3 pension plan assets
due to actual return on those assets was immaterial in 2016.
In order to maintain minimum funding requirements, the Company is required to make contributions to its
non-U.S. defined benefit pension plans of approximately $24 million in 2017.
The following estimated future benefit payments, which reflect expected future service, as appropriate, are
expected to be paid in the years indicated:
Year(s)
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2022 - 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
53
51
54
57
60
343
Postretirement Benefits Other Than Pensions
OI Inc. provides retiree health care and life insurance benefits covering certain U.S. salaried and hourly
employees. Benefits provided by the Company for hourly retirees are determined by collective bargaining.
Employees are generally eligible for benefits upon retirement and completion of a specified number of years of
creditable service. OI Inc. uses a December 31 measurement date to measure its postretirement benefit obligations.
The Company’s net periodic postretirement benefit income, as allocated by OI Inc., for domestic employees
was $2 million, $2 million, and $1 million at December 31, 2016, 2015 and 2014, respectively.
The Company also has postretirement benefit plans covering substantially all employees in Canada. The
following tables relate to the Company’s postretirement benefit plans in Canada.
The changes in the postretirement benefit obligations for the year are as follows:
Obligations at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in benefit obligations:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Actuarial (gain) loss, including the effect of changing discount rates . . . . . . . . .
Benefit payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net change in benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Obligations at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
68
$
81
1
3
9
(2)
2
13
81
$
1
3
(1)
(3)
(13)
(13)
68
$
178
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The funded status of the postretirement benefit plans at year end is as follows:
Postretirement benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
(81) $
(68)
Items not yet recognized in net postretirement benefit cost:
Actuarial gain (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
(6)
(87) $
3
(65)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The net amount recognized is included in the Consolidated Balance Sheets at December 31, 2016 and 2015
as follows:
Current nonpension postretirement benefit, included with Other accrued liabilities . .
Nonpension postretirement benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
(3) $
(78)
(6)
(87) $
(2)
(66)
3
(65)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The following changes in benefit obligations were recognized in accumulated other comprehensive income
at December 31, 2016 and 2015 as follows (amounts are pretax):
Current year actuarial (gain) loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
9
$
—
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The components of the net postretirement benefit cost for the year are as follows:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net postretirement benefit cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
1
3
4
$
$
1
3
4
$
$
1
4
5
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
The weighted average discount rates used to determine the accumulated postretirement benefit obligation
and net postretirement benefit cost are as follows:
Accumulated postretirement benefit obligation . . . . . . . . . . . . . . . . . . .
Net postretirement benefit cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.55%
3.80%
3.80%
3.75%
3.75%
4.47%
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
The weighted average assumed health care cost trend rates at December 31 are as follows:
Health care cost trend rate assumed for next year . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rate to which the cost trend rate is assumed to decline (ultimate trend rate) . . . . . . . .
Year that the rate reaches the ultimate trend rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
5.00%
5.00%
N/A
5.00%
5.00%
N/A
179
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Assumed health care cost trend rates affect the amounts reported for the postretirement benefit plans. A
one-percentage-point change in assumed health care cost trend rates would have the following effects:
(cid:21)(cid:30)*(cid:8)(cid:4)(cid:11)(cid:8)(cid:15)(cid:6)(cid:12)+(cid:8)(cid:5)*(cid:3)(cid:27)(cid:15)(cid:6)
@(cid:15)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)
(cid:17)(cid:8)(cid:11)(cid:4)(cid:8)(cid:12)(cid:10)(cid:8)
Effect on total of service and interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Effect on accumulated postretirement benefit obligations . . . . . . . . . . . . . . . . . . . . . .
$
1
13
(1)
(10)
Amortization included in net postretirement benefit cost is based on the average remaining service
of employees.
The following estimated future benefit payments, which reflect expected future service, as appropriate, are
expected to be paid in the years indicated:
Year(s)
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2022 - 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
3
3
3
3
3
18
(cid:21)(cid:24)Q(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)7(cid:12):(cid:8)(cid:10)
The provision for income taxes was calculated based on the following components of earnings (loss) before
income taxes:
(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:27)(cid:15)+(cid:5)(cid:3)?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:17)(cid:27)(cid:10)(cid:11)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)(cid:5)(cid:3)?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
185
383
568
$
$
125
269
394
$
$
231
271
502
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
— $
(7)
(7) $
— $
(4)
(4) $
—
(4)
(4)
$
$
$
$
180
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The provision (benefit) for income taxes consists of the following:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Current:
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
Deferred:
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
8
123
131
(1)
(7)
(8)
$
9
85
94
5
2
7
Total:
U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
7
116
123
$
14
87
101
$
8
103
111
—
(18)
(18)
8
85
93
A reconciliation of the provision for income taxes based on the statutory U.S. Federal tax rate of 35% to the
provision for income taxes is as follows:
Tax provision on pretax earnings (loss) from continuing operations at
statutory U.S. Federal tax rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
199
$
138
$
177
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Increase (decrease) in provision for income taxes due to:
Non-U.S. tax rates under U.S. rates . . . . . . . . . . . . . . . . . . . . . . . . . .
Changes in valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Withholding tax, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-deductible acquisition costs . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. tax on intercompany dividends and interest . . . . . . . . . . . . . . .
U.S. tax consolidation benefit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax exempt income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax law changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in tax reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mexico inflationary adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
(22)
8
20
3
(74)
(2)
(3)
(17)
8
6
(3)
123
$
(12)
21
18
16
(70)
(3)
(3)
(14)
5
3
2
101
(22)
(24)
18
1
(47)
(5)
(3)
(13)
11
93
Deferred income taxes reflect: (1) the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes;
and (2) carryovers and credits for income tax purposes.
181
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
Significant components of the Company’s deferred tax assets and liabilities at December 31, 2016 and 2015
are as follows:
Deferred tax assets:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Accrued postretirement benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign tax credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating and capital loss carryovers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other credit carryovers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred tax liabilities:
Property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangibles and deferred software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
21
414
280
14
75
30
51
885
112
119
9
240
(600)
45
$
$
18
389
296
13
68
27
38
849
112
131
26
269
(603)
(23)
Deferred taxes are included in the Consolidated Balance Sheets at December 31, 2016 and 2015 as follows:
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
$
$
189
(144)
45
$
$
177
(200)
(23)
The Company reviews the likelihood that it will realize the benefit of its deferred tax assets and therefore
the need for valuation allowances on a quarterly basis, or whenever events indicate that a review is required. In
determining the requirement for a valuation allowance, the historical and projected financial results of the legal
entity or consolidated group recording the net deferred tax asset is considered, along with other positive and
negative evidence.
In certain foreign jurisdictions, the Company’s analysis indicates that it has cumulative losses in recent
years. This is considered significant negative evidence which is objective and verifiable and, therefore, difficult
to overcome. However, the cumulative loss position is not solely determinative and, accordingly, the Company
considers all other available positive and negative evidence in its analysis. Based on its analysis, the Company
has recorded a valuation allowance for the portion of deferred tax assets where based on the weight of available
evidence it is unlikely to realize those deferred tax assets.
At December 31, 2016, before valuation allowance, the Company had unused foreign tax credits of
$414 million expiring in 2017 through 2026, and research tax credit of $14 million expiring from 2019 to
2036, which will be available to offset future income tax. Approximately $151 million of the deferred tax
assets related to operating and capital loss carryforwards can be carried over indefinitely, with the remaining
$129 million expiring between 2017 and 2036.
182
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
At December 31, 2016, the Company’s equity in the undistributed earnings of foreign subsidiaries for
which income taxes had not been provided approximated $2.2 billion. The Company intends to reinvest these
earnings indefinitely in the non-U.S. operations. It is not practicable to estimate the U.S. and foreign tax which
would be payable should these earnings be distributed. Deferred taxes are provided for earnings of non-U.S.
jurisdictions when the Company plans to remit those earnings.
The Company is included in OI Inc.’s consolidated tax returns for U.S. federal and certain state income
tax purposes. The consolidated group has net operating losses, capital losses, alternative minimum tax credits,
foreign tax credits and research and development credits available to offset future U.S. Federal income tax.
Income taxes are allocated to the Company on a basis consistent with separate returns.
The Company records a liability for unrecognized tax benefits related to uncertain tax positions. The
Company accrues interest and penalties associated with unrecognized tax benefits as a component of its income
tax expense. The following is a reconciliation of the Company’s total gross unrecognized tax benefits for the
years ended December 31, 2016, 2015 and 2014:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Balance at January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Additions and reductions for tax positions of prior years . . . . . . . . .
Additions based on tax positions related to the current year . . . . . . .
Reductions due to the lapse of the applicable statute of limitations . .
Reductions due to settlements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance at December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unrecognized tax benefits, which if recognized, would impact the
Company’s effective income tax rate . . . . . . . . . . . . . . . . . . . . . . . .
Accrued interest and penalties at December 31 . . . . . . . . . . . . . . . . . . . .
Interest and penalties included in tax expense for the years ended
December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
$
$
74
$
15
(3)
(12)
74
66
23
$
$
$
77
1
10
(5)
(1)
(8)
74
67
25
$
$
$
$
100
(13)
10
(8)
(1)
(11)
77
70
29
(2) $
(1) $
(2)
Based upon the outcome of tax examinations, judicial proceedings, or expiration of statute of limitations,
it is reasonably possible that the ultimate resolution of these unrecognized tax benefits may result in a payment
that is materially different from the current estimate of the tax liabilities. The Company believes that it is
reasonably possible that the estimated liability could decrease up to $11 million within the next 12 months. This
is primarily the result of audit settlements or statute expirations in several taxing jurisdictions.
The Company is currently under examination in various tax jurisdictions in which it operates, including
Argentina, Bolivia, Brazil, China, Canada, Colombia, Ecuador, France, Germany, Indonesia, and Italy. The
years under examination range from 2006 through 2014. The Company has received tax assessments in excess
of established reserves. The Company believes that adequate provisions for all income tax uncertainties have
been made. However, if tax assessments are settled against the Company at amounts in excess of established
reserves, it could have a material impact to the Company’s results of operations, financial position or cash
flows. During 2016, the Company concluded income tax audits in several jurisdictions, including the Czech
Republic, Germany, Italy, and Hungary.
183
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:21)(cid:21)Q(cid:5);:(cid:6)(cid:8)(cid:4)(cid:15)(cid:12)(cid:13)(cid:5)(cid:17)(cid:8)(cid:19)(cid:6)
The following table summarizes the external long-term debt of the Company at December 31, 2016
and 2015:
Secured Credit Agreement:
Revolving Credit Facility:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
Revolving Loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
— $
—
Term Loans:
Term Loan A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Term Loan A (€279 million at December 31, 2016) . . . . . . . . . . . . . . . . . . .
Term Loan B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Senior Notes:
6.75%, due 2020 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.875%, due 2021 (€330 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.00%, due 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.875%, due 2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.125%, due 2024 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capital leases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less amounts due within one year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
1,395
282
523
345
495
682
520
297
294
55
20
4,908
32
4,876
1,546
301
563
542
357
494
680
296
293
52
30
5,154
67
5,087
$
On April 22, 2015, the Company entered into a Senior Secured Credit Facility, which subsequently has
been amended several times with the most recent amendment being entered into on February 3, 2016 (the
“Amended Agreement”). In connection with the closing of the Vitro Acquisition on September 1, 2015 (see
Note 17), the Company incurred $1,250 million of senior secured incremental term loan facilities, comprised of
(i) a $675 million term loan A facility on substantially the same terms and conditions (including as to maturity)
as the term loan A facility in the Amended Agreement and (ii) a $575 million term loan B facility, which was
subsequently repaid in full in November 2016 as described below.
At December 31, 2016, the Amended Agreement includes a $300 million revolving credit facility, a $600
million multicurrency revolving credit facility, a $1,575 million term loan A facility ($1,395 million net of debt
issuance costs), and a €279 million term loan A facility ($282 million net of debt issuance costs), each of which
has a final maturity date of April 22, 2020. At December 31, 2016, the Company had unused credit of $884
million available under the Amended Agreement. The weighted average interest rate on borrowings outstanding
under the Amended Agreement at December 31, 2016 was 2.39%.
The Amended Agreement contains various covenants that restrict, among other things and subject to certain
exceptions, the ability of the Company to incur certain liens, make certain investments, become liable under
contingent obligations in certain defined instances only, make restricted payments, make certain asset sales
within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing
arrangements, alter its fundamental business, and amend certain subordinated debt obligations.
184
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The Amended Agreement also contains one financial covenant, a Total Leverage Ratio, that requires the
Company not to exceed a ratio calculated by dividing consolidated total debt, less cash and cash equivalents,
by consolidated EBITDA, as defined in the Amended Agreement. The Total Leverage Ratio could restrict the
ability of the Company to undertake additional financing or acquisitions to the extent that such financing or
acquisitions would cause the Total Leverage Ratio to exceed the specified maximum of (i) 4.5x for the four
fiscal quarters ending December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, and (ii)
4.0x for the fourth fiscal quarter ending December 31, 2017 and each fiscal quarter thereafter.
Failure to comply with these covenants and restrictions could result in an event of default under the
Amended Agreement. In such an event, the Company would be unable to request borrowings under the
revolving facility, and all amounts outstanding under the Amended Agreement, together with accrued interest,
could then be declared immediately due and payable. If an event of default occurs under the Amended
Agreement and the lenders cause all of the outstanding debt obligations under the Amended Agreement to
become due and payable, this would result in a default under a number of other outstanding debt securities
and could lead to an acceleration of obligations related to these debt securities. As of December 31, 2016, the
Company was in compliance with all covenants and restrictions in the Amended Agreement. In addition, the
Company believes that it will remain in compliance and that its ability to borrow funds under the Amended
Agreement will not be adversely affected by the covenants and restrictions.
The interest rates on borrowings under the Amended Agreement are, at the Company’s option, the Base
Rate or the Eurocurrency Rate, as defined in the Amended Agreement, plus an applicable margin. The
applicable margin for the term loan A facility and the revolving credit facility is linked to the Company’s Total
Leverage Ratio and ranges from 1.25% to 1.75% for Eurocurrency Rate loans and from 0.25% to 0.75% for
Base Rate loans. In addition, a facility fee is payable on the revolving credit facility commitments ranging from
0.20% to 0.30% per annum linked to the Total Leverage Ratio.
Borrowings under the Amended Agreement are secured by substantially all of the assets, excluding real
estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign
subsidiaries. Borrowings are also secured by a pledge of intercompany debt and equity investments in certain
of the Company’s domestic subsidiaries and, in the case of foreign borrowings, of stock of certain foreign
subsidiaries. All borrowings under the Amended Agreement are guaranteed by certain domestic subsidiaries of
the Company.
Also, in connection with the Vitro Acquisition, during August 2015, the Company issued senior notes
with a face value of $700 million that bear interest at 5.875% and are due August 15, 2023 (the “Senior Notes
due 2023”) and senior notes with a face value of $300 million that bear interest at 6.375% and are due August
15, 2025 (together with the Senior Notes due 2023, the “2015 Senior Notes”). The 2015 Senior Notes were
issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The
net proceeds from the 2015 Senior Notes, after deducting the debt discount and debt issuance costs, totaled
approximately $972 million and were used to finance, in part, the Vitro Acquisition.
During November 2016, the Company issued senior notes with a face value of €500 million that bear
interest at 3.125% and are due November 15, 2024. The notes were issued via a private placement and are
guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds, after deducting the debt
discount and debt issuance costs, totaled approximately $520 million and were used to repay the term loan B
facility under the Amended Agreement.
185
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into
additional credit facilities and seek to issue equity and/or debt securities in the domestic and international
capital markets if market conditions are favorable. Also, depending on market conditions, the Company may
elect to repurchase portions of its debt securities in the open market.
The Company has a €185 million European accounts receivable securitization program, which extends
through March 2019, subject to periodic renewal of backup credit lines.
Information related to the Company’s accounts receivable securitization program as of December 31, 2016
and 2015 is as follows:
Balance (included in short-term loans) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
152
$
0.74%
158
1.21%
(cid:23)(cid:24)(cid:21)(cid:25)
2015
The carrying amounts reported for the accounts receivable securitization program, and certain long-term
debt obligations subject to frequently redetermined interest rates, approximate fair value. Fair values for the
Company’s significant fixed rate debt obligations are based on published market quotations, and are classified
as Level 1 in the fair value hierarchy.
Annual maturities for all of the Company’s long-term debt through 2021 are as follows: 2017, $33 million;
2018, $287 million; 2019, $101 million; 2020, $2,074 million; and 2021, $354 million.
Fair values at December 31, 2016, of the Company’s significant fixed rate debt obligations are as follows:
*(cid:4)(cid:27)(cid:15)(cid:11)(cid:27)?(cid:12)(cid:13)
=(cid:18)(cid:3)(cid:29)(cid:15)(cid:6)
@(cid:15)(cid:16)(cid:27)(cid:11)(cid:12)(cid:6)(cid:8)(cid:16)
&(cid:12)(cid:4)](cid:8)(cid:6)(cid:5)*(cid:4)(cid:27)(cid:11)(cid:8)
(cid:2)(cid:12)(cid:27)(cid:4)(cid:5)l(cid:12)(cid:13)(cid:29)(cid:8)
Senior Notes:
6.75%, due 2020 (€500 million) . . . . . . . . . . . . . . . . . . . . . . . .
4.875%, due 2021 (€330 million) . . . . . . . . . . . . . . . . . . . . . . .
5.00%, due 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.875%, due 2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.125%, due 2024 (€500 million) . . . . . . . . . . . . . . . . . . . . . . .
5.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6.375%, due 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
526
347
500
700
526
300
300
$
120.63
114.00
103.49
105.37
100.01
101.17
106.28
635
396
517
738
526
304
319
(cid:21)(cid:23)Q(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)+(cid:8)(cid:15)(cid:11)(cid:27)(cid:8)(cid:10)
Certain litigation is pending against the Company, in many cases involving ordinary and routine claims
incidental to the business of the Company and in others presenting allegations that are nonroutine and involve
compensatory, punitive or treble damage claims as well as other types of relief. The Company records a
liability for such matters when it is both probable that the liability has been incurred and the amount of the
liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the
factors upon which the estimates are based including additional information, negotiations, settlements, and
other events. The ultimate legal and financial liability of the Company in respect to this pending litigation
cannot reasonably be estimated. However, the Company believes, based on its examination and review of such
matters and experience to date, that such ultimate liability will not have a material adverse effect on its results
of operations or financial condition.
186
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The Company’s joint venture in China had been involved in litigation with its partner regarding whether
the joint venture should be dissolved. Following an ownership change in 2016 with respect to the joint venture
partner, this litigation has been withdrawn.
Other litigation is pending against the Company, in many cases involving ordinary and routine claims
incidental to the business of the Company and in others presenting allegations that are non-routine and involve
compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability
for such matters when it is both probable that the liability has been incurred and the amount of the liability can be
reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which
the estimates are based, including additional information, negotiations, settlements and other events.
(cid:21)(cid:20)Q(cid:5)=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5)(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)(cid:5)/_(cid:3)(cid:10)(cid:10)6
The components of comprehensive income are: (a) net earnings; (b) change in fair value of certain
derivative instruments; (c) pension and other postretirement benefit adjustments; and (d) foreign currency
translation adjustments. The net effect of exchange rate fluctuations generally reflects changes in the relative
strength of the U.S. dollar against major foreign currencies between the beginning and end of the year.
The following table lists the beginning balance, annual activity and ending balance of each component of
accumulated other comprehensive income (loss):
8(cid:8)(cid:6)(cid:5);(cid:28)(cid:28)(cid:8)(cid:11)(cid:6)(cid:5)(cid:3)(cid:28)
;:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)<(cid:12)(cid:6)(cid:8)
(cid:2)(cid:13)(cid:29)(cid:11)(cid:6)(cid:29)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
$
(55) $
(513)
Change in
Certain
(cid:17)(cid:8)(cid:4)(cid:27)[(cid:12)(cid:6)(cid:27)[(cid:8)
@(cid:15)(cid:10)(cid:6)(cid:4)(cid:29)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
2
(4)
;(cid:18)?(cid:13)(cid:3)(cid:14)(cid:8)(cid:8)
\(cid:8)(cid:15)(cid:8)(cid:9)(cid:6)(cid:5)*(cid:13)(cid:12)(cid:15)(cid:10)
$
(255)
27
7(cid:3)(cid:6)(cid:12)(cid:13)
=(cid:11)(cid:11)(cid:29)(cid:18)(cid:29)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)
Other
(cid:26)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)
Loss
$
Balance on January 1, 2015 . . . . . . . . . . . .
Change before reclassifications . . . . . . . . .
Amounts reclassified from accumulated
other comprehensive income . . . . . . . .
Translation effect . . . . . . . . . . . . . . . . . . . .
Tax effect . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss)
attributable to the Company . . . . . . . .
Balance on December 31, 2015 . . . . . . . . .
Change before reclassifications . . . . . . . . .
Amounts reclassified from accumulated
other comprehensive income . . . . . . .
Translation effect . . . . . . . . . . . . . . . . . . . .
Tax effect . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss)
attributable to the Company . . . . . . . .
Balance on December 31, 2016 . . . . . . . . .
(1)(a)
(1)
(6)
(4)
7
6 (a)
$
(513)
(568) $
(220)
(220)
(788)
$
13
9
15 (b)
(31)
2
13
(242)
(96)
$
18 (b)
25
15
(38)
(280)
(308)
(490)
14
(31)
1
(506)
(814)
(309)
24
25
15
(245)
(1,059)
(a) Amount is included in Cost of goods sold on the Consolidated Results of Operations (see Note 7 for
additional information).
’(cid:7)*(cid:6) +(cid:18)(cid:12)(cid:28)(cid:5)(cid:8)(cid:6)(cid:11)(cid:10)(cid:6)(cid:11)(cid:5)!(cid:13)(cid:28)(cid:2)(cid:3)(cid:2)(cid:6)(cid:11)(cid:5)(cid:6)(cid:8)(cid:31)(cid:3)(cid:6)!(cid:12)(cid:18)(cid:9)(cid:28)(cid:8)(cid:14)(cid:8)(cid:11)(cid:12)(cid:5)(cid:6)(cid:12)(cid:15)(cid:6)(cid:5)(cid:3)(cid:8)(cid:6)(cid:9)(cid:3)(cid:16)(cid:11)(cid:12)(cid:2)(cid:11)!(cid:6)(cid:9)(cid:3)(cid:5)(cid:10)(cid:11)(cid:12)(cid:5)(cid:6)!(cid:12)(cid:10)(cid:8)(cid:6)(cid:14)(cid:5)(cid:2)(cid:6)(cid:5)(cid:3)(cid:8)(cid:6)(cid:9)(cid:12)(cid:10)(cid:8)(cid:16)(cid:3)(cid:8)(cid:11)(cid:16)(cid:3)(cid:18)(cid:3)(cid:5)(cid:8)(cid:6)(cid:7)(cid:3)(cid:5)(cid:3)(cid:4)(cid:8)(cid:6)!(cid:12)(cid:10)(cid:8)(cid:6)’(cid:10)(cid:3)(cid:3)(cid:6)
Note 9 for additional information).
187
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:21)jQ(cid:5)%(cid:6)(cid:7)(cid:8)(cid:4)(cid:5);:?(cid:8)(cid:15)(cid:10)(cid:8)(cid:22)(cid:5)(cid:15)(cid:8)(cid:6)
Other expense, net for the years ended December 31, 2016, 2015 and 2014 included the following:
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Restructuring, asset impairment and other charges . . . . . . . . . . . . . . . . .
Intangible amortization expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment of equity investment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on China land compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Royalty income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Strategic transaction costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition-related fair value intangible adjustments . . . . . . . . . . . . . . .
Non-income tax charge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency exchange loss (gain) . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other expense (income) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
102
39
25
(71)
(13)
6
(10)
78
$
$
$
75
21
68
1
(12)
4
10
(10)
(11)
77
$
(12)
69
(2)
15
138
In 2016, the Company evaluated the future estimated earnings and cash flow of an equity investment
and determined that it was other-than-temporarily impaired. As such, the Company recorded an impairment
charge of $25 million to reduce its carrying value down to its estimated fair value. The Company classified
the significant assumptions used to determine the fair value of the impaired assets as Level 3 in the fair value
hierarchy as set forth in the general accounting principles for fair value measurements.
In 2014, the Company recorded a charge of $69 million resulting from a non-income tax assessment from a
foreign tax authority.
(cid:21)!Q(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:15)+(cid:5)_(cid:8)(cid:12)(cid:10)(cid:8)(cid:10)
Rent expense attributable to all warehouse, office buildings, and equipment operating leases was
$76 million in 2016, $68 million in 2015 and $53 million in 2014. Minimum future rentals under operating
leases are as follows: 2017, $61 million; 2018, $42 million; 2019, $28 million; 2020, $18 million; 2021,
$12 million; and 2022 and thereafter, $18 million.
(cid:21)(cid:25)Q(cid:5)>(cid:29)??(cid:13)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:12)(cid:13)(cid:5)(cid:26)(cid:12)(cid:10)(cid:7)(cid:5)(cid:2)(cid:13)(cid:3)#(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
Changes in the components of working capital related to operations (net of the effects related to
acquisitions and divestitures) were as follows:
Decrease (increase) in current assets:
Receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Increase (decrease) in current liabilities:
Accounts payable and accrued liabilities . . . . . . . . . . . . . . . . . . . . .
Salaries and wages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. and foreign income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
$
$
(25) $
13
148
(91)
20
23
88
$
(20) $
(13)
(8)
139
16
(13)
101
$
83
(27)
29
48
12
13
158
188
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The Company uses various factoring programs to sell certain receivables to financial institutions as part
of managing its cash flows. At December 31, 2016 and 2015, the amount of receivables sold by the Company
was $318 million and $317 million, respectively. Any continuing involvement with the sold receivables
is immaterial.
Interest paid in cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes paid in cash (all non-U.S) . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
241
99
$
207
101
179
101
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
Cash interest for the years ended December 31, 2016, 2015 and 2014 includes $9 million, $32 million and
$9 million of note repurchase premiums, respectively.
(cid:21)"Q(cid:5)(cid:5)\(cid:29)(cid:10)(cid:27)(cid:15)(cid:8)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:18)(cid:19)(cid:27)(cid:15)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
On September 1, 2015, the Company completed the Vitro Acquisition in a cash transaction valued at
approximately $2.297 billion in cash, subject to a working capital adjustment and certain other adjustments.
The Vitro Business in Mexico is the largest supplier of glass containers in that country manufacturing glass
containers across multiple end uses, including food, soft drinks, beer, wine and spirits. The Vitro Acquisition
included five food and beverage glass container plants in Mexico, a plant in Bolivia and a North American
distribution business, and provided the Company with a competitive position in the glass packaging market
in Mexico. The results of the Vitro Business have been included in the Company’s consolidated financial
statements since September 1, 2015 and contributed approximately $608 million of incremental net sales and
$122 million of incremental segment operating profit in the year ended December 31, 2016. Vitro’s food
and beverage glass container operations in Mexico and Bolivia are included in the Latin American operating
segment while its distribution business is included in the North American operating segment.
The Company financed the Vitro Acquisition with the proceeds from a senior notes offering, cash on hand
and the incremental term loan facilities (see Note 11).
The total purchase price was allocated to the tangible and identifiable intangible assets and liabilities based
upon their respective fair values. The purchase agreement contained customary provisions for working capital
adjustments, which the Company resolved with the seller in the first quarter of 2016. The Company completed
the purchase price allocation process in the third quarter of 2016. The following table summarizes the fair value
of the assets and liabilities assumed on September 1, 2015 and subsequent adjustments identified through the
purchase price allocation process and recorded through the measurement period:
>(cid:8)?(cid:6)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:21)(cid:22)(cid:5)
2015
Cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Customer list intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net assets acquired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
17
344
1,073
406
597
2,437
93
11
36
2,297
189
&(cid:8)(cid:12)(cid:10)(cid:29)(cid:4)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)
Period
=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
$
>(cid:8)?(cid:6)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:24)(cid:22)(cid:5)
(cid:23)(cid:24)(cid:21)(cid:25)
— $
(10)
(236)
202
48
4
(7)
11
— $
$
17
334
837
608
645
2,441
86
11
47
2,297
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
The fair value of the tangible assets was estimated utilizing income and market approaches, considering
remaining useful life. The customer list intangible asset includes the Company’s established relationships with
its customers and the ability of these customers to generate future economic profits for the Company. The value
assigned to customer list intangibles is based on the present value of future earnings attributable to the asset
group after recognition of required returns to other contributory assets.
Recognized goodwill is attributable to the assembled workforce, expected synergies and other intangible
assets that do not qualify for separate recognition. The Vitro Acquisition goodwill is not deductible for
tax purposes.
The balance sheet adjustments identified above did not result in any significant adjustments to the periods’
income statements.
(cid:21)$Q(cid:5)(cid:5)*(cid:4)(cid:3)(cid:5)(cid:2)(cid:3)(cid:4)(cid:18)(cid:12)(cid:5)@(cid:15)(cid:28)(cid:3)(cid:4)(cid:18)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:5)y(cid:5)l(cid:27)(cid:6)(cid:4)(cid:3)(cid:5)=(cid:11)m(cid:29)(cid:27)(cid:10)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)
Had the Vitro Acquisition, described in Note 17 and the related financing described in Note 11, occurred
at the beginning of each respective period, unaudited pro forma consolidated net sales and earnings from
continuing operations would have been as follows:
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations attributable
to the Company . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
(cid:21)(cid:31)Q(cid:5)(cid:17)(cid:27)(cid:10)(cid:11)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)(cid:5)%?(cid:8)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:5)‘(cid:8)(cid:12)(cid:4)(cid:5);(cid:15)(cid:16)(cid:27)(cid:15)+(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)!
As
<(cid:8)?(cid:3)(cid:4)(cid:6)(cid:8)(cid:16)
=(cid:11)m(cid:29)(cid:27)(cid:10)(cid:27)(cid:6)(cid:27)(cid:3)(cid:15)
=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:15)+
=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:18)(cid:8)(cid:15)(cid:6)(cid:10)
*(cid:4)(cid:3)(cid:5)(cid:2)(cid:3)(cid:4)(cid:18)(cid:12)
=(cid:10)(cid:5)=(cid:16)x(cid:29)(cid:10)(cid:6)(cid:8)(cid:16)
6,156
$
574
$
— $
6,730
270
$
79
$
(46) $
303
On April 4, 2016, the annulment committee formed by the World Bank’s International Centre for
Settlement of Investment Disputes (“ICSID”) ruled that a subsidiary of the Company is free to pursue the
enforcement of a prior arbitration award against Venezuela. That award amounts to more than $485 million
after including interest from the date of the expropriation by Venezuela (October 26, 2010). Venezuela’s
application to annul the award is still pending, although the annulment proceedings were suspended in October
2016 because Venezuela has not paid its fees owed to ICSID. If the proceeding is stayed for non-payment
for a consecutive period in excess of six months, ICSID’s Secretary General could move that the committee
discontinue the annulment proceeding altogether. The Company intends to take appropriate steps to vigorously
enforce and collect the award, which is enforceable in approximately 150 member states that are party to the
ICSID Convention. However, even with the lifting of the stay of enforcement, the Company recognizes that the
collection of the award may present significant practical challenges. Because the award has yet to be satisfied
and the annulment proceeding is pending, the Company is unable at this stage to reasonably predict the efforts
that will be necessary to successfully enforce collection of the award, the amount of the award or the timing of
any such collection efforts. Therefore, the Company has not recognized this award in its financial statements.
The loss from discontinued operations of $7 million, $4 million and $4 million, for the years ended
December 31, 2016, 2015 and 2014, respectively, relates to ongoing costs for the Venezuelan expropriation.
190
%#(cid:8)(cid:15)(cid:10)(cid:30)\(cid:4)(cid:3)(cid:11)]#(cid:12)(cid:14)(cid:5)Z(cid:13)(cid:12)(cid:10)(cid:10)(cid:5)(cid:26)(cid:3)(cid:15)(cid:6)(cid:12)(cid:27)(cid:15)(cid:8)(cid:4)(cid:22)(cid:5)@(cid:15)(cid:11)Q
8%7;>(cid:5)7%(cid:5)(cid:26)%8>%_@(cid:17)=7;(cid:17)(cid:5)(cid:2)@8=8(cid:26)@=_(cid:5)>7=7;&;87>(cid:5)/(cid:26)(cid:3)(cid:15)(cid:6)(cid:27)(cid:15)(cid:29)(cid:8)(cid:16)6
7(cid:12)(cid:19)(cid:29)(cid:13)(cid:12)(cid:4)(cid:5)(cid:16)(cid:12)(cid:6)(cid:12)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:5)(cid:27)(cid:15)(cid:5)(cid:18)(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)
(cid:23)(cid:24)Q(cid:5)Z(cid:29)(cid:12)(cid:4)(cid:12)(cid:15)(cid:6)(cid:8)(cid:8)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)(cid:17)(cid:8)(cid:19)(cid:6)
OI Group and the Company guarantee OI Inc.’s senior debentures on a subordinated basis. The fair value of
the OI Inc. debt being guaranteed was $266 at December 31, 2016.
(cid:23)(cid:21)Q(cid:5)<(cid:8)(cid:13)(cid:12)(cid:6)(cid:8)(cid:16)(cid:5)*(cid:12)(cid:4)(cid:6)(cid:14)(cid:5)7(cid:4)(cid:12)(cid:15)(cid:10)(cid:12)(cid:11)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
Charges for administrative services are allocated to the Company by OI Inc. based on an annual utilization
level. Such services include compensation and benefits administration, payroll processing, use of certain general
accounting systems, auditing, income tax planning and compliance, and treasury services.
Allocated costs also include charges associated with OI Inc.’s equity compensation plans. A substantial
number of the options, restricted share units and performance vested restricted share units granted under these
plans have been granted to key employees of another subsidiary of OI Inc., some of whose compensation costs,
including stock-based compensation, are included in an allocation of costs to all operating subsidiaries of
OI Inc., including the Company.
Management believes that such transactions are on terms no less favorable to the Company than those that
could be obtained from unaffiliated third parties.
The following information summarizes the Company’s significant related party transactions:
Revenues:
Sales to affiliated companies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expenses:
Administrative services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate management fee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Year ended
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
2015
2014
(cid:23)(cid:24)(cid:21)(cid:25)
$
$
$
— $
— $
2
75
77
$
$
2
74
76
$
$
—
2
75
77
The above expenses are recorded in the results of operations as follows:
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative expenses . . . . . . . . . . . . . . . . .
Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
— $
77
77
$
— $
76
76
$
Year ended
(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)
2015
(cid:23)(cid:24)(cid:21)(cid:25)
2014
—
77
77
191
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SIGNATURES
OWENS-ILLINOIS, INC.
(Registrant)
By:
/s/ MARY BETH WILKINSON
Mary Beth Wilkinson
Attorney-in-fact
Date: February 10, 2017
192
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by
the following persons on behalf of Owens-Illinois, Inc. and in the capacities and on the dates indicated.
>(cid:27)+(cid:15)(cid:12)(cid:6)(cid:29)(cid:4)(cid:8)(cid:10)
>(cid:27)+(cid:15)(cid:12)(cid:6)(cid:29)(cid:4)(cid:8)(cid:10)
Andres A. Lopez
Jan A. Bertsch
7(cid:27)(cid:6)(cid:13)(cid:8)
President and Chief Executive Officer (Principal
Executive Officer)
Senior Vice President and Chief Financial Officer
(Principal Financial Officer; Principal Accounting
Officer)
Carol A. Williams
Chairman of the Board
Gary F. Colter
Joseph D. DeAngelo
Gordon J. Hardie
Peter S. Hellman
Anastasia D. Kelly
John J. McMackin, Jr.
Alan J. Murray
Hari N. Nair
Hugh H. Roberts
Dennis K. Williams
Date: February 10, 2017
Director
Director
Director
Director
Director
Director
Director
Director
Director
Director
By:
193
/s/ MARY BETH WILKINSON
Mary Beth Wilkinson
Attorney-in-fact
INDEX TO FINANCIAL STATEMENT SCHEDULE
(cid:2)(cid:27)(cid:15)(cid:12)(cid:15)(cid:11)(cid:27)(cid:12)(cid:13)(cid:5)>(cid:6)(cid:12)(cid:6)(cid:8)(cid:18)(cid:8)(cid:15)(cid:6)(cid:5)>(cid:11)(cid:7)(cid:8)(cid:16)(cid:29)(cid:13)(cid:8)(cid:5)(cid:3)(cid:28)(cid:5)%#(cid:8)(cid:15)(cid:10)(cid:30)@(cid:13)(cid:13)(cid:27)(cid:15)(cid:3)(cid:27)(cid:10)(cid:22)(cid:5)@(cid:15)(cid:11)Q(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)>(cid:29)(cid:19)(cid:10)(cid:27)(cid:16)(cid:27)(cid:12)(cid:4)(cid:27)(cid:8)(cid:10)u
For the years ended December 31, 2016, 2015, and 2014:
II—Valuation and Qualifying Accounts (Consolidated) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PAGE
S-1
>(cid:26)v;(cid:17)c_;(cid:5)@@(cid:5)y(cid:5)l=_c=7@%8(cid:5)=8(cid:17)(cid:5)pc=_@(cid:2)‘@8Z(cid:5)=(cid:26)(cid:26)%c87>(cid:5)/(cid:26)%8>%_@(cid:17)=7;(cid:17)6
OWENS-ILLINOIS, INC.
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)(cid:25)(cid:22)(cid:5)(cid:23)(cid:24)(cid:21)!(cid:22)(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:23)(cid:24)(cid:21)j
/&(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)(cid:17)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)6
Reserves deducted from assets in the balance sheets:
Allowances for losses and discounts on receivables
Additions
\(cid:12)(cid:13)(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)(cid:12)(cid:6)
(cid:19)(cid:8)+(cid:27)(cid:15)(cid:15)(cid:27)(cid:15)+
(cid:3)(cid:28)(cid:5)?(cid:8)(cid:4)(cid:27)(cid:3)(cid:16)
Charged to
(cid:11)(cid:3)(cid:10)(cid:6)(cid:10)(cid:5)(cid:12)(cid:15)(cid:16)
(cid:8):?(cid:8)(cid:15)(cid:10)(cid:8)(cid:10)
Other
(cid:17)(cid:8)(cid:16)(cid:29)(cid:11)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
(Note 1)
\(cid:12)(cid:13)(cid:12)(cid:15)(cid:11)(cid:8)
(cid:12)(cid:6)(cid:5)(cid:8)(cid:15)(cid:16)(cid:5)(cid:3)(cid:28)
?(cid:8)(cid:4)(cid:27)(cid:3)(cid:16)
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
29
34
39
$
$
$
15
12
15
$
$
$
(2) $
(10) $
(5) $
(12) $
(12) $
(8) $
32
29
34
(1) Deductions from allowances for losses and discounts on receivables represent uncollectible notes and
accounts written off.
Valuation allowance on net deferred tax assets
\(cid:12)(cid:13)(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)(cid:12)(cid:6)
(cid:19)(cid:8)+(cid:27)(cid:15)(cid:15)(cid:27)(cid:15)+(cid:5)(cid:3)(cid:28)
?(cid:8)(cid:4)(cid:27)(cid:3)(cid:16)
Charged to
(cid:27)(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)
Charged to other
(cid:11)(cid:3)(cid:18)?(cid:4)(cid:8)(cid:7)(cid:8)(cid:15)(cid:10)(cid:27)[(cid:8)
(cid:27)(cid:15)(cid:11)(cid:3)(cid:18)(cid:8)
(cid:2)(cid:3)(cid:4)(cid:8)(cid:27)+(cid:15)(cid:5)(cid:11)(cid:29)(cid:4)(cid:4)(cid:8)(cid:15)(cid:11)(cid:14)
(cid:6)(cid:4)(cid:12)(cid:15)(cid:10)(cid:13)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
Other
\(cid:12)(cid:13)(cid:12)(cid:15)(cid:11)(cid:8)(cid:5)(cid:12)(cid:6)
(cid:8)(cid:15)(cid:16)(cid:5)(cid:3)(cid:28)
?(cid:8)(cid:4)(cid:27)(cid:3)(cid:16)
2016 . . . . . . . . . . . .
2015 . . . . . . . . . . . .
2014 . . . . . . . . . . . .
$
$
$
1,135
1,223
1,209
$
$
$
3
1
$
$
(2) $
(32) $
(3) $
(9) $
1,094
5
55
$
$
(20) $
(74) $
1,135
(15) $
(24) $
1,223
S-1
EXHIBIT 12
OWENS-ILLINOIS, INC.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
/&(cid:27)(cid:13)(cid:13)(cid:27)(cid:3)(cid:15)(cid:10)(cid:5)(cid:3)(cid:28)(cid:5)(cid:16)(cid:3)(cid:13)(cid:13)(cid:12)(cid:4)(cid:10)(cid:22)(cid:5)(cid:8):(cid:11)(cid:8)?(cid:6)(cid:5)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:10)6
Earnings from continuing operations before income taxes . . $
Less: Equity earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Add: Total fixed charges deducted from earnings . . . . . . .
Dividends received from equity investees . . . . . . . . .
Earnings available for payment of fixed charges . .
$
Fixed charges (including the Company’s proportional
share of 50% owned associates):
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Portion of operating lease rental deemed to
be interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total fixed charges deducted from earnings . . . . . . . .
Ratio of earnings to fixed charges . . . . . . . . . . . . . . . . . . .
$
$
‘(cid:8)(cid:12)(cid:4)(cid:10)(cid:5)(cid:8)(cid:15)(cid:16)(cid:8)(cid:16)(cid:5)(cid:17)(cid:8)(cid:11)(cid:8)(cid:18)(cid:19)(cid:8)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)
(cid:23)(cid:24)(cid:21)(cid:25)
2015
2014
2013
356 $
(60)
284
38
618
$
268 $
(60)
264
53
525
$
307 $
(64)
238
54
535
$
468
(67)
242
67
710
279
$
259
$
235
$
239
5
284
2.2
$
5
264
2.0
$
3
238
2.2
$
3
242
2.9
SUBSIDIARIES OF OWENS-ILLINOIS, INC.
Owens-Illinois, Inc. had the following subsidiaries at December 31, 2016 (subsidiaries are indented
following their respective parent companies):
EXHIBIT 21
8(cid:12)(cid:18)(cid:8)
Owens-Illinois Group, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI General Finance Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI General FTS Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Castalia STS Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Levis Park STS Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens-Illinois General Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens Insurance, Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Universal Materials, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Advisors, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Securities, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Transfer, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Maumee Air Associates Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Australia Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Continental PET Holdings Pty. Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ACI America Holdings Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ACI Ventures, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens-Brockway Packaging, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens-Brockway Glass Container Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Americas Holding LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Packaging Solutions LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Bolivia Holdings Limited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vidrio Lux S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Andover Group, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The Andover Group Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Brockway Realty Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
NHW Auburn, LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Auburn Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SeaGate, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SeaGate II, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SeaGate III, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OIB Produvisa Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI California Containers Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Puerto Rico STS Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Caribbean Sales & Distibution Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Latam HQ, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bolivian Investments, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fabrica Boliviana de Vidrios S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI International Holdings Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Glass C.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Holding LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Global Holdings LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Global Holdings C.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Americas LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
>(cid:6)(cid:12)(cid:6)(cid:8)J(cid:26)(cid:3)(cid:29)(cid:15)(cid:6)(cid:4)(cid:14)
(cid:3)(cid:28)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:4)?(cid:3)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
or Organization
Delaware
Delaware
Delaware
Delaware
Delaware
Delaware
Bermuda
Ohio
Delaware
Delaware
Delaware
Delaware
Delaware
Australia
Delaware
Delaware
Delaware
Delaware
Delaware
Delaware
United Kingdom
Bolivia
Delaware
Delaware
Pennsylvania
Delaware
Delaware
Ohio
Ohio
Ohio
Delaware
Delaware
Delaware
Delaware
Delaware
Delaware
Bolivia
Delaware
Netherlands
Delaware
Delaware
Netherlands
Delaware
8(cid:12)(cid:18)(cid:8)
O-I Americas C.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Mexico Holdings I B.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Mexico Holdings II B.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Envases de Vidrio de las Americas, S. de R.L. de C.V. . . . . . .
Especialidades Operativas de America, S. de R.L. de C.V. . . .
Glass International OISPV, S.A.P.I. de C.V. . . . . . . . . . . . . . . . . . . .
Owens America, S. de R.L. de C.V. . . . . . . . . . . . . . . . . . . . . .
Owens Vimosa, S. de R.L. de C.V. . . . . . . . . . . . . . . . . . .
Owens Vigusa, S. de R.L. de C.V. . . . . . . . . . . . . . . . . . .
Owens Virreyes, S. de R.L. de C.V. . . . . . . . . . . . . . . . . .
Owens Viquesa, S. de R.L. de C.V. . . . . . . . . . . . . . . . . . .
Owens Vitolsa, S. de R.L. de C.V. . . . . . . . . . . . . . . . . . .
OI Global C.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Hungary LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Manufacturing Hungary Limited . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Sales & Distribution Hungary Kft. . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Ecuador LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cristaleria del Ecuador, S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI European Group B.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens-Illinois Singapore Pte. Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI China LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Wuhan Owens Glass Container Company Limited . . . . . . . . .
ACI Beijing Limited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI (Tianjin) Glass Co. Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens-Illinois Services H.K. Limited . . . . . . . . . . . . . . . . . . . . . . .
ACI Guangdong Limited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ACI Guangdong Glass Company Limited . . . . . . . . . . . . . . . .
ACI Shanghai Limited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ACI (Shanghai) Glass Company Limited . . . . . . . . . . . . . . . . .
Owens-Illinois (HK) Limited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I (Shanghai) Management Co Ltd. . . . . . . . . . . . . . . . . . . . .
O-I Zhaoqing Glass Co. Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Sihui Glass Recycling Co. Ltd. . . . . . . . . . . . . . . . . . . . . .
Owens-Illinois (Australia) Pty Ltd . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ACI Packaging Services Pty Ltd . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ACI Operations Pty. Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ACI International Pty Ltd . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ACI Glass Packaging Penrith Pty Ltd . . . . . . . . . . . . . . . .
PT Kangar Consolidated Industries . . . . . . . . . . . . . . . . .
ACI Operations NZ Limited . . . . . . . . . . . . . . . . . . . . . . .
O-I Asia-Pacific Holdings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution Netherlands B.V. . . . . . . . . . . . . . . . . . . . . . .
O-I Europe Sarl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution UK Limited. . . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution Poland Sp Z.o.o. . . . . . . . . . . . . . . . . . . .
O-I Business Service Center Sp. Z.o.o. . . . . . . . . . . . . . . . . . . . . . .
O-I Manufacturing Poland S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
UGG Holdings Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
>(cid:6)(cid:12)(cid:6)(cid:8)J(cid:26)(cid:3)(cid:29)(cid:15)(cid:6)(cid:4)(cid:14)
(cid:3)(cid:28)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:4)?(cid:3)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
or Organization
Netherlands
Netherlands
Netherlands
Mexico
Mexico
Mexico
Mexico
Mexico
Mexico
Mexico
Mexico
Mexico
Netherlands
Delaware
Hungary
Hungary
Ohio
Ecuador
Netherlands
Singapore
Delaware
China
Hong Kong
China
Hong Kong
Hong Kong
China
Hong Kong
China
Hong Kong
China
China
China
Australia
Australia
Australia
Australia
Australia
Indonesia
New Zealand
Mauritius
Netherlands
Switzerland
United Kingdom
Poland
Poland
Poland
United Kingdom
8(cid:12)(cid:18)(cid:8)
O-I Overseas Management Company Ltd. . . . . . . . . . . . . . . . . . . . .
United Glass Group Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Manufacturing (UK) Limited . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution Spain SL . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vidrieria Rovira, S. L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Spanish Holdings B.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens-Illinois Peru S. A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Manufacturing Italy S.p.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Manufacturing Czech Republic A.S. . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution Czech Republic s.r.o. . . . . . . . . . . .
San Domenico Vetraria S.r.l. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution Italy S.r.l . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Manufacturing Netherlands B.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Veglarec B.V.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Europe SAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Manufacturing France SAS . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution France SAS . . . . . . . . . . . . . . . . . .
O-I Distribution SO. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Champagne Emballage . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Glasspack Beteiligungs & Verwaltungsgesellschaft GmbH. . . . . . . .
OI Glasspack GmbH & Co. KG . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution Germany GmbH . . . . . . . . . . . . . . .
OI Canada Holdings B.V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Canada Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Manufacturera de Vidrios Planos, C.A. . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens-Illinois de Venezuela, C. A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fabrica de Vidrio Los Andes, C. A. . . . . . . . . . . . . . . . . . . . . . . . . .
CMC S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Latam Services S.A.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cristaleria Peldar, S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cristar S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Industria de Materias Primas S.A. . . . . . . . . . . . . . . . . . . . . . . . . . .
Vidrieria Fenicia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens-Illinois do Brasil Industria e Comercio S.A. . . . . . . . . . . . . . . . .
Mineracao Silminas Ltda. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mineracao Descalvado Ltda. . . . . . . . . . . . . . . . . . . . . . . . . . .
OI Finnish Holdings Oy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution Finland OY . . . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution LT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Production Estonia AS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Sales and Distribution Estonia OU . . . . . . . . . . . . . . . . . . . . . . .
O-I GMEC Lurin srl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
O-I Jaroslaw Machine Service Center . . . . . . . . . . . . . . . . . . . . . . . . . . .
Owens-Illinois Argentina S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
>(cid:6)(cid:12)(cid:6)(cid:8)J(cid:26)(cid:3)(cid:29)(cid:15)(cid:6)(cid:4)(cid:14)
(cid:3)(cid:28)(cid:5)@(cid:15)(cid:11)(cid:3)(cid:4)?(cid:3)(cid:4)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)
or Organization
Delaware
United Kingdom
United Kingdom
Spain
Spain
Netherlands
Peru
Italy
Czech Republic
Czech Republic
Italy
Italy
Netherlands
Netherlands
France
France
France
France
France
Germany
Germany
Germany
Netherlands
Canada
Venezuela
Venezuela
Venezuela
Colombia
Colombia
Colombia
Colombia
Colombia
Colombia
Brazil
Brazil
Brazil
Finland
Finland
Lithuania
Estonia
Estonia
Peru
Poland
Argentina
DIRECTORS AND OFFICERS
(cid:17)(cid:27)(cid:4)(cid:8)(cid:11)(cid:6)(cid:3)(cid:4)(cid:10)
%(cid:28)(cid:28)(cid:27)(cid:11)(cid:8)(cid:4)(cid:10)
=(cid:15)(cid:16)(cid:4)(cid:8)(cid:10)(cid:5)=Q(cid:5)_(cid:3)?(cid:8)w
President and Chief Executive Officer
&(cid:27)+(cid:29)(cid:8)(cid:13)(cid:5)I. =(cid:13)[(cid:12)(cid:4)(cid:8)w
President, O-I Latin America
{(cid:12)(cid:18)(cid:8)(cid:10)(cid:5)’Q(cid:5)\(cid:12)(cid:8)(cid:7)(cid:4)(cid:8)(cid:15)
Senior Vice President of Corporate Development and
Special Advisor to the Chief Executive Officer
{(cid:12)(cid:15)(cid:5)=Q(cid:5)\(cid:8)(cid:4)(cid:6)(cid:10)(cid:11)(cid:7)
Senior Vice President and Chief Financial Officer
7(cid:27)(cid:18)(cid:5)M. Connors
President, O-I Asia Pacific
>(cid:8)(cid:4)+(cid:27)(cid:3)(cid:5)\Q(cid:5)%Q(cid:5)Z(cid:12)(cid:13)(cid:27)(cid:15)(cid:16)(cid:3)
President, O-I North America
{(cid:3)(cid:7)(cid:15)(cid:5)=Q(cid:5)v(cid:12)(cid:29)(cid:16)(cid:4)(cid:27)(cid:11)(cid:7)
Senior Vice President and Chief Strategy and
Integration Officer
*(cid:12)(cid:29)(cid:13)(cid:5)=Q(cid:5){(cid:12)(cid:4)(cid:4)(cid:8)(cid:13)(cid:13)
Senior Vice President and Chief
Administrative Officer
l(cid:27)(cid:6)(cid:12)(cid:13)(cid:27)(cid:12)(cid:15)(cid:3)(cid:5)7(cid:3)(cid:4)(cid:15)(cid:3)
President, O-I Europe
&(cid:12)(cid:4)(cid:14)\(cid:8)(cid:6)(cid:7)(cid:5)’(cid:27)(cid:13)](cid:27)(cid:15)(cid:10)(cid:3)(cid:15)(cid:5)
Senior Vice President, General Counsel and
Corporate Secretary
(cid:26)(cid:12)(cid:4)(cid:3)(cid:13)(cid:5)=Q(cid:5)’(cid:27)(cid:13)(cid:13)(cid:27)(cid:12)(cid:18)(cid:10)
Chairman of the Board
Special Advisor to the Chief Executive
Officer(retired), Dow Chemical Company
Z(cid:12)(cid:4)(cid:14)(cid:5)(cid:2)Q(cid:5)(cid:26)(cid:3)(cid:13)(cid:6)(cid:8)(cid:4)
President, CRS Inc.
{(cid:3)(cid:10)(cid:8)?(cid:7)(cid:5)JQ(cid:5)(cid:17)(cid:8)=(cid:15)+(cid:8)(cid:13)(cid:3)
Chairman of the Board, President and Chief
Executive Officer, HD Supply Holdings Inc.
Gordon J. Hardie
Managing Director, Bunge Food & Ingredients
*(cid:8)(cid:6)(cid:8)(cid:4)(cid:5)>Q(cid:5)v(cid:8)(cid:13)(cid:13)(cid:18)(cid:12)(cid:15)
President and Chief Financial and Administrative
Officer (retired), Nordson Corporation
=(cid:15)(cid:12)(cid:10)(cid:6)(cid:12)(cid:10)(cid:27)(cid:12)(cid:5)(cid:17)Q(cid:5)q(cid:8)(cid:13)(cid:13)(cid:14)
Co-Managing Partner (Americas), DLA Piper
=(cid:15)(cid:16)(cid:4)(cid:8)(cid:10)(cid:5)=Q(cid:5)_(cid:3)?(cid:8)w
President and Chief Executive Officer, Owens Illinois
{(cid:3)(cid:7)(cid:15)(cid:5){Q(cid:5)&(cid:11)&(cid:12)(cid:11)](cid:27)(cid:15)(cid:22)(cid:5){(cid:4)Q
Principal, Williams & Jensen, PLLC
=(cid:13)(cid:12)(cid:15)(cid:5){Q(cid:5)&(cid:29)(cid:4)(cid:4)(cid:12)(cid:14)
Managing Board Member for North America
(retired), Heidelberg Cement AG
Hari N. Nair
Chief Executive Officer, Anitar Investments LLC
v(cid:29)+(cid:7)(cid:5)vQ(cid:5)<(cid:3)(cid:19)(cid:8)(cid:4)(cid:6)(cid:10)
President (retired), Kraft Foods International
Commercial
(cid:17)(cid:8)(cid:15)(cid:15)(cid:27)(cid:10)(cid:5)qQ(cid:5)’(cid:27)(cid:13)(cid:13)(cid:27)(cid:12)(cid:18)(cid:10)
Chairman of the Board (retired), IDEX Corporation
COMPANY INFORMATION
;:(cid:11)(cid:7)(cid:12)(cid:15)+(cid:8)(cid:5)_(cid:27)(cid:10)(cid:6)(cid:27)(cid:15)+
Owens-Illinois common stock (symbol OI) is listed
on the New York Stock Exchange.
=(cid:15)(cid:15)(cid:29)(cid:12)(cid:13)(cid:5)&(cid:8)(cid:8)(cid:6)(cid:27)(cid:15)+(cid:5)
The annual meeting of share owners will be held at
9:00 a.m. on Thursday, May 11, 2017, in Plaza 2 of the
O-I World Headquarters Campus, Perrysburg, OH.
(cid:2)(cid:3)(cid:4)(cid:18)(cid:10)(cid:5)(cid:21)(cid:24)(cid:30)q(cid:5)(cid:12)(cid:15)(cid:16)(cid:5)(cid:21)(cid:24)(cid:30)p
The Company’s Annual Report on Form 10-K
and Quarterly Reports on Form 10-Q, filed with
the Securities and Exchange Commission, may be
obtained without charge by contacting:
Owens-Illinois, Inc.
Investor Relations
One Michael Owens Way
Perrysburg, OH 43551
Phone: (567) 336-2400
These reports are also available without charge on the
Company’s website at www.o-i.com
’(cid:8)(cid:19)(cid:10)(cid:27)(cid:6)(cid:8)
For further information about O-I, visit the
Company’s website at www.o-i.com
=(cid:15)(cid:15)(cid:29)(cid:12)(cid:13)(cid:5)(cid:26)(cid:8)(cid:4)(cid:6)(cid:27)(cid:28)(cid:27)(cid:11)(cid:12)(cid:6)(cid:27)(cid:3)(cid:15)(cid:10)
The most recent certifications by the Chief Executive
Officer and the Chief Financial Officer pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002 are
filed as exhibits to the Company’s Form 10-K. The
Company has also filed with the New York Stock
Exchange the most recent Annual CEO Certification
as required by Section 303.12(a) of the New York
Stock Exchange Listed Company Manual.
(cid:26)(cid:3)(cid:4)?(cid:3)(cid:4)(cid:12)(cid:6)(cid:8)(cid:5)v(cid:8)(cid:12)(cid:16)m(cid:29)(cid:12)(cid:4)(cid:6)(cid:8)(cid:4)(cid:10)
Owens-Illinois, Inc.
One Michael Owens Way
Perrysburg, OH 43551
7(cid:4)(cid:12)(cid:15)(cid:10)(cid:28)(cid:8)(cid:4)(cid:5)=+(cid:8)(cid:15)(cid:6)(cid:5)(cid:28)(cid:3)(cid:4)(cid:5)(cid:26)(cid:3)(cid:18)(cid:18)(cid:3)(cid:15)(cid:5)>(cid:6)(cid:3)(cid:11)]
Computershare Trust Company, N.A.
P.O. Box 30170
College Station, TX 77842-3170
Private couriers and registered mail:
211 Quality Circle, Suite 210
College Station, TX 77845
Computershare website:
http://www.computershare.com/investor
Phone: (781) 575-2724 or 1-877-373-6374
Hearing-impaired: TDD 1-800-952-9245
Any inquiries regarding your account or certificates
should be referred to Computershare Trust
Company, N.A.
7(cid:4)(cid:29)(cid:10)(cid:6)(cid:8)(cid:8)(cid:10)
U.S. Bank, N.A.
Global Corporate Trust Services
60 Livingston Avenue
EP-MN-WS3C
St. Paul, MN 55107-1419
5.00 % Senior Notes, due 2022
5.375 % Senior Notes, due 2025
5.875% Senior Notes, due 2023
6.375% Senior Notes, due 2025
The Bank of New York
101 Barclay Street
New York, NY 10286
7.80% Senior Debentures, due 2018
Deutsche Trustee Company Limited
Winchester House
1 Great Winchester Street
London, England EC2N 2DB
6.75% Senior Notes, due 2020
4.875% Senior Notes, due 2021
3.125% Senior Notes, due 2024